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ABSTRACT
Boron neutron capture therapy (BNCT) is a binary targeted therapy that uses
suitably designed pharmaceuticals to deliver

10

B to tumor cells. The region is then

irradiated with neutrons and neutron capture by the 10B nucleus leads to the emission
of an alpha particle and lithium ion. These have very short ranges similar to the
dimensions of a biological cell and therefore the technique could have potential for
selective killing of tumour cells. In order to achieve adequate neutron fluxes at the
site of the tumour epithermal (0.5 eV – 10s of keV) neutron beams are used. A
review of the general details of BNCT is presented in this thesis.
This thesis investigates the use of two semiconductor devices for measuring
the neutron and gamma dose components involved in epithermal neutron beams used
for BNCT.
The silicon lattice in PIN diodes undergoes displacement damage when
irradiated with neutrons. This leads to a change in the forward bias voltage of the
diode that is proportional to the neutron dose received.
To verify that the energy dependence of this effect follows the published
silicon displacement damage KERMA (Kinetic Energy Released per Mass of
Absorber) data measurements were performed using quasi-monoenergetic neutrons
obtained from a Van de Graff accelerator (Ansto) in the energy range from 90 keV –
890 keV. These measurements were in agreement with the published data for silicon
displacement damage KERMA. A sensitivity factor for the diodes was also derived
from these measurements. The thermal neutron sensitivity of the PIN diodes was then
determined using the TC-10 thermal neutron column on the Moata reactor at Ansto.
The sensitivity results were in general agreement with the Van de Graff derived
xiv

sensitivity factor.
Since the silicon damage KERMA is not the same as the tissue KERMA
function PIN diodes are not intrinsically tissue equivalent. A Monte Carlo (MNCP)
ideal beam study was undertaken to see if for some limited energy range tissue dose
could be parameterised in terms of silicon damage dose and foil activation. This was
found to be approximately true for neutron energies from thermal to 100 keV.
Coefficients are given that allow tissue dose to be determined on the basis of a single
PIN diode and activation foil measurement in spectra where the maximum neutron
energy is 100 keV or less.
MOSFETS can be used as gamma radiation dosimeters by measuring the
change in threshold voltage (simplistically understood as the potential applied to the
gate to initiate current flow from source to drain electrodes) that occurs when they
are exposed to radiation. The MOSFETs used in this study were characterised using a
Varian 2100C medical linac beam and low energy x-rays from a superficial x-ray
unit. The sensitivity of the MOSFETs was measured with different potentials applied
to the gate during irradiation. Depth dose profiles in 6 MV x-ray beams were
measured and found to be in good agreement with both ionisation chamber
measurements and MCNP simulations. This good agreement was also obtained for
the buildup region.
Although the silicon oxide layer of the MOSFET is not intrinsically very
sensitive to neutron irradiation the presence of encapsulating materials leads to the
generation of secondary photons and electrons which lead to shifts in threshold
voltage and therefore confound gamma ray measurements in mixed neutron / gamma
fields. To determine the energy dependant neutron response function of the MOSFET

xv

a detailed MCNP simulation was used. A lithiated shield was also incorporated into
this model. The calculated neutron response functions were used to correct for
neutron contributions to MOSFET measurements in mixed fields.
MOSFET thermal neutron responses were measured using a series of
measurements with MOSFETS both with and without lithiated covers exposed in the
the Moata thermal neutron column at Ansto. The measurements were repeated with
various gate potentials. The gamma doses measured were consistent with gamma
doses measured using paired ionisation chambers.
The Petten HB11 facility is briefly described as are phantoms and MCNP
models fabricated by S Wallace for an associated work. Measurements using PIN
diodes and MOSFETs in phantoms exposed in the HB11 beam are described. Foil
activation data is compared to MCNP calculations to validate the MCNP models
used. This thesis presents a number of results that have been recalculated in more
detail and with various parameters changed. In particular the effect of variations in
phantom hydration have been incorporated as have response functions for MOSFET
detectors and associated shields.
PIN diode measurements in a Perspex cube phantom exposed in the HB11
beam show good agreement with MCNP calculated silicon displacement dose.
Similarly good agreement is obtained for a cylindrical phantom filled with tissue
equivalent gel when the hydrogen content of the gel in the original model is corrected
for dehydration. Measurements in a more complex skull phantom show larger
discrepancies between the experimental results and a MCNP simulation especially at
depth. The discrepancies range from 25 – 300% in absolute terms but are only 2-3%
of the maximum silicon dose.

xvi

MOSFET measurements performed in the Perspex cube phantom using
lithiated covers show excellent agreement with ionisation chamber measurements
(also with lithiated covers). Measurements in a cylinder phantom and head phantom
using lithium/perpex covered MOSFETs are compared with Monte Carlo
calculations of induced gamma dose. In this case the measured gamma doses at
approximately 2 cm depth appear to be too low. Further investigation involving a
detailed MCNP simulation including the lithiated MOSFET covers in the model
indicated that the covers suppress the thermal neutron flux at the measurement point
and therefore the gamma dose is also reduced. Measurements at greater depths show
a similar effect but to a lesser extent.
The epithermal neutron beam at the Brookhaven Medical Research Reactor
(BMRR) is described is described. PIN diode and MOSFET measurement results in a
Perspex cube phantom are also presented. Reasonable agreement between calculated
and measured PIN diode results is observed. MOSFET measurements show good
agreement with the known percentage depth dose curve for the total gamma dose.
However there is a discrepancy in the absolute magnitude of the measured gamma
doses. It is proposed that this is also due to thermal neutron flux depression arising
from the use of relatively thick lithiated neutron shields around the MOSFETS.
In summary; It is demonstrated that PIN diodes could be useful for verifying
treatment planning dose distributions in epithermal neutron beams. This includes the
possibility of on line real-time measurements. They could also be used in conjunction
with an activation foil to yield tissue equivalent dose measurements where the
maximum neutron energy is less than 100 keV.

Lithium shielded MOSFET

measurements can be reconciled with calculated gamma dose distributions when the

xvii

effect of flux depression is taken into account. However the perturbations introduced
by the shield mean that the measured dose does not represent the dose at the
measurement point in the absence of the shield. In order to use MOSFETs for gamma
dosimetry in epithermal neutron beams different encapsulation is required to
minimise neutron response and eliminate the need for lithiated covers. It is suggested
that MCNP simulations of MOSFETs similar to the models in this thesis would
provide an adequate tool for optimising the appropriate encapsulation.

xviii
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CHAPTER 1 INTRODUCTION

This thesis describes the development and application of a number of
techniques useful for the dosimetric characterisation of mixed gamma and neutron
fields such as are to be found in boron neutron capture therapy (BNCT). Because of
the very different biological effects of neutron and gamma (γ) radiation the accurate
quantification of each of the radiation components present in a epithermal neutron
beam is of paramount importance. This detailed knowledge is required both for the
purpose of better understanding radiobiological effects in basic radiobiology studies
and also for the purpose of predicting dose distributions within patients being
exposed to epithermal neutron beams for therapy (treatment planning and treatment
plan verification).
BNCT is a binary therapy for cancer which makes use of a boron (10B) laden
drug which accumulates preferentially in the tumour cells that are the object of the
treatment. The region of the target tumour cells is then irradiated with neutrons.
Neutrons with thermal energies have a relatively high probability of reacting with 10B
due to the large capture cross section of the boron. The

10

B cross section is up to 3

orders of magnitude greater than the capture cross sections of most nuclides naturally
occurring in any significant quantity in the body. The capture of a thermal neutron by
10

B leads to a reaction which results in the emission of an alpha particle (α) and a

lithium (7Li) ion. These are both high linear energy transfer (LET) particles with
short ranges (∼10 µm) and therefore highly effective in damaging the DNA of cells.
The short range of these particles ensures that tumour cells can be killed very

1

selectively if the boron is localised in the target cells or on the surface of the cells.
This means that the pattern of energy deposition on a microscopic scale is paramount
in understanding the biological effects of this mode of cancer therapy.
The neutron beams of choice for BNCT applications have neutron energies in
the epithermal range (∼1 eV - ∼ 30 keV) and are derived from nuclear reactors or
accelerator based neutron sources. In both cases these beams are moderated and
filtered to tailor the neutron spectrum to that desired, however, some fast neutrons,
thermal neutrons and γ radiation are inevitably present in the final beam.
The techniques used for measuring neutron and gamma doses in mixed fields
are many and varied. Amongst the most frequently used are ionisation chambers (IC),
proton recoil proportional counters, thermoluminescent dosimeters (TLD), activation
foils and track etch detectors. Each of these have many advantages and some
disadvantages depending on the part of the neutron energy spectrum to be measured,
the actual quantity to be measured (e.g. flux or dose), the spatial resolution required
or the speed with which results are required. For absolute neutron spectrum
determinations resonance activation foils and proton recoil proportional counters can
be considered as the gold standards. Resonance activation foils allow accurate
absolute flux measurements at neutron energies corresponding to the resonances in
the cross sections of the foil being used. The foils commonly used have resonances
that span the epithermal part of the spectrum in a discontinuous way. Proton recoil
spectroscopy by contrast provides continuous spectral information and has the good
energy resolution for the faster end of the neutron spectrum.
For determining doses rather than fluxes paired ionisation chambers offer
greater ease of operation, and in principle at least, the possibility of a more or less
2

direct readout of tissue equivalent (TE) dose. However in practice obtaining true
tissue equivalence and correct calibration is a non trivial exercise. TLDs offer high
spatial resolution but require significant deconvolution to extract mixed field dose
components. Track etch detectors (e.g. CR-39 polycarbonate film) offer very high
spatial resolution for the recording of individual high LET particle tracks. They can
therefore be used for mapping of thermal neutron flux by using a suitable
converter/radiator or for recording fast neutron dose via proton recoil tracks. Track
etch detectors are perhaps most useful for microdosimetry studies where they can be
used to record individual particle tracks the position of which can then be related
back to histological or biological features of interest (e.g. cells, microvasculature or
regions in tumours1).
In addition to experimental measurement techniques, Monte Carlo radiation
transport computer simulations are increasingly used to determine doses in complex
geometries in mixed neutron - γ fields. For most materials and neutron energy ranges
of interest for BNCT, neutron cross section data and the physics of the Monte Carlo
codes are adequate to provide accurate calculations of dose. However these Monte
Carlo dose calculations depend for their accuracy on an accurate knowledge of the
geometry and isotopic make up of the materials being simulated as well as an
accurate knowledge of the initial neutron spectrum as an input to the calculation.
Therefore it is essential that the results of Monte Carlo simulations are verified
experimentally. Once verified for some standard geometry and material
configurations for a given neutron beam facility more weight can be placed on the
computed results of simulations for more complex geometries (e.g. patients) which
are less amenable to invasive experimental measurements.
3

The work described in this thesis will focus on dosimetry considerations for
BNCT with a particular emphasis on the development and application of some new
detectors. These are the MOSFET and PIN diode dosimeters.
Metal Oxide Semiconductor Field Effect Transistors (MOSFETs) change
their electrical characteristics in response to gamma radiation, and to a lesser extent
and dependant on their encapsulation, in response to neutron irradiation. MOSFETs
have very small physical dimensions (several 10’s or 100’s of µm) giving them good
spatial resolution. They can be configured for use in an active mode to provide real
time dose data which could be useful for on line monitoring of patient doses. They
can also be used in passive mode unconnected to any external circuit as an
integrating dosimeter which stores the accumulated dose information for periods of
months or years with very little fading.
PIN diodes have previously been applied to fast neutron dosimetry as
personnel accident dosimeters and for military applications. Like the MOSFET they
have the advantage of small size (junctions with dimensions of a few mm). The mode
of operation of PIN diodes relies on the characteristic behavior of charge carriers in
intrinsic high resistivity silicon. When silicon is exposed to neutron radiation lattice
defects are introduced into the silicon crystal. These act as recombination centres for
charge carriers. As the neutron dose and thus the number of recombination centres
increases the carrier lifetime decreases due to the larger probability of carriers
recombining at lattice defect sites. This is macroscopically observable as an increase
in the forward bias voltage of the diode. The change in bias voltage is proportional to
the neutron dose being measured.
One advantage of using silicon for fast neutron dosimetry is that the energy
4

response function of the silicon at neutron energies above 200 keV is approximately
proportional to tissue KERMA (kinetic energy released per mass of absorber). That
is, the silicon response function in a fast neutron spectrum is tissue equivalent.
Unfortunately this is not the case for lower energy neutrons although PIN diodes do
respond to all parts of the neutron spectrum of interest for BNCT.
In this thesis the photon and neutron responses of MOSFETs and PIN diodes
are characterised. Response as a function of accumulated dose, neutron and photon
energy and temperature are all investigated. The photon response of the MOSFET is
investigated experimentally using x-ray and gamma photon sources. The neutron
response of the MOSFET and the dependence of this response on the encapsulation
of the device is investigated both experimentally and with Monte Carlo radiation
transport simulations. The response of the PIN diode is measured in a number of
different neutron fields derived from reactors and accelerators.
Measurements using PIN diodes and MOSFETs in phantoms exposed in
epithermal neutron beams are described. These included measurements in the HB11
BNCT beam at the High Flux Reactor (HFR) in Petten, The Netherlands as well as
measurements on the epithermal BNCT beam at the Brookhaven Medical Research
Reactor at Brookhaven National Laboratory (BNL), USA.
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CHAPTER 2

REVIEW OF BNCT

INTRODUCTION
In this chapter the basic principles of BNCT will be explained, a brief
summary will be given of neutron sources for BNCT, dosimetry techniques for
determining the physical dose components of importance and radiobiological
considerations in determining the effect of this dose. The most commonly used
boronated pharmaceuticals and their behaviour will be briefly summarised as well as
treatment planning techniques and the characteristics of some tumours proposed for
BNCT treatment. Finally a history of clinical trials of BNCT will be summarised.

THE PRINCIPLES OF BNCT

BNCT relies on a thermal neutron induced reaction in the

10

B isotope. This

reaction has a thermal neutron cross section of 3838 barns as shown in Figure 2-1
and proceeds as follows:
4

He + 7Li +2.79 MeV (6.3%)


10

B + nth  11B

4

He + 7Li* +2.31 MeV (93.7%)

7

Li + γ + 0.48 MeV

6

In the 6.3% probability branch the energy of the α particle is 1.78 MeV and of
the 7Li ion, 1.01 MeV. The ranges in water of the α and 7Li particles in this case are
8.9 µm and 4.5 µm. For the 93.7% branch the α particle and 7Li ion energies are 1.47
MeV and 0.84 MeV respectively. The ranges in water in this case are 7.2 µm for the
α and 4.1 µm for the 7Li ion. These ranges were determined by Charlton and Allen2
using the TRIM code of Ziegler3. The 0.48 MeV γ emitted in 93.7 % of reactions will
have a mean free path of approximately 10 cm in tissue.
When a

10

B(n,α)7Li reaction occurs most of the energy will be deposited

within approximately 9 µm of the interaction. This is of the same order of magnitude
as the diameter of most biological cells. A consequence of this is that if

10

B can be

delivered to the target cells and localised on or in them and if a sufficient fluence of
thermal neutrons can be delivered to the same region preferential cell kill can be
achieved with very high spatial resolution. Another consequence of the short range of
these high Linear Energy Transfer (LET) particles is that the efficiency of this cell
killing is very sensitive to the location of the

10

B. The efficiency of cell killing is

quite sensitive to the cell geometry and to whether the 10B is external to the surface of
the cell, within the cytoplasm or closely associated with the cell nucleus2,1.
In addition to the desired

10

B(n,α)7Li reactions in the tumour some reactions will

occur between incident neutrons and 10B which is not located in the tumour but rather
in other organs or the blood stream. This gives rise to an undesirable normal tissue
dose. This dose in combination with other dose components due to neutron reactions
with other elements in the body will determine the normal tissue tolerance dose
limits. These other reactions lead to a non selective dose which is not targeted to the
tumour cells. The main elemental components of tissue4 are listed in Table 2-1 along
7

with their total thermal neutron cross sections.

Cross Section (barns)

1.00E+06
Total Cross Section

1.00E+05
1.00E+04
1.00E+03
1.00E+02
1.00E+01
1.00E+00
1.00E-06

1.00E-03

1.00E+00

1.00E+03

1.00E+06

Energy (eV)

Figure 2-1. Neutron capture cross section for 10B. Note the very large thermal cross section.

Table 2-1. Elemental composition for average soft tissues from ICRU 44 and thermal
neutron cross sections5.

Element

% Mass Composition

Thermal Cross Section
(barns)

H

10.5

20.78

C

25.6

4.749

N

2.7

11.67

O

60.2

3.780

Na

0.1

3.496

P

0.2

3.134

S

0.3

1.488

Cl

0.2

45.60

K

0.2

3.926

8

Cross sections for the main components are plotted in Figure 2-2. From these
data it can be seen that the

10

B cross section is significantly higher than any of the

naturally occurring elements in the body.
The most significant non 10B contributions to normal tissue dose come from:
(1) The

14

N(n,p)14C reaction. The energy of the proton emitted from this

reaction is 0.59 MeV with a range of 10.3 µm in tissue. The recoiling
2

carbon atom has an energy of 0.04 MeV .
(2) Gamma rays in the neutron beam and gamma rays generated by capture in
the patient or phantom itself. The main reaction in this case is the
1

H(n,γ)2H reaction. The energy of the γ from the 1H(n,γ)2H reaction is 2.2

MeV. The dose arising from this γ component will be highest in regions
of high thermal neutron fluence but diffuse and widely distributed
(3) The 1H(n,n’)1H proton recoil reaction. The precise contributions will vary
depending on the neutron spectrum6 and the variations in tissue
composition from one organ to another. The energy of the knock on
protons will be deposited locally.
Because each of these dose components has a different biological effect they
all need to be quantified separately and accurately in order to determine the
biological effect that a given total physical dose will have. Once each physical dose
component is determined the appropriate weighting factor can be applied to
determine a dose parameter proportional to the total biological effect (see
below).
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Figure 2-2. Some (total) neutron cross sections for the main elements in the body5.

NEUTRON SOURCES
NEUTRON BEAM PARAMETERS
Early attempts at BNCT at Brookhaven and latter in Japan made use of
thermal neutron beams. Although the 10B cross section is largest at thermal energies
inadequate penetration of thermal neutrons confounds the treatment of all but
superficial tumours. Thus a therapeutic advantage can only be obtained within a few
centimetres of the surface depending on the 10B concentration obtained in the tumour.
In a thermal beam the thermal neutron flux falls to approximately half its incident
value at a depth of about 2 cm in a tissue equivalent phantom7.

10

,,

Therefore to enable the treatment of more deep seated tumours it is necessary
to use more energetic and therefore more penetrating neutrons. The use of purely fast
neutrons is not ideal either however since although these are more penetrating they
will also deliver a non specific high dose due to proton recoil reactions.
The determination of the best neutron energies has been performed using so
called “ideal beam” calculations8,9. These studies are done using Monte Carlo
transport simulations of monoenergetic neutrons in phantoms. The neutron energies,
source angular distributions and beam diameters can be varied as can the geometry of
the phantom itself.
A number of figures of merit (FOM) parameters are defined to compare
different ideal beams10. These are the advantage depth (AD), the advantage ratio
(AR) and the advantage depth dose rate (ADDR). These are defined for a given beam
and phantom configuration and for specified tumour and normal tissue

10

B

concentrations. The advantage depth is that depth where the total therapeutic dose is
equal to the maximum background dose. Since the therapeutic dose will depend upon
the tumour
tissue

10

10

B concentration the AD will increase as the ratio of tumour to normal

B concentration increases. The minimum AD is the AD with the ratio of

tumour to normal tissue 10B concentrations assumed to be 10. The maximum AD is
the AD with this ratio assumed to be infinite, i.e. normal tissue 10B concentration is
zero. The maximum AD can be increased by increasing the tumour

10

B

concentration. The AR is the ratio of the integral of the therapeutic dose to the
integral of the background dose over some depth range. The ADDR is the dose rate at
the minimum AD.
The ideal beam studies of Yanch and Harling9,11 studied beam energies
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ranging from thermal neutrons through to 800 keV neutrons with emission angles
ranging from 0 to 90°. Beam diameters from 6 cm to 33 cm were considered. They
assumed a

10

B concentration in tumour of 30 µg/g and in normal tissue of 3 µg/g.

Results of these calculations showed that for a 6 cm diameter parallel beam neutrons
in the energy range from 10 eV - 10 keV have advantage depths greater than or equal
to 7 cm. This useable energy range increases as the diameter of the beam increases
and for a beam of 14 cm diameter such as may be used in treatments of the brain the
useful neutron energy range is from 1 eV to 40 keV. The ADDR has a minimum at
an energy of about 2 keV before increasing at higher energies due to fast neutron
effects.
Thus from the point of view of treating tumours at depths up to 7 cm, which
corresponds with the midline of the brain, neutrons in the energy range from about 1
eV - 40 keV will be adequate although a range from 1eV to 10 keV is more
commonly specified as the ideal. This energy range corresponds approximately with
the minimum in the neutron tissue KERMA curve shown in Figure 2-3. For neutron
beam energies less than the minimum in this curve the

14

N(n,p)14C contribution

increases and will deliver an undesired dose to the surface of the patient since these
low energy neutrons do not penetrate far. For neutron energies greater than the
minimum in the KERMA curve the 1H(n,n’)1H proton recoil reaction contribution
will increase doses to normal tissue over a depth range that depends on the energy of
the primary beam.
The depth of penetration of the beam as well as the induced gamma dose
generated in the patient can be further modified by heavy water substitution in the
patient (effectively reducing the 1H(n,γ)2H and the 1H(n,n’)1H contributions to dose).
12
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Figure 2-3. Neutron KERMA for tissue as function of neutron energy.

This has been used in clinical applications with thermal BNCT and a
simulation study by Wallace et al12 demonstrated that by replacing 20% of the H2O in
the patient with D2O a similar advantage can be obtained with epithermal neutron
beams. With D2O substitution it is possible to reduce the induced gamma dose rate
by approximately 30% and also to improve the epithermal neutron penetration
resulting in a more homogeneous neutron field at depth and therefore improved
therapeutic ratios.
The following parameters define the specification of an epithermal neutron
beam for BNCT13.
(1)

Epithermal Beam Intensity (defined as the flux of neutrons in the
beam with energies between 0.5 eV and 10 keV) should ideally be
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at least 109 neutrons cm-2.s-1. Less intense beams than this will
require unreasonably long irradiation times (> 1 hour) which
presents clinical difficulties in terms of prolonged immobilisation
of the patient and may also be sub-optimal in terms of the boron
drug biodistribution kinetics.
(2)

Fast neutron flux component (taken as neutron flux with E >10
keV) should be as low as possible since this will lead to a non
targeted normal tissue dose from recoil protons. Reducing the fast
neutron component will always be to some extent a compromise
with increasing the epithermal flux. The fast neutron component in
most operating epithermal beams is typically in the range 2.5 – 13
× 10-13 Gy cm-2 per epithermal neutron.

(3)

The gamma ray component in the beam should be minimised.
Some gamma rays are unavoidably generated in the patient
(“induced gammas”) however the beam gamma KERMA
component is typically between 1 – 13

× 10-13 Gy cm-2 per

epithermal neutron and should be at the lower end of this range.
(4)

Thermal flux in the incident beam will lead to increased superficial
tissue dose and should therefore be minimised. A maximum
thermal flux 5% of the epithermal flux has been suggested.

(5)

Neutron currenta to flux ratio reflects the proportion of forward
directed neutrons in the beam. A higher ratio results in minimal

a

Neutron current is the number of neutrons per second crossing a unit area normal to the direction of
neutron flow.
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beam divergence and enables better dose delivery at depth. A
suggested target for this parameter is 0.7.
(6)

Maximum usable beam diameter is typically between 12 and 14
cm on exiting beams.

In practice the available neutron source will be the final determinant of the
precise range of neutron energies which will be delivered. However preliminary ideal
beam calculations determine the preferred neutron energies for the design of neutron
sources for BNCT. A combination of moderators, collimators and scattering or
attenuation filters is then used to tailor the primary neutron source to the desired
spectrum and geometry.

FILTERS AND MODERATORS
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To obtain an epithermal neutron beam with the required specifications
elaborate arrangements of moderators and filters are required14. For reactor designs
where the reactor core subtends a large angle at the beam port a moderator based
design may be possible (eg Choi et al15). In this case the exit port of the beam
effectively views a large section of the core and if an optimised moderator can be
introduced into the space in between the core and the exit port fast neutrons from the
core can be moderated and collimated (by scattering) to exit the beam port with the
required energy spectrum. In this design a spectrum shifter is inserted as close as
possible to the core and this serves to moderate and scatter fast neutrons towards the
beam port. Materials used for moderators13 include Al, Al2O3, AlF3, D2O, C and S.
The patented metal ceramic composite of Al and AlF3 called FLUENTAL has been
used in the construction of the Finnish BNCT facility on the FiR. These are all light
15

elements and therefore effective moderators. They do not have long lived activation
products and are durable in high radiation environments. Combinations of Al2O3 and
AlF3 have been used to good effect for this application because the combined cross
sections of the O and F eliminate most of the minima in the Al cross section.
For a given reactor power the main beam design parameter determining the
number of available neutrons at the treatment port is the core to patient distance. By
reducing this distance the beam intensity can be increased. However this is at the cost
of also reducing the neutron current to neutron flux ratio. In practice about 1.5 –2.5m
is required to accommodate the necessary filters and moderator components. In some
cases the intensity of the beam can be improved by the use of a conical collimator
that converges to the beam exit port. This collimator can be lined with high atomic
weight neutron reflecting materials13.
The reduction of unwanted thermal neutron and gamma dose components is
achieved by use of filters13. Both lead and bismuth are effective attenuators of
gamma rays but bismuth has a lower cross section for epithermal neutrons and is
therefore more often used. Another material sometimes used (eg Petten HFR HB11
beam) for gamma attenuation is liquid argon. Clearly there are extra difficulties
arising from incorporating a volume of liquefied gas and the associated cryogenics
into a beam line and this material is not used elsewhere for this purpose. To eliminate
thermal neutrons from the beam cadmium, boron or lithium could be used. Cadmium
has a sharp cutoff at 0.5 eV but generates an energetic gamma ray upon neutron
capture. Whereas 10B generates a low energy gamma ray and 6Li generates no gamma
ray but both of these isotopes have 1/v cross sections and therefore will tend to
attenuate some of the desirable epithermal neutrons as well as absorbing the thermal
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neutrons.
Where only a narrow beam channel between the exit port and the core is
available the reactor power generally needs to be higher16. In this case the volume of
the beam line is occupied with filters the purpose of which is to attenuate the fast
neutron component of the beam as well as the thermal flux and gamma dose
components. Filter components typically used or proposed for this purpose include
Fe, S, Ni, and Ar.

FISSION PLATES
Another method currently being utilised on some reactors to enhance
epithermal beam flux involves the use of a fission plate. This technique introduces a
plate of fissile material outside the reactor core and close to the exit of the beam port.
In this way the thermal neutron flux in the beam originating from the reactor core is
used to generate a high flux of fast neutrons closer to the patient. These are then
moderated using the types of moderators described above. An example of this
arrangement is the fission plate converter designed for the Brookhaven Medical
Research Reactor17. In this case the core is surrounded by a graphite reflector.
Adjacent to this reflector along the axis of the beam is a 19 cm thick Bi gamma
attenuator. Eight fission plates are then interposed in the beam. These are contained
in a container filled with moderator/coolant (D2O) to remove the heat generated in
the plates. Each plate contains approximately 1 kg of 20% enriched

235

U and

measures 100 × 10 × 0.3 cm. This is then followed by a 48 cm thick Al filter and a 24
cm thick Al2O3 moderator. A thin layer of Cd (0.05cm) is used to remove thermal
neutrons from the beam and a further 10 cm of Bi is used to remove gamma rays
17

generated in the fission plate / filter / moderator assembly. The design study for this
arrangement indicated that the epithermal neutron flux could be boosted by a factor
of about 6-7 times the available epithermal flux without fission plates. The expected
epithermal flux with the fission plates was 1.2×1010 n/cm2.s. The fast neutron dose
per epithermal neutron would also reduced by approximately 30% and the current to
flux ratio also improved.

ACCELERATOR SOURCES
Currently used neutron sources for BNCT are reactor based. This is
principally due to the availability of such sources and the relatively high fluxes they
can deliver. For wider use of BNCT clinically the neutron source should ideally be
smaller and less expensive than a reactor so that it could be installed in a hospital
radiation oncology centre. Accelerator sources promise this possibility if current
clinical trials support the clinical efficacy of BNCT.
Sources of neutrons for BNCT which are under development include a
number of accelerator based systems. These make use of various accelerator
technologies including tandem electrostatic and (radio frequency quadrapole18) RFQ
proton accelerators19. In general the selection of reactions (targets and projectiles)
for accelerator based neutron sources depend upon several factors20:
1. Physical stability of the target material under the high temperature
conditions generated by high incident beam currents,
2. high natural abundance of the target isotope to reduce cost and also reduce
unwanted reaction products from sister isotopes in the target,
3. Suitable reaction Q values and preferably low threshold energies for the
18

projectile beam. For Q>0 the resultant neutrons will have energies in the
MeV range. Therefore ideally -3.0MeV < Q < -0.5MeV is desirable to
reduce the required accelerator energy.
4. Suitably large cross section to make the neutron yield efficient.

These criteria were applied to a range of reactions including 3H(p,n), 7Li(p,n),
9

Be(p,n),

11

B(p,n),

12

C(d,n),

19

F(p,n),

45

Sc(p,n) and

63

Cu(p,n) by Dolan et al20 who

concluded that the lithium reaction was the favoured option. A similar analysis was
performed by Brugger and Kunze21 which also considered a wider range of other
reactions including

51

V(p,n) and

65

Cu(p,n) both of which produce neutrons of

suitable energy (En<1 keV for Ep at the reaction threshold energy) but have low cross
sections.
The most studied reaction for neutron generation is the 7Li(p,n)7Be reaction
which has a reaction threshold of 1.88 MeV. This means that proton energies need
only be about 2.5 MeV22. The optimal energy will depend upon the precise design of
the moderator and accelerator arrangement but is probably about 2.8MeV23. However
to obtain adequate fluences of epithermal neutrons from a clinically useful
accelerator source based on this reaction proton currents of the order of 10-20 mA
would be required. For target currents of this magnitude heat removal from a lithium
target is a significant design consideration. The neutrons generated by the 7Li(p,n)7Be
reaction have an angular and energy distribution determined by the kinetics of the
reaction. In order to use the neutrons generated by this reaction a reflector is located
around the target and a moderator is placed on the neutron beam axis between the
target and the patient

19,22

. An alternative and perhaps more attractive design
19

philosophy24,

25

uses a proton energy very close to the reaction threshold (1.93-

1.99MeV) to obtain neutrons at energies where only minimal moderation is required.
In this case the reduced neutron yield due to the lower reaction cross section just
above the threshold is compensated by the smaller thickness (~5 cm) of D2O
moderator used so that a clinically useful beam intensity may be generated with beam
currents as low as 5 mA. Such a system has been shown to probably be feasible for
intraoperative BNCT26.
Other reactions that have been considered in more detail for clinical27,

28

application include the 9Be(p,n) reaction with incident proton energies of 4 MeV29. A
similar quality beam can be obtained using either lithium or beryllium targets. The
use of beryllium as the target has some advantages over lithium due to the better
mechanical and physical properties of the former. However a higher energy (4 MeV)
accelerator is required for the beryllium reaction compared to the energy of
approximately 2.5 MeV (or even less) required for a lithium based neutron source.
This may make the lithium target system the less expensive option. One innovative
suggestion has been to use a target consisting of lithium contained in a beryllium
shell to take advantage of the desirable characteristics of both materials30.
More recently the

13

C(d,n) reaction has been studied31,32 with MCNP

simulations and experimental measurements in phantoms. A 4mA beam of 1.5 MeV
deuterons could deliver typical treatment doses in under one hour assuming

10

B

tumour concentrations of 40ppm.
All accelerator based neutron sources require some moderator and filter
around the target where the neutrons are produced. Depending on the reaction used
and the accelerator energy the average energy of the neutrons produced may be

20

decreased in order to reduce the amount of moderator required and bring the
treatment point closer to the target. However, in general, reducing the projectile
energy at energies close to the threshold for the reaction will result in diminished
yield thereby offsetting the advantage of decreasing the amount of moderator
required.
Generally the moderator extends all around the target to both minimise the
leakage of fast neutrons and to moderate and reflect as many of these as possible
towards the treatment point. These typically consist of combinations of Al2O3, BeO
and D2O. Some additional gamma shielding may be required to remove gamma rays
resulting from activation of the target. This could also be minimised by regular
replacement of the target.

OTHER NEUTRON SOURCES
Other neutron sources that have been proposed for BNCT include isotopic
sources of neutrons such as 252Cf. This isotope of californium spontaneously fissions
emitting fast neutrons. These could be used either in combination with filters and
moderators to produce an epithermal neutron beam33 or as a brachytherapy source
with boron pharmaceuticals used to enhance the dose to the tumour following
moderation of the fast neutrons in the surrounding tissue34.
A Monte Carlo study by Yanch et al33 demonstrated that with appropriate
arrangements of Al filters and D2O moderator it was possible to obtain an epithermal
neutron beam with dosimetry characteristics similar to a reactor based beam except
for the beam intensity which was several times lower than obtainable from a reactor
even with a large 1.0g 252Cf source. The limited half life (2.645 years) of 252Cf would
21

also lead to significant expense with the regular replacement of large sources.
Another study by Yanch and Zamenhof34 used MCNP to calculate the dose
distribution around implanted linear wire sources of
concentrations of
absence of

10

10

252

Cf with different

B in surrounding tissues. The calculated dose profiles in the

B were found to be in good agreement with measured data. The dose

close to the source drops sharply as the fast neutrons are thermalised. The dose at a
point 1cm from the source is approximately 10% of the dose maximum around the
source. The addition of 50ppm of

10

B to the medium has a minimal effect within

about 1 cm of the source but increases to represent a physical dose enhancement of
between 23 –28% at distances between 5 and 10 cm from the source (where neutrons
have thermalised). At a distance of 25 cm from the source the enhancement has
dropped to approximately 14%. This study concluded that dose enhancements of this
magnitude could under the right circumstances lead to significant improvement in
tumour control probability.
Another application of BNCT that has been suggested is the boron
enhancement of dose in fast neutron therapy (FNT)35, 36, 37, 38, 39. However the flux of
high energy (10’s of MeV) neutrons used for FNT means that the contribution from
boron fissions with thermalised neutrons only provides a dose enhancement of up to
about 5%. The additional dose contribution however is observed mostly at the higher
end of the microdosimetry spectrum. It has been suggested that filtration and
moderation of FNT beams would provide greater 10B dose enhancements that may be
more significant40. Modifications to the target (addition of Be) to enhance the flux of
low energy neutrons from an existing FNT facility at University of Washington State
have been successfully implemented41. In this case the aim was to of increase the 10B
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dose enhancement without substantially changing the depth dose profile or spectrum
of the original fast neutron beam.
DOSIMETRY TECHNIQUES
As previously noted each dose component of the BNCT epithermal neutron
beam will have a different biological effectiveness. Therefore it is important to
accurately measure or calculate each component separately.

FOIL ACTIVATION
The thermal neutron flux can be measured reliably using bare and cadmium
covered gold foil activation. Once the thermal flux is known a KERMA factor can be
applied for each type of tissue involved and the thermal neutron dose can be
determined. If necessary the contributions of each individual element can be
determined by using the appropriate thermal neutron KERMA factors. Similarly the
10

B dose can be determined using the thermal neutron flux and the KERMA if the

10

B concentration is known or is assumed.

IONISATION CHAMBERS
The standard method for determining beam gamma dose and epithermal
neutron dose is by using the paired ionisation chamber technique13. This technique
makes use of a graphite walled ionisation chamber filled with CO2 and a tissue
equivalent (TE) ionisation chamber (made of A-150 material) filled with tissue
equivalent gas. A magnesium chamber filled with argon is sometimes used instead of
the graphite walled chamber. The graphite or magnesium chamber has minimal
23

neutron response and is used to measure ionisation due to the gamma dose. The TE
chamber responds to both gamma radiation and neutrons in the epithermal neutron
beam. By subtracting the gamma dose measured using the graphite or Mg chamber
from the dose measured by the TE chamber the neutron dose can be determined.
A detailed description of the paired ionisation chamber technique (and other
dosimetry techniques) applied to epithermal neutron beams for BNCT applications
has been presented by Rogus et al42 and by Raaijmakers et al200. The reader is
directed to these excellent descriptions for more detail and only a brief summary of
the methods based on these papers will be presented here for completeness.
The ionisation chambers used by Rogus et al and Raaijmakers et al were
manufactured by Far West Technologies and Extradin respectively. The diameters of
the chambers are approximately 8mm – 10mm. Tissue equivalent gas composed of
64.4% CH4, 32.4% CO2 and 3.2% N2 by partial pressure was used by both groups.
Rogus et al maintained the flow rate of the TE and CO2 at 20 cm3.min-1 and
Raaijmakers used a flow rate of 10 cm3.min-1 for the TE gas and the Ar. The flow
rate must be kept constant during calibrations and measurements to avoid changes in
gas density and the resultant changes in ionisation. A chamber voltage of 250 V was
used by both groups. The wall thickness of the ionisation chambers themselves
provide enough buildup to establish charged particle equilibrium for all anticipated
neutron energies. However extra buildup caps were used to provide charged particle
equilibrium for

60

Co gamma energies. In air measurements are performed with the

buildup caps on but the presence of some higher energy gamma rays in the neutron
beam will lead to a small error.

24

The response of the two ion chambers in a mixed field is given by Rogus et
al42 as (Raaijmakers et al43, 200 follow a very similar method):
QTE = ATE Dγ + BTE Dn + f φ φ 2200
QCG = ACG Dγ + BCG Dn + f φ φ 2200

where QTE and QCG are the charges accumulated by the chambers under
irradiation, Dγ and Dn are the gamma and neutron dose rates and the factors A and B
respectively represent the gamma sensitivity and neutron sensitivity of each chamber.
The thermal neutron flux is φ2200 and fφ is the thermal neutron sensitivity of each
chamber. The gamma sensitivity A for each chamber is determined by exposure
calibration in a

60

Co gamma field and application of appropriate exposure to dose

conversion factor. If this calibration is performed with air in the chambers then a
separate factor to correct for air versus CO2 or TE gas filling needs to be measured.
The neutron sensitivity factors, B are based on the neutron to gamma sensitivity ratio
B/A, a quantity that can be calculated using the Bragg-Gray theory or found in the
literature. For the TE chamber this factor will be dependant on the ratio of the energy
needed to produce an ion pair for photons in TE gas and for neutrons in TE gas
(Wg/Wn). Therefore it will change as the spectrum being measured changes leading to
an uncertainty in the final result. The contribution from thermal flux is subtracted
based on activation foil measurements of the thermal (2200 m.s-1) flux and measured
values of the thermal neutron response fφ. The measured charges in the ion chambers
are corrected for temperature, pressure, gas flow rate and reactor power and
conditions.
The estimated contributions from each step of the measurement process to the
total uncertainty in gamma dose and fast neutron dose are tabulated by Rogus et al42.
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The estimated total uncertainty in epithermal beam measurements of photon dose is
±9% and for fast neutron dose it is ±17%. Similar uncertainty estimates by
Raaijmakers et al were ±5% for photon dose and ±13% for fast neutron dose at 1 cm
depth in a phantom but this dropped off to ±18% at 2 cm depth.
In addition to these standard methods of measurement for the dose
components in epithermal beam BNCT several other dosimetry techniques are used
more or less commonly. These include thermoluminescent dosimeters (TLD)43,44
ferrous sulphate gel dosimetry45,46, and acrylamide polymer dosimetry gel47 and
semiconductor dosimeters in various forms including the ones described in this
thesis. For the initial spectral characterisation of epithermal beams various types of
activation foils and foil stacks may be used as well as proton recoil spectrometry.

RADIOBIOLOGY

As previously noted the dose absorbed in tissue containing 10B exposed in an
epithermal neutron beam consists of several components: gamma dose, neutron dose
(mainly proton recoil), dose from the

14

N(n,p) reaction and dose from the

10

B(n,α)

reaction including the prompt gamma ray48. Each of these dose components will have
a different relative biological effectiveness (RBE) principally due to the different
linear energy transfer (LET) of these dose components49. In the case of the proton
recoil dose the RBE may change as the average energy of the neutrons changes with
depth in the tissue50. The proportions of each of these dose components will also
change with location in the irradiated tissue, i.e. the epithermal flux decreases with
depth and the thermal flux while also diminishing constitutes a larger proportion of
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the total neutron flux at greater depths. It has been shown by Woollard et al51 that it
is reasonable to use the same RBE for the proton recoil and 14C(n,p) components of
the dose throughout the treatment volume for typical epithermal neutron beam
spectra.
The RBE of a particular radiation is traditionally defined as the ratio of the
dose of that radiation to the dose of X-rays (usually 250kVp) that is required to
produce some defined biological effect52. The value of the RBE will depend on the
endpoint chosen, the dose rate and fractionation, the oxygenation of the tissue, the
kind of tissue or cells being tested and potentially many other factors. The
determination of an appropriate RBE for each of the dose components in BNCT and
then its application to a particular physical dose is not a straight forward exercise.
In general and certainly in the clinical situation it is only possible to calculate
the reaction rate for the 10B(n,α) reaction for some average concentration of 10B in a
particular volume. For most biological systems and for most 10B pharmaceuticals the
10

B distribution will be highly inhomogeneous. Combined with the short range of the

resulting α particles this makes it impossible to calculate a meaningful RBE based on
the actual dose distribution (which is highly inhomogeneous on a microscopic scale).
Therefore to account for the effect of the microscopic distribution of the 10B and its
effect on the ‘RBE’ for the

10

B(n,α) reaction in a particular system a compound

factor (CF) or compound biological effectiveness factor (CBE) is introduced. This
factor accounts for the different biological effects that may be observed for the same
average boron concentration but with different microscopic distributions (i.e.
predominantly in the cytoplasm, the nucleus or the cell wall, etc) depending on the
boronated drug being used. These compound factors are generally determined by in27

vivo or in-vitro measurements of dose effects with and without the

10

B

pharmaceuticals present.
Compound factors could also be considered as effectively consisting of
several other more basic factors53 that describe the geometry of cells and the

10

B

distribution within them. These factors take into account the relative contributions to
the dose received by the cell nuclei depending on the boron concentration, the
microdistribution of 10B in the cells (relative intracellular efficiency), the contribution
from

10

B in contiguous cells (contiguous cell correction) and fractionation effects.

Some of these factors can be derived based on measured microscopic distributions of
10

B in particular tissues in conjunction with microdosimetric (often Monte Carlo)

calculations of energy deposition in simulated typical cellular geometries.
The methods used for determining RBE and CBE factors are well described
by Coderre and Morris in a review paper54 and the literature referenced therein. The
reader is directed to this literature for an extensive review of the topic but a brief
summary will be presented here.
The principle high LET dose components arising from the incident neutron
beam itself are recoil protons and the 590 keV protons arising from the 14N(n,p)14C
reaction. The RBE of these protons can be determined by observing the total physical
dose (proton dose, Dproton and gamma ray dose, Dγ) required to achieve a specified
biological endpoint in the neutron beam. A similar measurement is performed to
determine the x-ray dose (Dx-ray) required to reach the same endpoint (effect). That is
(after Coderre54):
D proton (effect ) * RBE proton + Dγ = D x − ray (effect )
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The gamma ray dose component is assumed to have an RBE of 1 and
therefore the gamma dose is subtracted from the x-ray dose required to reach the
same endpoint. The RBE of the proton dose is simply the ratio of the remaining x-ray
dose to the proton dose:
RBE proton =

D x − ray (effect ) − Dγ
D proton (effect )

The proton RBE will be determined in part by the neutron spectrum which
dictates the recoil proton spectrum. It ranges from approximately 1 for keV range
neutrons up to 6.2 for 350 keV neutrons6. For clinically relevant biological endpoints
and typical epithermal beam spectra it is probably approximately54 3.
Once the RBE of the proton dose has been determined then another
measurement can be conducted where

10

B is introduced into the biological system.

Again the cells are irradiated in the neutron beam to reach some predefined endpoint.
A similar exposure using only x-rays is used to reach the same endpoint. Again
adapting the exposition of Coderre:
D x − ray (effect ) = Dγ + D proton * RBE proton + Dboron * CBE
Where Dboron is the

10

B(n,α)7Li contribution to the total dose required to

achieve the same endpoint (effect). The CBE for the boron dose contribution is then:

D
CBE =



x − ray 

effect  − D − D

γ

proton

* RBE

proton

D
boron

This methodology applied to in-vivo irradiation of 9L gliosarcoma cells and
in-vitro survival assay measurements results in CBE factors54 in the range of 3.4 to
2.8 for the most commonly used boron drugs, BPA and BSH as well as for boric acid
relative to 250 kVp x-rays at cell survival levels between 0.1% – 10%. It should be
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noted that the actual boron dose Dboron and therefore the CBE factor will be sensitive
to the assumed (or measured) boron concentration in the cells. A check of
consistency of the RBE and CBE factors can be obtained by generating cell survival
curves using both x-ray irradiations and neutron irradiations with

10

B present. If all

assumptions and CBE and RBE factors are correct the two cell survival curves
should lie exactly on top of each other when the neutron survival curve is plotted as a
function of photon equivalent dose (ie physical dose modified by RBE and CBE
factors)54.
Based on BNCT treatments of melanoma in six humans at the Musashi
Institute of Technology reactor and the Kyoto University reactor the overall
biological effectiveness factor for

14

N(n,p) and

10

B(n,α) reactions with BPA is

estimated to be approximately 2.3-2.5 where the endpoint is moist desquamation of
the skin54,55.
Radiation damage to the CNS occurs via more than one pathway and is a
result of vascular damage, demyelination and probably several other factors56,57.
Determination of BNCT effects on the central nervous system is complex. Depending
on the boron compound used tumour control effects as well normal tissue
complications are probably mediated by more than one effect. Damage to the microvasculature in the CNS leads to normal tissue damage58 and this effect is probably
also responsible for some of the tumour control effects observed.
For a compound like BSH that does not actively cross the blood brain barrier
(BBB) except where the BBB is compromised (eg fenestrated capillaries in
tumours59,60) the concentration of boron within the capillaries and the

10

B(n,α)

reactions occurring in the lumen leads to a geometric sparing of the vascular
30

endothelial cells. This occurs since the dimensions of the capillary lumens61 are of a
similar magnitude to the range of the reaction products while the endothelial cell
walls are very thin and therefore do not absorb much dose. In contrast to this BPA is
transported across the BBB and therefore the concentration of

10

B in the brain

surrounding a capillary is likely to be similar to the concentration in the blood. In this
case the endothelial cell walls are more likely to receive a higher dose from the
surrounding 10B. This results in a higher CBE for BPA in the CNS. For an endpoint
of myeloparesis irradiating rat spinal cord with a single fraction of thermal neutrons62
the CBE for BPA was found to be approximately 1.3. The CBE for the same effect
using BSH63 was 0.53 with various concentrations of BSH resulting in total physical
absorbed doses ranging from approximately 21 – 32 Gy. The difference between the
CBE for the two compounds reflects the different distribution of boron between the
vasculature and the normal brain surrounding it for these two compounds.
The corresponding CBE factors for tumors using BPA or BSH have been
estimated54 to be approximately 3.8 and 1.2 respectively in a 9L gliosarcoma rat
model. These were both based on in-vivo irradiation with in-vitro survival assay.
Using overall animal survival data would be a preferable method for determining
CBEs where tumor control is the required endpoint. However normal tissue toxicity
resulting from large single x-ray fractions prevents this CBE measurement being
made. The validity of assaying tumor cell survival to determine tumour control CBE
has been questioned on the basis that it may in fact be damage to the vasculature
rather than direct clonogenic cell kill which determines tumour control54.
It has been suggested that theoretically there may be some advantages to
fractionation of BNCT treatments. In general the benefits of fractionation that exist
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for low LET radiation are smaller or not significant for higher LET radiations64.
Since BNCT involves both high and low LET components it may be expected that
the low LET component of the radiation dose would result in some repairable sublethal damage and that fractionation of the dose may allow normal tissue toxicities to
be reduced. However no significant effect has been observed in this regard, possibly
due to the interaction of high and low LET components resulting in low LET damage
being “fixed” by the presence of high LET damage inhibiting repair54. Reduction of
normal tissue complication probability is not therefore considered an adequate
rationale for fractionation in itself.
For tumor cell populations the fractionation benefits of cell cycle
redistribution and reoxygenation are not expected to be significant for high LET
radiation and have not been observed with BNCT in animal models (mainly 9L
gliosarcomas in rats). However an oxygen enhancement effect has been observed for
fast neutrons65. However these animal models may not be truly representative of real
glioblastoma multiformae tumors which may have a significant sub-population of
cells in a quiescent phase as opposed to the models where most of the cells were
actively proliferating54. It has been proposed that a fractionated BNCT treatment
could allow the boron delivery agent to perfuse tumour cells not previously
accessible for the initial fraction of BNCT. This limited access could arise due to the
adverse osmotic and pressure gradients, convoluted tumor vasculature and other
factors that conspire to confound the delivery of any therapeutic agent to solid
tumors66. Some reasons that fractionation (of the boron dose and radiation) may
actually lead to worse results include the possibility that biodistributions of
subsequent administrations of boronated compounds may be less specific. A high
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normal tissue concentration may result from previously damaged vasculature67 and
normal tissue reactions to the previous fractions.

On these grounds Corderre

concludes that clinical trials of fractionated BNCT are worthy of investigation54. In a
gliosarcoma model using BPA no loss of therapeutic efficacy was observed for two
fractions separated by up to 5 days, however a break of up to 9 days was required to
improve normal tissue tolerance (oral mucosa in this case)68.
It has been proposed that there may be a synergistic effect (supra-additivity63)
between high and low LET radiations delivered either sequentially or concurrently. If
this is the case it may be necessary to consider this supra-additivity63 in any
radiobiological model used for BNCT. Zaider and Rossi69 proposed a model (based
on the theory of dual radiation action70) that showed synergistic effects from
sequential high and low LET radiations resulting from interactions between
sublesions produced by the two types of radiation. This was later extended for
application to simultaneous irradiations and compared well with experimental
neutron and gamma cell survival data by Suzuki71. Earlier data from McNally et al72
and others demonstrated similar interactions between high and low LET irradiations.
Zaider and Wuu subsequently extended the model further to include the effects of
variable radiosensitivity of cells due to oxygenation and cell cycle stage73.
The effects of these synergistic interactions may be expected to be observed
as the ratio of high to low LET dose changes with different concentrations of 10B in
tissue and different ratios of gamma to neutron doses at different depths in the tissue
being irradiated. This would lead to different values of CBE for experiments
performed with different concentrations of 10B. It could also cause CBE to vary with
position in clinical BNCT. Hitherto no such variation in CBEs with different
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doses has been observed63. Any synergistic effects between the high and low LET
components have so far remained obscured by other variability in the available data
from cell and animal models and clinical trials.

BORON DRUGS
The first trials of BNCT in the 1950s used borax (Na2B4O7.10H2O) or sodium
petaborate (Na2B10O16.10H2O). These were not taken up selectively by tumours and
therefore the tumours only had a concentration marginally exceeding that in normal
tissue for a very short period. Later p-carboxybenzeneboronic acid and sodium
decahydrodecaborate were developed and tested. these showed favourable tumour to
brain boron ratios of between 5:1 and 8:1 for periods of hours

112

. However histology

results showed significant damage to vascular endothelial cells due to high blood
boron concentrations. Subsequently new boron compounds were developed which
showed improved tumour to blood boron ratios. Sodium Borocaptate referred to as
BSH (Na2B12H11SH) was the first of these and was used in the thermal BNCT trials
in Japan. BSH has been shown to accumulate in the nuclei of glioma cells74. BSH has
shown clinically useful uptake levels in human gliomas and minimal normal brain
tissue uptake75.
Another boron drug used for BNCT is p-boronophenylalanine (BPA). The
rationale for this is that BPA is an analogue of the amino acid phenylalanine and may
be actively taken up by tumour cells due to their increased metabolic rate. In the case
of melanoma cells phenylalanine is known to be a precursor of melanin and therefore
BPA uptake is enhanced in these cells76. Tumour to blood boron ratios of 4.4±3.2 for
metastatic melanoma patients have been observed with a maximum ratio of 10. In
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high grade gliomas ratios of 2.2±1.2 have been observed . Significant clinical
experience has now been gained with BPA (and in particular the BPA.fructose
complex used to improve solubility for administration of BPA). Effective
biodistribution kinetics models for BPA based on human data have been
published77,78 and show good agreement with experimental observations.
An essential difference in the behaviour of BSH and BPA is that the
accumulation of BSH in tumours relies on the diffusion of BSH out of the
vasculature in regions where the vasculature is leaky or damaged (eg tumors)
whereas BPA is transported across the endothelial cell wall but is selectively
accumulated in tumor cells due to their higher proliferative activity. This may mean
that BSH is less cell cycle dependant that BPA79 for some tumors and has lead to the
suggestion that combinations of BPA and BSH could be advantageous80. This
difference has important implications for the radiobiological effects of these boron
carriers as noted in the Radiobiology section above.
Other boron compounds investigated81 include boronated nucleic acid
precursors which could be incorporated into the DNA of proliferating cells. Such
compounds are attractive because of microdosimetric considerations. A much greater
amount of energy can be deposited in the nucleus of a cell if the 10B(n,α)7Li reaction
occurs there rather than in the cytoplasm or on the external surface of the cell wall.
Boronated monoclonal antibodies82,83, liposomes, combinations of liposomes and
antibodies84 and low density lipoproteins (LDL) have also been investigated.
It may be possible to increase the boron load in tumor cells by administering
agents designed to increase the permeability of the blood brain barrier such as
Cereport and mannitol85. One test of this technique using a nude rat melanoma model
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showed a significant improvement in mean survival time and the number of long
term survivals when Cereport or mannitol were administered to the animals with
BPA prior to neutron irradiation86. Minimal difference in normal tissue damage was
observed compared to animals treated without mannitol disruption of the blood brain
barrier during irradiation87.

TREATMENT PLANNING

Treatment planning for BNCT involves many variables, elaborate data
collection, setup and computation. Therefore only a brief and necessarily superficial
overview can be given here. It is necessary to know both the physical dose
distribution from the beam component of the epithermal neutron beam and also the
boron distribution in normal tissue and tumour. It may be possible to perform some
uptake measurements of the boron agent and use these in conjunction with
compartment models of the known biodistribution and kinetics for the boron
pharmaceutical77,78. An attractive way of achieving this is to use positron emitting
analogs of the boron therapy agents. This technique can now be used for treatments
with BPA88. The geometry of the patient anatomy and tumour is determined using
CT and MRI as it is for conventional radiotherapy treatment planning.
The treatment planning system used for BNCT trials at BNL was developed
specifically for BNCT89 treatment planning at INEEL. It consists of several modules
to allow the import of CT or MRI images, outlining of structures and a Monte Carlo
based transport code module. The geometry for the Monte Carlo model is constructed
using a B-spline reconstruction from outlined regions on the diagnostic scans. The
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output of the calculated dose distributions including CBE modified physical doses
can be displayed as isodose contours on the CT or MR images. Dose volume
histograms can also be generated.
Treatment planning for patients at the MIT epithermal beam is performed
using the MacNCTPLAN package90. A PC version is now available. This package
combines the proven radiation transport accuracy and power of the MCNP182 code
from Los Alamos with the user friendly graphical interface and image processing
capabilities of the public domain NIH Image code. This planning system accepts CT
and MRI images. The CT images are used for tissue composition definition while the
MRI with and without contrast is used for target delineation.
In NCTPLAN the image data is converted into a voxel model consisting of
11,025 cells each of 1cm-3 in a parallelepiped box of dimensions 21×21×25 cm91.
Each 1cm-3 cell has a composition based on the average composition of the tissue
types in the CT pixels that contribute to its volume. The segmentation of the images
into different tissue types is accomplished semi-automatically with manual
identification of Houndsfield ranges that correspond to particular tissues (using a
frequency histogram). Once the dose in each voxel is calculated a 1mm-3 voxel grid
is generated by interpolation and subsequently smoothed using a Fourier transform
and ramp filter. Isodose contours are then generated from this array.
An advantage of the MacNCTPLAN system is that as well as calculating the
dose distribution within the specific patient the dose distribution within a standard
head phantom is also calculated. By making absolute dose measurements at a
reference point in the phantom the actual calculated treatment plan dose distribution
can be scaled to ensure that the absolute dose is correct. That is the relative dose
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distribution in the patient is generated by Monte Carlo (MCNP) and this is then
scaled based on phantom measurements to ensure that the absolute dose levels are
accurate. During treatment, real-time monitoring of blood boron concentration using
prompt gamma detection is performed and in conjunction with readouts from
calibrated beam monitors92 the real equivalent dose is calculated.
A direct comparison93 has been made by the Petten group between
MacNCTPLAN and the code now designated as SERA94 by INEEL/Montana State
University. This found that the accuracy of the MacNCTPLAN was influenced by the
approximations involved in the voxel model used. The Finnish BNCT group has
developed a new deterministic transport code called Multitrans SP395 which has been
benchmarked against Monte Carlo calculations and experimental data. Multitrans
SP3 shows reasonably good agreement with measurements for neutrons but some
discrepancies still exist for gamma doses. It has the advantage of being
approximately an order of magnitude faster than the Monte Carlo based techniques.
Another deterministic method proposed for BNCT treatment planning is removal
diffusion theory96 which has demonstrated good agreement with MCNP results for
test geometries.

TARGET CANCERS
BNCT has been proposed as a treatment modality for a number of different
cancers. These include principally gliomas of the brain97,98,99,100 and cerebral
melanoma101,102. However in-vitro experiments, investigations of animal models and
dosimetry studies for various other neoplasms have included undifferentiated thyroid
cancer103, mammary carcinoma104, liver tumours194,105 and pancreatic cancer106.
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GLIOMA
Gliomas constitute approximately 46% of all primary intracranial tumours. Of
these 47% are glioblastoma multiforme (GBM) and 36% are other malignant
astrocytomas107. The prognosis for patients with tumours in either category is poor.
The median survivals are only about 8.6 months and 36 months respectively108
Conventionally these tumours are treated with surgical debulking, chemotherapy
and/or external beam radiotherapy.

MELANOMA
The incidence of melanoma107 in the US in 1996 was approximately 17 cases
per 100 000 per year for men and 11.4 cases per 100 000 per year for women. The
mortality rates for men and women were 2.3 and 3.2 per 100 000 per year
respectively. The higher mortality in men being due to the fact that a larger
proportion of melanomas in men occur on the trunk, whereas in women a larger
proportion occur on the extremities and therefore the prognosis is better107. The
incidence of melanoma is increasing fairly rapidly. There was a 140% increase in
incidence between 1973 and 1996. However over the same period the mortality rate
increased by only 44% among males and 15 % for women. Melanoma is a relatively
aggressive tumor and is also relatively radioresistant.

HISTORY OF CLINICAL TRIALS
Boron Neutron Capture Therapy (BNCT) was first proposed by Gordon
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Lochler109 at the Franklin Institute in Swarthmore PA in 1936 shortly after the
discovery of the neutron by Chadwick in 1932. It was not until 1951 however that the
first clinical trials were begun by William Sweet of the Massachusetts General
Hospital110,109 and others at the Brookhaven Graphite Research Reactor111. The
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compounds used were borax and sodium pentaborate given intravenously. These
early attempts were directed at treatment of glioblastoma multiforme and were
unsuccessful in terms of controlling this disease. No prolongation of survival time
was demonstrated112. This was mainly due to inadequate uptake of 10B in the tumour
cells and poor penetration of the thermal neutrons being used. These trials were
discontinued.
Another series of clinical trials commenced in Japan in 1968. These were lead
by Hatanaka113, who had participated in the initial Brookhaven trials, and were
performed on patients having a range of different types of tumours including low to
high grade glioblastomas. The
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B drug used was borocaptate (BSH) and a reactor

thermal neutron beam was used. Most of these treatments were performed after
surgical debulking of the tumour and were intraoperative irradiations. This was
required to maximise the neutron fluence at the tumour site due to the poor
penetration of thermal neutrons. Some success was claimed for these trials113 (over
100 patients were treated over the following 20 years). However due to patient
selection and lack of control data the outcomes are not considered to conclusively
112

support the efficacy of the treatment

.

Hatanaka’s results have rekindled interest in BNCT and a number of clinical
trials using epithermal neutron beams and new boron compounds were commenced
at the Brookhaven National Laboratory, the Massachusetts Institute of Technology
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and at the European Community Reactor in Petten114,115, the Netherlands. These
commenced with phase I trials to show no detrimental effect and progressed to phase
II dose escalation trials. Phase III trials will test efficacy of the treatment. The BNL
program was subsequently terminated when the BNL reactor was closed. Other
clinical trials are underway or planned in Finland, Czechoslovakia116 and Japan.
Two trials are currently open at the Beth Israel Deaconess Hospital utilising
the MIT epithermal neutron beam. These include a phase II trial for cutaneous
melanoma using BPA which is aimed at evaluating tumour response rates, acute and
delayed normal tissue skin reactions as well as BPA biodistribution. The other trial is
a phase I/II trial of BNCT treatment for cerebral melanoma and glioblastoma
multiforme. The aims of this trial are to determine normal brain tolerance doses and
the maximum treatment dose that can be given as well as to assess tumour response
to BNCT117.
Some early clinical trial results are available in the journal literature. For the
group of 10 glioblastoma patients treated at BNL in 1994/95 using BPA the
minimum dose in the tumor ranged from 20 to 32.4 Gy-Eq118. The dose to the scalp
was from 10–16 Gy-Eq resulting in alopecia in all patients. No treatment related CNS
morbidity was observed. Median time to local progression was 6 months post BNCT
with a trend to delayed progression with higher tumour doses. Overall 54 patients
were treated between 1994 and 1999 at BNL119. Patients received 250, 290 or
330mg/kg of BPA as part of the dose escalation. Between 1 and 3 treatment fields
were used for total treatment times of 38 –120 minutes. The reference dose levels
(dose to 1 cm-3 of normal brain at peak thermal flux) were set at either 10.5 , 12.6 or
15 Gy-Eq. Some oedema post treatment was observed and subsequently all patients
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were premedicated with steroids and antiseizure agents. No improvement in tumor
control was observed with increasing doses when time to progession is used as the
endpoint. All recurrences were observed in the region of preoperative oedema and
therefore the target volume was expanded to include this volume. At an average brain
dose of 6 Gy-Eq no significant CNS toxicity was observed on autopsy.
The Petten trial involves the delivery of four fractions over four consecutive
days and uses BSH as the boron agent to treat glioblastoma and gliosarcoma patients.
The EORTC BNCT protocol is a post-surgical protocol and of the patients so far
reported on in the literature120 approximately half had complete tumor resection and
the other half of the patients had subtotal resection prior to BNCT. The initial group
of ten patients received a dose of 8.6Gy-equivalent to the point of maximum thermal
flux. Five of these patients received bilateral irradiation and the other half unilateral
irradiation of the head. The BSH infusion was tailored to establish an average of
30ppm blood concentration of
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B during the four fractions. Some patients

experienced reactions and haematological toxicities which were attributed to BSH
and required GSF rescue. However acute radiation related toxicities were milder than
observed in patients treated with conventional radiotherapy for the same type of
tumors. Late toxicities associated with the BNCT were difficult to distinguish from
symptoms of disease progression and post operative sequelae. Overall survival times
and early and late toxicities were similar to those that would be expected for
conventional radiotherapy.
A novel on-line gamma ray telescope technique for assaying the boron
concentration spatial distribution has been applied to some of these patients121 during
treatment.
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CHAPTER 3

EPITHERMAL NEUTRON BEAM DOSIMETRY
USING PIN DIODES

PIN DIODES
In order to understand the application of PIN diodes to neutron dosimetry in
BNCT neutron beams it is first necessary to present a brief summary of the normal
behaviour of PIN diodes in the absence of radiation effects. Then a brief summary of
radiation interactions with silicon will be presented. From this basis an explanation
of the operation of PIN diodes as dosimeters will be given.
A silicon PIN diode consists of a section of intrinsic silicon sandwiched
between an n-type section on one side and a p-type section on the other (Figure 3-1).
Metallic contacts are attached to both the p and the n type sections. It is assumed that
the electron concentration in the n region is the same as the hole concentration in the
p region and that carrier mobilities are equal (µp = µn) and the diffusion constants are
equal (Dp = Dn) in each of the regions. There are approximately equivalent
concentrations of holes and electrons in the intrinsic region. The p and n type regions
are assumed to be very thin in comparison to the intrinsic region so that the electron
concentration in the p region and the hole concentration in the n region varies linearly
with distance.
The total voltage drop across the diode is the sum of the voltage drop across
the two junctions and the voltage drop across the intrinsic "base" section of the diode.
126

Swartz and Thurston

have shown that for low current densities in the diode the

carrier density depends linearly on the current density in the base. Therefore the
conductivity increases proportionally to the current and the voltage across the base is
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independent of the current in the base. The voltage across the base depends upon the
ratio of the base width to the diffusion length (W/L). The total junction voltage under
these conditions is proportional to the natural logarithm of the current density. That
is, the familiar junction diode equation where current is proportional to exp(eV/2kT).
Where e is electronic charge, V is voltage across junction, k is Boltzmans constant
and T is the temperature.
As the current density in the intrinsic base section of the diode increases126
the current becomes more dependant on the square of the number of injected carriers.
Under these circumstances the voltage across the base of the diode is proportional to
the square root of the current density and also depends upon the base width to
diffusion length ratio (W/L). For these higher currents the total junction voltage is
proportional to the natural log of the current density (current proportional to
exp(eV/kT)) and to the carrier lifetime, τ.

p+- i junction

Intrinsic base

W

Figure 3-1. Schematic representation of p-i-n diode .
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INTERACTION OF NEUTRONS WITH SILICON

Gamma rays impinging on silicon produce primarily ionisation. Neutrons,
due to their neutral charge and mass, can collide with silicon atoms and dislodge
them from their place in the crystal lattice. This creates a vacancy in the lattice at the
point where the atom was dislodged from and the dislodged atom is located in an
interstitial site. Thus a lattice defect is created. For energetic neutrons enough energy
may be imparted to the atom to enable it to dislodge further atoms. Some of these
defects will be stable at room temperatures and will therefore remain present in the
lattice structure and are referred to as displacement damagea. The increased number
of mobile vacancies in the semiconductor, prior to formation of stable defects,
transiently act as trapping centres for minority carriers. In the operation of PIN diodes
as neutron dosimeters we are primarily concerned with the neutron induced
formation of defects that are stable at room temperatures.
The amount of energy required to dislodge a silicon atom from its lattice site
is 25 eV122. An estimate of the number of dislodged atoms is given by Messenger and
Ash

122

as follows. The cross section of silicon for 1 MeV neutrons is approximately

5 barns (Figure 3-2). The atomic density of silicon is 5×1022 cm-3. This gives a mean
free path for 1 MeV neutrons in silicon of λ=4 cm. If each primary displaced atom
dislodges a cascade of another 500 atoms then silicon exposed to a 1 MeV neutron
fluence of 1013 cm-2 would result in a fraction of displaced atoms of approximately
2.5×10-8 cm-3, or about 1 atom in every 40×106. For lower neutron energies the

a

The kinetic energy released per mass absorber through interactions which lead to displacement
damage is known as displacement damage KERMA or simply damage KERMA.
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number of atoms in the cascade would be less and as the silicon cross section also
decreases for lower energies the number of dislodged atoms and defects formed
would be an even smaller fraction per incident fluence.

1.E+02

Cross Section (barns)

1.E+01
1.E+00
1.E-01
1.E-02
1.E-03
1.E-04
1.E-05
1.E-04

Elastic Scattering
Absorption
n,alpha
Total

1.E-01

1.E+02

1.E+05

1.E+08

Energy (eV)
Figure 3-2. Silicon cross sections

For silicon exposed in fast neutron beams there are a number of possible
reactions which can occur. These include the

28

Si(n,α)25Mg and the

28

Si(n,p)28Al

reactions. Since the threshold energies for these reactions are of the order of several
MeV such effects will not be so significant for epithermal neutron beams used in
BNCT.
If only the total silicon KERMA (i.e. both ionising and non ionising energy
loss) is taken into account in calculations of the effect of BNCT beams on PIN diodes
then calculations of the dose to silicon will overestimate the amount of damage
expected in the diodes. The total silicon KERMA is the sum of the silicon damage
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Arising from this research are accepted theoretically calculated values of silicon
displacement KERMA which have been published as standard data sets for
reference125. These values have been experimentally validated and found to have
uncertainties of less than 10%. The total and displacement damage KERMAs for
silicon are shown in Figure 3-3.

NEUTRON INDUCED CHANGES IN PIN DIODE I-V CHARACTERISTIC
CURVES
Each dislodged silicon atom which becomes a stable defect in the silicon
lattice will act as a recombination site and therefore have the effect of reducing the
minority carrier recombination time and conductivity of the silicon. The resulting
minority carrier lifetime, τ is given by:

1

τ

=

1

τi

+ KΦ

3-1

where τi is the initial minority carrier recombination time, Φ is the neutron
fluence and K is a constant known as the damage constant. K will be a function of
neutron energy and of the initial resistivity of the silicon.
The relationship between the current - voltage characteristic of a PIN diode
and the neutron fluence it is exposed to was determined by Swartz and Thurston126.
They showed that under conditions of low injection (small currents) and where the
width of the base was small compared to the diffusion length of the charge carriers
(small W/L ratios) the overall neutron sensitivity is negative because the junction
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voltage decreases with decreasing carrier lifetime and this effect predominates. For
low currents but larger W/L ratios the voltage sensitivity is positive as a function of
neutron exposure due to the base voltage increasing as the carrier lifetime and
diffusion length decrease. Under these low current conditions for a given fixed ratio
of W/L the voltage sensitivity is proportional to Kτ and to KW2.
For larger injected currents of carriers the voltage drop across the junctions is
independent of carrier lifetime. Therefore the change in voltage across the diode as a
whole is dominated by the change in voltage across the base section of the diode and
the sensitivity is positive for all values of W/L. For a fixed W/L the sensitivity of the
voltage across the diode to neutron fluence is proportional to Kτ3/2 and to KW3.
From these results it can be seen that the approximate sensitivity of PIN diode
dosimeters is determined at manufacture and can be increased by making diodes with
wider intrinsic silicon base sections. The PIN dosimeter sensitivity could also be
increased by using high resistivity silicon with a large initial carrier lifetimes, τ.
The theoretical predictions of Swartz and Thurston were later summarised
and experimentally verified by Van Antwerp and Youngblood127 who present the
voltage across the base as:
Vb =


2kT
W 
 W 
sinh   tan −1 sinh  
e
 2L 
 2 L 


3-2

Where W is the width of the base region of the diode, e is the electron charge,
T is the temperature and k is Boltzmans constant. L is the diffusion length which is
related to τ the carrier lifetime after neutron irradiation by:
L = Dτ

3-3

Where D is the diffusion constant (i.e.: kTµ/e, where µ is the carrier mobility).
49

100
90

Current (mA)

80
70

Unirradiated PIN
diode I-V curve

60

Irradiated PIN
diode I-V curve

50
40
30
20
10
0
0

1

2

3

4

5

Voltage (V)

Figure 3-4. PIN diode I-V characteristic curves. The curve on the left represents a PIN
diode that has not been exposed to a neutron dose. The carrier lifetime is unmodified. The
curve on the right represents a diode that has been irradiated with neutrons with the
consequent decrease in carrier lifetime in the base section of the diode and resulting increase
in the overall voltage drop across the diode.

PIN READOUT TECHNIQUE

In order to determine the damage imparted to the PIN diodes by neutrons the
macroscopic parameter usually measured is the forward bias voltage for a fixed small
current. In principle it is possible to directly measure the change in carrier lifetimes
by observing the voltage decay across the diode following the disconnection of a
forward bias voltage to the diode. This voltage decay represents the recombination of
carriers close to the junctions and the slope of the curve allows the carrier lifetime to
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be calculated126. For more sensitive diodes with a larger W/L ratio (i.e. wider base
region) this technique is not very accurate. Therefore usually the forward bias voltage
is measured.
A number of authors have described PIN diode dosimetry readout
systems128,129.
Awschalam et al128 describe a reader based on a constant current generator,
sample and hold circuit and a analog to digital converter with display. The constant
current source was set to 25 mA. The voltage across the diode was measured using a
single 10 mS duration pulse of 25 mA during which the forward bias voltage was
captured with the sample and hold circuit. A stability of ±1mV was obtained with
this reader over the course of several days.
Nagarkar et al

129

describe investigating a reader which used a series of three

to five 10 mS duration pulses of 25 mA each. However they found that this method
caused heating of the diode with the consequent annealing of the radiation induced
defects. They therefore developed a reader that employed a single 1 mS duration 10
mA pulse.
Other authors127,

130

conducting experiments more aimed at characterising

silicon damage cross sections in earlier publications employed constant current (non
pulsed) readout circuits with currents of up to 100 mA and as low as 1 mA.
For the PIN diodes used in this work the change in this forward bias voltage
is of the order of 200 mV/cGy of silicon displacement damage dose. For most
epithermal neutron spectra used in BNCT this corresponds to approximately 1-2
mV/cGy of tissue dose. Therefore to measure neutron doses in the range that is useful
for BNCT beam dosimetry changes in the forward bias voltage of a less than 1 mV
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should be accurately measurable.
Readouts of the forward bias voltage change accurate to within 1 mV can be
easily achieved using a constant current source based on a commercial operational
amplifier and a JFET. In practice the readout circuit makes use of a pulsed current
source to avoid ohmic heating of the PIN diode. The effect of constant current
heating the junction would be to heat the diode and anneal some of the neutron
induced defects in the diode.
By using a current source of approximately 1 mA pulsed at a frequency of
about 100 Hz and with a pulse period of 1 mS and a peak detector circuit it is
possible to readout the diodes with a duty cycle of 0.1. This minimises heating of the
diode and annealing of the defects.
That such a biasing scheme leads to minimal heating can be shown by
assuming that the voltage drop across the base of the diode is of the order of 1 volt. If
the power dissipated in the base of the diode is estimated as approximately VI where
V is the voltage drop across the base section and I is the current then the average
power dissipated would be of the order of 1mA x 1volt x 0.1 = 0.1 mW. Assuming a
heat capacity of 0.7 J.g-1.K-1 for silicon and a mass of approximately 2.33 mg (1mm3)
of silicon in the diode the temperature rise would be < 0.1°C per second. Therefore
the temperature in the PIN diode would be unlikely to rise by more than a few °C
during the course of several seconds while it was connected to the pulsed current
source for readout. This is important for two reasons; firstly any annealing is avoided
and secondly changes in the forward bias voltage of the diode due to thermal effects
on silicon conductivity are avoided.
A block diagram of the readout system used to measure the forward voltage
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change of the PIN diodes used in this work is shown in Figure 3-5.
The full circuit131 (including a MOSFET reader incorporated into the same
circuit) is shown in Figure 3-6. This circuit was tested on resistors and showed a
readout accuracy of ± 4mV over the course of several weeks. A standard resistor was
periodically tested to maintain constancy and check calibration. Since most readouts
prior to and following irradiation of the PIN diodes were performed in the same
session over the course of a few hours the accuracy of the readout circuit was
certainly better than ± 1mV and probably better than ±0.5 mV for measurements
performed during one experimental session on single day. The precision of the
readout was ± 0.1mV.

Constant current
source (1 mA)

PIN
Diode

Pulse circuit
(1 mS, ~100 Hz)

Digital Voltmeter
(±0.1 mV)

Peak
Detector

Figure 3-5. Block diagram of PIN diode readout circuit.
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PIN DIODE SPECIFICATIONS

The PIN diodes were obtained from the Institute of Nuclear Research (INR)
Ukraine. They were manufactured with an intrinsic silicon base with a resistivity132
of approximately 50Ω.cm. The width of the base was approximately 1mm. A PIN
diode of the type used in shown in Figure 3-7.

~ 1cm

Figure 3-7. Silicon PIN diode supplied by INR Ukraine as used for measurements in this
thesis.

I-V CHARACTERISTIC

The I-V characteristic curve for a typical unirradiated diode is shown in
Figure 3-8. This was measured directly under constant current conditions rather than
with a pulsed current source as is used for readout during dosimetry measurements.
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Figure 3-8. Measured forward bias characteristic I-V curve for an unirradiated PIN diode.
(Diode #18 from the batch used for all PIN diode measurements described in this thesis.)

TEMPERATURE COEFFICIENT

The PIN diode temperature coefficient was measured as -1.3 mV.°C-1. As
expected the relationship between the forward bias voltage of the diode at a constant
current of 1mA was linear with temperature changes over the range from
approximately 10 - 60 °C. This covers the anticipated operating range of the PIN
diodes. The measurement of this temperature coefficient is described in Chapter 11
of this thesis describing the PIN diode measurements on the Petten HFR HB11 beam.
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Si KERMA / Tissue KERMA

SILICON PIN RESPONSE VERSUS TISSUE EQUIVALENT DOSE.
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Figure 3-9. The Ratio of silicon displacement KERMA125 to tissue KERMA4.

As will be investigated in later chapters the response of the PIN diode
forward bias characteristic as a function of neutron energy is proportional to the
silicon displacement damage KERMA. Over limited energy ranges this is in constant
proportion with tissue KERMA. However the response of a PIN diode to neutron
radiation will not be directly proportional to tissue neutron dose for a general neutron
spectrum. The ratio of silicon displacement KERMA to tissue KERMA as a function
of neutron energy is shown in Figure 3-9. It can be seen that the PIN diode is
relatively more sensitive to fast neutrons.
There are two situations where it may be possible to use a PIN diode to
measure tissue neutron dose. The first of these is where all of the neutrons present
fall into a narrow energy range (eg thermal to several eV) and the silicon to tissue
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KERMA ratio is constant over this range. The second possible situation is where the
total tissue dose is so dominated by the fast neutron contribution that the thermal
neutron contribution is negligible and therefore the under estimate of thermal neutron
dose provided by the PIN diode does not introduce a significant error into the total
neutron dose measurement. This condition may exist for example in close proximity
to californium brachytherapy sources.
However since the PIN diode clearly responds to a wide range of neutron
energies it can be used in combination with activation foil measurements to provide
estimates of tissue dose over a wider range of energies (approximately thermal to 100
keV). The development of a technique for parameterising tissue dose in terms of PIN
diode and foil activation measurements is described in more detail in Chapter 6.
The PIN diode response to a wide range of neutron energies can also be used
as a check on Monte Carlo treatment plans and other dose calculations. In this case
both the tissue dose and silicon displacement dose are calculated using the Monte
Carlo (or other) technique. The accuracy of the tissue dose calculation is then
indirectly verified by ensuring that the measured silicon dose matches the calculated
silicon dose. If good agreement is obtained between the silicon dose measurement
and calculation then confidence is established that the calculated tissue dose is also
accurate. This is based on the response of the silicon to a wide range of neutron
energies. This is a characteristic not shared by most activation foil measurements
where the observed activation is heavily weighted towards activation from thermal
and one or two resonance energies.
The small size and ease of readout of PIN diodes make them useful for
routine in-vivo measurements of this nature compared to ionisation chambers. They
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can also be used in an on-line mode to yield real-time dose measurements for dose
mapping in water phantoms or verification of calculated patient dose distributions
during treatment.
Some measurements aimed at matching measured and calculated silicon
diode responses in phantoms in epithermal beams are described in Chapter 11 and
Chapter 13 of this thesis.

ION CHAMBERS
The ionisation chamber measurements performed or referred to as part of this
thesis (Chapter 11 and Chapter 12) were made using the techniques and equipment
described by Raaijmakers
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and will not be repeated here. They are briefly

described in Chapter 2 under the heading of Dosimetry Techniques.

ACTIVATION FOILS
A number of activation foils were used for determining neutron fluences at
points throughout phantoms for the studies described in this thesis. Resonance foil
activation is one of the best established methods for determining neutron fluxes. It
enables very accurate measurements of the neutron flux at the energy of the neutron
capture resonance in the foil. However the data obtained from resonance foil
activation is point wise flux data for the resonance energies only. Although KERMA
per neutron factors can be used to convert these fluences into doses the true dose
from a spectrum of neutrons cannot be determined on the basis of foil activation data
alone without making some assumptions about the shape of the neutron spectrum at
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energies between those where resonances exist.
Unfortunately, although several suitable activation materials exist which have
resonances in the range from 1 eV up to tens or hundreds of eV, in commonly used
foils there are only sparsely spaced resonances at energies in the keV range which is
of importance for any epithermal BNCT beam (Table 3-1.)

Table 3-1. Resonance energies and resonance integrals for some activation foils used for
neutron flux measurements.

Foil element

Resonance energy (eV)

Resonance integral
(barns)

Au

4.906

1558

Mn

337

14

Cu

580

5.6

In

1.457

3243

Co

132
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Thus the role of foil activation is primarily to serve as a validation of Monte
Carlo transport calculations and for baseline measurements of beam characteristics.
Foil activation data because of its absolute nature lends itself to normalisation of
Monte Carlo flux data and validation of Monte Carlo transport calculations. Due to
the collisional slowing down process of neutrons in a scattering and absorbing
medium such as a patient or tissue equivalent phantom measurements made in the 1
eV - 1 keV range will reflect contributions from incident higher energy neutrons as
well. Therefore although the multi keV neutron spectral component is not being
measured directly using activation foils, in most cases an inaccuracy in the
calculation of that component will be reflected in a corresponding inaccuracy in the
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number of down scattered neutrons. This may be evident in activation foils.
Therefore as a first step in measuring neutron flux distributions activation foils are
most useful. They are irreplaceable in the design and development phase of
characterising neutron beams. They also allow for very accurate determination of
thermal flux and therefore thermal neutron tissue dose from the 14N(n.p)14C reaction
and the

10

B reaction rate and therefore the 10B dose. Ultimately however for routine

patient dosimetry a real time readout of dose rather than just fluence would be useful.
In using activation foils a number of factors must be taken into consideration.
For most resonance activation foils it is necessary to take into account the self
shielding effect of the resonance. Because of the large resonance absorption peak in
the neutron capture cross section at the resonance energy the population of neutrons
at that energy at a small depth inside the foil will be depressed. Therefore if the
fluence calculation derived from the activation of the foil is based on all of the atoms
in the foil without some allowance for self shielding then the resulting fluence will be
too low. Self shielding increases with foil thickness. Therefore the foil thickness
must be known quite accurately and the appropriate self shielding factors applied.
In addition to self shielding effects the thermal neutron activation effects must
be accounted for. To determine the neutron fluence at the resonance energy at a
particular point the thermal and the resonance activation components must be
determined. Usually two foils are used (the cadmium difference method). One is used
bare and the other is enclosed in a Cd cover. The effect of the Cd cover is to shield
the activation foil from thermal neutrons. The cadmium cut off is at approximately
0.5 eV. Therefore the activation on the Cd shielded foil will be due to neutrons
captured by the resonance only. The bare foil will be activated by both thermal
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neutrons and the resonance energy neutrons. The Cd cover must be thick enough to
attenuate all of the thermal neutrons which in practice is easily achieved by using a
thickness of about 1 mm.
The resulting data must be corrected for decay between the time of the
exposure and the time of counting. Using the known resonance integral and the
thermal capture cross section the fluence to which the foil was exposed can then be
calculated.

62

CHAPTER 4

PHOTON

DOSIMETRY

USING

MOSFET

DOSIMETERS
MOSFET OPERATION

MOSFETs are metal oxide semiconductor field effect transistors. A
schematic diagram of a MOSFET is shown in
Figure 4-1. In ordinary operation a small voltage applied to the gate electrode
is used to modulate or switch the current flow between the source and drain
electrodes. The MOSFETS used in this work were developed by INR Ukraine. They
were made on a p-type silicon substrate with a resistivity of approximately 10
ohm.cm. The gate electrode is insulated from the substrate by means of a silicon
oxide insulating layer which has a thickness of approximately 1µm.

γ
Gate
SiO2

Drain

Source

+++++++

-----------Induced n-type channel
~ 5 mm

Figure 4-1. Conceptual schematic outline of MOSFET shown with dosimetry MOSFET
developed by INR Ukraine.
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This is in contrast to commercial MOSFETs where the oxide layer is usually
less than one tenth of this thickness. The gate electrode is formed from a thin
(approximately 1µm) layer of Al deposited on top of the oxide layer. A schematic
representation of the electrode arrangement is shown in Figure 4-2.

Substrate

(g)

Source

(s)

Gate
Drain

(d)

Figure 4-2. Schematic of typical electrode configuration for a dosimetry MOSFET as used
in this work.

In normal operation if there is no potential connected to the gate electrode the
current between the source and drain electrodes will be zero because of the pn
junctions at both. As a positive potential is applied to the gate electrode the holes in
the p type substrate will be repelled from the region under the gate. This forms an ntype channel between the source and drain regions which allows a current to flow.
The gate voltage at which this channel is established and current begins to flow (the
"strong inversion" condition) is called the threshold voltage133, VT, and is given
by138:
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VT = φ MS + φ B −

Qox QB
C ox C ox

4-1

where φMS is potential difference due to the work functions of the gate metal
and the silicon substrate, φB is total potential difference due to band bending, Qox is
charge in the oxide due to processing, Cox is the oxide capacitance and QB is the
charge in the depletion region. As the gate voltage is increased the source drain
current increases. This is shown in schematically in Figure 4-3. The source drain
current can be modeled as being proportional to the square of the voltage on the gate.
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Figure 4-3.

MOSFET characteristic curve for an n-channel MOSFET operating in

enhancement mode.

When it is necessary to routinely measure the threshold voltage of a MOSFET
the potential at which strong inversion occurs as defined in terms of the work
function of the MOSFET materials is not the ideal parameter to measure in practice.
Instead of this some small Id is defined as representing the practical threshold
condition. This current may typically be of the order of several µA or 10's of µA. So
what is actually measured and referred to as "threshold voltage" is actually a potential
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applied to the gate that represents the voltage at which a specified level of current
flows rather than the true "threshold" voltage at which the MOSFET characteristic
curve intercepts the voltage axis on the Id vs Vg graph (see Figure 4-3). The actual
level of current that is chosen to represent the threshold condition for the purposes of
measurements is discussed below.

MOSFET THERMOSTABLE POINT.

The slope of the MOSFET characteristic curve is a function of temperature.
The temperature dependence of the surface inversion potential causes the threshold
voltage (the real theoretical threshold voltage as defined in equation 4-1) to change
with temperature. This change has a small negative coefficient typically leading to
changes in the threshold voltage in the order of 2-3 mV per °C. This effect dominates
the temperature dependence of the characteristic curve at very low drain currents (a
few µA). However at higher drain currents the temperature dependence of mobility,
µ(T), of carriers within the induced channel will have the main impact on the changes
in drain current as a function of temperature. The behavior of µ as a function of
temperature is given by:
T 
µ (T ) = µ (T0 ) ⋅  
 T0 

−1.5

4-2

Therefore the temperature behavior of the transconductance parameter is also
proportional to this change in mobility with temperature, ie.
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T 
β (T ) = β (T0 ) ⋅  
 T0 

−1.5

4-3

The combination of the small negative temperature coefficient for VT and the
temperature dependence of the transconductance at higher levels of Id leads to a
family of Id vs Vg characteristic curves having different slopes but intersecting at a
common point. This has been called the "thermostable point"134, 135.
For the purpose of performing routine measurements of the nominal threshold
voltage of a MOSFET some small predefined level of Id is chosen. In order to
minimise the temperature dependence of the threshold voltage measurements the
value of Id chosen should be the drain current that corresponds to the thermostable
point of the MOSFET. Under these measurement conditions, when no other changes
have affected the MOSFET (radiation etc), the measured values of the nominal
threshold voltage at the thermostable point should change very little.
For the MOSFETs used in the work described in this thesis the thermostable
point was expected to be at approximately 42µA. This was based on information
provided by measurements undertaken by G Kaplan136. For all the measurements
reported in this thesis the nominal threshold voltage represents the MOSFET gate
voltage required to establish Id=42µA. Therefore for brevity and readability any
reference in this thesis to threshold voltage measurements refers to Vg(Id=42µA)
except where stated otherwise.
When the MOSFET is employed as a dosimeter the characteristic curve is
shifted due to radiation effects as described below. Under these circumstances the
drain current at which the thermostable point occurs will also change. Therefore
temperature effects can minimised but not eliminated completely by measuring the
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MOSFET gate potential at a drain current corresponding to the thermostable point.
Variability from one MOSFET to another even within the same batch leads to
different thermostable points in each device134.
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Figure 4-4. Radiation effect on Id vs Vg characteristic of MOSFET.

EFFECT OF RADIATION ON MOSFET

Under exposure to ionising radiation electron hole pairs are produced in the
SiO2 layer as the Si=O bonds are broken. Some of these electron hole pairs
recombine immediately but others become trapped. Holes may be trapped throughout
the oxide or at the insulator - channel interface. These trapped positive charges
throughout the oxide layer have a similar effect to the application of a positive gate
bias. They repel holes from the substrate region underneath the oxide layer thus
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setting up an n-type channel between the source and drain regions. This has the effect
of moving the Id versus Vg characteristic curve to the left (Figure 4-4). In effect to
maintain the same Id the voltage applied to the gate of the MOSFET must become
more negative to compensate for the presence of radiation induced positive charges
in the oxide layer.
In general commercial MOSFETs are made with the oxide layer as thin as
possible to minimise their radiation sensitivity. In the case of the MOSFETs which
were used for our study the oxide layer is 1 µm in order to increase their sensitivity.
The thicker oxide layer impacts on the radiation sensitivity in two ways137. The
thicker the gate oxide layer the greater the potential which must be applied to the gate
to establish an electric field great enough to compensate for the holes distributed in
the oxide. The larger the volume of oxide the more electron hole pairs are generated.
The bias applied to the gate will also influence the sensitivity of the MOSFET
to radiation. If a positive bias is applied to the gate during irradiation a greater
proportion of the holes with some mobility will migrate to regions closer to the SiO2
/ Si interface. The effect of this is that a larger change in the threshold voltage is
required to offset it. A second effect of having a bias applied whilst the device is
being irradiated is that it decreases the recombination of the electron hole pairs
immediately after their formation. This leave more holes free to be trapped and
thereby increases the radiation sensitivity.
Other factors which influence the sensitivity of the MOSFET to radiation
include the method used to grow the oxide layer on the substrate and any impurities
in the oxide layer. This effects the sensitivity via hole and electron transport
mechanisms in the oxide and the number of traps available to immobilise the
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electrons. The temperature of the device will also influence how may of the electrons
and holes are trapped and where they are trapped thereby affecting the threshold
voltage change.
A simple model of the threshold voltage change in irradiated MOSFETs was
developed by Freeman and Holmes-Seidle137. The trapped holes with area charge
density Qox were considered to be located as a sheet of charge at a distance x1 from
the oxide / silicon interface and a distance x2 from the oxide gate interface. The
thickness of the oxide layer was dox = x1 + x2. The presence of Qox in the oxide
induces negative image charges in the silicon, Qs, and in the metal of the gate
electrode, Qm. The magnitude of the charge in the silicon is given by:

Qs =

x2
Qox
d ox

4-4.

To compensate for this charge in the semiconductor the potential applied to
the gate electrode must be reduced by an amount:

ΔVT = −

Qox x 2

ε ox ε o

=−

qN ox x 2

4-5

ε ox ε o

Where ΔVT is the MOSFET threshold voltage shift, εox is the oxide dielectric
constant, εo is the permittivity of free space, q is the electronic charge and Nox is the
number of trapped holes per unit area.
It is further assumed that Nox depends upon the number of holes produced by
ionising radiation, g, and the fraction of these, f(E), which escape recombination and
are available for transport within the oxide layer. This fraction is a function of the
applied electric field, E, in the oxide layer. The number of holes generated, g, can be
estimated based on the average energy required to create an electron hole pair in SiO2
(approx. 18 eV) and the density of the oxide (approx. 2.27 g.cm-3). The fraction of
70

holes that are created and available for transport and that are captured in the trapping
zone of the oxide is designated as A. For a positively biased gate this gives:
N ox = gx 2 . f ( E ). A cm −2 cGy −1

4-6

By combining equation 4-5 and 4-6 it can be seen that the threshold voltage
shift is (at least initially) a linear function of dose to the oxide layer.

 qg 2

ΔVT = −
x 2 . f ( E ). A D
 ε ox ε o


4-7

In the case where x2 = dox, ie all of the trapping assumed to occur right on the
oxide silicon interface, then the change in threshold voltage per unit dose is
proportional to dox2. This is the result given by McGarrity138.
As the amount of dose absorbed by the MOSFET increases the initial linear
relation between dose and ΔVT eventually saturates137. This occurs as traps fill up and
therefore the fraction being trapped, A, decreases. The electric field also decreases
leading to a lower fractional yield f(E).
The amount of change in ΔVT per unit dose as the MOSFET is exposed to
successive radiation doses depends on the potential applied to the gate during the
irradiation. This change in sensitivity was measured for the Ukrainian MOSFETs
used in this thesis under conditions where no bias was applied to the gate during
irradiation. The results of these measurements are described in later chapters. Where
necessary a correction for this saturation effect is applied to MOSFET measurements
described in this thesis. The change of sensitivity with accumulated dose for the
MOSFETs irradiated with a bias applied has also been characterised136.
It has been estimated that when an electron hole pair is created in the oxide
layer the high mobility electrons typically migrate out of the oxide layer within about
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2 picoseconds139, 140. The holes have lower mobilities and under a positive gate bias
migrate towards the oxide - silicon interface where some are trapped. As previously
noted the fraction of holes that are available for transport in the oxide layer,
sometimes called the fractional yield, f(E), is a function of the electric field in the
oxide layer. It is also a function of the pattern of energy deposition along the incident
radiation track and the dose rate. Brown and Dozier141 have modeled the patterns of
energy deposition in SiO2 resulting from different incident energy photons (Co-60
and Cu x-rays). The initial energies of electrons resulting from these incident photons
have different track structures. The volumes within which electron - hole pairs would
be created for each of these track structures were determined and recombination
proportional to the square of the hole density was assumed. A characteristic time
during which recombination could occur before the electron - hole pairs were swept
apart was defined as a function of the applied electric field in the oxide. The results
of this model have achieved a satisfactory match to experimental data142.
Different fractional yields have been observed experimentally for
combinations of various types of radiation and oxide fields. For example138 at an
oxide field of 1 MV.cm-1 the fractional yield is 0.85 for 12 MeV electrons143, 0.7 for
Co-60 gamma rays144 and approximately 0.5 for 5 keV electrons145.

MECHANISM OF FADING

146

The time behaviour of the threshold voltage shift is a function of the various
trapping mechanisms at work. These include, the speed at which holes are trapped
which is almost instantaneous, the slow recombination of holes with electrons at the
SiO2 / Si interface which causes a slight drift in the threshold voltage back to a more
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positive value. The possibilities for holes trapped near the oxide - silicon interface
are summarised by Fleetwood et al139. The first possibility is that the hole is bound in
a trap. In the absence of a trap the hole may arrive at the interface and recombine
with an electron from the silicon. Alternatively the hole may be trapped at the
interface but compensated by a shallow trapped electron. This can in some
circumstances be explained as a tunneling effect. The final alternative is that it may
not be possible for an electron to transfer from the silicon across to the hole in the
oxide layer. However a lattice relaxation associated with the hole transport may take
place which allows a defect or impurity atom to form a trap that can capture an
electron from the silicon. The charge from this electron becomes deeply trapped and
forms a stable dipole with the adjacent trapped hole.
By measuring the thermally stimulated currents from MOS junctions
following irradiation it is possible to elucidate the depth of the trapped electrons and
holes. As the temperature of the MOS is slowly increased the current arising from
electrons and holes escaping from their traps is observed.
Depending on the method of MOSFET manufacture migration of positive
ions within the silicon oxide layer can also play some part in the slow drift of the
measured threshold voltage following MOSFET irradiation.
Over time the holes trapped in the oxide will anneal out (this can be
accelerated by heating the MOSFET - which suggests the possibility of reuse of
MOSFETs for dosimetry purposes however this is not explored in this thesis). At
room temperatures this process takes place on a timescale of months to years for the
MOSFETs that we used. Therefore for measurement techniques that measure the Vth
just before irradiation and again shortly afterwards (minutes to hours) the effect of
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fading is considered to be negligible. Any small initial fading (ie shift in Vth back to a
more positive value) can be allowed for by always measuring at the same temperature
and at a similar delay post irradiation.

EFFECT OF DOSE ENHANCEMENTa

As noted above the fractional yield of trapped holes can vary with the energy
and type of radiation the MOSFET junction is exposed to. Another effect that
impacts upon the sensitivity of MOSFETs and in general may be considered energy
dependant is the so called "dose enhancement" effect. The dose enhancement effect
occurs at all photon energies but becomes most significant for incident energies
below about 100 keV. Dose enhancement is of major interest when considering the
appropriate encapsulation and fabrication materials for manufacture of integrated
circuits to ensure that they have minimal radiation sensitivity.
Dose enhancement in MOSFETs (and other semiconductor devices) arises at
interfaces between materials of different Z. For example between a gold contact
bonded to the silicon chip. It can also occur as a result of high Z materials present in
the device encapsulation as is the case for the MOSFETs in this study. Incident
photons interact147 in the high Z material overlying or surrounding the sensitive part
of the device (SiO2 for the MOSFETs). From these interactions scattered electrons
are produced. These electrons in turn scatter further electrons which deposit their

a

The term “dose enhancement” to describe detector over-response is unfortunate in the context of
BNCT dosimetry where it could be mistaken to imply increased tissue dose. It is used here in the sense
of its accepted meaning in semiconductor device radiation effects literature.
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energy in the surrounding material. At depths in the silicon or SiO2 that are greater
than the range of the secondary electrons from the high Z material dose equilibrium
exists. However at shallower depths there is electronic disequilibrium and the dose is
higher than the equilibrium dose in the silicon or SiO2. The effect is greatest for
higher Z materials overlying the silicon or SiO2 because of the higher photon
interaction cross sections of these elements. The effect is also most pronounced at
lower energies where the photoelectric effect predominates. At higher energies most
interactions are Compton scatters for which the cross section is not very dependant
on the Z of the absorbing material. However even where Compton scatters
predominate some dose enhancement may be seen due to stopping power differences
for the scattered electrons in the two adjoining materials.
For a gold - silicon interface a maximum enhancement factor of
approximately 30 has been estimated for 100 keV x-rays and a maximum
enhancement of about 2 for
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Co gamma rays147. The same authors provide

tabulations based on calculation and experiment for estimating the dose enhancement
factors for various combinations of chip electrodes and chip encapsulations. For a
kovar package with an aluminium electrode covering SiO2 they estimate an
enhancement factor of 1.4 for 60Co gamma rays and a factor of 6.3 - 6.7 for a 15 keV
blackbody x-ray spectrum. This combination of packaging and aluminium electrode
corresponds in general to the structure of the MOSFETs that were used in this thesis.
However calculated enhancement factors such as these (especially the low energy xray estimate) should be treated as estimates only since more recent experiments and
simulations by Fleetwood et al148 have demonstrated inconsistencies between
simulated and measured enhancement factors. This is attributed by Fleetwood et al to
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shortcomings in the TIGER simulation code used for many of the dose enhancement
factor calculations. In particular this may be due to the know inaccuracies of the
TIGER code treatment of low energy electron scattering in low Z materials at the
time those calculations were performed. The failure of the simulations to track
electrons with energies < 1keV was also pointed out by Fleetwood to be a potential
source of inaccuracy since these low energy electrons have been shown to be
important in the pattern of dose deposition and the response of MOSFETs149.
Hamm149 used the OREC code to simulate transport of electrons and calculate dose
and hole distributions in silicon and silicon oxide layered structures. Analog electron
transport was used down to an energy 20 eV below which a condensed history model
was implemented. These simulations demonstrated that transport of electrons with
energies below 9 eV made a significant impact on the spatial distribution of dose and
hole formation in sub µm SiO2 layers. Therefore transport of electrons down to very
low energies is probably necessary for accurate calculation of dose enhancement
factors.
When using any MOSFET as a dosimeter the possible implications of dose
enhancement need to be considered particularly where measurements are being made
in low energy x-ray environments. Failure to take dose enhancement effects into
account could lead to overestimates of measured dose at low energies. The
conversion from absorbed dose in silicon to absorbed dose in tissue also needs to be
taken into account. For this reason the approximate dose response as a function of
energy for the MOSFETs used in this thesis was experimentally measured and is
described in later chapters. However for application to measuring gamma dose rates
in epithermal neutron beams the contribution of very low energy x-rays is not
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expected to be great enough to warrant any special treatment of the raw measured
data to correct for dose enhancement effects. If the MOSFET is calibrated in terms of
threshold voltage change per unit of tissue dose in a high energy gamma field and
measurements are performed in a high energy gamma field then a single gamma
calibration factor should be adequate.
It should be noted however that measurements performed in the presence of
neutrons will lead to some effective "dose enhancement" or over response due to
neutron interactions in the MOSFET packaging. The application of neutron shielding
and calculation of the energy response function for these neutron contributions is
discussed in Chapter 5.

READOUT

CIRCUIT

FOR

DETERMINING

MOSFET

THRESHOLD

VOLTAGE, VT

As previously noted, for routine measurements of VT a drain current was
chosen to match the expected thermostable current. A constant current source was
used to apply the appropriate gate voltage to achieve this drain current. The voltage
applied to the gate could then be determined. The basic measurement configuration is
shown in Figure 4-5.
Because of the virtual ground conditions at the summing point on the
inverting input of the operational amplifier the current determined by V1/R sets the
magnitude of the current through the MOSFET by negative feedback. The MOSFET
gate potential is controlled via the amplifier output to maintain a current equal to
V1/R (typically a few tens of µA). In practice V1 is provided by a regulated reference
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source (eg an LM7912 regulator or similar). The reference voltage may also be
pulsed to minimise noise in the measured

output voltage from the operational

amplifier. For pulsed readout a sample and hold circuit or a peak detector is used to
store the magnitude of the output voltage from the operational amplifier which is
then read on a standard laboratory digital voltmeter.

+15 v

+15 v

R
V1

+

-15 v

VT

Figure 4-5 MOSFET readout circuit. In practice V1 is usually pulsed and VT is sampled
using a peak detector or sample and hold circuit connected to a digital voltmeter.

ACCOUNTING FOR THERMAL EFFECTS DURING EXPERIMENTS
As discussed above, the characteristic curve of a MOSFET undergoes small
changes with temperature. Despite attempting to measure the threshold voltage at a
drain current as close to the expected thermostable point as possible it was observed
that the measured threshold voltage increased as the ambient temperature is
increased. The temperature dependence of the MOSFETs used was measured over
the range of temperatures which were expected to occur in our experiments and in
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normal operation. This measurement was achieved simply by immersing the
MOSFET protected by a waterproof sleeve in a heated water bath. As the bath cooled
the temperature was measured with a mercury thermometer and this was noted along
with the threshold voltage. The results of these measurements are given in a later
experimental chapter. The variation of VT over the expected range of temperatures
shows an approximately linear relationship and is thus easy to correct for in
dosimetry measurements if the temperature is known. The shift in VT per °C was
assumed to be constant over the range of measurement conditions occurring in our
experiments (ie despite radiation induced shifts in the Id vs Vg characteristic curve).
An alternative technique that has been used for correction of temperature
effects150 involves the use of two MOSFETs on the same substrate that have different
gate biases applied during the irradiation. The sensitivity of the threshold voltage to
temperature effects is assumed to be the same but due to the different gate biases
applied during irradiation (and therefore different radiation sensitivities) the change
in VT for each MOSFET is different. The difference in the threshold voltage changes
between the two MOSFETs will be proportional to the radiation dose received and
any shift in VT due to temperature changes will cause the VT on both MOSFETs to be
shifted by the same amount. Therefore temperature independence is obtained.

AUTOMATIC CORRECTION FOR THERMAL EFFECTS
Because the source and drain connections on the MOSFETs are actually p-n
junctions it is possible to utilise this structure to determine the temperature of the
MOSFET. This can be achieved by measuring the forward bias voltage drop across
these p-n junctions. The change in bias voltage with temperature for a given current
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should obey the familiar diode equation:
 eV

I = I 0 e kT − 1



4-8

where V is the applied bias, I0 is the saturation current, k is Boltmann's
constant, e is the electronic charge and T is temperature.
The bias voltage for a nominated current across the source-substrate junction
can be measured at a known temperature or at several temperatures. Then for each
readout of the MOSFET threshold voltage the temperature is calculated from the
source - substrate bias voltage. The temperature calculated from the bias voltage of
the source substrate junction can then be used to read a lookup table to determine the
appropriate temperature correction to the measured threshold voltage. In this way any
temperature variations in the dosimeter response can be internally corrected for. This
technique was not implemented for the measurements performed in this thesis151.

MOSFETS AND NEUTRONS

As described above MOSFETs are sensitive to x-ray and gamma radiation
and this sensitivity is well characterised and has been extensively studied. The
response of MOSFETs to neutrons is much lower and is not so extensively described
in the literature, particularly with respect to any neutron induced threshold voltage
changes.
Typical (non dosimeter) MOSFETs are immune to 1 MeV equivalent neutron
fluences152 of up to 1014 n.cm-2. Thick oxide (dosimetry) MOSFETs have been
reported153 to have sensitivities of up to 0.025 mV.cGy-1 (tissue dose) for 3 MeV
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neutrons and 12 volt bias on a 0.2µm gate oxide.

Displacement damage in

MOSFETs due to neutrons is generally of minor consequence due to the low
resistivity silicon used for MOSFET fabrication. Possible neutron effects on the
oxide layer are limited to single event upsets (SEU) in memory chips and single
event induced burnout (SEB) or gate rupture in power MOSFETs154. Neither of these
effects are relevant when considering the threshold voltage change in small signal
dosimetry MOSFETs.
In the literature most discussion of electronic device neutron sensitivity
(MOSFETS, PIN diodes and other devices) is focused around the effects of fast
neutrons. This is because most of the literature is concerned with neutron radiation
effects from either cosmic origins, high energy accelerators or nuclear weapons. It is
true that these high energy neutrons have minimal effect on MOSFETs. However
when large fluxes of lower energy neutrons are considered (eg epithermal neutron
beams for BNCT) sufficient neutron interactions occur in the MOSFET to have a
significant effect on the threshold voltage. Despite the limited intrinsic sensitivity of
MOSFETs to neutrons the impact of neutrons interacting with the MOSFET
packaging needs to be considered155. The measurement of, and attempts to correct for
this MOSFET sensitivity to neutrons is discussed in later chapters. Ultimately the
optimum design for MOSFETs intended for use in neutron fields should have very
minimal packaging composed of low cross section materials. Certainly the traditional
kovar encapsulation is (as will be demonstrated in later chapters) sub-optimal for
measurements in epithermal neutron beams.
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CLINICAL APPLICATIONS OF MOSFET DOSIMETRY.

The use of MOSFETs for dosimetry in medical or pre-clinical situations156,
157

has recently begun to attract more interest and applications to diagnostic

radiology158,

159, 160, 161, 162, 163, 164

, external beam radiotherapy165,

including IMRT171 and microbeam treatments172

,173

166, 167, 168, 169, 170

,

, as well as therapeutic nuclear

medicine174, 175, 176 have been reported.
One of the principle attractions of MOSFETs for dosimetry is their small size
and the potential for online readout175,

157, 134

. This makes them suited for some

measurements that have previously been performed using TLDs or film.
Dong et al158,

159

have applied MOSFET dosimeters to the measurement of

skin surface entrance doses in mammography and observed good linearity over the
dose ranges typically used. Good energy linearity (~3%) was also reported however
this was over the very limited range of tube potentials from 25 - 30 kV. For a more
general application at a wider range of diagnostic x-ray energies163 the effects of dose
enhancement need to be considered and the encapsulation materials carefully
selected. This applies to both surface dose measurements but also to measurements at
multiple points within phantoms such as were performed by Hintenlang et al160 and
Sessions et al161. Both of these studies used MOSFETs in phantoms to measure
diagnostic radiography doses in pediatric phantoms. In this case spectral changes in
the

incident beam may lead to significant variations in MOSFET response at

different depths in the beam. This may in part account for the larger discrepancies
observed between MCNP calculated doses and MOSFET measurements that were
observed by Sessions et al for points in the phantom that lay outside the field.
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The changes in energy response (at diagnostic x-ray energies) of commercial
MOSFET dosimeters were investigated by Edwards et al177 using a quasimonoenergetic x-ray source (Pantak H320). They investigated the response of
Thompson and Neilson MOSFETs over an energy range from 12-208 keV. The
maximum relative sensitivity was found to occur at an energy of 33 keV. The
response at this energy relative to the response to 6MV x-rays was approximately
4.2-4.4. A similar result was obtained by Kron et al178 using different MOSFETs
exposed in a sychrotron beam. This enabled the MOSFET energy response to be
determined using truly monoenergetic x-rays ranging in energy from 10 - 99.6 keV.
In this study an over-response of approximately 7 times was observed for the
MOSFETs.
The design of some commercial MOSFET dosimetry systems that incorporate
the MOSFET on a small circuit board covered with a bubble of polymer material has
also been shown to lead to significant angular dependence of the devices. This is to
be expected in air and also at diagnostic x-ray energies but has also been reported for
in phantom measurements162.
The low doses in diagnostic radiology limit the accuracy of MOSFET
measurements for typical radiographic exposures since even commercial dosimetry
MOSFETs sold as "high sensitivity" have sensitivities of approximately 3mV.mGy-1.
This leads to a 25% uncertainty (95% CI) for a single measurement of a 1.5 mGy
surface dose163. One approach to overcoming this limited sensitivity is to stack
several MOSFETs in a series in order to increase the total measured threshold
voltage change179. A sensitivity of approximately 5 mV.cGy-1 was achieved for a
stack of 3 MOSFETs irradiated with no bias. This is slightly greater than three times

83

the sensitivity of a single equivalent MOSFET. Accurate compensation for thermal
effects is required for this arrangement180.
In radiotherapy the MOSFET is being used for high spatial resolution
measurements in sharp dose gradients such as x-ray beam penumbra166 where
reproducible spatial resolutions of the order of 0.1 mm have been observed. Doses in
the buildup region of megavoltage x-ray beams have also been measured using
MOSFETs. These surface dose measurements168, 165 gave results within ±2% of doses
measured using an Attix chamber and within ±3% of doses measured using TLD
extrapolation techniques.
The intrinsic high spatial resolution of the MOSFET can be further improved
and exploited by using it in the edge on configuration (as proposed by A
Rosenfeld181). This allows it to be applied to characterisation of x-ray microbeams.
Instead of having the radiation incident on the top surface of the junction (ie normal
to the plane of the gate electrode) the MOSFET is turned on its side so that the 1µm
edge of the SiO2 is presented to the incident beam173. Using this method Kaplan and
Carolan et al173 achieved a spatial resolution of approximately 1 µm in measurements
of the profile of a 200µm wide collimated x-ray microbeam. The same technique was
first used by Rosenfeld et al181 to measure syncrotron microbeams at the KEK Photon
Factory in Japan and the Syncrotron National Light Source at BNL, USA. A spatial
resolution equivalent to the thickness of the gate oxide was again demonstrated.
Automated multiple MOSFET readout systems have facilitated the use of
MOSFETs for IMRT treatment plan verification. Chuang et al

171

have used a

phantom with multiple MOSFET access holes for comparison of measured dose with
dose calculated on a IMRT treatment planning system (Corvus) and found the
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measurements to agree with calculations to within 5%. This compares to 3%
differences between ionisation chamber measurements and calculated doses.
In the field of radioimmunotherapy MOSFETs have been applied to internal
dose measurement. The determination of internal doses in radioimmunotherpay
requires knowledge of the internal dose rate in organs over time. With gamma
emitters this can be achieved using gamma camera images at different time points
subsequent to radionuclide administration. However when selecting radionuclides for
therapy applications gamma emitters are usually avoided in favour of pure beta
emitters to allow more specific dose delivery. MOSFETs fitted into catheters175 have
been inserted into mice receiving antibodies labeled with Y-90. This allowed real
time monitoring of the dose rate in the tumour volume over a period of 23 hours post
injection. Measurements with this system have been calibrated in standard volumes
and validated against EGS4 calculations176.
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MOSFET NEUTRON RESPONSE CHARACTERISATION.

As will be demonstrated by experimental results in later chapters MOSFET
dosimeters respond to neutron irradiation as well as photon irradiation. In order to
characterise the energy dependence of this response accurately a large number of
measurements would need to be performed using a range of monoenergetic or at least
well defined neutron sources of different energies. Unfortunately the availability of
neutron sources covering the energy range of interest (thermal to a few MeV) makes
a purely experimental determination of the MOSFET neutron response impractical.
However the interaction cross sections of the individual materials used in MOSFET
construction are well known. The MOSFET neutron response (in terms of threshold
voltage change per unit neutron flux at a particular energy) will be a complex
function of these cross sections. It will result from both direct neutron interactions in
the silicon oxide layer of the MOSFET as well as interactions of a spectrum of
secondary particles in the silicon oxide layer. These secondary particles arise from
interactions of neutrons within the packaging of the device and are expected to be the
main contributors to the MOSFET neutron reponse.
To use MOSFETs in mixed neutron gamma fields it is necessary to determine
the neutron response so that it can be taken into account when gamma dose
measurements are performed. For this purpose the neutron energy response of the
MOSFET and its package was calculated using MCNP4a182 Monte Carlo radiation
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transport code. Clearly it is not possible to directly determine the threshold voltage
response of the MOSFET to neutrons using MCNP4a. The approach taken was to
model the detail of the MOSFET geometry and thereby simulate the neutron induced
production of secondary particles in the silicon and the MOSFET package. A region
of interest corresponding to the approximate location of the silicon dioxide layer of
the MOSFET was used to tally fluxes of neutrons, photons and electrons.

~ 1 mm

~ 1 mm

Figure 5-1. Photograph of the MOSFET with the lid removed showing internal structure to
be modeled using MCNP.

MCNP MODEL OF MOSFET
The geometry of the MOSFET and its package was determined by removing
the encapsulation and measuring its dimensions with a micrometer. (MOSFET with
lid removed shown in Figure 5-1.) A diagram of the geometry based on these
measurements that was assumed in the model is shown in Figure 5-2. The simulation
of the MOSFET was also repeated with the inclusion of the LiF epoxy shield as was
used in the measurements. The lithiated shield is shown in Figure 5-3 and the model
geometry in Figure 5-4.
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Figure 5-2. The geometry of the MOSFET assumed in the MCNP4a model used to
determine the neutron response of the MOSFET. Not to scale.

~ 1 cm

~ 1 cm

Figure 5-3. Lithium Fluoride / epoxy shield used to reduce neutron contribution to
MOSFET measurements of gamma dose.
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Figure 5-4. The geometry of the MOSFET including the LiF epoxy encapsulation.

The MOSFET structural geometries shown were entered into an MCNP input
file. The only significant departure from equivalence with the real geometry was in
the definition of the SiO2 volume. In the actual MOSFET this is about 1µm thick and
several 10s of µm in length and width. To increase the efficiency of the calculation
the SiO2 layer in the MCNP input was defined to be volume 150µm thick and 2 mm
on edge. This increases the probability of secondary particles generated in the
MOSFET encapsulation contributing to the tallies. This volume is much larger than
the actual oxide layer however it is still small compared to the dimensions of the
MOSFET package. Therefore the efficiency of the calculation can be improved with
this larger tally volume without a large effect on the accuracy of the calculation. As
discussed below the quantities that were tallied were based on fluxes through the
tally volume rather than explicit energy depositions in the tally volume (using the
MCNP *f8 tally for example).
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A spherical shell neutron source centered around the MOSFET was defined.
Such a source allows the simulation of the MOSFET in an isotropic neutron field.
The neutron response function derived using such a source definition will be the
average response considering neutrons from all angles. As a first approximation of
the MOSFET response when it is embedded in a phantom this was considered a
reasonable assumption.

SOURCE DEFINITION
There are a number of ways of approaching the design of the simulation.
Rather than doing a series of simulations using a different monoenergetic sources of
neutrons for each one it was decided to break the spectrum up into a number of
energy ranges or groups. It would be possible to determine a MOSFET neutron
response function with very fine energy resolution using a series of monoenergetic
sources. However this would introduce the risk of using a source energy that either
coincided with or missed altogether a fine structure in the cross section of one of the
MOSFET materials. Therefore with insufficient monoenergetic energy points in the
response function it would be possible to significantly under or over estimate the
energy response for one part of the spectrum. The alternative to this is to break the
spectral range of interest into a series of uniformly sampled discrete groups. By doing
this the entire neutron spectrum (within the range of interest) is sampled. The use of
energy groups of finite width has the effect of smoothing the calculated response
function. However all of the spectrum does contribute to the final result. On the
assumption that the spectra to be measured were reasonably slowly changing
functions of energy seventeen energy bins spanning the energy range from 10-3 eV to
90

1 MeV were used. The energy bins used are shown in Table 5-1.
Since the a priori knowledge of the expected neutron energy response
function was not great a number of separate MCNP runs were performed. A separate
run was used for each source energy group. This allowed the easy redefinition of the
energy bins if necessary without having to re run the simulation for all energies.
Using separate runs for each energy bin also allowed more histories to be selectively
run for particular parts of the neutron spectrum if this was found necessary in order to
improve the variance of the results due to lower neutron responses at those energies.

Table 5-1. Energy groups used for determination of MOSFET neutron energy response
function.

Energy Group Lower Bound (MeV) Upper Bound (MeV)
1

0.001e-6

0.01e-6

2

0.01e-6

0.05e-6

3

0.05e-6

0.1e-6

4

0.1e-6

0.5e-6

5

0.5e-6

1e-6

6

1e-6

5e-6

7

5e-6

10e-6

8

10e-6

50e-6

9

50e-6

100e-6

10

100e-6

500e-6

11

500e-6

0.001

12

0.001

0.005

13

0.005

0.01

14

0.01

0.05

15

0.05

0.1

16

0.1

0.5

17

0.5

1.0
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MATERIAL DEFINITIONS
A number of simulations were run, each one incorporating more detail of the
materials the MOSFETs are made of. The packaging of the MOSFETs is made of an
alloy known as kovar. This is made of iron, cobalt and nickel in the proportions of
0.54, 0.17 and 0.29 by weight with a density of 8.401 g.cm-3. The kovar base inside
the cap and the leads were coated in gold. This was incorporated into the model by
assuming that the kovar in the base and the leads contained 3.28% gold by weight.
This gold was assumed to be homogeneously distributed throughout the kovar rather
than plated on the inner surface. The cap itself was not gold plated and therefore was
assumed to be only kovar. The space inside the kovar base was filled with glass. The
precise makeup of this is unknown so it was assumed to have the following
constituents182; boron, aluminium, sodium, oxygen, silicon in the proportions of
0.037, 0.01, 0.041, 0.535, 0.377 by weight with a density of 2.23 g.cm-3.
Because MOSFET measurements (detailed in later chapters) were conducted
with 6LiF epoxy shields most of the simulations performed included these shields.
Two different sets of lithiated (6Li enriched) epoxy shields were simulated and used
in measurements. Measurements performed at the Petten HFR epithermal neutron
beam used shields with a wall thickness of 0.24 cm and an end cap thickness of 0.34
cm. For the purposes of these simulations the constituency of the lithiated shielding
material was assumed to be 44.6% PMMA and 55.4% 6LiF by weight. The density
was measured as 1.69 g.cm-3. For the measurements performed on the BMRR
epithermal beam at BNL thicker shields were used. The wall thickness was 0.568 cm
and the end caps were 0.8 cm thick on top and 0.6cm thick on the base. The material
was defined as 43% PMMA and 57% 6LiF by weight with a density of 1.69 g.cm-3.
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The MCNP input files for these simulations are given in Appendix A.

TALLIES
The objective of the simulation is to calculate the threshold voltage response
of the MOSFET to irradiation with neutrons of different energies. The threshold
voltage change depends on the amount of ionisation in the silicon oxide layer and the
number of electrons and holes that remain trapped in this insulating layer after the
irradiation.
A tally of the neutron flux through the silicon oxide layer is not adequate for
this purpose because:
1. The neutron flux in the silicon oxide volume does not take into
account the interaction probability of the neutrons with the silicon
oxide.
2. The neutron flux in the silicon oxide layer does take into account the
attenuation of neutrons in the surrounding package materials but does
not take into account doses to the silicon oxide due to secondary
particles generated by neutron interactions in the surrounding package.
Therefore neutron flux in the silicon oxide layer of the MOSFET is not an
adequate proxy for determining the number of electrons and holes immobilised in the
silicon oxide layer.
The average neutron dose in the silicon oxide layer as calculated by MCNP
would be a better quantity to calculate but is not adequate either because:
1. Although the (energy dependent) probability of interaction in the
silicon oxide layer is taken into account much of the kinetic energy
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released in these interactions is carried away by secondary particles
and therefore escapes the silicon oxide volume (which is of the order
of 1µm thick).
2. Although the neutron attenuation in surrounding materials is taken
into account the energy deposited in the silicon oxide layer by the
secondary particles from these interactions is not included in the tally.
The photon flux in the silicon oxide volume is not adequate for determining
the MOSFET response because:
1. The probability of interaction with the silicon oxide is not taken into
account.
The photon flux multiplied by a photon heating factor is not an ideal proxy
for the number of electrons and holes generated and immobilised in the silicon oxide
layer but could be used. In this case:
1. The neutron attenuation in the surrounding package is implicitly taken
into account.
2. The probability of the photon interaction in the silicon oxide layer is
taken into account.
3. Some of the interactions of the photons in the silicon oxide layer will
result in secondary electrons that may in fact escape the oxide layer so
that not all of the energy released in the interaction is deposited in the
oxide layer cell of the model. However the use of the photon heating
tally multiplier in MCNP implicitly assumes that all of the energy
released in the interaction would be deposited in the cell where the
interaction takes place. Therefore the dose deposited by photons in the
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(very thin) oxide layer may be over estimated by use of this technique.
If on average the proportion of the released energy lost from the oxide
cell is similar over the whole range of source neutron energies for this
set of simulations then the neutron response should be approximately
correct. This would be true if the photon energy spectrum in the oxide
layer is similar for all energies of the source neutrons.
4. Since a photon heating tally counts only photon flux and multiplies
this by an energy dependent heating factor for the cell in question no
contributions from non photon secondary particles from surrounding
cells will be included. Electrons generated as a result of neutron or
neutron induced photon interactions in surrounding material will not
be taken into account if they enter the oxide layer volume.
Taking the photon flux in the cell and multiplying it by a photon kerma factor
for the material involved using an FM card in MCNP is essentially the same as using
the heating multiplier as discussed above.
The actual number of electrons traversing the oxide layer can be calculated
using an electron flux tally in MCNP. This technique:
1. Implicitly takes into account neutron (and secondary photon)
attenuation in surrounding materials,
2. Includes the electrons arising from neutron induced photon
interactions in both the oxide layer and the materials surrounding the
oxide layer.
3. Does not take into account the interaction probability of the electrons
in the oxide layer.
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Of all the methods of estimating the neutron induced electron and hole
population in the oxide layer the electron flux may be the best. A short coming of this
method is that many more source neutron histories need to be run in order to achieve
reasonable statistical certainty. Using a track length estimate of photon flux (or this
flux multiplied by a dose factor) is able to reduce the variance of the resultant tally
more quickly because all of the photons passing through the volume of interest can
contribute to the tally even if they do not actually under go any interaction in the
oxide layer cell.
In principle an improvement on simply counting the electron flux in the
silicon oxide cell would be to tally the amount of dose deposited by the electrons in
the volume of interest. This can be achieved using a *f8 tally in MCNP. However the
size of the cell defining the silicon oxide layer involved is such that this is
calculationally very inefficient since the path lengths in the oxide layer are very short.
The actual silicon oxide layer is of the order of 1µm thick and the region under the
gate electrode is about 50µm wide.
The problem was run in neutron, photon and electron mode in order to track
all of the particles generated by the incident source neutrons. The following tallies
were generated during each simulation run; photon flux, photon heating, photon flux
* silicon gamma kerma, electron flux and average neutron dose.

RESULTS

The tallies as a function of the source neutron energy groups are shown in the
following figures for a MOSFET contained in a 6LiF-epoxy shield. Note that with the
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exception of the tally of SiO2 neutron KERMA in the oxide layer all the other
response curves have approximately the same form.
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(arbitrary units)
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Figure 5-5. MCNP calculated MOSFET average neutron response. Neutron flux times SiO2
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Figure 5-6. MCNP calculated photon flux in the silicon oxide layer as a function of the
incident neutron energy.
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Figure 5-7. MCNP calculated photon heating in silicon oxide layer. (-6 tally multiplier).
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Figure 5-8. MCNP MOSFET neutron response for MOSFET in thick LiF shield (as used in
BMRR measurements). Gamma flux multiplied by the SiO2 photon kerma.
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Figure 5-9. MOSFET neutron response. Electron flux in SiO2 layer. Note that the statistical
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uncertainties for some of this data are in the range of 10 – 100%.
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Figure 5-10. MCNP calculated photon heating in silicon oxide layer for MOSFET with
thick LiF shield
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For the sake of comparison the response function of a MOSFET encapsulated
in the thicker lithiated shielding (as used for the BNL experiments) is shown in
Figure 5-10.
Comparing Figure 5-7 and Figure 5-10 shows that the thicker shielding does
reduce the neutron response by a small amount. As expected this is especially so for
thermal neutrons. Unfortunately further increasing the size of the shielding eliminates
any size advantage the MOSFET has. Increasing the amount of lithiated shielding
also contributes to a possible reduction in neutron flux not only within the shield but
also in the surrounding medium. This suppression of neutron flux may in turn reduce
the level of induced gamma dose at the measurement point.
A preferable option is therefore to make use of MOSFETs without
encapsulation such as kovar and to eliminate other materials such as gold from the
packaging as far as possible. Once the amount of encapsulation around the MOSFET
junction is sufficient to absorb recoil protons and other ions generated by neutron
reactions in the surrounding phantom the neutron sensitivity should be as low as
possible. If the encapsulation material is of minimum size, is low Z and does not
contain hydrogen then the MOSFET junction should be approximately in equilibrium
with the photon and electron flux in the surrounding tissue materials. This should
enable measurements of gamma dose with minimal neutron contribution. A
MOSFET design with the junction in a graphite encapsulation of suitable thickness to
block most neutron generated secondary charged particles originating outside the
device would be a good configuration to evaluate. All kovar and gold should be
eliminated except for the essential electrical contacts and even these should be made
from an alternative material if possible. Unfortunately implementation of such a
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design was beyond the scope of this thesis.

NORMALISATION

OF

THE

CALCULATED

NEUTRON

RESPONSE

FUNCTIONS

In order to use these response functions to correct actual MOSFET
measurements in neutron beams they have to be normalised or calibrated in terms of
the MOSFET threshold voltage change per unit neutron response. The overall
scheme used to normalise the calculated MOSFET neutron responses is shown in
Figure 5-11.
For the Petten HFR measurements the response curves shown above were
used as tally multipliers in a subsequent MCNP simulation of an experiment where
the MOSFETs were irradiated using the HB11 epithermal neutron beam in Petten
(described in Chapter 12). The HB11 neutron spectrum was assumed to be known
and the gamma dose component of the beam was also assumed to be known.
From this (neutron only) simulation the integral MOSFET neutron response
in terms of the above response functions was determined. The threshold voltage
changes from the real experiment were then used with this data to find the MOSFET
neutron response in terms of mV of threshold voltage shift per unit of the response
functions above. The units of these response functions were in terms of fluxes per
source particle as per the usual MCNP conventions.
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Figure 5-11. Overview of technique used to normalise the MOSFET neutron response
functions determined using MCNP.

An alternative method used the observed threshold voltage change of
MOSFETs irradiated in the MOATA TC-10 thermal column at Ansto. In this case it
was assumed that thermal neutron fluence in the TC-10 facility was known on the
basis of gold foil activation measurements and also that the gamma dose rate was
known on the basis of previous ionisation chamber measurements at the TC-10
facility. Under these circumstances a direct determination of the MOSFET thermal
neutron sensitivity was possible (in terms of mV of threshold voltage change per
n.cm-2). This factor can then be used to calibrate the thermal part of the response
functions shown above and the rest of the curve is then normalised to this.
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NORMALISATION OF MOSFET NEUTRON RESPONSE USING HB11 AT
PETTEN AND BMRR AT BNL.

A MCNP model of the HB11 beam was used to convolve the HB11 neutron
spectra at the measurement point (20 cm from the face of the beam port) with the
MOSFET neutron response functions derived from the detailed MCNP model of the
MOSFET described above. The details of the HB11 beam model were the same as
those used for all of the MCNP simulations of that facility in this work and are
described in more detail in the chapter on the measurements at the Petten reactor. The
model of the beam geometry included collimators and treatment room but did not
include the model of the reactor core. At the point where the MOSFETs were
exposed a thin tally volume (0.25 cm) was used to determine the neutron flux with a
f4 type tally. Three such tallies were generated. One was multiplied by the MOSFET
energy dependent response function based on the photon kerma in the silicon oxide
layer of the MOSFET (i.e. the one shown in Figure 5-8). The second was multiplied
by the response function represented by the photon heating tally in the silicon oxide
layer of the MOSFET ( Figure 5-7). The third tally was multiplied by the energy
dependent electron flux in the MOSFET oxide layer (Figure 5-9).
This results in three numbers, each one representing the neutron response for
a MOSFET exposed at the measurement point in the HB11 beam as determined using
each of the three different curves for MOSFET neutron responses. Note that the units
of the calculated response functions are in terms of either MeV per source neutron
(for the KERMA and heating tally) or electron flux per cm2 per source neutron for
the electron flux representation of the response function. When these response
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functions are then used as histogram tally multiplying factors in the HB11 beam
model the final quantities will be per source neutron in the HB11 beam model. Using
the measured threshold voltage changes in the HB11 beam a normalisation factor can
be determined which converts the response functions (or MCNP tallies multiplied by
the response functions) to units of threshold voltage change per source neutron (as
per Figure 5-11).
The determination of the response function and normalisation was performed
in a similar manner for the MOSFET detectors in the thicker shielding which were
used for the measurements at BMRR. Again the spectrum of the bare beam at BMRR
was assumed to be known and was used as the calibration spectrum for determining
the normalisation factors for the response functions.

USE OF CALCULATED RESPONSE FUNCTIONS TO CORRECT MOSFET
MEASUREMENTS IN MIXED GAMMA NEUTRON FIELDS.

Once the MOSFET response functions have been generated and normalised in
some known neutron spectrum they can be used to correct MOSFET measurements
of gamma dose where there is a significant neutron contribution. Firstly a
measurement using the MOSFET is made. The threshold voltage change is recorded.
The neutron spectrum at the measurement point also needs to be known. This
spectrum is multiplied by the MOSFET neutron response function and the previously
determined normalisation factor is applied to yield the neutron component of the
threshold voltage change. This neutron component is subtracted from the total
measured threshold voltage change. The remaining component of the threshold
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voltage change is attributed to gamma dose. The known gamma sensitivity factor is
then applied to determine the measured gamma dose.
This technique was used to apply the neutron response functions calculated in
this chapter to correct gamma dose measurements performed in phantoms in the
Petten HB11 and BMRR epithermal neutron beams. The results of these
measurements are detailed in later chapters.
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CHAPTER 6

MONTE CARLO IDEAL BEAM STUDY OF PIN
DIODES

FOR

EPITHERMAL

NEUTRON

DOSIMETRY

INTRODUCTION: USING PIN DIODES AND FOIL ACTIVATION TO
MEASURE TISSUE NEUTRON DOSE

In this section an attempt is made to demonstrate that it is possible to
experimentally measure the tissue dose at a point in a phantom or patient by means of
silicon PIN diode and activation foil measurements.
Both of these measurement techniques are relatively easily applied and due to
the small size of the detectors involved lend themselves to high resolution spatial
measurements. They are also insensitive to the photon component of the mixed field.
These qualities of such a technique are advantages not necessarily shared by paired
ionisation chamber techniques.

AIM
The hypothesis is that it should be possible to parameterise the neutron
contribution to tissue dose at a point in the mixed epithermal neutron and photon
field in terms of silicon displacement damage KERMA and one or more foil
activation terms (for some predefined range of neutron energies). That is:
Tissue Dose = A * (Si Damage KERMA) + B * (Foil Activation)
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Where A and B are coefficients to be determined. The silicon damage
KERMA can be measured using silicon PIN diodes. Likewise foil activation can be
measured directly in the normal way.
ASSUMPTIONS

For the proposed technique to be generally applicable, it is not adequate to
demonstrate simply that the tissue dose can be expressed as a function of silicon dose
and foil activation at some point in a particular epithermal neutron spectrum. Such a
demonstration would be subject to unknown inaccuracies for any different epithermal
spectrum or at any points other than those where the relationship was demonstrated.
To be generally applicable the relationship between neutron tissue dose, silicon
displacement damage and foil activation must be shown to hold and for all
anticipated neutron spectra. Even then some assumptions need to be made regarding
what constitutes “all anticipated neutron spectra”.
It was assumed that the spectra to which this technique is to be applied are
epithermal neutron spectra designed for BNCT use. It was further assumed that if a
series of (simulated) monoenergetic neutron beams ranging in energy from 0.25 eV
up to 1 MeV were applied to a brain tissue equivalent phantom and the spectra at
points along the beam axis of this phantom were considered then this should
constitute the basis set of all anticipated spectra. In practice even the small
component of neutrons with energies greater than 1 MeV in some epithermal beams
may invalidate this assumption at shallow depths in phantoms. Although all real
BNCT treatment beams will not be ideal monoenergetic beams clearly a linear
combination of ideal beams can be used to construct the desired spectrum of any
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actual beam. Likewise the moderated spectrum of an actual epithermal neutron beam
at some point in a phantom will be a linear combination of the moderated spectra of
the individual ideal beams that combine to make the actual spectrum of the incident
epithermal beam. That is if an incident monoenergetic neutron beam, φinc(E1), with
energy E1, impinges on a phantom then at some point x in that phantom the resultant
spectrum is φE1(E,x). A more general incident spectrum can be represented as a linear
combination of monoenergetic beams, i.e.:
n

Incident Spectrum = ∑ anφinc ( En )

6-1

0

The resulting spectrum at some point x in the phantom is then:
n

Moderated Spectrum( x) = ∑ anφ En ( E , x)

6-2

0

As an initial approximation it was assumed that the variations in density and
materials encountered within the body would not cause the neutron spectra in that
region to depart so radically from the spectra found in the phantom as to invalidate
the relationships between tissue dose, silicon dose and foil activation derived on the
basis of the spectra in the homogeneous tissue phantom. It is noted however that of
course the variations in materials and densities encountered in the body will lead to
very different KERMA’s and doses as the tissue elemental constituency changes. In
order to determine the doses appropriate to the different tissue types it would be
necessary to derive a separate relationship between the dose for each tissue type and
the measured parameters, i.e. silicon dose and foil activation.
(A simulation with an incident neutron energy of 10 MeV was also run.
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Although neutrons of this energy constitute a small fluence component of most
proposed epithermal BNCT neutron beam sources they can make a significant
contribution to the PIN diode response.)
METHOD

A series of Monte Carlo (MCNP4a) simulations were performed. The input
file for the MCNP model is included in Appendix C. The problem geometry was a
cylindrical phantom of ICRU 92 brain equivalent material at room temperature with
density 1.04 g.cm-3. The phantom was 16.0 cm in diameter and 23.0 cm long. A
parallel neutron beam of 10.0 cm diameter was normally incident on one end of the
cylinder.
The resultant moderated neutron spectrum and some tallies modified by
KERMA factors and foil activation cross sections were tallied in coaxial cylindrical
volumes of diameter 0.5 cm along the axis of the phantom. The first tally cell on the
front face of the cylinder was 0.25 cm thick. The next 30 tally cells were each 0.5 cm
thick. This resulted in a neutron spectra being tallied in 31 volumes along the axis of
the cylinder from the front face upon which the neutron beam was incident to a depth
of 15.25 cm. The size of the tally cells (0.5 cm) was chosen to approximate the order
of magnitude of the dimensions of the PIN diodes and activation foils. This
minimises the effect of averaging the resultant neutron spectra over a volume that is
larger than the measurement devices to be used. Since the spectra are expected to be
quite well moderated and far from monoenergetic at most points in the phantom the
effect of averaging the neutron spectra over volumes slightly larger than the detectors
in question is probably not great in terms of deriving the required relationships
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between the measured quantities and tissue dose. However it was considered best to
avoid this potential source of error.
In addition to the neutron spectra the following quantities were tallied in each
cell; silicon damage KERMA, brain tissue equivalent KERMA, gold foil activation,
copper foil activation and manganese foil activation. Each of the foil activations was
broken up into sub and super cadmium cutoff energy bins. The silicon damage
KERMA and the tissue KERMA was also broken up into several energy bins to
allow retrospective analysis of the contributions of each part of the spectrum if
necessary.
A series of simulations was performed with monoenergetic neutron beams
ranging from 0.25 eV to 10 MeV. The energies used were; 0.25 eV, 1 eV, 10 eV, 100
eV, 500 eV, 700 eV, 1 keV, 2 keV, 5 keV, 10 keV, 20 keV, 30 keV, 50 keV, 100
keV, 1 MeV and 10 MeV. Each simulation was run for 100 minutes on a 366 MHz
Pentium II PC. The number of histories run during this time varied depending on the
source energy.
The tallies of KERMAs and foil activations for each of the cells along the
axis of the phantom were extracted to a Microsoft Excel spreadsheet. These
quantities were then plotted as a function of depth in the phantom for each incident
energy. The raw MCNP output quantities were in terms of cGy.cm2 per source
neutron for the KERMAs and activation reactions per source neutron for the foil
activation results. This resulted in the tissue and silicon KERMA values in each tally
being numerically many orders of magnitude smaller than the activation quantities
due to the units used for each. To overcome this for the purpose curve fitting and
regression analysis the silicon KERMA was scaled by a factor of 1016 and the tissue
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KERMA was scaled by a factor of 1013.
These MCNP tally quantities were not converted to experimental observable
quantities (i.e. PIN diode bias voltage change and saturation activities) at this stage.
A least squares regression analysis was used to fit the tissue dose at each
point in the phantom as a function of the silicon damage KERMA, and the foil
activation (Microsoft Excel Regression Analysis Tool). This could be achieved with
minimal residuals for the depth dose curves associated with individual ideal beams.
However to be generally applicable it is necessary to achieve a good fit for all of the
ideal beam depth dose curves at once. This ensures that the coefficients derived in
this process will be as accurate as possible for the whole range of neutron energies
encountered in an epithermal neutron beam.
Various forms of relationships between the tissue dose and the silicon dose
and the foil activations were tested. Initially a simple linear combination of all terms
was tested. This included silicon damage KERMA, sub-cadmium cutoff and total
activations for gold, manganese and copper foils. One by one the least significant
terms were omitted from the regression analysis in order to get the simplest
expression possible. The fitted curves derived using this process were assessed on the
basis of the residuals and by visually checking to see at what energies and at what
depths deviations from the calculated tissue dose occurred. Where agreement could
not be achieved over all energies the effect of removing the higher energy ideal beam
data was investigated. However this is not considered a good solution overall since it
will result in inaccurate results if high energy neutrons are present in the spectrum
being measured. This is particularly so due to the higher response of silicon at higher
neutron energies.
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Once a set of coefficients was derived a MCNP simulation was performed
using a realistic epithermal neutron beam spectrum incident on the same phantom.
The silicon dose and foil activations in each tally cell in the phantom were calculated.
This data in conjunction with the previously determined coefficients was used to
calculate the expected tissue dose at each point along the phantom axis. These
predicted values were then compared with the direct MCNP calculated values of the
tissue dose at the same points. The correct factors for conversion from MCNP tally
quantities to experimentally observable quantities were then determined to allow
application to experimental data.

RESULTS

From the curves shown in Figure 6-1 to Figure 6-15 it can be seen that the
tissue and silicon damage KERMA curves are well behaved as expected, so are the
foil activation curves. The fluctuations in some of the activation curves are due to
statistical error in some tallies at some energies. The problem is then one of choosing
the best combination of parameters that will describe the tissue depth dose curves
over as wide a range of incident neutron energies as possible. The process used was
guided by a number of objectives. To minimise the number of experimental pieces of
data required, e.g. use total foil activation if possible to avoid the need for cadmium
covered foil measurements and to use as few different types of foils possible. To
obtain an expression using the smallest number of parameters derived from the
experimentally observable quantities adequate to describe the tissue dose for the
neutron energy range of interest.
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Figure 6-1. Tissue, Silicon KERMA and foil activation for a 0.25 eV ideal beam.
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Figure 6-2. Tissue, Silicon KERMA and foil activation for a 1 eV ideal beam.
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Figure 6-3. Tissue, Silicon KERMA and foil activation for a 10 eV ideal beam.
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Figure 6-4. Tissue, Silicon KERMA and foil activation for a 100 eV ideal beam.
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Figure 6-5. Tissue, Silicon KERMA and foil activation for a 500 eV ideal beam.
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Figure 6-6. Tissue, Silicon KERMA and foil activation for a 700 eV ideal beam.
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Figure 6-7. Tissue, Silicon KERMA and foil activation for a 1 keV ideal beam.
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Figure 6-8. Tissue, Silicon KERMA and foil activation for a 2 keV ideal beam.
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Figure 6-9. Tissue, Silicon KERMA and foil activation for a 5 keV ideal beam.
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Figure 6-10. Tissue, Silicon KERMA and foil activation for a 10 keV ideal beam.
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Figure 6-11. Tissue, Silicon KERMA and foil activation for a 20 keV ideal beam.
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Figure 6-12. Tissue, Silicon KERMA and foil activation for a 30 keV ideal beam.
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Figure 6-13. Tissue, Silicon KERMA and foil activation for a 50 keV ideal beam.
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Figure 6-14. Tissue, Silicon KERMA and foil activation for a 100 keV ideal beam.
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Figure 6-15. Tissue, Silicon KERMA and foil activation for a 1 MeV ideal beam.

The initial strategy was to use regression analysis to fit the data starting at the
lowest energies first. This is because for any initial neutron beam energy it must be
assumed that all lower energies are present due to neutrons slowing down in the
moderating media of tissue. As a satisfactory fit was obtained higher incident neutron
energies were included.
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Figure 6-16. Silicon125 and tissue4 KERMAs.

An inspection of the tissue and silicon damage KERMA’s as a function of
energy as shown in Figure 6-16 suggests that there are several discrete neutron
energy ranges where there is a simple ratio between the silicon and the tissue doses.
However these ratio’s vary from one section of the curves to another and
dramatically so once energies approaching 100 keV are reached. At this point fine
structure in the silicon KERMA curve will prohibit using any simple energy index
parameter to “scale” the silicon dose as measured by a PIN diode to a tissue
equivalent dose.
SPECIAL CASE: EN < 10 EV
For an environment with only sub 10 eV neutrons present the relationship is
trivial. This can be seen from Figure 6-16. A linear regression with only one
parameter (Silicon damage KERMA) is adequate. When the regression analysis is
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done for the 0.25, 1 and 10 eV depth dose curves the following result is obtained.
DTE = a1 DSI

6-3

Where DTE is the MCNP tissue dose tally in cGy, DSI is the MCNP silicon
damage KERMA tally in cGy and a1 = 0.3950(±0.0009) x 103. (Confidence interval
at 95% level.) The r2 was 0.999. The resulting depth dose curves for the ideal beams
are shown in Figure 6-17. When the same value of a1 is used for depth dose curves
with incident neutron energies of up to 500 eV a satisfactory fit is observed. As the
incident neutron energy increases the scaled silicon KERMA tends to over estimate
the tissue dose at shallow depths. At 500 eV the over estimate is approximately 7%
for depths less than 0.5 cm. This can be also be seen in Figure 6-17.
However with an incident neutron energy of 700 eV (not shown in figure) this
over estimate has reached 14.5% for depths of less than 0.5 cm. The deviations from
tissue equivalence at depths greater than 1.0 cm are still less than 1%.

TWO PARAMETER FIT

If two parameters are used it is possible to extend the energy range over
which a satisfactory fit is achieved. Using a linear combination of the silicon damage
KERMA and sub-cadmium cutoff contribution to the gold foil activation for energies
between 0.25 eV and 30 keV achieved an acceptable fit with r2=0.9996.
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Figure 6-17. Silicon KERMA based estimate of tissue dose for 0.25, 1, 10 eV and 500 eV
ideal beams using single factor to scale silicon damage KERMA to tissue dose. Coefficient
based on depth dose curves for ideal beam with energies 0.25 eV - 10 eV.

The tissue dose DTE (cGy) was fitted with silicon damage DSI (cGy) and foil
activation Act (Bq/atom):
DTE = a1 DSI + b1 Act

6-4

The coefficients were a1=0.2817(±0.0006)×103 and b1= 0.394(±0.007)×10-13,
where a1 is the coefficient for the silicon KERMA tally and b1 is the coefficient for
the sub cadmium cutoff activation tally (dimensions: cGy.atoms/Bq). These curves
are shown in Figure 6-18 and Figure 6-19. Deviations of the estimate from the
calculated tissue equivalent depth dose profiles occurred predominantly within the
first 1 cm of the depth dose profile. All deviations were less than 3% except for the
first 1.5 cm at some ideal beam energies. All deviations greater than 3% were less
than 10% except for a 14% underestimate at 0.125 cm depth in the 100eV beam.
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Figure 6-18. Tissue equivalent dose and fitted curve based on silicon KERMA and sub
cadmium cutoff gold foil activation (0.25,1, 10, 100, 500, 700, 1000, 2000 eV ideal neutron
beams). Coefficients based on ideal beams from 0.25 eV - 30 keV.
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Figure 6-19. Tissue equivalent dose and fitted curve based on silicon KERMA and sub
cadmium cutoff gold foil activation (5, 10, 20, 30 keV ideal neutron beams). Coefficients
based on fitting ideal beam depth dose curves from 0.25 eV - 30 keV.

Similar results were observed over the 0.25 - 30keV energy range using the
silicon KERMA and the total copper foil activation (Figure 6-20 and Figure 6-21). In
this case the coefficients were a1=0.2806(±0.0007)×103 and b1=9.98(±0.19)×10-13 for
the silicon KERMA and the copper activation tallies respectively.
A similar or marginally superior fit was achieved with the silicon KERMA
and the total manganese activation (r2=0.99) for the same neutron energy range. The
coefficients were a1=0.2808(±0.0006)×103 and b1=2.846(±0.051)×10-13 respectively.
The calculated tissue dose and estimates based on calculated silicon damage and
manganese activation are shown in Figure 6-22 and Figure 6-23.
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Figure 6-20. Tissue equivalent dose and fitted curve based on silicon KERMA and copper
foil activation (0.25,1, 10, 100, 500, 700, 1000, 2000 eV ideal neutron beams). Coefficients
based on fitting ideal beam depth dose curves from 0.25 eV - 30 keV.
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Figure 6-21. Tissue equivalent dose and fitted curve based on silicon KERMA and copper
foil activation (5, 10, 20, 30 keV ideal neutron beams.
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Figure 6-22. Tissue equivalent dose and fitted curve based on silicon KERMA and
manganese foil activation (0.25,1, 10, 100, eV ideal neutron beams).
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Figure 6-23. Tissue equivalent dose and fitted curve based on silicon KERMA and
manganese foil activation (0.5, 0.7, 1, 2, 5, 10, 20, and 30 keV ideal neutron beams).
Coefficients based on fitting ideal beam depth dose curves from 0.25 eV - 30 keV.
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EXTENSION TO NEUTRON ENERGIES > 30 KEV

Attempting to fit a linear combination of foil activations and silicon dose to
sets of ideal beam depth dose (TE) profiles that included neutron energies greater
than 30 keV significantly increased the errors in the estimate of the tissue dose.
Regression fits of tissue dose to linear combinations of silicon damage kerma
and total manganese and total copper activation were obtained for ideal beam
energies up to and including 100 keV. The fitted tissue dose curves for ideal beams
based on a linear combination of silicon damage and copper activation are shown in
Figure 6-24 and Figure 6-25. In this case the coefficients are a1 =
0.287(±0.0035)×103, b1 = 7.55(±2.3)×10-13.
For incident ideal beam energies less than 5 keV these coefficients lead to an
under estimate of the tissue dose which is most pronounced between depths of 1 3.5cm in the phantom. Over this depth range the average magnitude of the
underestimate of the tissue dose based on silicon damage and copper activation is
approximately 5 - 6 % when the incident energy is less than 5 keV. For energies from
5 keV to 30 keV the magnitude of the underestimate at these depths is approximately
1%. At 50 keV the under estimate is about 7% and at 100 keV the silicon and copper
activation based value overestimates the actual tissue dose by an average of 19% over
depths from 1 to 3.5 cm.
At depths from 4 cm to 15cm in the phantom the average discrepancy
between the estimate based on the silicon damage / copper activation and the tissue
dose is 4 - 5% underestimate. This is true of all the beam energies except for the 100
keV beam where the silicon / copper data exceeds the tissue dose by 5% on average.
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Figure 6-24. MCNP calculated TE dose (solid curves) in a cylinder phantom exposed to
ideal beams of 0.25, 1, 10, 100, 500, 700, 1000 and 2000 eV neutron beams. The data points
show an estimate of tissue dose based on MCNP simulated silicon kerma and copper foil
activation. Coefficients based on ideal beam energies from 0.25 eV -100 keV.
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Figure 6-25. MCNP calculated TE dose (solid curves) in a cylinder phantom exposed to
ideal neutron beams of 5, 10, 20, 30, 50 and 100 keV. The data points show an estimate of
tissue dose based on MCNP simulated silicon kerma and copper foil activation. Coefficients
based on ideal beam energies from 0.25 eV -100 keV.

The same procedure was followed for the silicon damage and manganese
activation data. The results for these are shown in Figure 6-26 and Figure 6-27.

127

6.0

0.25 eV

5.0

Tissue Dose (x10 13 cGy / source
neutron)

Tissue Dose (x10 13 cGy / source
neutron)

6.0
TE
Si and Mn activation

1 eV

5.0

4.0

TE
Si and Mn activation

4.0

3.0

3.0

2.0

2.0

1.0

1.0

0.0

0.0

0

2

4

6

8

10

12

14

16

0

2

4

6

Depth (cm)

8

10

12

14

16

Depth (cm)

6.0
5.0

TE
Si and Mn activation

4.0

Tissue Dose (x10 13 cGy / source
neutron)

Tissue Dose (x10 13 cGy / source
neutron)

6.0

10 eV

TE

100 eV

5.0

Si and Mn activation

4.0

3.0

3.0

2.0

2.0

1.0

1.0

0.0

0.0

0

2

4

6

8

10

12

14

16

0

2

4

6

Depth (cm)

8

10

12

14

16

Depth (cm)

Tissue Dose (x10 13 cGy / source
neutron)

500 eV

5.0

TE
Si and Mn activation

Tissue Dose (x10 13 cGy / source
neutron)

6.0

6.0

700 eV

5.0

TE
Si and Mn activation

4.0

4.0

3.0

3.0

2.0

2.0

1.0

1.0

0.0

0.0
0

2

4

6

8

10

12

14

0

16

2

4

6

8

10

12

14

16

Depth (cm)

Depth (cm)
Tissue Dose (x10 13 cGy / source
neutron)

TE

1 keV

5.0

Si and Mn activation

Tissue Dose (x10 13 cGy / source
neutron)

6.0

6.0

2 keV

5.0

TE
Si and Mn activation

4.0

4.0

3.0

3.0

2.0

2.0

1.0

1.0

0.0

0.0
0

2

4

6

8

10

12

14

0

16

2

4

6

8

10

12

14

16

Depth (cm)

Depth (cm)

Figure 6-26. Ideal beam study. Silicon damage KERMA and Mn activation estimate of
tissue dose, 0.25, 1, 10, 100, 500, 700, 1000 and 2000 eV neutron beams. Coefficients based
on ideal beam energies from 0.25 eV -100 keV.
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Figure 6-27. Ideal beam study. Silicon damage dose and manganese activation estimate of
tissue dose. Incident neutron beam energies of 5, 10, 20, 30, 50 and 100 keV. Coefficients
based on ideal beam energies from 0.25 eV -100 keV.

When the MCNP calculated tissue dose is fitted to a linear combination of the
silicon damage dose and the manganese activation the coefficients are found to be;
a1= 0.2874(±0.0035)x103 and b1= 2.157(±0.66)x10-13.
The accuracy of this fit was similar to the results using silicon damage and
copper activation detailed above. At 2 keV and below the fitted data tended to
underestimate the tissue equivalent dose at depths between 1 and 3.5 cm. The
129

average magnitude of this underestimate was 5 -7 % for ideal neutron beam energies
of 2 keV and below. For energies between 5 keV and 30 keV the average difference
for depths from 1 cm to 3.5 cm was between -1% and +1%. At 50 keV the silicon
and manganese data underestimated the tissue dose by an average of 7% over the
same range of depths. For the same depths the estimate of tissue dose in the 100 keV
beam was approximately 20% in excess of the MCNP calculated tissue dose. At
depths of 4 cm or greater the silicon and manganese based estimate of tissue dose
was on average between 4 and 5% below the calculated tissue dose for all ideal beam
energies tested except 100 KeV. In the 100 keV beam the average silicon and
manganese based estimate was 5% above the tissue dose at depths greater than 4 cm.
Unfortunately if the coefficients (a1 and b1) derived on the basis of ideal
beams having energies between 0.25 eV and 100 keV are applied to ideal beams with
neutron energies of 1 MeV or 10 MeV a large over estimate of the real tissue dose
occurs. If the coefficients based on silicon damage dose and copper activation are
used this results in the tissue dose at all depths being overestimated by a factor of
between 3.4 and 3.9 for a 1 MeV ideal neutron beam and between 2.75 and 2.87 for a
10 MeV beam. In the case of the silicon damage dose and the manganese activation
the magnitude of the resulting overestimate of the tissue dose is the same as for the
silicon and copper activation with neutron energies of 1 MeV and 10 MeV. This can
be seen in Figure 6-28 for the case of the silicon and manganese based estimate of
tissue dose in 1 and 10 MeV beams.
Therefore in any practical application to neutron beams where neutrons with
energies greater than 100 keV contribute a significant proportion of the total dose this
measurement technique is not accurate. This is seen in Figure 6-29 for the case of a
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Figure 6-28. MCNP calculated tissue equivalent dose in a phantom compared with an
estimate of tissue dose based on the silicon damage dose and manganese foil activation. The
ideal beam neutron energies were 1 MeV and 10 MeV but the coefficients used derived
from ideal beam with energies between 0.25 eV and 100 keV.
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Figure 6-29. MCNP calculated tissue dose in a cylinder exposed in Petten HB11 epithermal
neutron beam. Also shown are the estimates of tissue dose based on silicon damage dose in
combination with copper or manganese activation.
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CONVERSION OF UNITS

The results of the ideal beam simulation studies that are presented above and
that were used to determine regression coefficients are in terms of the raw MCNP
tally quantities. In order to use the regression fits derived above with measured
experimental data the units of the regression coefficients need to be converted to
more directly applicable ones. This change reflects the difference between the units
of the MCNP tallies and the units commonly used for experimental measurements.
For the silicon damage kerma in the simulations the tally multiplier
dimensions and units are silicon damage dose per unit neutron flux, cGy.cm2. When
multiplied by the track length estimate of neutron flux (tally type 4 with units of flux
per source neutron) this gives a tally quantity of silicon damage kerma in cGy per
source neutron.
For experimental measurements the directly observed quantity for the PIN
diodes will be the change in the forward bias voltage observed during the irradiation
time. The units will be mV per unit time. Dividing the observed diode forward bias
change by the diode calibration factor (mV.cGy-1) yields a measured value for silicon
damage dose in cGy per unit time.
The tissue kerma factors used in the simulations were in terms of dose per
unit neutron flux (cGy.cm2). When multiplied by the neutron flux in the tally cell per
source neutron this gives the tissue kerma in cGy per source neutron. The units of
tissue dose (rate) that we require in an expression for practical use are cGy per unit
time.
For the foil activation data the tallied quantity is given by:
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Act = ∫

E max

0

φ (E )R n dE

6-5

where φ(E) is the neutron flux in the tally cell (cm-2 per source neutron) and
Rn(E) is the cross section for the (n,γ) activation reaction (in barns per atom) for the
activation foil being used. Therefore the units of the quantity above are barns.cm-2
per atom per source neutron. This quantity was left unscaled during the regression
curve fitting.
A quantity more directly related to experimental measurements can be
obtained by multiplying this tally by a factor of 10-24 cm2.barn-1 and the number of
source neutrons per second. This converts the tally to a saturation activity with
dimensions of reactions per atom per second.
The experimentally measured foil activation per atom at a time t after an
irradiation of duration te is given by:

R(t , t e ) =

Ameas ( Bq) AW ( g / mol )
fM ( g ) N A (atoms / mol )

6-6

Where NA is Avagadro's number, Ameas is measured activity of the foil, M is
the mass of the foil in grams, AW is the atomic weight of the foil material, and the
abundance of the isotope in foil that undergoes activation is f.
saturation activity can be found using:

R0 =

R (t , t e )

6-7

(1 − e −te / τ )e −t / τ

133

From this the

Where R0 is the saturation activity in Bq per atom, τ is the half-life of the
activated isotope in the foil divided by ln(2).
The tissue dose in cGy can therefore be represented as
DTE = A DSImeas + B Ro
Where DSImeas is silicon damage dose measured with a PIN diode, Ro is
saturation activity derived from measured foil activities and the coefficients are
related to the previously derived a1 and b1 by A = a1 and B = 1024 b1.

CONCLUSIONS

Due to the nature of the silicon displacement damage KERMA cross section
PIN diodes respond to a wide range of neutron energies. While over some limited
energy ranges there is a direct proportional relationship between silicon damage
KERMA and tissue KERMA this is not generally true. Therefore silicon PIN diode
responses cannot be assumed to be tissue equivalent in typical epithermal neutron
beam spectra. However due to some similarities in the KERMA energy response
curves for tissue and silicon it is possible to make a linear combination of silicon
damage KERMA and gold, copper or manganese foil activations that approximates
tissue equivalence over a limited range of neutron energies.
MCNP simulations were used to determine tissue dose, silicon displacement
damage and gold, copper and manganese foil activations in a tissue equivalent
phantom exposed to ideal beams ranging in energy from 0.25 eV up to 10 MeV.
Using linear regression of the depth dose curves for each of these quantities it was
possible determine a coefficient that can be used to scale silicon damage dose to give
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tissue equivalent dose for incident neutron energies less than 10 eV. This factor was
found to be 0.395 x 103. This factor was found to be able to scale silicon depth dose
distributions to tissue depth dose distributions for incident monoenergetic neutron
beams up to 500 eV. Discrepancies were less than 7% for a 500 eV incident beam.
For higher energies it was necessary to add a foil activation term. Using the
activation of gold below the cadmium cutoff in combination with silicon achieved a
reasonably good prediction of tissue dose for incident beam energies up to 30 keV.
For all depths greater than 1.5 cm the maximum deviation between the calculated
tissue dose and the silicon/gold foil estimate was approximately 3%. In some energy
ranges deviations of about 10% were observed in the first 1.5 cm of the phantom.
Similarly accurate predictions of tissue dose for this energy range were
achieved using silicon and copper foil total activation or manganese foil total
activation. From a practical point of view estimates based on total foil activation are
preferable to ones based on sub cadmium cutoff activation because no cadmium
covered measurements would need to be made in this case. No advantage was
obtained by using more than one type of foil or by including separate terms for
activation above and below the cadmium cutoff.
When ideal beam energies up to 100 keV are included in the determination of
the silicon and activation coefficients the estimated values of tissue dose become less
accurate. For silicon and copper or silicon and manganese at depths in the phantom
greater than 4 cm the predicted tissue dose is 4-5% less than the MNCP calculated
tissue dose. The largest discrepancies tend to be at shallow depth (<3.5 cm) and for
the high (100 keV) and low (<5 keV) energy extremes. However the discrepancy is
still only about 5-6% for energies <5 keV at depths less than 3.5 cm. Errors of up to
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20 % are evident for the 100 keV beam for these superficial depths.
Application of coefficients derived using ideal beam energies up to 100 keV
to beams with higher energy neutrons present does not yield good results. This is to
be expected due to the structure of the silicon damage kerma curve for these higher
energies. The sharp increase in the silicon damage KERMA for energies greater than
100 keV means that any spectral component >100 keV leads to a significant over
estimate of the tissue dose as was observed for the case of the HB11 spectrum. The
discrepancy decreases with depth in the phantom as the incident beam becomes more
moderated.
For similar reasons using coefficients derived from ideal beams with E > 100
keV leads to very poor fits for lower energies.
Therefore the technique is probably only relevant to neutron sources where
the maximum energy present is ≤ 100 keV. This may be the case for some accelerator
based neutron sources or for quasi-thermal neutron sources. One possible solution to
these energy limitations may be to find some experimentally observable parameter in
terms if silicon damage and foil activations that indicates when higher energy
spectral components are present so that different coefficients can be applied to
determine tissue dose. Preliminary investigations show that simple ratios of silicon
damage and foil activations are probably not adequate for this.
Further refinements could involve the calculation of coefficients to convert
from silicon damage and foil activation to doses for the various ICRU tissue
compositions.
PIN diodes have been used for several decades as dosimeters to estimate
approximate tissue dose in high energy (>1 MeV) neutron environments. The
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simulations and analysis presented here demonstrate that in combination with a
single activation foil they could also be applied to measurement of tissue dose in
neutron beams with energies less than 100 keV.

137

CHAPTER 7

CHARACTERISATION OF PIN DIODES USING
THE ANSTO VAN DE GRAFF ACCELERATOR

AIM
The PIN diode is assumed to respond to neutron irradiation damage with an
energy dependence that matches the published silicon damage KERMA125 curve
shown in Chapter 3. In order to verify that the PIN diodes being used follow this
energy

response

some

experiments

were

conducted

with

approximately

monoenergetic neutrons obtained from the Ansto Van de Graff accelerator183.

METHOD
The L2 facility on the 3 MeV single ended Van De Graff accelerator was
used. This beam is usually used to produce beams of a few 100keV using protons
accelerated onto a lithium target. For the current work approximately monoenergetic
neutrons from the Li(p,n)Be reaction at seven energies in the range from 90 keV to
900 keV were used. This covers a range of neutron energies of prime interest for PIN
diode applications in BNCT. A PIN diode was irradiated at a point 5 cm from the
lithium target on the beam axis (i.e. at 0°). Estimates of the neutron flux were derived
from two methods; long counter measurements and yield calculations based on a
known approximate lithium target thickness of 50 keV.
The experimental set up was as shown in Figure 7-1.
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Van de Graff Accelerator

Target

Long Counter

PIN diode

5 cm
211 cm

Figure 7-1. Van de Graff PIN diode irradiation experimental set up.

LONG COUNTER CALIBRATION

The long counter was calibrated using an Am Be source of known activity.
The dependence of source detector distance was determined using this source. Small
corrections were made to take into account the change in effective centre of the long
counter with variations in neutron energy. A correction was also applied to account
for the difference in efficiency of the long counter at Am Be neutron energies (4.24.5 MeV) compared to the energies used to irradiate the PIN diode (90 - 990 keV). A
separate energy dependant efficiency factor was determined for each irradiation
energy used in the PIN diode experiment. The details of the long counter calibration
can be found in Appendix D.

PIN DIODE IRRADIATIONS
The following data was recorded for a series of PIN diode irradiations using
the setup described above. Table 7-1 shows the flux at the irradiation point for the
PIN irradiations.
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Table 7-1. Neutron fluxes at measurement point for PIN diode irradiations using Ansto Van
De Graff Accelerator.

Nominal

Long Counter

En (keV)

Efficiency

90

7.16×10-3

140

Raw counts

Corrected

Flux at 5 cm

counts

(n.cm-2)

2.065×107

2.88×109

7.00×109

7.23×10-3

2.426×107

3.36×109

8.14×109

165

7.26×10-3

2.935×107

4.04×109

9.80×109

196

7.30×10-3

1.983×107

2.72×109

6.59×109

230

7.35×10-3

1.154×107

1.57×109

3.81×109

350

7.50×10-3

2.267×107

3.02×109

7.33×109

891

8.20×10-3

1.483×107

1.81×109

4.39×109

The corrected long counter counts is the total number of neutrons emitted
from the target that are subtended by the front surface of the long counter. The flux at
5cm is simply the number of neutrons passing through a 1cm2 area orthogonal to the
axis of the beam, at a point 5 cm from the target. This flux was calculated assuming
that the distribution of neutron flux across the surface of the long counter was
uniform. This condition would be approximately true for the isotropic AmBe source
used for calibration of the long counter. In the case of the accelerator produced
neutrons however the flux density would be higher close to the central axis and this
effect would increase with the energy of the proton beam. Therefore the fluxes
quoted may slightly under estimate the actual flux at the point where the PIN diode
was irradiated. However this effect would be small compared to the other
uncertainties in this experiment.
The change in forward bias voltage per unit flux is given in Table 7-2 and
shown in Figure 7-2. This information is adequate to give a picture of the energy
dependence of the PIN diode over the range of energies used.
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Nominal En (keV)

Flux (n.cm-2)

V/(n.cm-2)

90

7.00×109

4.86×10-13

140

8.14×109

2.46×10-13

165

9.80×109

1.02×10-13

196

6.59×109

1.82×10-12

230

3.81×109

4.73×10-12

350

7.33×109

2.59×10-12

891

4.39×109

4.79×10-12

1.0E-10

1.0E-10

1.0E-11

1.0E-11

1.0E-12

1.0E-12

1.0E-13

1.0E-13
dV/flux
KERMA

1.0E-14

KERMA (cGy/(n.cm-2))

dV/dN (volts/(n.cm-2))

Table 7-2. PIN ΔVf per target source neutron as function of energy.
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Figure 7-2. Change in forward voltage per source neutron (left axis) compared with silicon
damage KERMA (right axis).
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It can be seen that the PIN diode experimental data has a similar form to the
known silicon damage kerma. It can also be seen that the minimum in the PIN diode
response does not quite match up with the minimum in the KERMA data. This is
because no account has been taken of the Li target thickness. The nominal neutron
energies are simply the proton energy minus the reaction threshold energy. The Li
target is known to be approximately 50 keV thick. Therefore we can expect that on
average protons will loose approximately 25 keV before interacting to yield a
neutron. Thus the mean neutron energies should be approximately 25 keV less than
the nominal maximum neutron energies given above. In this case the PIN data in

1.0E-10

1.0E-10

1.0E-11

1.0E-11

1.0E-12

1.0E-12

1.0E-13

1.0E-13
dV/flux
KERMA

1.0E-14
1

10

100

1000

1.0E-14
10000

Neutron Energy (keV)
Figure 7-3. PIN response and KERMA with the pin response adjusted to take account of
target thickness.

From these two pieces of data an approximate calibration factor (V/cGy) for
the PIN diode can be derived. If the target thickness is assumed to be 50 keV and the
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KERMA (cGy/(n.cm-2))

dV/dN (volts/(n.cm-2))

Figure 7-2 more closely resembles the KERMA curve. This is shown in Figure 7-3.

average proton energy lose in the target before generating a neutron is assumed to be
25 keV then the approximate PIN calibration factors are given in column 4 of Table
7-3. These calibration factors assume a single energy KERMA factor based on a
monoenergetic neutron beam of the energy shown in the table (i.e. 25 keV less than
the incident proton energy).
The actual neutron spectrum will be spread over at least 50 keV due to the
target thickness. Therefore it is probably more correct to estimate the calibration
factors based on the average of the damage KERMA function over a 50 keV energy
range centered on a neutron energy 25 keV less than the incident proton energy. The
calibration factors assuming KERMA averaged over ±25 keV are shown in column 5
of Table 7-3.

Table 7-3. PIN diode approximate calibration factors

Neutron

PIN diode

Si Damage

PIN

PIN calibration

energy

response

KERMA

calibration

factor (average)

(keV)

V/(n.cm-2)

cGy/(n.cm-2)

factor (mono)

(V/cGy)

(V/cGy)
65

4.86×10-13

2.52×10-12

1.93×10-1

1.44×10-1

116

2.46×10-13

1.40×10-12

1.75×10-1

1.80×10-1

140

1.02×10-13

6.83×10-13

1.49×10-1

4.78×10-1

171

1.82×10-12

1.57×10-11

1.16×10-1

1.02×10-1

205

4.73×10-12

3.20×10-11

1.48×10-1

1.56×10-1

325

2.59×10-12

1.71×10-11

1.51×10-1

1.51×10-1

866

4.79×10-12

3.24×10-11

1.48×10-1

1.48×10-1

The average calibration factor is 133 mV.cGy-1 with a standard deviation of
44mV.cGy-1. This is lower than other estimates based on irradiations in filtered
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neutron beams in Petten (Chapter 11). The spread in these values is at least in part
attributable to the large uncertainty in some of the measured forward bias voltage
changes. A plot of the calibration factors showing estimated uncertainties is given in
Figure 7-4.

PIN diode calibration factor
(V/cGy)

3.00E-01
2.50E-01
2.00E-01
1.50E-01
1.00E-01
5.00E-02
0.00E+00
0

200

400

600

800
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Average Neutron Energy (keV)
Figure 7-4. Uncertainties in PIN diode calibration factor. The error bars show the
propagated uncertainty due to the readout uncertainty of the change in forward bias voltage
only. The uncertainty in the absolute calibration due to the efficiency of the long counter is
not included in these error bars.

CONCLUSIONS

Over the neutron energy range studied in this set of experiments (60 – 900
keV) the PIN diode response follows the silicon damage KERMA. This is clear
qualitatively from Figure 7-3. The ratio of the threshold voltage change per unit flux
to the KERMA (cGy per unit flux) has a standard deviation of 44 mV/cGy. Part of
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this can probably be accounted for by the large uncertainties in some of the forward
voltage measurements. The data points with large uncertainties are also associated
with regions of the KERMA function where the KERMA is rapidly changing with
respect to neutron energy. This makes the calibration factor very sensitive to the
mean energy and the spread of energies present in the neutron beam used for the
measurements. Unfortunately the precise thickness of the target was not able to be
determined and hence nor can the exact spectrum of neutron energies be known. The
target was nominally 50 keV thick with a probable uncertainty of at least ±10 keV. If
the measurements with the greatest uncertainty due to these reasons are excluded the
standard deviation in the calibration factors is approximately 5 mV/cGy. This is
certainly adequate to show that the pin diode follows the silicon damage KERMA in
its response to neutron irradiation. While this was expected it was still necessary to
validate the behavior of the PIN diodes prior to using the published silicon damage
KERMA function as the assumed PIN response in Monte Carlo calculations and
other measurements. In order to obtain more precise values for the PIN diode neutron
dose calibration factors a more accurately known and characterised neutron source is
required. Apart from the ill defined neutron spectrum used here the absolute
calibration of the long counter is inadequate to base the PIN diode calibrations on.
The long counter calibration was based on an AmBe source of well known activity.
However the assumptions implicit in extrapolating the efficiency of the long counter
from an isotropic (or nearly isotropic) AmBe source to a significantly lower energy
spectrum of non isotropic neutrons can not be quantified accurately enough to give a
confident absolute calibration for the PIN diode. Not with standing this the relative
calibration factors derived here are adequate to show that the PIN diode responds in a
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similar way to silicon neutron damage KERMA.
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CHAPTER 8

MOSFET

MEASUREMENTS

IN

A

6MV

MEDICAL LINAC BEAM

To characterise the MOSFET dosimeter response in a purely photon field
experiments were conducted using the MOSFET dosimeters in a megavoltage x-ray
beam. These measurements involved measuring the dose at various depths in tissue
equivalent material exposed to x-ray beams from a Clinac 2100C medical linear
accelerator. Depth dose curves were measured with the MOSFETs and compared
with MCNP calculations and also depth dose curves measured with ionisation
chambers. The measurement of doses in the steep dose gradients of the buildup
regions was investigated. The angular dependence of the surface dose in a 6 MV
beam was also measured with the MOSFET.
These investigations were subsequently extended by Butson, Carolan and
Kron et al165, 166, 184.
Measurements were also performed using the linear accelerator to determine
the change in MOSFET sensitivity as a function of the bias applied to the gate
electrode of the MOSFET.
A Pantak therapax superficial/orthovoltage therapy unit was used to
determine the variation in MOSFET response as a function of photon energy.
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MATERIALS AND METHODS

LINAC

The x-ray source used was a Varian Clinac 2100C linear accelerator located
at the Illawarra Cancer Care Centre in Wollongong. The linac was operated at 6MV
in the normal service mode at a dose rate of 200 monitor units per minute. The linac
dose per monitor unit had previously been calibrated using a thimble ionisation
chamber with a calibration factor traceable to the national standard. With this
calibration the dose rate per monitor unit at a depth of 1.5 cm in the phantom when
the surface of the phantom is located at a distance of 100 cm from the source
(SSD=100 cm) is 1 cGy per monitor unit for a 10 cm × 10 cm square field.
For each irradiation of the MOSFETs at a different depth the Linac was set to
deliver 10 monitor units. This corresponds to a dose of 10 cGy at a depth of 1.5 cm
for a 10 cm × 10 cm square field.

MOSFETS

The MOSFETS used were the same devices used throughout this thesis
(produced by INR, Ukraine).
Three sets of data were recorded. One with a MOSFET in its normal TO-18
packaging, one with the top lid of the kovar TO-18 package cut off and another with
the kovar cap completely removed to leave the MOSFET device exposed (i.e. no
encapsulation). This configuration allowed measurements in the buildup region of the
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depth dose curve without interference from the MOSFET encapsulating material.
Measurements were performed with both MOSFETs simultaneously. A bias
of 10 v was applied to the gate electrode of the MOSFET during the irradiations. The
MOSFET threshold voltage was measured before and after each irradiation using the
pulsed constant current source previously described. The threshold voltage was
measured approximately 1–2 minutes following the completion of each irradiation.

PHANTOM

The measurements were conducted in a slab phantom consisting of multiple
layers of RMI185 Solid Water. The dimensions of the phantom were 30 cm × 30 cm
square and 30 cm thick (along the beam axis). A 1 cm thick disc of solid water
(approx 2.5 cm in diameter) was machined to allow two MOSFETS to be recessed
into it. Two holes within 1 cm of the centre of this disc of solid water allowed the
MOSFETS to fit into the solid water with minimal air spaces surrounding them. The
MOSFETs were positioned with the device gate electrodes parallel to the surface of
the phantom. The encapsulated MOSFET was located so that the top surface of the
package was level with the surface of the solid water. The MOSFET with the
encapsulation removed was located so that the MOSFET junction itself was within
less than 0.5mm of the top surface of the solid water. The small circular Solid water
plug assembly containing the two MOSFETS was then inserted into a 30 cm square
slab of Solid Water. This slab with a small central circular recess was originally
designed and used for holding an Attix ionisation chamber. A narrow channel
(approx. 2 mm × 2mm) from the centre to the edge of the Solid Water slab allowed
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fine cables to be connected for applying bias and reading out the MOSFETs. After
the cables were soldered to the MOSFETS the whole assembly was put together and
molten wax was used to fill any small remaining cavities surrounding the insert with
the MOSFETS. When filling the air gaps with wax care was taken to leave the top
surface of the unencapsulated and open topped MOSFETs exposed. A schematic
view of the phantom assembly is shown in Figure 8-1.

Incident Megavoltage
photon beam

TO-18

Top of
TO-18 can
removed

TO-18 can
Completely
removed

RMI Solid Water

Figure 8-1. Configuration of MOSFET dosimeters with and without encapsulation removed
from measurement of photon dose in 6MV linac beam. Not to scale.

In order to record the dose at various depths slabs of solid water were
removed from the base of the phantom and added to the top of the phantom. This
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maintained the SSD at 100 cm and gave dose measurements at points throughout the
phantom.
In the superficial regions the depth of the MOSFETs was incremented by 1
mm steps. After a depth of 1.5 cm (approximately Dmax) was reached measurements
were made at depth increments of 20 mm.

MCNP MODEL OF THE PHANTOM.

The experimental arrangement was modeled using MCNP4A. The phantom
was modeled as a 30 × 30 × 30 cm cube of ICRU 92 brain equivalent material.
Impinging upon the top surface of this phantom was a 6 MV photon beam. Tallies of
energy deposition along the central axis (which was also the central axis of the
photon beam) of this phantom were made for comparison with the MOSFET and
ionisation chamber measurements.
The model was relatively simplistic since it was not the intention to develop a
detailed model of a Clinac 2100C photon beam. The aim was simply to establish that
reasonable agreement could be obtained between the model, MOSFET and ionisation
chamber dose measurements. The phantom model was a 30 cm cube of ICRU 92
brain equivalent material. The top layer was divided into 1 mm layers for the first 1
cm. From a depth of 1 cm to 2 cm the phantom was divided into 2 mm thick layers
and beyond 2 cm into 1 cm thick layers. The tallies were calculated at depths defined
by these layers and by other surfaces that defined a volume with a square cross
section of 0.5 × 0.5 cm along the central axis. In a 10 × 10 cm field a tally volume of
this size in the middle of the field should represent the dose recorded by dosimeters
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smaller than this dimension along this axis.
The x-ray source was modeled as an isotropic point source. The energy
distribution used was based on that given by Mohan
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for a 6MV Clinac 2100C

photon beam. The point source was located at a distance of 100 cm from the phantom
surface. The 10 cm square field incident on the phantom surface was defined by
“virtual” collimators set at a distance of 50 cm from the phantom surface. These
collimators were simple void regions with photon and electron importances set to
zero. In this way any particles entering the collimator cells were killed and did not
contribute any further to the calculation. Clearly in this approximation no collimator
or other “head” scatter is taken into account. No flattening filters were included in the
model nor was any angular dependence of the energy spectrum. The empty space
between the photon source and the phantom surface was left as a void, i.e. no air was
included. These approximations may effect the calculated surface doses due to
omission of air scatter and scattered x-rays generated in the head. However we do not
expect these effects to contribute significantly to our measurements. The role of air
scatter and surface dose was further investigated by this author with simulations and
measurements in separate work that is described by Butson et al187.
In order to accurately determine the energy deposited in the buildup region
using 1 mm thick tally volumes along the beam central axis it was necessary to set
the ESTEP parameter to 40 to ensure adequate electron transport sub-steps in each 1
mm thick tally volume188. In each tally volume a *f8 tally was used to calculate the
total energy deposited by the electrons.
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RESULTS

The known depth dose profile for a 10 cm square 6 MV beam incident on
water as measured using diodes in a Scanditronix RSA water tank is shown in Figure
8-2. This curve constitutes the standard depth dose curve against which other
measurements and calculations will be compared. It has been verified to coincide
well with the depth dose curve as measured using a Farmer ionisation chamber for
depths greater than Dmax.
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Figure 8-2 Depth dose curve measured in a 10 x 10 cm square field at an SSD of 100 cm for
a 6MV photon beam from the Illawarra Cancer Care Centre Varian Clinac 2100C linear
accelerator. Note the limited accuracy at depths <1.5 cm as described in the text below.

In order to compare and verify the MCNP model of the photon beam Figure
8-3 shows the same data (solid line) with the calculated MCNP data superimposed.
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Except for the statistical errors in the tallies there are no large deviations from the
curve measured with the diode for depths beyond Dmax at approximately 1.5 cm
depth. In the buildup region there is a discrepancy. The MCNP calculations predict a
lower surface dose than is observed with the diode measurements. This is expected
since the most superficial tally from the MCNP model is the average dose within the
first 1 mm of the buildup curve. The dimensions and encapsulation of the
Scanditronix diode are of the order of several millimetres. Therefore we cannot
expect to measure the doses in this superficial region accurately with the diode. The
MCNP model does not account for scattered radiation from the accelerator head. If
this was included in the model slightly higher surface doses may be observed in the
results of the simulation. Despite this we can expect that the MCNP model may give
a more accurate estimate of the dose at the surface of the phantom.
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Figure 8-3. Buildup and depth dose curve as calculated using MCNP compared to the depth
dose curve measured using a Scanditronix diode in a water tank.
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When a fully encapsulated MOSFET is used to measure the depth dose curve
in solid water a similar effect is seen in the buildup region. The effective Z and
electron density of the kovar cap is significantly higher than the Z and electron
density of tissue or water. Therefore a depth dose curve measured with the fully
encapsulated (TO-18 packaged) MOSFET appears to move the buildup part of the
curve towards the surface when compared with the MCNP calculated depth dose
curve or even the diode depth dose curve. This is shown in Figure 8-4. The “surface
dose” measured by the diode was 43.9 % of the maximum dose. The most superficial
dose measured by the fully encapsulated MOSFET was 64.8% of Dmax. These
compare to a surface dose integrated over the first millimetre of the phantom
predicted by MCNP to be 16.7% of Dmax. However at depths beyond Dmax where
electron equilibrium exists there is reasonably good agreement between the diode and
the encapsulated MOSFET. It should also be remembered that for this encapsulated
MOSFET the silicon oxide layer was approx 2 - 3 mm below the surface level of the
surrounding phantom.
The experimental error in the determination of the MOSFET threshold
voltage was estimated to be approximately ± 2mV at the time of measurement. This
was based on the fluctuations observed in the digital voltmeter readout used for the
measurements and was thought to arise from the noisy electrical environment around
the linac where the measurements were performed. More adequate shielding of
cables on subsequent measurements enabled this variation to be reduced. A 2 mV
uncertainty in measurements of threshold voltage propagates to give an overall
uncertainty of approximately ± 4% of Dmax. (The measured change in threshold
voltage for this series of measurements was approximately 90 mV at Dmax.) For
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clarity these error bars are not shown in Figure 8-4 however they encompass the
expected depth dose curve beyond Dmax as measured by the diode.
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Figure 8-4. Depth dose curve in a 10 x 10 cm square 6 MV photon beam as measured using
a MOSFET in TO-18 encapsulation and a Scaditronix diode.
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Figure 8-5. Comparison of 6MV, 10 x10 cm field depth dose curve measured using a
MOSFET with the top surface of its lid removed and measured with diode.
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When the lid of the MOSFET was removed in an attempt to eliminate the
source of the extra buildup and therefore give a more faithful measurement of the
tissue doses in the buildup region of the phantom a significant change was observed
in the MOSFET measurement of surface dose. This yielded a surface dose of 34 % of
Dmax as opposed to 64.8 % for the intact MOSFET package. This is lower than the
most superficial dose as measured by the diode but still in excess of the MCNP
predicted dose for the 1 mm at the surface. It can be seen that much better agreement
is also obtained between the depth dose curve for the MOSFET and the diode at
depths beyond Dmax. This is not due to the removal of the MOSFET lid but rather to
improved accuracy of the threshold voltage readout achieved with shorter and better
shielded cables.
Even with the lid removed, due to the remaining part of the MOSFET
encapsulation it was not possible to position this MOSFET so that the junction was
within less than 1 mm of the phantom surface level. That is the MOSFET was
recessed into the solid water in such a way that the remaining portion of the
packaging was flush with the phantom surface. This locates the actual junction
approximately 3 mm below the surface of the phantom (although open from the
front). In this arrangement photons can be scattered from the surrounding phantom
and kovar onto the junction resulting in the effective depth of the junction being
greater than what would be expected just from the air layer in front of it.
For another series of measurements with the MOSFET encapsulation fully
removed it was possible to measure even lower surface doses as a proportion of Dmax.
In this case the MOSFET junction was located within less than a millimetre of the
surface. The resulting depth dose curve can be seen in Figure 8-6. The measured
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surface dose using the MOSFET in this arrangement was 16.1 % of the Dmax which is
approximately the same as the dose predicted by MCNP for the first 1mm of tissue
(16.7%).
One method often used for determining superficial doses in megavoltage
photon beams is to use thin entrance window ionisation chambers such as the Attix
chamber. Superficial doses were measured in the solid water phantom with the same
x-ray beam and field size using an Attix chamber.
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Figure 8-6. MOSFET measurements of dose in first 5 cm of solid water phantom exposed to
10 x 10 cm field from a 6 MV photon beam.

These Attix chamber measurements are compared to two sets of
unencapsulated MOSFET depth dose data in the surface / buildup region which is
shown in Figure 8-7. Clearly very good agreement is obtained for these two methods.
To directly compare the MOSFET dose measurements in the buildup region
and the MCNP calculations for the same depth both of these sets of results are
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plotted along with the Attix chamber measurements in Figure 8-8. It should be noted
that for each 1 mm thick MCNP tally cell in the first 1 cm of the phantom the
corresponding data point is plotted at the average depth of the volume. (E.g.. The
data point for the tally volume extending from 0mm to 1mm deep is plotted at 0.5
mm in Figure 8-8.)

120

Dose (% Dmax)

100
80
60
40
Attix
MOSFET no encapsulation 1
MOSFET no encapsulation 2

20
0
0

5

10

15

20

Depth (mm)
Figure 8-7. Dose in buildup region of 6 MV photon beam as measured by Attix ionisation
chamber and a two MOSFETs with encapsulation removed.

The data points for the Attix chamber and the MOSFET are plotted at depths
corresponding approximately to the front surface of the detector. This may account
for the slight discrepancy between the MCNP results and the measured data.
However allowing for the statistical uncertainty in the MCNP results reasonably good
agreement is seen even in this region of steep dose gradient.
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Figure 8-8. A comparison on Attix chamber, MOSFET and MCNP Monte Carlo calculated
doses in the buildup region of a 10 x 10 cm square 6 MV photon beam incident on a solid
water phantom.

ANGULAR RESPONSE OF MOSFET MEASURED SURFACE DOSE

Whilst characterising the MOSFET in the 6 MV x-ray beam some additional
data was collected with the MOSFET on the surface of the solid water phantom but
with different incident beam angles, Figure 8-9. All other parameters were the same
as for the measurements above. Measurements of the surface dosea as a function of
incident beam angle using an Attix chamber with the same phantom and linear
accelerator are also shown for comparison. The Attix chamber measurements
significantly exceed the MOSFET measurements for incident beam angles greater

a

Attix chamber measurements made by M Butson and M Perez, Illawarra Cancer Care Centre, Oct
1994.
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than about 40°. Due to its design this is unlikely to be due to scattering contributions
from the wall of the Attix chamber. The much smaller thickness of the MOSFET
junction and essential lack of a “wall” in its unencapsulated form lead to less
contribution from scatter originating at the sides of the MOSFET.
It should be noted that the angular dependence of the dose measurements
shown in Figure 8-9 represent the dependence of dose at the surface of a phantom
exposed to a megavoltage x-ray beam. The angular dependence shown does not
represent the intrinsic angular response of the MOSFET itself.
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Figure 8-9. Surface dose measured in a 6 MV beam, field size 10 x 10 cm, using an
unencapsulated MOSFET and an Attix ionisation chamber.

MOSFET SENSITIVITY AS A FUNCTION OF GATE BIAS

The sensitivity of the TO-18 packaged and the unencapsulated MOSFETs
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was measured with different gate bias voltages applied during the irradiations. Using
the same phantom and 10 x 10 cm square 6 MV x-ray beam the MOSFET dosimeter
was located at a depth of 1.5 cm from the surface of the phantom on the central axis
of the normally incident photon beam. During the irradiations biases of 0, 5, 10 and
15 volts (± 0.05 V) from a stabilised DC power supply were applied to the gate
electrode of the MOSFETs. Ten monitor units of 6MV beam were delivered to the
MOSFETs at each applied bias with the threshold voltage of the MOSFETs being
readout between each irradiation.
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Figure 8-10. Sensitivity of two MOSFETs as a

function of applied gate bias during

irradiation. Measurements made at 1.5 cm depth in solid water phantom. Therefore
sensitivity is not package dependant.

At a depth of 1.5 cm and an SSD of 100 cm for a field size of 10 x 10 cm ten
monitor units corresponds to a 10 cGy dose to the MOSFETs for each measurement.
The sensitivities of these MOSFETs as a function of gate bias can be seen in
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Figure 8-10. A second order polynomial curve was found to fit this data very well
(r2=0.999). The fitted sensitivity curve was:

Sensitivity (mV/cGy) = -0.012 Vg2 + 0.788 Vg + 1.59

Where Vg is the bias applied to the gate during irradiations and the sensitivity
is the change in threshold voltage observed per cGy.
PHOTON ENERGY RESPONSE.

In addition to the measurement of the depth dose curve measurements
performed using MOSFETs on the 6 MV linear accelerator x-ray beam some further
measurements were performed aimed at further characterising the MOSFET response
to photons of different energies. Although the main gamma dose contribution
anticipated in BNCT applications will arise from photons with MeV energies it is
possible that lower energy photons from neutron activation of detector or phantom
materials may also contribute. Therefore any variation in response for lower energy
photons should be characterised (e.g. dose enhancement).

METHODS

These measurements were performed using a Pantak Therapax 300
Superficial /Orthovoltage treatment unit. The accelerating potential of the Pantak can
be varied from 50 kVp up to 300 kVp. The MOSFETS were irradiated with x-rays of
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50kV, 75kV, 100kV, 125kV, 150kV, 200kV and 250kV which are the standard
potentials used for treatment on the Pantak at the Illawarra Cancer Care Centre. The
5 cm diameter applicator with a FSD of 30 cm was used for the irradiations. To
determine the x-ray dose in the middle of the field for each potential a field factor
and monitor unit calibration factor is applied. Between 10 and 15 monitor units were
applied to the MOSFETs at each potential and the appropriate factors for each
different x-ray energy were then applied. The monitor unit calibration factor varies
with beam potential. The MOSFETs were irradiated mounted on a thin perspex rod
to minimise any backscatter contributions. They were located at an FSD of 30 cm in
the middle of the field (beam axis).
The measurements were repeated for both a TO-18 packaged MOSFET and
also for a MOSFET with the encapsulation removed. During irradiation the
MOSFETs had a bias of 5.422 volts applied to the gate electrode. According to the
relationship given in the previous section this would correspond to a sensitivity of 5.5
mV/cGy in a 6MV photon beam.
RESULTS
The results of these measurements are shown in Figure 8-11. Measurements
in air such as these show a difference in response between the TO-18 packaged
MOSFET and the unencapsulated MOSFET because the extra thickness of kovar
around the TO-18 MOSFET generates extra scattered electrons which interact with
the MOSFET junction. This is not the case for the unencapsulated MOSFET.
However the unencapsulated MOSFET does show some increased response at low
photon energies. The TO-18 MOSFET response drops off for incident beam energies
below ~125 kVp. This is due to filtering through the kovar encapsulation.
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Figure 8-11. Measured energy response of MOSFETs to low energy x-rays.
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Figure 8-12. MOSFET sensitivity at low energies relative to 6MV response. Also shown is
the ratio of silicon photon KERMA to water photon KERMA (from endfb-v data).
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The enhancement of response for both of these MOSFETs at low energy is
due to the difference in silicon or silicon oxide photon KERMA and tissue KERMA.
Note that the units of sensitivity in Figure 8-11 are mV/cGy of tissue dose since the
calibration factors for exposures with the Pantak unit are always in terms of tissue
dose.
If the same sensitivity data is normalised to unity for the 6 MV response per
cGy we have a normalised plot of the dose enhancement as a function of energy. This
is shown in Figure 8-12.
The energy of the response data in Figure 8-12 is expressed as the average
effective photon energy of the beams from the Pantak Therapax 300. The effective
energy is approximately 1/3 of the peak accelerating potential (kVp)a. Also shown for
comparison is a plot of the ratio of silicon photon KERMA to water photon kerma
over the same energy range and normalised to unity at 2 MeV. This curve has the
same form as the response of the unencapsulated MOSFET and does not drop off at
very low energies like the encapsulated MOSFET response curve. A full Monte Carlo
model of the MOSFET and its encapsulation in photon fields of different energies
may be expected to demonstrate this fall off at very low energies and to fit the
experimental data better.

CONCLUSIONS
The accurately calibrated and well measured depth dose profiles of a medical
linear accelerator provide an excellent opportunity for characterising the response of

a

Copper half value layers (HVL) for the Pantak beams used were: 50kV:0.055mm, 75kV:0.09mm,
100kV:0.15mm, 125kV:0.35mm, 150kV:0.7mm, 200kV:1.5mm, 250kV:2.3mm, 300kV:3.9mm.
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the MOSFETs in pure photon fields without interference from any neutron effects.
Using a Varian linear accelerator it was possible to demonstrate a good
agreement between MOSFET measurements of the depth dose profile in a solid water
phantom. Variations from the known dose as measured using commercial dosimetry
diode detectors and ionisation chambers were less than 4% at depths greater than
Dmax. For measuring doses in buildup regions the MOSFET encapsulation was found
to cause an over response in the first several mm of a 6 MV beam. By removing the
kovar cap and using the MOSFET with the junction exposed a excellent agreement
was found with other techniques for the dose in the buildup region.
These measurement also served as a simple test of the MCNP modelling of
photon doses in phantoms. A simple MCNP simulation of the 6MV photon beam
incident on the phantom showed good agreement with doses measured using the
MOSFET at depth in the phantom and with slightly worse agreement in superficial
layers of the phantom. The discrepancies at superficial depths result primarily from
simple nature of the geometry modeled (i.e. the lack of a detailed model of the
accelerator head). However concordance achieved between the MCNP model and the
MOSFET measurements in the pure photon field give confidence that similar
agreement should be possible for the photon component of a BNCT beam.
A simple empirical relationship between the gate bias voltage and the dose
response of the MOSFETs used was determined in the 6 MV linac beam. The
measured sensitivity of the Ukrainian MOSFETs used ranged from approximately
1.6 mV.cGy-1 to 10.5 mV.cGy-1 for gate bias voltages between 0 volts and 15 volts
respectively. The sensitivity as a function of gate bias could be fitted well with a
simple second order polynomial.
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An orthovoltage radiotherapy beam was used to measure the low energy
response of the MOSFET. An over response of approximately 8 times relative to the
6 MV beam response was observed for x-ray beams with average energies

of

approximately 40 - 50 keV. However the filter effect of the kovar lid then sharply
reduces this over response to a factor of 2 for energies of approximately 20 keV. The
overall shape of the low energy response curve matches fairly well the ratio of silicon
photon KERMA to water photon KERMA. It was possible to reduce the over
response by removing the MOSFET encapsulation. In this case an over response of
approximately 6 times (relative to 6 MV) was observed at average photon energies
around 20 - 30 keV. To further reduce the over response at low energies a completely
different type of encapsulation (low Z) would be required. Beyond that over response
due to the silicon itself and to the dose enhancement effects of electrode materials on
the actual MOSFET chip may still arise. For pure photon fields further minimisation
of this over response may be achievable using filters optimised using Monte Carlo
simulations. However for BNCT applications this would probably be at the expense
of increased the neutron response and so was not pursued as part of this thesis. As
previously noted the average energy of photons encountered in BNCT related
measurements is expected to be more comparable to those in 6 MV beams. However
the low energy responses measured in this chapter would allow corrections to be
made for sub 100 - 200 keV photons if necessary.
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CHAPTER 9

MOSFET AND PIN DIODE MEASUREMENTS IN
THE MOATA REACTOR THERMAL NEUTRON
FACILITY

The MOATA reactor was a 100kW water moderated and cooled reactor with
a graphite reflector. The fuel elements were 80% enriched

235

U. MOATA was

primarily used for neutron radiography and biological experiments. The neutron
irradiation facility used in all of the work described here was a horizontal thermal
column designated TC-10 which has previously been described by Allen et al189. The
beam is heavily moderated and filtered to provide a thermal neutron field with only a
small amount of epithermal neutron contamination and a low gamma dose rate. The
gamma shielding is in the form of bismuth and lead. The moderator and coolant is
light water with a graphite reflector surrounding the core. The thermal flux in the TC10 irradiation column is approximately 1010 n.cm-2.s-1 as measured by gold foil
activation. The gold activation foil cadmium ratio is 38. The higher energy
component of the neutron field is therefore not great but is not well characterised. It
is assumed to have the form of a slowing down spectrum. The gamma dose rate as
measured by a combination of TLDs and ionisation chambers is approximately 4.8
Gy.hr-1.
The biological irradiations performed in the thermal neutron beam include in
vitro and in vivo experiments which have been described previously 190, 191.
In the work described in this chapter both PIN diodes and MOSFET
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dosimeters were irradiated in the MOATA thermal neutron beam in order to
determine their thermal neutron response. MOSFETs and PIN diodes were irradiated
with and without thermal neutron shields to separate any thermal neutron response
from epithermal neutron or gamma responses. The response of the PIN diode to
thermal neutrons and also to the epithermal part of the spectrum in TC-10 is
compared. The MOSFET thermal neutron response is determined. The gamma dose
rate in TC-10 was measured using the MOSFET detectors with three different gate
potentials applied (i.e. at three different sensitivities). The thermal neutron sensitivity
is also determined at three different gate potentials.
PIN

The PIN diode response has been measured in epithermal neutron fields using
accelerator produced neutrons (Chapter 7). In these measurements the PIN response
was found to have an energy dependence corresponding to published silicon damage
KERMA data in the literature to within experimental uncertainty. The series of
experiments described here aim to approximately determine the thermal neutron
response of the PIN diode. This will verify that the PIN forward bias voltage
responds in an energy dependent way which matches the known silicon damage
KERMA for thermal neutrons.
The TC-10 neutron field is highly moderated and has a gold activation foil
cadmium ratio of 38. The MOATA TC-10 beam is known to have a small (~0.8%)
epithermal neutron flux component. Any measurements aimed at determining the
PIN diode response to thermal neutrons must therefore correct for contributions from
non thermal neutrons. Due to the shape of the silicon response function even a
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relatively low fluence of non thermal neutrons could obscure the forward bias voltage
shift due to thermal neutrons alone.
To allow the effect of non thermal neutron response during the irrradiations
using the TC-10 facility to be detected and compensated for the PIN diode was
irradiated in both the “bare” beam and also encapsulated in several different thermal
neutron attenuating shields. These shields included 1 mm cadmium, epoxy/LiF pots
and polymethylmethacrylate vials full of 6LiF powder with the PIN diode embedded
in the centre. During the irradiations gold activation foils were used to monitor the
flux both inside the shield adjacent to the PIN diode and also in the free beam away
from the Cd and Li attenuators.

METHOD

A diagram of the TC10 thermal facility is shown in Figure 9-1. During
irradiations the PIN diodes were located on a PMMA rack that was inserted into the
channel by means of a pair of long handled tongs. The PMMA rack was positioned
reproducibly by pushing it to the far end of the channel. There was no freedom of
movement in the lateral or vertical planes when the PMMA rack was inserted into the
thermal column channel. The steel and lead plug which seals and shields the TC10
thermal column during reactor operation was manually rolled into position after the
PIN diodes (or other samples) had been inserted and before the reactor power was
raised. For safety reasons this plug was part of an opto-electronic scram trigger
circuit to prevent the thermal column being opened while the reactor was at any
power above 20 watts.
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PIN diodes were then placed on the PMMA rack. The PIN diodes to be irradiated
bare were attached to the rack with adhesive tape. The cadmium covered PIN diode
was wrapped in a single layer of 1mm Cd sheet. The edges of this cadmium envelope
were overlapped to prevent thermal neutron leakage. The cadmium wrapped PIN
diode was attached to the rack with adhesive tape and irradiated separately from all
other samples to ensure that the cadmium did not introduce any thermal flux
depression which could interfere with other measurements. In the case of the PIN
diodes encapsulated in lithium fluoride powder small polycarbonate sample vials
(3.5cm diameter, 8cm length) were half filled with the powder, the PIN diodes with
gold foils attached were placed in the centre of the vials and more lithium fluoride
powder added to fill the vials. The lid was then securely attached and the vial and its
contents placed on the PMMA rack and secured with adhesive tape. As for the case
of the cadmium covered PIN diodes, the lithium shielded diodes were each irradiated
in separate reactor runs to avoid any possible interference with other samples.
The PIN diodes were irradiated in the TC 10 thermal column for a period of 4
minutes at full power. When the contribution of flux during the raising and lowering
of power is taken into account this amounts to 5 minutes of full power equivalent
irradiation. When the reactor power was reduced to less than 20 watts the TC10 plug
was removed and the samples recovered. The PIN diode forward bias was measured
and the gold activation foils placed in shielded vials for counting at a latter date.
The activity of the gold foils was determined by counting in a NaI well
counter with an efficiency calibration traceable to the national standard. The NaI well
crystal was attached to a Canberra multi-channel analyser system. Sufficient counts
were accumulated to reduce the statistical uncertainty in the activity to less than 1 %.
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The counting dead time was always less than 2%.
The cadmium ratio in the TC-10 channel has been measured with gold foils to
be 38. If the spectrum is assumed to consist of a thermal component and a small
slowing down component of epithermal neutrons then an estimate can be made of the
epithermal flux. (See Appendix E for details.) Assuming a well moderated thermal
spectrum with a small slowing down component and using gold foil measurements of
the cadmium ratio and the thermal flux gives an estimated epithermal flux of 8×10-3
φo. Where φo is the thermal flux at the TC-10 irradiation point.

RESULTS

The results for the PIN diodes irradiated in TC 10 are summarised in Table
9-1.

Table 9-1. PIN diode forward bias voltage change in TC-10.

Effective

Unattenuated

ΔV

Estimated

Irradiation

thermal

(mV)

epithermal

time (min)

fluence

fluence (average)

(average)

n.cm-2

Encapsulation

n.cm-2
5

3.45x1012

59.1

2.81x1010

Bare

5

3.45x1012

46.5

2.81x1010

LiF

5

3.45x1012

45.3

2.81x1010

LiF

5

3.45x1012

42

2.81x1010

LiF

5

3.45x1012

45

2.81x1010

LiF

5

3.45x1012

47.5

2.81x1010

Cd
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There is an average of 13.84 mV difference between the shielded and the
unshielded PIN diodes. This voltage difference is therefore due to the thermal
component of the flux in the TC 10 facility. Assuming negligible attenuation of
epithermal neutrons by the Li and Cd shields the remainder of the forward bias
voltage change (~ 45.26 mV) must be due to the epithermal component of the TC-10
flux. These measurements result in a PIN diode response for the TC-10 thermal
neutron spectrum of 4.01×10-12 mV/n.cm-2. If the effective energy of the thermal
neutron beam is considered to correspond to the peak thermal flux at 0.025 eV, the
known silicon damage KERMA at this energy is 3.3 ×10-14 cGy/n.cm2. This would
yield a PIN diode silicon dose response factor of 121.5 mV/cGy (Silicon Damage).
This factor is less than what has been measured in other experiments. For example
the calibration factor derived from the Van de Graff accelerator measurements was
133 ± 44 mV.cGy-1. The same factor derived from measurements on the well
characterised HB11 beam of the Petten HFR is ~ 190 – 200 mV.cGy-1. However the
assumption of an effective energy of 0.025 eV is only an approximation since the
experimental arrangement in these measurements used cadmium and lithium as the
thermal neutron attenuating materials. Therefore the difference in the shielded and
bare PIN diode responses will depend on the cadmium cutoff and the 6Li "cutoff"
energies. In other words the difference between the spectrum for the unshielded
measurements and the spectrum for the shielded measurements will not be a true
Maxwellian thermal distribution, only an approximation. The silicon neutron
KERMA function also changes significantly over this energy range (ie 0.025 eV ~
0.5 eV).
Therefore the effective energy of the thermal fluence (silicon damage
175

KERMA weighted) is greater than the energy of the peak thermal fluence. A
calibration factor of 190 mV.cGy-1 would give a silicon damage kerma dose of
0.0728 cGy for the 13.84 mV change in forward bias voltage observed in these
measurements. In this case if the thermal fluence is taken to be as measured at
3.45×1012 n.cm-2 then the silicon damage KERMA factor would be 2.11×10-14
cGy.n.cm-2, which corresponds to an effective energy of 0.065 eV.
The epithermal flux component of the TC-10 beam is estimated to be
0.00816φo which is 2.82×1010 n.cm-2. The forward bias voltage change for the
shielded PIN diode measurements is 45.26 mV. If the calibration factor derived using
the thermal part of the beam is used (i.e. 121.5 mV/cGy) then this voltage change
corresponds to 0.373 cGy of silicon damage dose. The KERMA factor becomes
1.32×10-11 cGy/n.cm2 which corresponds to a silicon damage weighted effective
energy of ~ 55 keV.

DISCUSSION

From these data it is not possible to confirm that the PIN diodes respond to
thermal neutrons as described by the published ASTM silicon damage kerma data.
However the results of these measurements are consistent with that data. The forward
bias change per cGy calibration factor derived assuming an effective energy of 0.025
eV for the flux measured by gold foils is also in agreement with other measurements
of the calibration factor to within experimental uncertainties. A numerical integration
of the silicon damage kerma data convolved with a Maxwellian flux distribution may
provide a more precise match between the measured voltage changes and the known
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damage kerma data. However since this would be an integral over sub cadmium
cutoff energies it would not be a sensitive way to show agreement with the exact
form of the KERMA curve. A much more accurate knowledge of the neutron
spectrum in the now decommissioned MOATA TC-10 facility would be required to
draw more accurate conclusions about the PIN diode response function.

MOSFET PASSIVE MODE MEASUREMENTS

MOSFET thermal neutron irradiations were performed simultaneously with
the PIN diode irradiations described above. The SiO2 layer in a MOSFET is known
to have a minimal intrinsic sensitivity to fast neutrons however the kovar
encapsulation of the MOSFETs used is expected to contribute to some neutron
sensitivity especially at lower neutron energies.
The MOSFET threshold voltage was measured immediately prior to attaching
the MOSFET to the PMMA rack used to hold the PIN diodes and MOSFETS in the
TC-10 column.
RESULTS

The threshold voltage changes observed for each exposure in the TC-10
facility is shown in Table 9-2. The thermal flux quoted is as measured using gold
activation foils. The data for the single MOSFET irradiated for 11 minutes was
scaled by a factor of 2.2 to normalise this measurement to a 5 minute total irradiation
time. The total flux is an estimate of the flux that the MOSFET was exposed to either
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bare or inside the LiF shielding. This was estimated for the bare MOSFET case as
being equivalent to the thermal fluence as measured by gold foils, and for the
shielded MOSFETs it was estimated to be the epithermal component of the beam.
That is approximately 0.00816φo as derived above for the case of the PIN diodes.

Table 9-2. Measured MOSFET response to thermal neutron irradiation in MOATA TC10
facility.

Irradiation

Thermal

Threshold

time (min)

flux

voltage change

Total flux

Configuration

(mV)
11

1.06×1013

1326

1.06×1013

Bare

5

3.45×1012

424

3.45×1012

Bare

5

3.45×1012

54.1

2.82×1010

LiF

5

3.45×1012

63.2

2.82×1010

LiF

5

3.45×1012

51

2.82×1010

LiF

5

3.45×1012

53

2.82×1010

LiF

These data are shown in Figure 9-2 along with a fitted curve showing a
threshold voltage change of 50.9 mV for a 5 minute irradiation when the neutron
fluence is extrapolated to zero.
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Figure 9-2. MOSFET threshold voltage change as a function of neutron fluence when
irradiated in the TC 10 facility on MOATA reactor.

Assuming that the MOSFET responds to neutrons of all energies and gamma
rays if the neutron fluence and the gamma dose rate in TC-10 is known the MOSFET
response to each component can be determined. This is described as:

ΔVtotal = φ o K therm + φ epi K epi + Dγ K γ

9-1

Where φo is the thermal fluence, φepi is the epithermal fluence and Dγ is the
gamma dose, Ktherm, Kepi and Kγ are the thermal, epithermal and gamma dose
efficiencies respectively.
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The thermal fluence was measured using gold foils and the epithermal fluence
was estimated assuming a slowing down spectrum with a gold foil cadmium ratio of
38. The gamma dose rate in the TC-10 facility on MOATA has been determined to
be 4.8 Gy.h-1 using paired Exradin Mg/TE ion chambersa. This gives a dose of 8 cGy
per minute or 40 cGy for the 5 minute irradiation used for these measurements. As a
first approximation a uniform sensitivity over all neutron energies was assumed i.e.
Ktherm = Kepi. This is considered reasonable and conservative first approximation
since the neutron cross sections of the MOSFET constituents will decrease with
energy in the epithermal energy range relative to their values at thermal energies.
This is shown elsewhere in MCNP models of the MOSFET device (Chapter 5).
For this particular experiment the final impact of the epithermal response
term (φepiKepi) on the determination of the thermal neutron sensitivity is small since
φepi << φo. For epithermal BNCT beams the epithermal response is more significant
and an energy dependent neutron response factor must be introduced as described
elsewhere (Chapter 5). In this case the threshold voltage change for the unshielded
MOSFET in TC-10 becomes:

ΔVunshielded = φ o K therm + 0.00816φ o K therm + Dγ K γ
= 1.00816φ o K therm + Dγ K γ

9-2

Where φepi is taken as 0.00816φo as derived from the slowing down spectral
component of TC10 (see Appendix). For the shielded MOSFETs the threshold

a

H Meriaty and BJ Allen, Ansto, unpublished data.

180

voltage change is:

ΔVshielded = 0.00816φ o K therm + Dγ K γ

9-3

Therefore

ΔVunshielded − ΔVshielded = φ o K therm

9-4

From this relation and the measured data the thermal neutron sensitivity is
derived to be 1.08×10-10 mV/n.cm-2. Using this value in equation 9-3 gives a value of
47.86 mV for DγKγ. Assuming the gamma dose sensitivity factor of 1.8 mV/cGy as
measured for this batch of MOSFETs in an AECL Theratron 60Co field is appropriate
for the gamma spectrum in TC-10 these measurements yield a gamma dose of 26.6
cGy for the 5 minute TC-10 irradiation. This is significantly less than the expected
dose based on ion chamber measurements. However this does not take into account
the attenuation of the gamma dose component through the LiF shield around the
MOSFETs.
The diameter of the LiF shields used was 3.5 cm and the length 8 cm.
Therefore a MOSFET on the central axis of one of these pots has approximately 1.75
cm of LiF attenuating the gamma dose component that is radially incident, and 4 cm
of LiF for the gamma dose component that is axially incident. The total attenuation
coefficient for LiF derived from the XCOM1 program of M.J. Berger192 at a photon
energy of 1 MeV is 5.89×10-2 cm2.g-1. The density of the LiF was taken as 2.5 g.cm-2.
This gives a linear attenuation coefficient of 0.14725 cm-1 and a total attenuation of
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0.77 for 1.75 cm of LiF. This would reduce the actual dose to the MOSFET from 40
cGy to 30.9 cGy for a 5 minute irradiation Implicit in this simple estimate of the dose
to the MOSFET is an assumption that the gamma photons are normally incident on
the side of the cylinder containing the LiF and the MOSFET. No data is available
regarding the angular distribution of the gamma flux in the TC-10 facility but in the
absence of this data it is reasonable to assume that it is more an isotropic field than a
parallel beam due to the large mass of surrounding scattering and moderating
material. Therefore there would be some component of the beam incident on the top
and bottom of the LiF shield that would experience a significantly greater attenuation
than the 0.77 that is expected for the gamma flux entering through the sides of the
LiF shield. Attenuation of a 1 MeV photon through the top or bottom of the cylinder
would be 0.55. The overall attenuation of the gamma flux reaching the LiF shielded
MOSFET will be somewhere in this range. The average of these two values will be
taken as the estimate of the attenuation factor, i.e. 0.66±0.11. Therefore based on the
previously measured TC-10 gamma dose rate of 4.8 Gy.hr-1 the dose inside the
lithium shield where the MOSFET is located during a 5 minute irradiation may be
estimated as 26.4 cGy ± 4.4 cGy. This is consistent with the experimentally observed
value of 26.6 cGy.
When the estimated gamma attenuation is added to equations 9-3 and 9-4
become

ΔVshielded = 0.00816φ o K therm + 0.66 Dγ K γ

9-5

ΔVunshielded − ΔVshielded = φ o K therm + 0.34 Dγ K γ

9-6

182

Using the expected gamma dose rate of 8 cGy per minute and the

60

Co

determined Kγ of 1.8 mV.cGy-1 gives a Ktherm of 1.01(±0.02) ×10-10 mV/n.cm-2. This
value is 6.9% lower than the thermal neutron sensitivity factor neglecting the effect
of gamma attenuation in the LiF shields. The LiF attenuation factor is not well
known due to the lack of information available about the angular and energy
distribution of the gamma flux in the TC-10 facility. Therefore the uncertainty quoted
for it spans the range of attenuations expected for a 1 MeV gamma flux incident
radially or axially on the LiF MOSFET holders. As can be seen the value of Ktherm is
not highly sensitive to this relatively large uncertainty in the gamma attenuation. This
factor could be used for the normalisation of the MOSFET energy dependant neutron
response functions determined in Chapter 5.

MOSFET ACTIVE MODE MEASUREMENTS

Greatly increased sensitivity and linearity of dose response can be obtained by
using MOSFETs in “active mode”. “Active mode” refers to use of the MOSFET with
a bias voltage attached to the gate electrode during the irradiation period instead of
having the gate at the same potential as the source, drain and substrate during this
period. The effect of applying a gate bias is to sweep more of the holes produced into
traps along the oxide substrate interface thereby increasing the threshold voltage
relative to what it would be if those holes were distributed throughout the oxide
layer.
The effect of applying a gate bias during mixed gamma neutron irradiations
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was investigated using the MOATA TC-10 facility. A MOSFET was calibrated using
a Co 60 Theratron gamma source and then irradiated in TC-10. This process was
repeated using a number of different epoxy-lithium fluoride and epoxy-lithium
carbonate shields. Gold activation foils were also placed in each shield during the
irradiations. The gamma and neutron attenuation factors for each of three different
neutron shields were determined.
A 0.6 cc Farmer ionisation chamber in conjunction with a Farmer
electrometer was used to monitor the gamma dose delivered to the MOSFETs by the
Theratron. The gamma attenuation was also measured by placing the Farmer chamber
inside the Li shields and measuring the dose rate.

LiF shields
Cylindrical lithium fluoride / epoxy and lithium carbonate / epoxy shields
previously manufactured for biological irradiations (mouse and in-vitro) in the
MOATA TC-10 thermal column were used. These shields had various thicknesses
and the exact constituency was not determined.
Shield number 1 had internal and

external diameters of 1.9 and 5 cm

respectively. It was 4.6 cm long with ends that were 1.5 cm thick. It was fabricated
from 6LiF epoxy. Shield number 2 had internal and external diameters of 2.5 and 5.5
cm respectively with 1 cm thick endcaps. It was fabricated from natural LiF epoxy.
Shield number 3 was made from natural Li2CO3 and epoxy and had an internal
diameter of 3 cm and an external diameter of 4 cm. The endcaps were 0.5 cm thick.
Because their exact composition (and therefore thermal neutron attenuation
factors) were unknown the neutron attenuation factors were measured using gold foil
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activation measurements both inside and external to the shields.

The neutron

attenuation factors were taken as the ratio of the specific activity of gold foils
measured inside and outside the shields after corrections for decay had been made.
Similarly the gamma attenuation factors for the shields were measured in the
Co-60 Theratron beam using a Farmer ionisation chamber. The gamma attenuation
factor was determined as the simple ratio of the dose rate measured inside the shield
versus the dose rate without the shield in a 10 x 10 cm beam.

RESULTS
Gamma attenuation factors
The measured gamma attenuation factors are shown in Table 9-3 and Table
9-4. Clearly the maximum correction required for attenuation of gamma rays with
these shields is approximately 6% for shield number 2.

Table 9-3. Gamma attenuation factors for the Li-epoxy neutron shields, measurement 1.

Lithium/epoxy
neutron shield

60

Co gamma dose

Unattenuated 60Co

Attenuation

dose rate

factor

rate (cGy.min-1)

(cGy.min-1)
No shield

38.9

38.9

1.000

1

37.0

38.9

0.951

2

36.5

38.9

0.938

3

38.2

38.9

0.982
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Table 9-4. Gamma attenuation factors for the Li–epoxy neutron shields, measurement 2.

Lithium/epoxy

Co 60 gamma dose

Unattenuated 60Co

Attenuation

neutron shield

rate (cGy.min-1)

dose rate

factor

(cGy.min-1)
No shield

39.0

39.0

1.000

1

37.4

39.0

0.958

2

37.0

39.0

0.948

3

40.9

41.6

0.983

Table 9-5. Neutron attenuation factors for lithiated neutron shields.

Li Shield

Outer foil specific

Inner foil specific

Attenuation

activity (Bq.mg-1)

activity (Bq.mg-1)

1

4948.5

58.16

0.012

2

6065.4

425.1

0.07

2

7665

505.7

0.066

3

4969.7

996.2

0.20

3

6177

1244

0.20

The neutron attenuation factors for the lithiated shields based on gold foil
activation are shown in Table 9-5. The results from the series of exposures for
MOSFET number 1 using a bias of 5 volts in the

60

Co gamma field and the TC-10

neutron field were as shown in Table 9-6. The corresponding results from the series
of irradiations of MOSFET number 2 with a 10 volt bias are shown in Table 9-7.
Figure 9-3 shows the MOSFET threshold voltage changes as a function of neutron
fluence during the 5 minute irradiations in TC-10 using different neutron attenuating
shields. Data for both MOSFETs is shown. MOSFET number 1 had a 5 volt bias
applied during irradiation and MOSFET number 2 had a 10 volt bias applied during
irradiation. The total threshold voltage change was 3598 mV for MOSFET number 1
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and 5243 mV for MOSFET number 2. Therefore it may be expected that the
MOSFET was operating well beyond its linear dose response range.

Table 9-6. Threshold voltage changes for gamma and thermal neutron irradiations (5v bias).

Radiation

Lithium

Dγ

φo

ΔVf

Source

shield

(cGy)

(n.cm-2)

1

Co 60

1

37.0

0

243.9

2

TC-10

1

40

4.14×1010

202.0

3

Co 60

3

38.2

0

263.0

4

TC-10

3

40

6.9×1011

515.4

5

Co60

3

40.5

0

230.6

6

Co60

2

41.4

0

233.0

7

TC-10

2

40

2.35×1011

399.0

8

Co60

none

38.9

0

210.0

9

TC-10

none

40

3.45×1012

1301

Table 9-7. Threshold voltage changes for gamma and thermal neutron irradiations (10v
bias).

ΔVf

Radiation

Lithium

Dγ

φo

Source

shield

(cGy)

(n.cm-2)

1

Co 60

1

39.0

0

350

2

TC-10

1

40

4.14×1010

259.3

3

Co 60

3

40.9

0

399

4

TC-10

3

40

6.9×1011

820.5

5

Co60

2

37.0

0

356

6

TC-10

2

40

2.35×1011

551.4

7

Co60

None

38.5

0

316

8

TC-10

None

40

3.45×1012

1892

9

Co60

None

38.3

0

299
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Figure 9-3. MOSFET threshold voltage change as a function of neutron flux in TC 10.
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Figure 9-4. Five volt bias MOSFET data corrected for drop off in sensitivity.
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Figure 9-5. MOSFET irradiated with 10 volt gate bias. Both raw data and data corrected for
decrease in sensitivity are shown.

By using the

60

Co irradiations in between each TC-10 neutron irradiation to

determine a new calibration factor the data points can be corrected for the decrease in
sensitivity with the large cumulative threshold voltage change. The known gamma
dose and the observed threshold voltage change for each 60Co irradiation was used to
calculate a new gamma sensitivity which in turn was used to correct the observed
voltage change during the subsequent TC-10 irradiation. All voltage changes
observed during TC-10 irradiations were corrected back to the voltage change that
would be observed for the MOSFET with its initial sensitivity. The initial sensitivity
for the 5 volt MOSFET was 6.59 mV.cGy-1. The initial sensitivity for the MOSFET
with 10 volts applied to the gate was 8.97 mV.cGy-1.
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Figure 9-6. Correlation between Neutron Dose sensitivity and gamma dose sensitivity for
MOSFETs with 0v, 5v and 10 v bias during neutron and gamma irradiations.

The corrected threshold voltage changes as a function of neutron fluence for
the two MOSFETs are shown in Figure 9-4 and Figure 9-5 along with the
uncorrected data for comparison. A straight line has been fitted to the corrected data.
The intercept of the fitted curve for the 5 volt MOSFET was 264 mV and for the 10
volt MOSFET it was 345 mV. By extrapolating this curve to zero neutron fluence in
this manner we obtain a measure of the gamma dose contribution to the MOSFET in
the TC-10 field. Assuming that the gamma sensitivity factor for the gamma field in
TC-10 is the same as the sensitivity factor for 60Co radiation (ie 6.59 mV.cGy-1 for a
MOSFET with 5 v on gate and 8.97 mV.cGy-1 with 10 v on the gate) we obtain
gamma doses for 5 minute irradiations of 40.1 cGy and 38.5 cGy for the 5 v and 10 v
MOSFETS respectively. This corresponds to gamma dose rates of 481 cGy.hr-1 or
462 cGy.hr-1 respectively. These values are in accord with previously measured
gamma dose rates of 4.8 Gy.hr-1 using paired ionisation chambers.
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CONCLUSIONS

By measuring PIN diode neutron dosimeter responses in the MOATA TC-10
thermal column both bare and covered with Li or Cd thermal neutron shielding it was
possible to demonstrate that in this irradiation facility the PIN diodes respond to both
the thermal component and the epithermal component of the neutron spectrum.
Although the TC-10 port is a thermal neutron irradiation facility, because of the
shape of the silicon neutron KERMA function, the diode bias voltage shift observed
for Li or Cd shielded devices was approximately 75% of the bias voltage change
observed for diodes with no Cd or Li shields.
These measurements yielded a PIN diode sensitivity of approximately 4×10-12
mV/n.cm-2 for the thermal component of the TC-10 spectrum. If the silicon damage
KERMA factor for the thermal component is assumed to be 3.3×10-14 cGy/n.cm-2 (ie
assume effective energy of 0.025 eV) this gives an approximate calibration factor of
121.5 mV.cGy-1 (silicon damage dose).

This agrees to within experimental

uncertainties with the factor measured using the Van de Graff accelerator however it
is significantly lower than the value of approximately 190 mV.cGy-1 derived from
measurements in the HB11 epithermal beam on the Petten HFR. It should be noted
however that because of the uncertainty present in the assumed spectrum of the TC10
port the calibration factor measured in this chapter is based on an effective energy of
0.025 eV. If the KERMA function from the literature was convolved with a more
accurate estimate of the spectrum in TC-10 a more accurate estimate of the diode
calibration could be determined. This was not pursued here due to the uncertainties
that exist regarding the exact spectrum in TC-10.
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The sensitivity of the PIN diodes to the epithermal part of the TC-10
spectrum was found to be 1.60×10-9 mV/n.cm-2. This is a factor of 400 greater than
the sensitivity to the thermal part of the spectrum. This shows that for thermal
neutron beams measurements of the silicon dose using PIN diodes can potentially be
confounded by even a very small component of epithermal or fast neutrons. However
this in itself suggests that PIN diodes could be applied as quite sensitive monitors of
the epithermal or fast components of the spectrum in these environments. This
intrinsic low sensitivity can be further diminished by the addition of cadmium or
lithiated covers as were employed in the measurements here.
MOSFETs were irradiated with the PIN diodes both with lithiated shields
ands without. By taking the difference in the threshold voltage changes for the
shielded and unshielded MOSFET measurements it was possible to determine both a
thermal neutron sensitivity factor for the MOSFETs and an estimate of the gamma
dose in the TC-10 facility. The neutron sensitivity of a bare MOSFET operated with
no bias during irradiation was found to be 1.08×10-10 mV/n.cm-2 for the MOATA
TC-10 spectrum. Since the MOSFET neutron response drops off rapidly with
increasing neutron energy and the TC10 facility has a gold foil cadmium ratio of ~38
this factor can be reasonably to applied to MOSFETs of the same type in any thermal
spectrum. This factor could also be used for the normalization of the Monte Carlo
calculated energy dependent neutron response function of the MOSFETs determined
in Chapter 5.
The gamma dose measured in TC-10 assuming negligible neutron response of
the lithium shielded MOSFETs was found to be 3.19 Gy.hr-1. This is significantly
lower than the value of 4.8 Gy.hr-1 previously measured using paired ionization
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chambers. However when the gamma attenuation of the lithium shields is taken into
account the dose rate is found to be 4.8(±0.8) Gy.hr-1 which is quite consistent with
previous measurements using more conventional ionization chamber techniques.
Similar measurements were repeated using MOSFETs with a bias applied to
the gate during irradiation in TC-10. This resulted in much higher sensitivity. To
account for changes in intrinsic sensitivity due to the large threshold voltage changes
the MOSFETs were calibrated in a standard

60

Co field between each irradiation on

MOATA. For a MOSFET with a 5 volt bias during irradiation a thermal neutron
sensitivity of 3.84×10-10 mV/n.cm-2 was measured. For a MOSFET with a 10 volt
gate bias the thermal neutron sensitivity was 5.04×10-10 mV/n.cm-2. The
corresponding 60Co gamma sensitivities were 6.59 and 8.97 mV.cGy-1 respectively.
Using the biased MOSFETs the measured gamma dose rate in TC-10 was
4.81 Gy.hr-1 and 4.62 Gy.hr-1 for the 5 volt and the 10 volt biased MOSFETs
respectively. Again these measurements are in agreement with the previous unbiased
MOSFET measurements and ionization chamber measurements. Because of the
higher threshold voltage changes for the biased MOSFETs and also due the
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calibration performed prior to each measurement in TC-10 these biased MOSFET
measurements of gamma dose may be considered more reliable than the unbiased
MOSFET results.
The technique used here demonstrates an effective way to measure gamma
dose in mixed thermal neutron and gamma fields. By using a bare MOSFET and one
or more different thermal neutron shields the neutron component of the MOSFET
response can be extrapolated to zero and the remaining response presumed to be due
to gamma dose. The short comings of this technique include the relatively large
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shields required and the possibility of perturbing the neutron induced gamma field
due to the presence of lithiated shields. The size of the shields could be minimized by
using materials with higher concentrations of enriched 6Li if necessary. Unfortunately
the technique is not so easily applied to mixed fields where there is a large epithermal
neutron component because this cannot be attenuated so effectively with simple
lithiated shields. As demonstrated elsewhere in this thesis to use neutron shields of a
reasonable size in an epithermal neutron beam it is necessary to calculate a neutron
spectrum dependent correction factor to account for the MOSFET neutron response.
A direct linear relationship was observed between the neutron sensitivity and
the gamma sensitivity of the MOSFETs as the bias voltage on the gate is increased
between 0 and 10 volts. This indicates that the ionization caused in the SiO2 layer
during gamma and neutron irradiation of these MOSFETs leads to similar hole
trapping phenomenon. This supports the assumption that ionization in the oxide layer
during low energy neutron radiation of these MOSFETS is mediated by secondary
electron, gamma and x-ray radiation rather than neutrons directly. If direct action by
neutrons was contributing significantly to the ionization within the oxide it might be
expected that for such a process the change in sensitivity observed as the gate bias
increased would not be the same as for gamma fields. In these experiments neutron
sensitivity was always proportional to gamma sensitivity. It is most likely that the
neutron sensitivity is due to secondary electrons and gamma rays generated in the
MOSFET encapsulation.
Future use of MOSFETs for gamma dosimetry in mixed neutron and gamma
fields could be simplified by careful selection and optimization of the MOSFET
encapsulation materials to minimize neutron sensitivity due to interactions in the
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MOSFET encapsulation.
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CHAPTER 10 PETTEN

HFR

HB11

MEASUREMENTS:

BNCT

DESCRIPTION

BEAM
OF

FACILITY, PHANTOMS, MCNP MODELS AND
FOIL ACTIVATION MEASUREMENTS

INTRODUCTION

A series of in phantom measurements using PIN diodes and MOSFETs were
performed using the HB11 filtered epithermal neutron beam at the High Flux Reactor
(HFR) located in Petten at the European Commission Joint Research Centre (JRC).
This neutron beam has been well characterised193 and is therefore used in the
following measurements as a reference beam as well as an epithermal neutron source
for measurements in phantoms.
Some of the semiconductor dosimeter measurements described here were part
of a set of measurements aimed at verifying a MCNP treatment planning model
which is fully described elsewhere by Wallace194. Among other things, that work
describes the fabrication of a detailed human head phantom as well as the
development of a Monte Carlo model of epithermal neutron beams incident on it.
Results from some parts of the measurements described here were used in an attempt
to validate that Monte Carlo model.
The substance of this current chapter and the two that follow are the
experimental measurements themselves. In particular this includes the detailed
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characterisation and analysis of the MOSFET and PIN dosimeter responses that are
required to give good agreement between the model described by Wallace and the
data derived from measurements in the HB11 beam.
MATERIALS AND METHODS

THE HB11 EPITHERMAL NEUTRON BEAM ON THE PETTEN JRC HFR.

The HB11 beam on the High Flux Reactor (HFR) at the EC Joint Research
Facility has been customised to provide a high quality epithermal neutron beam
specifically for BNCT trials and treatments.
The HFR is a 45 MW light water swimming pool reactor mainly used for
materials testing. Initial MCNP simulations195, 196 of a beam on the HB11 port of the
reactor using a filter of Cd(1mm), Al (150mm), S(50mm), Ti (10mm) and Ar
(1500mm) predicted a beam with the following characteristics. A neutron flux of
1.1x109 n.cm-2 s-1, a fast neutron dose per incident neutron of 7.8x10-13 Gy.cm2, a
gamma dose of 0.5 Gy per incident 3x1012 n.cm-2 and an average neutron energy of <
8keV. The treatment point in the HB11 beam is approximately 5 m from the reactor
core which was expected to result in a beam with minimal divergence.
The beam design optimised using MCNP 4A simulations and subsequently
constructed197 consisted of a filter made of 1 mm of Cd, 80 mm of Al, 10 mm of Ti,
50 mm of S and 1501.2 mm of liquid Ar. The S and Ar were contained in Al vessels
giving a total thickness of Al of 150mm. The filter assembly also included a void of
approximately 44 cm thickness which acts as a water shutter in case the main beam
shutter fails or the liquid argon is lost. Under normal operation of the beam this
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volume is empty but if the beam needs to be shut off in an emergency the volume can
be flooded with water. The Al, S and Ti components of the filter define the
epithermal neutron spectrum which is transmitted. The cadmium layer removes
thermal neutrons from the core entering the beam. The role of the 1.5 m section of
liquid argon in the filter is to serve as a gamma ray attenuator. The presence of the
argon has minimal effect on the neutron spectrum.
The room arrangement has been described well by Raaijmakers193. The beam
tube is at a 5° angle to the reactor core and exits the reactor shielding at the same
angle. For this reason the HB11 treatment room has been constructed with a 5 cm
thick polyethylene wall perpendicular to the beam axis. This facilitates the correct
alignment of patients and phantoms within the room. The diameter of the beam can
be modified by inserting 19 cm long collimating apertures into the beam line at the
point where it exits into the treatment room. These collimators are made of a
sandwich of 5 cm of lithiated polyethylene, 9cm of lead and another 5cm of lithiated
polyethylene and can define exiting beam diameters of 8 cm , 12 cm or 15 cm.
Raaijmakers193 undertook a full characterisation of the HB11 beam including
thermal neutron fluence, fast neutron dose rates and gamma dose rates in phantoms at
different distances from the beam exit hole (0, 20, 30, 40 and 50 cm) and for different
aperture sizes (8 cm, 12 cm and 15 cm). The thermal neutron fluence depth dose
curve in water phantoms did not depend on the separation of the phantom from the
beam exit hole. The absolute value of the thermal neutron fluence (at 2cm depth in a
water phantom) was found to change according to the inverse square of the distance
between the phantom and a virtual source located at 3 m beyond the beam exit hole.
The ratio of the fast neutron and gamma dose to the thermal neutron fluence was
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constant with changes in the phantom to beam exit separation.
Increasing the field size from 8 cm to 15 cm resulted in a thermal neutron
fluence increase of 52%, a gamma dose rate increase of 67%, and a fast neutron dose
rate increase of 6%. There was also a trend towards larger percentage thermal
fluences at depth for increased aperture sizes. The vertical and horizontal beam
profiles were shown to be similar and therefore the beam has been treated as axially
symmetric for the purpose of the measurements described here.

PHANTOMS

Three phantoms were used in the measurements described here. They were, in
order of decreasing complexity:
1) A detailed anthropomorphic phantom of the human head. This was
fabricated from a human skull, tissue equivalent gel and thermosetting
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plastic. Its fabrication is described by Wallace

. It will be referred to

as ‘the skull phantom’. Details of the phantom and model pertinent to
this particular thesis are described in following sections.
2) A tissue equivalent-gel filled, polycarbonate cylindrical phantom. This
phantom is 16 cm in diameter and 23 cm in length. This will be
referred to as the cylinder phantom.
3) A cubic solid polymethylmethacrylate (PMMA, also known as perspex
or lucite) phantom of side length 15 cm. This will be referred to as the
cube phantom.
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THE SKULL PHANTOM

As noted above the fabrication of this phantom is fully described by
Wallace194 and is only briefly summarised here. The phantom consisted of a human
skull contained in a molded thermoplastic (cellulose acetate) outer skin. This mold
was produced from a plaster cast of the skull. Once the molded plastic was completed
the skull was placed inside it. A region of low density (essentially a void) was then
inserted to represent the oral cavity, nasopharanx and oesophagus. This consisted of
expanded polyurethane foam. The remainder of the outer plastic shell was then filled
with tissue equivalent gel.
The fabrication of this gel is also described by Wallace194. It was based on the
recipe for tissue equivalent liquid given by Goodman198 but modified by the addition
of agarose to form a gel. According to Wallace the components of the gel by weight
are: water (64.9%), glycerol (26.5%), Urea (4.4%), agar (4.1%). This results in a gel
with a density of approximately 1.09 g.cm-3 and an elemental composition by weight
of H (10.1%), C (13.2%), N (2.1%), O (74.6%). This composition is close to the
elemental composition of ICRU 46 grey/white brain matter: H (10.7%), C (14.2%), N
(2.2%), O (71.2%).
The top of the skull was sliced transaxially. The top section could be
completely removed allowing access to the tissue equivalent gel representing the
brain in the intracranial region. To facilitate this the plastic shell also had a
removable top section. During the measurements the top of the plastic shell was
secured with fine nylon screws. During irradiation, the skull was supported on a jig
consisting of a PMMA base plate and a number of upright PMMA rods. See Figure
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parallelepiped 21 cm high, 20 cm from anterior to posterior and 15 cm wide in the
lateral direction. The geometry of the skull is therefore defined within a three
dimensional array of 50400 cubic 0.5 cm voxels. The transaxial slices are shown in
Figure 10-3, Figure 10-4 and Figure 10-5. The saggital slices are shown in Figure
10-6 and Figure 10-7.
The tissue compositions of the skull phantom are based on ICRU 46199. The
tissue equivalent gel used to fabricate the phantom was prepared to match the
composition of ICRU 46 brain as closely as possible194. For the purposes of the
current MCNP calculations the model was simplified further by setting all soft tissue
in the phantom to brain equivalent composition. However due to the delay of several
months between phantom fabrication and the actual measurements in the Petten beam
allowance was made in the MCNP model for some dehydration of the tissue
equivalent gel. For the MCNP model the amount of hydrogen in the form of water in
the brain equivalent gel was reduced by 10% for all the brain equivalent parts of the
phantom.
The soft tissue components of the phantom were therefore represented in the
MCNP model as having the following composition by mass; H (10.66%),
C(16.05%), N(2.44%), O(69.3%), Na(0.22%), P(0.44%), S(0.22%), Cl(0.33%) and
K(0.33%). This effectively represents the ICRU 46 brain equivalent composition but
with a ~10% reduction in the amount of water present.
The density of the brain equivalent material in the model representing the
brain and other soft tissue in the MCNP model was 1.047 g.cm-3 except for the
material of the same composition used to represent the airways which had a density
of 0.58 g.cm-3.
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Figure 10-3. Transaxial slices of skull phantom as used for MCNP model (ordered from
superior to inferior).
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Figure 10-4. Transaxial slices of skull model continued.
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Figure 10-5. Transaxial slices of the skull phantom as used for the MCNP model.

The bone composition of the skull was represented in the MCNP model as
per ICRU 46; H(5%), C(21.2%), N(4%), O(43.5%), Na(0.1%), Mg(0.2%), P(8.1%),
S(0.3%) and Ca(17.6%). The density of the bone was set to 1.5 g.cm-3. This may be a
slight over estimate due to the fact that the skull was obtained from an anatomy
department and was therefore more dehydrated than bone in vivo. Therefore there is
some uncertainty about how accurately this density and the H and O composition of
the MCNP skull model represents the real density and H concentration of the skull in
the phantom.
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Figure 10-6. Sagittal slices of MCNP skull model.

In the MCNP model used by Wallace194 extensive use was made of
importance factors greater than 1 for both neutrons and photons at depth in the skull
phantom. Importance factors were increased with depth along the direction of the
incident beam in an attempt to decrease the variance in calculated quantities. For
many voxels the importance for neutrons and neutron induced photons was set to
values of 64 or 128. This approach was taken to reduce variance and computation
time.
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Figure 10-7. Sagittal slices of MCNP model of skull phantom continued.

In the calculations described here all importance factors were less than 4 for
both neutrons and photons. This more conservative use of cell importances increases
the number of particle histories and the computation time needed to reduce the
variance of tallies at depth in the phantom but is less prone to artifacts that could
arise when very high cell importances are used. These may occur because with very
high importance factors on the distal side of the phantom significant amounts of
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computer time are spent tracking very low weight particles that arise from relatively
few higher weight particles entering from the source side. The much more
conservative use of cell importance factors in the simulation data shown here allows
more confidence in the results by minimizing the potential of cell importance
artifacts as a source of discrepancy between calculated and measured doses.
The thermal S(α,β) treatment was used throughout the model in appropriate
materials using the light water correction table at 300K. The source spectrum and
collimator geometry was supplied by P Watkinsa, 194.
Tallies of neutron flux and neutron dose, were made for planes coinciding
with the measurement axes of the phantom. Tallies of photon flux, photon dose,
silicon damage kerma, MOSFET neutron response and gold foil activation were
made for all cells along the measurement axes.
To generate most of the data displayed here the model was run for
approximately 37 million particle histories and a total CPU time of approximately
140 hours on a 366MHz PC.

THE CYLINDER PHANTOM

The cylinder phantom consisted of a polycarbonate cylinder of 16 cm
diameter and length 23.35 cm. See Figure 10-8. The ends of the phantom were also
made of polycarbonate. These ends had a diameter of 18 cm and were attached with
fine nylon screws. The cylinder was filled with brain equivalent gel similar to that

a

P Watkins, private communication to S Wallace, December 1993.
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used for the skull phantom and manufactured as described by Wallace

. To allow

for insertion of dosimeters four PMMA tubes (1.5 cm outer diameter, 1.25 cm inner
diameter) were located parallel to the cylinder axis and running the entire length of
the cylinder. These were all centred at 2.5 cm from the cylinder axis and distributed
at 90° intervals around it. Dosimeters were first loaded into a PMMA tube of 0.95 cm
inner diameter and 1.25 cm outer diameter separated by PMMA spacers. These
assembled tubes containing the dosimeters and spacers were then inserted into the
tubes in the phantom.
During irradiations the cylinder phantom was supported on a PMMA cradle
with the central axis of the neutron beam centred on the axis of the cylinder (i.e.
coaxial). See Figure 10-9.

Figure 10-8. Schematic diagram of cylinder phantom showing dimensions.

MCNP MODEL OF CYLINDER PHANTOM
For comparison with the experimental results a MCNP4A simulation of the
cylinder phantom exposed in the HB11 beam was performed. The front face of the
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cylinder was polycarbonate. With the exception of the front face the external
polycarbonate walls of the cylinder were neglected in the model.

Figure 10-9. Cylinder phantom supported on PMMA alignment jig showing dosimeter
access holes parallel to central axis.

For the purposes of the simulation the cylinder geometry was modeled as a
cylinder of homogeneous brain equivalent material. Annular tally regions with an
inner radius of 2.25 cm and an outer radius of 2.75 cm were used to accumulate a
tally of flux and foil activation along the length of the cylinder in 0.5 cm thick slices.
These regions corresponded to the radial position of the rods used to hold the
detectors in the actual phantom. The PMMA rods and the spacers between detectors
were not explicitly modeled in the MCNP simulation. Tally multipliers applied to
track length flux tallies were used to generate reaction rates for the foil materials in
the annular tally regions at each depth.
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Figure 10-10. MCNP model of tissue equivalent cylinder phantom irradiated in HB11
epithermal neutron beam.

The cylinder phantom was modeled using MCNP as a cylinder containing
tissue equivalent gel of the same constituency as the gel used in the skull phantom.
The geometry of the MCNP model including the beam and collimator is shown in
Figure 10-10. Similar geometry was also used for the simulations of the skull and
cube phantoms.
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THE CUBE PHANTOM.

The cube phantom consisted of a solid block of PMMA. It was 15cm on edge.
It had dosimeter access holes drilled into it from the top surface. These were
approximately 2 cm in diameter and approximately 10 cm deep, thus allowing
dosimeters to be placed at a number of points along the central axis of the phantom.
This phantom was manufactured by the NKI and has been used for numerous
measurements in the HB11 beam200 with various dosimeters. During irradiations it
was supported on the treatment table.

FOIL ACTIVATION MEASUREMENTS

Activation foils were used to measure reaction rates on all axes for
comparison with Monte Carlo predictions. For this purpose pairs of measurements
were performed using bare and cadmium covered gold, copper and manganese foils.
All foil activations were measured by the Petten counting laboratory using a sodium
iodide or high purity germanium detector. These raw activity data were then
corrected for decay and self shielding and specific activities were determined.

CYLINDER

Activation foil measurements were performed in the cylinder phantom using
gold, manganese and copper foils. Measurements were performed using bare and
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cadmium covered foils. Measurements were performed at multiple depths within the
phantom. Several repeats of the gold foil measurements were done. For the gold foils
measurements were made at depths of 2, 4, 6, 7 and 8 cm from the front face of the
phantom. Measurements were made at points 2.5 cm from the central axis of the
phantom. Since there were 4 PMMA access tubes in the phantom, one located in
each quadrant it was possible to perform up to four measurements simultaneously at
each depth.
For the manganese and copper foils a single bare and cadmium covered foil
activation measurement was made at depths of 2 cm and 7 cm.
During measurements the space between detectors in the PMMA tubes was
filled with PMMA spacer rods of appropriate length.

CUBE

For the PMMA cube phantom gold foil measurements were performed at
depths of 2, 5 and 8 cm from the front surface of the phantom. A cadmium covered
gold foil measurement was made at a depth of 2 cm. Unfortunately cadmium covered
foil measurements were not performed at 5 or 8 cm depths in this phantom.

SKULL

Only gold foil measurements were performed in the head phantom. A single
set of measurements was done using both bare and cadmium covered foils. All of the
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bare foils were irradiated during a single exposure of the phantom. All of the
cadmium covered foils were irradiated during a separate single exposure of the
phantom.

RESULTS: FOIL ACTIVATION VS MONTE CARLO SIMULATIONS

The raw data including activation and exposure times are tabulated in
Appendix D. In order to compare the foil activations with MCNP calculations of the
expected activation the saturation activity in Bq per atom was calculated for each foil
measurement. The corresponding quantity was derived from the MCNP calculations
for comparison.

CYLINDER PHANTOM

The cylinder phantom was originally intended to be the simple geometry
homogeneous phantom for use as a benchmark for measurements made in the more
complex skull phantom. Bare and cadmium covered gold foil measurements at a
radius of 2.5 cm and parallel to the phantom axis were consistent between separate
sets of measurements.
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Figure 10-11. Measured activation of bare and cadmium covered gold foils in the tissue
equivalent cylinder phantom. Note that the corresponding MCNP results were generated
assuming 10% dehydration of the tissue equivalent material.
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Figure 10-12. Bare and cadmium covered copper foil activation at 2 and 7 cm depths in the
cylinder phantom. MCNP results for the activations assume 10% dehydration of the gel.
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Figure 10-13. Bare and cadmium covered Mn foil activations in the cylinder phantom.
MCNP calculated activations assume 10% dehydration of the tissue equivalent gel.

This can be seen in Figure 10-11 where the gold activation foil data from a
number of separate exposures is presented on a single graph.
Similar results from measurements at depths of 2 cm and 7 cm for copper and
manganese foils are shown in Figure 10-12 and Figure 10-13. The bare and cadmium
covered activations with these three types of foils provide measurements spanning an
energy range from thermal to 580 keV.
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The tissue equivalent gel in the phantoms was produced by S Wallace

and

for the initial MCNP simulations was assumed to be ICRU 46 brain equivalent
material. However poor agreement between foil activation measurements and the
Monte Carlo simulations at depth suggested that either the density or the hydrogen
content of the gel may have decreased in the interval between fabrication of the
phantom and performance of the measurements. The experimental measurements,
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particularly for the cadmium covered foils, exceeded the MCNP calculated
activations as the depth increased suggesting that the incident neutron spectrum was
not being moderated in the phantom as much as would be expected for the assumed
constitution of the gel. This effect was greater for the Mn and Cu foils that have
higher energy resonances than the Au foils. This was also apparent in later
measurements with PIN diodes (see Chapter 11).
If the MCNP model was changed to reflect approximately 10% dehydration
of the gel good agreement was achieved between the foil activation (in terms of
saturation activities) calculated by the MCNP model and the experimentally
measured activation. See the solid and broken curves in Figure 10-11, Figure 10-12
and Figure 10-13.
In this way good agreement was achieved for all of the foil types (Au, Cu,
Mn) and also for PIN diode measurements and therefore justifies the assumption that
the hydrogen content of the gel was less than originally expected. On this basis a
similar adjustment was made to the assumed hydrogen content of the skull phantom.
The details of the HB11 collimator and beam spectrum used for the MCNP
simulations were supplied by Watkinsa. This HB11 source spectrum data had been
extensively verified and validated therefore the origin of the initial discrepancy in our
results was sought in the details of the phantom and its simulation rather than in the
accuracy of the source spectrum.

a

P Watkins, private communication to S Wallace, December 1993.
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PERSPEX CUBE PHANTOM

As noted above only gold foil measurements were made in the perspex cube
phantom. These were made at 2, 4 and 8 cm depths. A single cadmium covered gold
foil activation was done at 2 cm. When compared to a MCNP simulation the
cadmium covered gold activation at 2 cm depth was within 7% of the measured value
and the bare gold foil activation at the same depth was within 13% of the measured
value. The MCNP calculated bare gold foil activations at 5 cm and 8 cm depths were
within 20% of measured values. This data is shown in Figure 10-14.
The good agreement achieved between simulation and measurement for the
well defined geometry and material composition of the perspex cube phantom allows
confidence in the simulation of the other phantoms.
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Figure 10-14. Gold foil activation measurements along central axis of perspex cube
phantom exposed in HB11 beam.
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No adjustments were required to the density or assumed material composition
of the perspex phantom in the MCNP simulation to achieve this agreement. By
validating the measurement technique and MCNP model these consistent results
indirectly support the assumption previously made about the decreased hydrogen
content of the cylinder phantom.

SKULL PHANTOM

Gold foil measurements were made at each measurement location in the head
phantom. Both bare foils and cadmium covered foils were used. The results of these
measurements are presented along three axes; the beam axis from left to right
through the head, the vertical (superior-inferior) axis and the horizontal (anteriorposterior) axis. Along with the activation foil measurements are presented MCNP
calculations of the expected bare and cadmium covered gold foil activations at each
measurement point.
The concordance that was obtained between the MCNP calculated foil
activations and the experimental data for the case of the skull phantom was not as
good as the agreement that was achievable for the phantoms with simpler geometries.
The general trend in the observed discrepancies was for the cadmium covered foil
measured data to exceed the activation predicted by the MCNP model. Even
decreasing the hydrogen content in the tissue equivalent gel by 10% to allow for
dehydration of the gel did not fully correct this effect.
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Figure 10-15. Measured and MCNP calculated gold foil activation for bare and cadmium
covered foils along the beam axis in the head phantom exposed on HB11.
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Figure 10-16. Gold foil activation measurements and MCNP calculated activations along
the anterior–posterior axis of the head phantom.
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Figure 10-17. Measured and calculated gold foil activations along the vertical axis in the
head phantom exposed in the HB11 beam.

There also remains some uncertainty about the exact composition of the bone
in the skull since the skull that was used was a one previously used in a teaching
laboratory and therefore would be expected to have significantly lower hydrogen
content than live bone found in-vivo. In both the skull and the cylinder models the
PMMA tubes and spacer rods were not explicitly modeled. This may be expected to
introduce some error since both the mass density and the atomic density of hydrogen
in PMMA is less than that in tissue. For the PMMA rod that was coaxial with the
centerline of the neutron beam some streaming along this lower density channel
formed by the PMMA could be proposed. However this cannot account for all of the
discrepancy since clearly the foils located along the sagittal and axial axes display an
over response along their entire lengths. Most of the depth traversed by neutrons
reaching these points is via tissue equivalent gel and not along the PMMA rod
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coaxial with the beam. Another proposed explanation194 is that the beam divergence
is actually less than the 10° used in the MCNP model. A more forward directed beam
would result in a greater dose at depth.
CONCLUSIONS

MCNP models of a head phantom, a tissue equivalent cylindrical phantom
and a cubic PMMA phantom have been generated and simulated in the Petten HFR
epithermal neutron beam. Gold, Copper and Manganese activation foil measurements
were found to be in approximate agreement with the simulations. In each case the
cadmium covered foil measurements at depth overestimated the calculated foil
activations. By modifying the hydrogen content of the tissue equivalent gel a better
agreement was obtained. This modification to the hydrogen content is reasonable on
the basis that the gel used was fabricated well before the phantoms were used in these
measurements and it is possible that some dehydration occurred over this period of
many weeks. The agreement for the phantoms with simpler geometries was better
than that for the more complex skull phantom. In hindsight for the purpose of
benchmarking and characterization of the PIN diode and MOSFET dosimeters more
emphasis should have been placed on measurements in the simpler phantoms.
The principle aim of the measurements described in this chapter has been to
demonstrate that it is possible to experimentally verify MCNP calculations of the
neutron flux in the three phantoms used when they are irradiated in the Petten HFR
epithermal neutron beam (HB11). This has been achieved within the uncertainties
evident in the results given above. On this basis the same MCNP models will be used
to calculate silicon displacement damage dose and induced gamma dose for
223

comparison with experimental measurements using PIN diode dosimeters and
MOSFET dosimeters in the same phantoms. Ideally agreement with the MCNP
model at least equivalent to that obtained here should be achievable for the PIN diode
and MOSFET dosimeters.
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CHAPTER 11 PETTEN

HFR

HB11

MEASUREMENTS:

BNCT
PIN

BEAM
DIODE

MEASUREMENTS
INTRODUCTION
In this chapter PIN diode measurements of silicon damage dose are described
in three phantoms exposed in the Petten HB11 epithermal neutron beam. The
methods used will be described in the following order; the PIN diode readout system,
measurement and calculation of PIN diode linearity correction and temperature
coefficient, PIN calibration exposure in the bare HB11 beam and measurements in
the skull, cylinder and cube phantoms. The results of the phantom measurements are
then given and compared with MCNP simulations of the same.

MATERIALS AND METHOD
The construction of the phantoms and the details of the corresponding MCNP
simulation models are given in the previous chapter and will not be repeated here. A
description of the HB11 beam is also found in the previous chapter.

PIN DIODE READOUT
The PIN readout was performed using the circuit built at Anstoa. This
consisted of a pulsed constant current source of 1 mA. This source gave a 1 mA pulse

a

Readout circuit built by H Meriaty, Ansto.
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of 1 mS duration every 11.2 mS. This current pulse was used to forward bias the PIN
diode being measured. The voltage across the PIN junction was connected to the
inputs of a FET input operational amplifier. The signal from this amplifier was then
feed to a peak detector circuit. This is shown in Chapter 3, (Figure 3-6).
The output voltage from the peak detector was measured using a Keithly
digital voltmeter. The voltmeter has a reading resolution of ± 0.1 mV. Repeated
measurements of a standard 100 ohm resistor placed across the test points showed a
variability of approximately ± 4 mV in the output voltage over a time period of
several days. Throughout the course of the measurements at the Petten HFR the
standard 100 ohm resistor was used to check on this drift in the circuit. Since the data
of interest for the PIN diode measurements is the difference between the PIN
threshold voltage before and after the irradiation a small drift that affects both of
these readings does not yield significant errors in the final result. The observed
changes in the reader output when measuring the 100 ohm standard occurred over the
course of days. With few exceptions all measurements of PIN diodes before and after
irradiation were separated by no more than several hours. Short term fluctuations in
the readout of the PIN diodes arising from noise or other instabilities of
undetermined origin were less than 1 mV.
PINs were connected directly to the PIN reader circuit to avoid any voltage
drop arising due to resistance of leads and to keep the readout procedure
reproducible.
To ensure that the temperature during the PIN diode readout was as constant
as possible lead blocks were placed in contact with the outer surface of the PIN diode
encapsulation. One block was placed above and one below the diode. During the
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interval between readouts these blocks were left on the readout bench and were
therefore in thermal equilibrium with the ambient temperature in the Reactor
Containment Building (RCB). Throughout the series of measurements this
temperature was observed to be 22 ± 1° C. The RCB temperature was monitored via
built in thermocouples. The temperature of the lead blocks used to stabilise the
temperature of the PIN diodes was measured using a mercury thermometer that was
placed in direct contact with them. The readings on the thermometer were observed
to agree with the RCB thermocouples to within 0.2 ° C. As far as possible the PIN
diodes were handled using forceps to avoid heating them with body heat from the
experimenters fingertips. This technique also minimised dose and transfer of
contamination to the experimenter.
The PIN diodes were read out immediately prior to setting up the phantom
and commencing the irradiation. The forward bias voltage, the time and the
temperature were recorded. Following the pre-irradiation readout the PIN diodes
were installed in the phantom or mounted in the beam in the case of calibration
exposures. Depending on the phantom this involved a 15-30 minute delay between
the readout and the commencement of the irradiation. The time of the
commencement of the irradiation was taken to be when the in room Gieger Muller
monitors installed on the treatment room wall reached half maximum.
At the completion of the irradiation period the beam shutter was closed. The
shutter closure takes approximately 6 seconds to complete. Since the shortest
exposure (beam on) time used in these experiments was approximately 15 minutes
the shutter close time was not considered a significant source of error. The phantom
was then quickly disassembled in the treatment room and the PIN diodes removed.
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The PIN diodes were then removed to the area adjacent to the treatment room
for post irradiation readout. The unread diodes were placed on a lead block to ensure
that they were at the ambient temperature prior to readout. Measurements of the
temperature in the treatment room showed it to be within approximately ± 1° C of the
temperature outside in the RCB. Therefore there was not a large temperature
variation between the irradiation and the readout phases of the measurements and
there was no need to allow long periods for the PIN diodes to thermally equilibrate
when they were removed from the phantom.

LINEARITY CORRECTION

The approximate linear response of forward bias voltage to dose for the PIN
diode extends for about 100-200 mV depending on the degree of accuracy required.
For radiation exposures that lead to doses with forward bias voltage changes beyond
this range it is necessary to apply a correction of some kind to account for the roll off
in sensitivity with increasing dose.
The method of correction developed for this work is based on the general
shape of the voltage versus dose curve for the PIN diodes used. Once the shape of the
curve is known the only other inputs required to determine the correction are the
initial calibration factor and the initial forward bias voltage before the PIN was
exposed to any radiation. This initial forward bias voltage is referred to here as the
“forward bias voltage at birth”, Vf(birth), to distinguish it from the initial forward
bias voltage for any given measurement, Vf(i).
The general shape of the PIN diode response was determined by exposing a
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PIN diode to a constant low dose rate of 252Cf neutrons for approximately 2000 hours
at Ansto Laboratoriesa. This data was collected with the PIN diode unconnected to
the reader circuit except for the times at which forward bias measurements were
made. The neutron spectrum consisted of moderated and unmoderated components
since the PIN diode was placed in direct view of the source at the opening of the
source entrance channel of a cylindrical boronated wax storage drum. The dose rate
at this entrance is not known accurately and the PIN diode calibration was not based
on these measurements. Only the shape of the PIN diode response curve was derived
from these measurements. The PIN diode change in forward bias voltage as a
function of time at a constant rate of exposure is shown in Figure 11-1. The curve
fitted to the data in terms of the total change in forward bias voltage (in volts) and
exposure time in hours was:

−4

ΔV f = 4.296(1 − e −6.39×10 t ) + 0.0016

11-1

The line of linear response is based on the gradient of the response curve over
the first 10 hours of exposure which corresponded to approximately a 28mV shift in
the forward bias voltage. This magnitude of voltage change is a reasonable increment
over which to determine the initial slope and a calibration factor given a reader
accuracy of at least 0.1 mV. From these two curves, the extrapolated linear response
and the curve fitted to the measured data, the ratio of the linear response to the actual
response can be determined.

a

Cf-525 PIN diode measurements performed by H Meriaty, Ansto.
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Figure 11-1. PIN forward bias voltage as a function of exposure time with AmBe neutron
source.

This ratio is the factor by which the actual measured PIN forward bias voltage
needs to be adjusted to give the forward bias voltage that would be observed if the
PIN diode responded linearly with dose over its entire time of use.
Since the ordinate is currently in terms of exposure time the ratio was
calculated and then plotted as a function of the actual forward bias voltage change
relative to Vf(birth). A polynomial curve was fitted to resulting data. This polynomial
defines the correction factor to be applied for any given forward bias voltage in order
that the same calibration factor can be used for the whole of the useful life of the PIN
diodes. The curve describing the correction factor is clearly a continuous slowly
increasing function over the range of interest. This is shown along with the
polynomial expression in Figure 11-2.
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Figure 11-2. Correction factor for PIN diode linearity. A 6th order polynomial fitted to the
ratio of the initial linear response to the actual PIN diode response.

As a check of this correction curve and to ensure that no significant errors had
propagated through the calculations it was reapplied to the original PIN diode

252

Cf

exposure data. When linearity corrections derived from this polynomial were applied
to the measured data a straight line resulted for the forward bias versus exposure time
plot (Figure 11-3). This verified that the calculations were self consistent and no
significant rounding or other errors were present.
The polynomial describing the correction factor was applied to all PIN diode
forward bias data measured in this series of phantom experiments by means of a
spreadsheet calculation to correct for non linearity in all measured data.
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Figure 11-3. Linearity correction applied to the original PIN diode responses showing the
resultant straight line for corrected data and verifying the internal consistency of the
correction.

TEMPERATURE CORRECTION

As noted above the variation in temperature between the treatment room and
the RCB ambient temperature was minimal (usually < 1˚C). This meant that the
temperature of the dosimeters at the pre irradiation readout differed very little from
the temperature at the post irradiation readout. However in order to apply a correction
for any forward bias voltage change that was attributable to temperature effects a
characteristic forward bias voltage versus temperature curve was acquired.
A plastic (polyethylene) sheathed PIN diode from the same batch as the
dosimeters used for the phantom measurements was immersed in a water bath that
was heated to approximately 60˚C. The bath was allowed to cool to room
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temperature and was then lowered to approximately 10˚C by the addition of a small
quantity of ice. The temperature of the water bath was monitored by means of a
mercury thermometer. The average cooling rate was less than 0.5˚C.min-1 in order to
ensure that the thermometer, PIN diode and water were in equilibrium.
Measurements of forward bias voltage were made periodically over the 10-60˚C
temperature range which is considered to adequately cover the probable operating
temperature range of the dosimeters. These measurements were made with a 1.00 mA
forward current from a constant current source. The voltage versus temperature data
is displayed in Figure 11-4. It can be seen that over the temperature range measured a
least squares linear fit is quite adequate to describe the data. The temperature
coefficient is -1.3 mV.˚C-1.

0.08
ΔVf = -0.0013T + 0.0801

0.07

R2 = 0.9984
0.06

Δ Vf (V)

0.05
0.04
0.03
0.02
0.01
0
0

10

20

30

40

50

60

Temperature (oC)
Figure 11-4. Forward bias voltage temperature characteristic of PIN diode dosimeter.
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For all of the data collected a temperature correction based on this coefficient
was applied whenever there was a temperature difference between the pre and post
irradiation forward bias voltage readouts.

CALIBRATION EXPOSURES

The HB11 beam was well characterised prior to and independently of the
measurements described here. Therefore measurements in the direct beam with no
phantom present provided a good source of epithermal neutrons for determining the
calibration of the PIN diodes in terms of threshold voltage change per unit silicon
displacement damage KERMA.
This calibration consists of two steps. Firstly from the known spectrum of the
neutron beam at the point where the PIN diodes are to be exposed the silicon damage
KERMA is calculated. This was done by using a MCNP model of the beam and
applying an energy dependant tally dose factor to a flux tally at the measurement
point. The tally dose factor was the ASTM data125 for silicon displacement damage
KERMA for silicon. This yields the actual silicon damage dose per unit fluence of
the beam. The PIN diodes were then exposed in the beam for a known time at a
constant fluence rate. Normalisation factors for the MCNP model were based on gold
foil activation measurements. The forward bias voltage change is then known per
unit fluence and the MCNP simulation derived fluence to dose factor is used to
convert the PIN diode calibration into units of mV per cGy of silicon damage
KERMA.
The experimental assembly for the irradiation involved attaching all of the
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PIN diodes to a thin (~ 2 mm) aluminium sheet using adhesive tape. This aluminium
sheet was then clamped in the beam so that the axis of the beam was normally
incident on the sheet of aluminium holding the PIN diodes. All the diodes were at
least 2 cm from each other and no absorbent or scattering materials were placed
between the beam port and the diodes.
This process was repeated twice for the entire set of diodes used in the HB11
measurements. One irradiation was performed with the 8 cm collimator and another
was performed with the 15 cm collimator in place. The distance from the collimator
face to the point where the diodes were irradiated was 20cm in both cases. The range
of temperatures that existed during these irradiations was from 21.8˚C to 23˚C. All
forward bias voltage measurements were adjusted for any temperature differences
between the initial and final readouts. The reactor power was set at 45 MW during
both irradiations. The first exposure in the 8 cm diameter field was for 20 min 10 sec.
The exposure in the 15 cm diameter field was for 20 min 0 sec.

RESULTS

BARE BEAM CALIBRATIONS

The changes in threshold voltage for each PIN diode corrected for
temperature and for linearity are shown below in Table 11-1.
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Table 11-1. PIN diode ΔVf changes following calibration exposure in HB11.

PIN Diode

Collimator / Field size

Number

ΔVf per hour of exposure at
reactor power of 45MW.

1

8 cm diameter

0.055

2

8 cm diameter

0.076

4

8 cm diameter

0.078

5

8 cm diameter

0.083

6

8 cm diameter

0.095

7

8 cm diameter

0.069

8

8 cm diameter

0.078

9

8 cm diameter

0.068

10

8 cm diameter

0.101

11

8 cm diameter

0.098

12

8 cm diameter

0.087

13

8 cm diameter

0.085

14

8 cm diameter

0.093

1

15 cm diameter

0.138

2

15 cm diameter

0.128

4

15 cm diameter

0.131

5

15 cm diameter

0.127

6

15 cm diameter

0.127

7

15 cm diameter

0.120

8

15 cm diameter

0.119

9

15 cm diameter

0.111

10

15 cm diameter

0.122

11

15 cm diameter

0.124

12

15 cm diameter

0.127

13

15 cm diameter

0.121

14

15 cm diameter

0.116

1

15 cm diameter

0.152

2

15 cm diameter

0.091

4

15 cm diameter

0.100
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The Monte Carlo simulation of the experimental set up that was used to
derive the fluence to dose factor yields a silicon damage dose of 0.576 cGy h-1 for the
15 cm diameter beam. This assumes a MCNP model normalisation factor of
1.857×1011 source neutrons per second (based on activation foil measurements). This
in turn gives the PIN diode calibrations shown in Table 11-2.

Table 11-2. PIN diode calibration factors as measured in HB11.

Calibration (V.cGy-1

PIN Diode Number

silicon damage KERMA)
1

0.239

2

0.223

4

0.227

5

0.220

6

0.220

7

0.209

8

0.206

9

0.193

10

0.211

11

0.215

12

0.220

13

0.209

14

0.201

These give an average calibration factor (±1 SD) of 214.9 mV.cGy-1. (±11.9
mV.cGy-1).
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SKULL IRRADIATION RESULTS

All the measured diode forward bias changes were corrected for readout
temperature differences and the linearity correction was applied to account for the
stage of their life cycle. The calibration factor measured in the free beam appropriate
to each individual diode was then applied to each forward bias voltage change. This
yields a quantity that is the measured silicon damage dose at the point of
measurement. As previously described measurements were made at several points
along the major axes of the head phantom. These results are listed in Table 11-3 and
Table 11-4 below. Note that during the course of the experiment PIN diode number 3
was found to be defective (suspect internal connections) and use of this diode was
discontinued.
Table 11-3. Measured Silicon Damage Doses in Head Phantom, irradiation 1.

Location code

PIN Number

Measured Silicon
Damage Dose (cGy.h-1)

A1

1

0.281

A2

2

0.146

H4

3

--

H5

4

0.092

H1

5

0.072

H2

6

0.040

H3

7

0.050

V1

8

0.075

V2

9

0.106

V3

10

0.047

V4

11

0.030

V5

12

0.035
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Table 11-4. Measured Silicon Damage Doses in Head Phantom, irradiation 2.

Location code

PIN Number

Measured Si Damage
Dose (cGy.h-1)

H4

1

0.067

A2

2

0.165

H5

4

0.107

H1

5

0.095

H2

6

0.077

H3

7

0.075

V1

8

0.111

V2

9

0.098

V3

10

0.065

A3

11

0.048

A4

12

0.030

TISSUE EQUIVALENT CYLINDER RESULTS

All the measured diode forward bias changes were corrected for readout
temperature differences and the linearity correction was applied to account for the
stage of their life cycle. The calibration factor measured in the free beam appropriate
to each individual diode was then applied to each forward bias voltage change. This
yields a quantity that is the measured silicon damage dose at the point of
measurement. The measured silicon damage doses are shown in Table 11-5 below.
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Table 11-5. Measured silicon damage dose in a tissue equivalent cylinder.

Position, depth in cm

PIN Number

Measured Silicon Damage
Dose (cGy.h-1)

2

1

0.375

2

2

0.364

2

3

--

2

5

0.313

2

6

0.440

2

7

0.479

7

4

0.042

7

5

0.074

7

6

0.056

7

5

0.064

7

6

0.076

7

7

0.072

PMMA CUBE RESULTS

All the measured diode forward bias changes were corrected for readout
temperature differences and the linearity correction was applied to account for the
stage of their life cycle. The calibration factor measured in the free beam appropriate
to each individual diode was then applied to each forward bias voltage change. This
yields a quantity that is the measured silicon damage dose at the point of
measurement. The measured silicon damage doses are shown in Table 11-6 below.
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Table 11-6. Measured silicon damage dose in perspex (PMMA) cube.

Depth cm

PIN Number

Measured Silicon Damage
Dose (cGy.h-1)

2

1

0.369

8

2

0.040

COMPARISON OF PIN DIODE RESULTS WITH MONTE CARLO
CALCULATIONS

CYLINDER PHANTOM

The comparison of measured data and MCNP generated silicon damage dose
in a tissue equivalent cylinder exposed in HB11 is shown in Figure 11-5. The
measured data are the absolute silicon damage doses per hour as determined above.
The MCNP model normalisation factor of 1.857×1011 is based on foil activation data
in the bare beam. The only modification that has been made to the original MCNP
model is that the hydrogen content of the tissue equivalent gel filling has been
reduced by 10% to account for dehydration of the phantom in the interval between
fabrication and the measurements described here.
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Figure 11-5. Measured and calculated silicon damage dose in a tissue equivalent cylinder
exposed to a 15 cm diameter epithermal neutron beam on HB11 facility, Petten. Note that
the data points representing the measured data are the average of several measurements
(error bars represent ± 1 σ).

PERSPEX (PMMA) CUBE PHANTOM

The MCNP calculated silicon damage dose along the central axis of a PMMA
cube exposed in the HB11 beam is shown in Figure 11-6 below. Also shown is the
measured PIN diode data. No corrections to the MCNP model were necessary for the
cube phantom calculated data to achieve a good agreement with the measured data.
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Figure 11-6. PIN diode measurements of silicon damage dose along the central axis of a
PMMA cube exposed in the HB11 beam at Petten. MCNP Monte Carlo calculations of the
expected silicon damage dose are also shown. The normalisation of the MCNP data is based
on foil activation measurements.

SKULL PHANTOM DATA

Because of the more complex geometry involved and due to some presumed
dehydration of the tissue equivalent gel used in the skull phantom close agreement
between the PIN diode measurements of the silicon damage dose and the MCNP
calculated doses were not achieved in the first instance. As was shown above it was
necessary to adjust the cylinder hydrogen content in order to achieve a good
agreement between the PIN diode results and the MCNP calculations. However
having made this correction reasonable agreement was achieved.
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Figure 11-7. Measured silicon damage dose along the beam axis in the skull phantom.

It was therefore assumed that the same inaccuracy may be present in the
assumed hydrogen content of the tissue equivalent gel in the head phantom. For this
reason the hydrogen content was reduced to 90% in the brain tissue and the MCNP
simulation recalculated.
Adjusting the hydrogen content of the brain and soft tissue in the MCNP
model of the head still does not yield a close agreement in terms of absolute silicon
damage dose. However the trend in the measured data is toward increasing over
estimate of the silicon damage dose with increasing axial depth. This suggests that
the MCNP model is underestimating the faster component of the neutron spectrum at
depth. The explanation for this may be that the tissue equivalent gel was in fact more
dehydrated than estimated (i.e. more than 10%).
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Figure 11-8. Silicon Damage Dose measurements along the sagittal axis of the head
phantom. Data from two separate irradiations.
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Figure 11-9. Measured Silicon Damage dose along the vertical axis of the skull phantom.
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A further inaccuracy in the MCNP model was that the model assumed the
ICRP elemental composition and density for the skull component of the head
phantom. In fact the skull used to fabricate the head phantom was obtained from an
anatomy laboratory and was completely dehydrated. Therefore that actual average
density of the skull was less than that assumed in the model and the hydrogen content
was negligible.
The under estimate by the model at depth is observed in the data along the
sagittal axis as expected. This is also observed for the data on the vertical axis.

CONCLUSIONS

PIN diode dosimeters were calibrated in the well known spectrum of the
HB11 epithermal neutron beam on the Petten High Flux Reactor. The calibration is
in terms of forward bias voltage change per cGy of silicon displacement damage
dose. The resulting average calibration factor was 215 (±12) mV.cGy-1 for the batch
of 14 diodes used for these measurements.
Measurements were then performed in a PMMA cube phantom and a tissue
equivalent cylindrical phantom as well as a detailed tissue equivalent human head
phantom. Very good agreement was obtained between MCNP calculated silicon
damage dose and the measured values in the PMMA cube phantom. This is due to
the well defined geometry, density and composition of this phantom and the well
defined source spectrum available for use in the MCNP model.
Similarly good agreement was obtained for the cylindrical phantom once
allowance was made for some dehydration of the tissue equivalent gel. For both of
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these phantoms the PIN diode measured dose corresponded with the MCNP
predicted silicon dose to within better than 3% at depths of 2 cm but was still within
10% at depths of 7 cm and 8 cm.
In the case of the more complex head phantom the agreement at shallow
depths up to 5 cm was similar to that observed in the other two phantoms however
beyond this depth larger discrepancies were observed (25%-300%). However in
absolute terms these errors constitute at most only 2-3 % of the maximum silicon
damage dose in the depth dose profile.
It would probably have been more useful to undertake more extensive
measurements using the PIN diodes in simpler geometries to eliminate uncertainties
associated with the complex geometry and MCNP modelling of the head phantom.
However despite these difficulties it was possible to obtain absolute silicon dose
agreements that are comparable to the levels of accuracy with which the thermal
neutron fluence, epithermal neutron dose rate and gamma dose rate have been
determined for this beam200.
Based on the good agreement between MCNP and PIN diode measurements
for the simplest PMMA phantom it can be concluded that the slightly larger
uncertainties in the other phantoms can mainly be attributed to the modelling of the
phantoms rather than an intrinsic problem with the PIN diode dosimeters.
It has been demonstrated that the effects of temperature and non linearity in
PIN response can be overcome allowing the PIN diode to be used as an effective
dosimeter in epithermal neutron beams. Any effects of fading can be avoided by
measuring at a constant time post irradiation.
If the PIN diode measurements are to be used for more direct measurements
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of tissue dose the problem still remains of converting the measured silicon dose to a
tissue dose. As has previously been demonstrated by combining the PIN diode
measurements with foil activations a tissue equivalent dose can be determined for
neutron beams with neutron energies less than approximately 100 keV. However for
most existing beams like HB11 the spectral component above 100 keV makes the
derived dose conversion method invalid.
It is therefore likely that the PIN diode could be useful for measuring or
monitoring neutron doses in BNCT in small volumes in phantoms or in vivo.
However in this role it would only be serving as a monitor to validate other Monte
Carlo dose calculations from which actual tissue doses could be derived. The small
size, immediate readout and absence of the gas supplies and high voltages that are
associated with ionisation chamber measurements should be a significant advantage
for routine constancy or dose profile measurements. Absolute tissue dose calibrations
of epithermal neutron beams would still require these other more established
techniques.
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CHAPTER 12 PETTEN

HFR

HB11

BNCT

BEAM

MEASUREMENTS: MOSFET MEASUREMENTS
INTRODUCTION

MOSFETs were used to measure the gamma dose at points throughout three
phantoms exposed in the HB11 epithermal beam. These measurements were
compared with MCNP calculations of the expected gamma dose at the measurement
points. The methods used will be described in the following order; the MOSFET
readout system, measurement and calculation of MOSFET linearity correction and
temperature coefficient, MOSFET neutron response calibration exposure in the bare
HB11 beam and measurements in the skull, cylinder and cube phantoms. The method
used to correct the MOSFET measurements for neutron contributions is then
described. The results of the calibration and phantom measurements are then given
and compared with MCNP simulations of the same.

MATERIALS AND METHODS

The construction of the phantoms and the details of the corresponding MCNP
simulation models are given in Chapter 10 and will not be repeated here. A
description of the HB11 beam is also found in Chapter 10.
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READOUT SYSTEM

The readout circuit used to determine the change in MOSFET threshold
voltage was integrated with the PIN diode readout circuit in that it shared a number
of functional units with the PIN readout circuit (Figure 3-6). The MOSFET to be
readout was incorporated into a constant current source so that the source drain
current was maintained at 40 µA. The supply voltage to this circuit was pulsed by the
same pulser circuit as was used for the PIN diode readout. Therefore the source drain
current path of the MOSFET was subjected to 1mS 40µA pulse every 11.2 mS. The
voltage at the gate of the MOSFET during this pulse was sampled using a peak
detector circuit. The voltage at the output of the peak detector was displayed on the
Keithly digital voltmeter. The resolution of the voltmeter was 0.1 mV. Variations in
the readout voltage due to noise amounted to less than 1 mV.
During the HB11 epithermal beam measurements using MOSFETs a similar
procedure to that used with the PIN diodes was followed. The gate bias voltage of the
MOSFET was readout immediately prior to placing the MOSFET in the phantom to
be measured. During readout the MOSFETs were inserted into a socket to minimise
noise pickup and resistance effects in cables. The MOSFETs were handled with
forceps and long nosed pliers to minimise temperature variations due to direct
handling during readout.
After the pre-irradiation readout the source, drain, gate and substrate leads of
the MOSFET were bound with a single strand of fine copper wire. This serves two
purposes: 1) It prevents any damage to the MOSFET oxide layer arising from
breakdown due to inadvertent electrostatic discharges during handling and
250

measurement. 2) It ensures that the gate electrode is maintained at the same potential
as the source, drain and substrate. This is important for maintaining a constant
sensitivity. (Though not specifically demonstrated by any measurements here it is at
least possible that electrostatic buildups of charge on the MOSFET holders could
effectively place the gate electrode at a potential adequate to induce an electric field
in the oxide layer during irradiation that would change the sensitivity of the
MOSFET. This phenomena had been observed on previous occasions when
MOSFETs were embedded in polycarbonate phantom material and irradiated in
linear accelerator electron beams.)
During measurements in the phantoms the MOSFETs were placed in lithium
fluoride / epoxy encapsulation to minimise their thermal neutron response. These LiF
shielded MOSFETs were then introduced into the phantoms inside the perspex rods
as used for the PIN diodes and activation foils. The irradiations were initiated as soon
as the MOSFETs had been inserted into the phantom. Following the irradiations the
MOSFETs were removed from the phantom and transferred to the readout area
outside the treatment room. The temperature difference between the pre and postirradiation readouts in the RCB was generally less than 0.5°C, similar to that noted
for the PIN diode measurements. Again the temperature was monitored by a mercury
thermometer on the bench where the readouts were being performed. The MOSFETs
were allowed to rest on lead blocks prior to readout in order to allow them to reach
temperature equilibrium with the surroundings prior to readout avoiding temperature
drifts and therefore threshold voltage drifts during the readout. The gate threshold
voltage was measured within 15 to 30 minutes of the completion of the irradiation.
However fading effects observed in MOSFETs are so minimal that the exact time of
251

measurement following irradiation is not very critical.
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Figure 12-1. MOSFET threshold voltage change as measured in 60Co calibration field.

LINEARITY CORRECTION

The change in the threshold voltage of the unbiased MOSFET when exposed
to gamma radiation is shown in Figure 12-1. The threshold voltage response is
approximately linear with dose up to approximately 400 mV. Beyond this threshold
voltage change it is necessary to apply some correction if the MOSFET is to be used
to measure doses without repeated calibrations to correct for the roll off in sensitivity
with accumulated dose to the MOSFET.
Once the shape of the MOSFET response curve is measured it is possible to
create a linearity correction factor which is a function of the MOSFET forward bias
voltage. This factor can be used to normalise the sensitivity of the MOSFET
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(threshold voltage change per cGy) at any stage of its exposure history.
To determine this characteristic curve of the MOSFET dosimeters a
MOSFET from the same batch as those to be used in the Petten HFR measurements
was exposed in a 10 cm x 10 cm Co-60 beam. This beam was produced from a
Theratron Co-60 source at Ansto. The MOSFET was placed in a perspex (PMMA)
slab phantom at Dmax. The dose rate at this point was measured to be 29.6cGy/min
using a 0.66cc NE2571 ionisation chamber and a NE Farmer 2570 Electrometer.
The MOSFET was exposed for a total of 210 minutes to give a cumulative
dose of 6216 cGy and a total change in threshold voltage of 3.155V. A fourth order
polynomial was fitted to this data and can be seen from Figure 12-1to fit the data
over the entire range very well (R2>0.999). A line of linear response was extrapolated
from the first 426 mV of threshold voltage change.

Linearity Correction Factor
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Figure 12-2. The derived linearity correction curve for the MOSFETs.
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Figure 12-3. The original MOSFET threshold voltage versus dose data with the linearity
correction applied. By application of the linearity correction the response is made quite
linear over a dose range of several Gy and a threshold voltage range in excess of 5 volts.

TEMPERATURE CORRECTION

The sensitivity of the MOSFET threshold voltage to changes in temperature
was determined by immersing the MOSFET covered in a plastic sleeve in a water
bath and measuring the threshold voltage. The water bath was slowly heated from
ambient temperature (16°C) to 50°C using an electric hotplate. This rate of
temperature rise was approximately 1°C per minute. The temperature of the water
bath was measured with a mercury thermometer to within ± 0.05 °C. The MOSFET
threshold voltage was measured approximately every minute. The range from 16-
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50°C covers the expected operating temperature range of the MOSFET when used as
a dosimeter in BNCT beams. Over this range the threshold voltage change with
temperature was linear. This is shown in Figure 12-4. The temperature coefficient of
the threshold voltage was found to be 1.847mV.°C-1.
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Figure 12-4. MOSFET threshold voltage change as a function of operating temperature.

All threshold voltage changes measured due to irradiations of the MOSFET
were corrected for temperature effects by noting the MOSFET readout temperature
during the pre and post irradiation readouts. It was assumed that since the MOSFETs
were all from the same production batch the temperature coefficient would be the
same for all of the MOSFETs used. In general the differences in temperature between
pre and post irradiation readouts were less than 0.5°C. Therefore the correction to the
change in MOSFET threshold voltage was < 1mV in almost all cases.
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CALIBRATION EXPOSURES

The MOSFETs were all exposed at a point 20 cm from the collimator face.
During the irradiation the MOSFETs in their lithiated epoxy holders were taped to a
1-2 mm aluminium plate. The gamma dose rate measured using an Mg/Ar ionisation
chamber during this calibration exposure was 61 cGy.hr-1.For the purposes of
calculating the MOSFET neutron responses a threshold voltage equivalent to 61 cGy
of gamma dose was subtracted from the observed MOSFET threshold voltage
changes.

CORRECTION FOR NEUTRON CONTRIBUTION TO MOSFET RESPONSE

As described in Chapter 5 the energy dependant neutron response of the
MOSFET dosimeters was investigated using MCNP4A Monte Carlo simulations.
From these MCNP calculations an energy dependant curve was determined that
describes the dose deposited (as a proxy for ionisation and creation of electron hole
pairs) within the silicon oxide layer of the MOSFET. The curve that was derived was
in terms of tallies of electron fluxes or photon KERMAs in the oxide layer. It was not
in a form that could immediately be applied to correcting MOSFET threshold voltage
changes for contributions from neutron components of the radiation field being
measured.
Therefore to make this correction the following process was followed.
For a MOSFET exposed in a mixed neutron gamma field the total threshold
voltage change (ΔVt) is due to a contribution from the gamma component (ΔVγ) and
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the neutron component (ΔVn).

ΔVt = ΔVγ + ΔVn

12-1

For a calibration field where the gamma dose rate is known the gamma
contribution to the threshold voltage change can be given as:

ΔVγ = Dγ Kγ ,l

12-2

Where Dγ is the gamma dose (which is known in the mixed radiation
calibration field) and Kγ,l is the MOSFET gamma dose calibration factor (mV.cGy-1)
which has been determined in a pure photon calibration field. Kγ,l is assumed to have
a constant value for the energies of interest.
From equation 12-1 and equation 12-2 the threshold voltage change due to
the neutron contribution can be determined. Assuming that the neutron spectrum,
Φn(E) is known in the mixed radiation calibration field then the neutron component

of the threshold voltage change can also be written as:

E max

ΔVn = C

∫K

n,l

( E )Φ( E )dE

12-3

0

Where Kn,l(E) is the MOSFET neutron energy response function as derived in
Chapter 5, where the subscript n denotes neutron response and the subscript l denotes
the case where the MOSFET is covered with its LiF shield. Kn,l(E) defines the
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relative shape of the MOSFET neutron response curve. It is based on the MCNP
calculated electron fluence or photon kerma in the MOSFET silicon oxide layer per
source neutron as discussed in Chapter 5. For the mixed radiation calibration field
where Dγ is known ΔVn can be determined by measurement. To determine the
integral quantity in equation 12-3, i.e.

E max

∫K

n,l

( E )Φ ( E )dE

0

a MCNP simulation is performed where the values of Kn,l(E) are used as tally
multipliers for a tally cell located at the measurement position in the mixed radiation
calibration field. This allows the normalisation constant, C, in equation 12-3 to be
determined. This normalisation constant should be independent of the actual neutron
spectrum at the point of measurement.
For dose measurements in phantoms the quantity in equation 12-4 needs to be
calculated to determine the neutron contribution to the MOSFET threshold voltage
change. This can then be subtracted from the measured total threshold voltage change
to leave the gamma dose contribution. Unfortunately this requires a knowledge of the
neutron spectrum at the desired measurement point.
A possible alternative would be to parameterise the MOSFET neutron
response in terms of a second measurement technique such as foil activation or a
combination of foil activation and PIN diode measurements. This may allow the
determination of an approximate MOSFET neutron response based on measurements
only, without the need for accurate foreknowledge of the neutron spectrum at the

258

measurement point. The other alternative is to use thicker LiF shields in an attempt to
minimise the neutron contribution to the overall threshold voltage change of the
MOSFET. This approach would require the volume of the dosimeter to be increased
significantly thereby losing some of its advantage. Increased LiF shielding will also
perturb the neutron field being measured with a corresponding confounding effect on
the gamma dose rate which is the object of the MOSFET measurement.

RESULTS AND COMPARISON WITH MCNP

CALIBRATION RESULTS

The results from the calibration exposures in the

60

Co gamma calibration

facility are shown in summarised form in Table 12-1.

Table 12-1. MOSFET responses measured in 60Co gamma calibration facility.

MOSFET Number

Dose

Threshold voltage

Sensitivity

(cGy)

change (mV)

(mV.cGy-1)

1

46.67

58.4

1.25

2

46.67

88.5

1.896

3

46.67

79.0

1.692

4

46.67

90.0

1.928

5

46.67

88.8

1.902

6

46.67

66.0

1.141

The LiF epoxy shielded MOSFET responses measured under free beam
conditions on HB11 are summarised in Table 12-2.
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Table 12-2. Measured MOSFET responses when exposed in LiF shields in the HB11 beam.

MOSFET number

Threshold voltage

Threshold voltage

change (mV)

change per hour
(mV)

1

28.48

122.3

2

46.38

199.3

3

43.39

186.4

4

49.88

214.3

5

48.92

210.2

6

32.97

141.6

7

46.48

199.7

CYLINDER

A model of the cylinder including the polycarbonate case and the tissue
equivalent gel was run. In this model the hydrogen content of the gel was decreased
in order to take into account the suspected dehydration of the tissue equivalent gel
that had occurred. This was achieved by assuming that the hydrogen lost was in the
form of water and that 10% of the water had been lost. The hydrogen and oxygen
content of the tissue equivalent gel in the cylinder model was decreased accordingly.
As previously described this adjustment has enabled reasonably good fitting of the
PIN diode data and the activation foil data and is therefore considered to yield a more
accurate model of the neutron flux within the phantom. With this model the induced
gamma dose at the location of the MOSFETs (in a 2.5 cm diameter annulus around
the cylinder axis) is shown in Figure 12-5.
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Figure 12-5. Neutron induced gamma dose along a coaxial annulus of 2.5 cm in the cylinder
phantom calculated using MCNP. The tissue equivalent gel was assumed to be dehydrated
by a factor of 10%.

Tallies of the track length estimates of neutron flux multiplied by the
MOSFET neutron response functions derived in Chapter 5 were also included in the
model. These are shown in Figure 12-6 where the curves for each of the three
response functions are normalised to unity at their maximum points. In this form it
can be seen that any of the tally quantities used in Chapter 5 as a proxy for neutron
induced contribution to MOSFET response lead to the same overall neutron response
for any given position in the phantom.
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Figure 12-6. The calculated neutron response of MOSFET dosimeters positioned along a
2.5 cm radius annulus in the cylinder phantom. For comparison MOSFET responses derived
from the three response functions are normalised to unity at their maximum point.

When the MOSFET measurements at 2 cm and at 7 cm depths are corrected
for the neutron contribution to their threshold voltage shift based on these response
functions the remaining component of their response corresponds to the measured
gamma dose at these points. This is shown in Figure 12-7 along with the MCNP
calculated induced gamma dose. Very poor consistency is observed in this case. The
measurement at 2 cm is approximately the same as the induced gamma dose rate,
implying no external source of gamma dose is present. The measurement at 7 cm is
approximately the same as the measurement at 2 cm and therefore exceeds the
calculated induced gamma dose rate by approximately 80 cGy/hr. The primary source
of uncertainty is probably the accuracy of the MCNP predicted MOSFET neutron
responses and induced gamma doses at these points due to flux depression caused by
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the lithiated shields as discussed below.
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Figure 12-7. Three separate measurements of gamma dose using MOSFETs at 2 and 7 cm
depths in the cylinder phantom.

Other possible sources of inaccuracies lie in the less than perfect knowledge
of the tissue equivalent gel composition (i.e. possible density and hydration changes).
Some inaccuracies may also arise due to approximations present in the geometry
assumed for the cylinder model. The MOSFET measurements were performed by
inserting the MOSFETs complete with lithiated epoxy shield into 1 cm diameter
PMMA tube parallel to the cylinder axis at a distance 2.5 cm from the axis. The
MOSFETs were located along this tube by means of PMMA spacers. However the
MCNP model assumed that the cylinder phantom consisted of a polycarbonate
cylinder filled with tissue equivalent gel. This difference may lead to small errors in
both the calculated MOSFET neutron response function and also the induced gamma
dose.
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In Figure 12-7 the MCNP calculated induced gamma dose at the
measurement point in a tissue equivalent phantom is shown. This does not take into
account any perturbation of the neutron field (or induced gamma field) that may be
caused by the presence of the lithiated shielding.
To try to explain the discrepancy between the measured and calculated
gamma dose rates a MCNP simulation was performed to determine the effect of the
lithiated shields on the neutron flux and the gamma dose rate in the phantom. The
cylinder phantom was modelled in the HB11 beam with a lithiated shield of the same
dimensions as the ones used in the measurements included at 2 cm depth on the axis
of the cylinder. A separate simulation was performed with the MOSFET shield
centred at 7 cm depth on the cylinder axis. These two depths correspond to the points
at which measurements were made. The neutron flux was tallied along the central
axis. The gamma flux was also tallied along the central axis and multiplied by a
tissue dose function. The neutron flux distribution for a cylinder phantom irradiated
in the HB11 beam with and without lithiated MOSFET shields is shown in Figure
12-8 and Figure 12-9. At 2 cm the flux with E < 0.5 eV accounts for approximately
70% of the total flux. When a MOSFET shield is introduced this flux is reduced to
~3-4% of the total unperturbed neutron flux. At 7 cm the E < 0.5eV flux accounts for
approximately 95% of the total flux. With the introduction of a MOSFET shield this
again falls to approximately 3-4% of the unperturbed total flux at this depth.
For the neutron flux with E > 0.5 eV the introduction of a MOSFET shield at
2 cm results in about a 20% reduction. At 7 cm the corresponding reduction in
neutron flux with E > 0.5 eV is only about 2 – 3 %.
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Figure 12-8. The effect of a lithiated MOSFET shield located at 2cm depth on the thermal,
epithermal and total neutron flux in a cylindrical phantom exposed in the HB11 beam.
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Figure 12-9. Neutron flux perturbation when a lithiated MOSFET shield is places at a depth
of 7 cm in the cylinder phantom.
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Figure 12-10. Neutron induced gamma dose in cylinder phantom irradiated in HB11
showing the effect of a lithiated MOSFET shield at 2 cm and at 7 cm depth on the central
axis of the phantom.

The induced gamma dose rate in the cylinder phantom with a MOSFET shield
at 2 cm and at 7 cm is shown in Figure 12-10. At 2 cm depth the presence of the
lithiated shield leads to a 25 –30% reduction in induced gamma dose.
With a MOSFET shield at 7cm depth the gamma dose reduction effect is still
evident but is only 15 –20% of the unperturbed gamma dose at that point.
On the basis of these estimates it is concluded that the induced gamma
component of the measured gamma dose rates in the cylinder should be corrected by
30% at 2 cm and by 20% at 7 cm. Exactly what component of the measured gamma
dose is induced gammas and what fraction comes from external sources is not know.
An upper estimate of the total gamma dose can be arrived at by assuming that
induced gamma dose accounts for all of the measured gamma dose.
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In this case the measured dose rate of 205 cGy.hr-1 at 2 cm and at 7 cm
becomes 267 cGy.hr-1 and 246 cGy.hr-1 at 2 and 7 cm respectively. A large
component of the induced gamma dose is due to hydrogen gamma rays. Due to the
fall off in the H(n,γ) cross section with energy the largest impact on the induced
gamma dose rate is seen where the lithium shields impact on the thermal neutron flux
the most (i.e. at shallow depths in the phantom). The impact is still observable at 7
cm depth but is much less.

CUBE
An MCNP model of the perspex cube in the HB11 beam was run. This model
included tallies of the neutron induced gamma dose in the cube as well as neutron
tallies multiplied by the MOSFET neutron response functions. The three differently
derived response functions discussed in Chapter 5 were included. These were energy
dependent histogram response functions of electron flux, SiO2 photon kerma and the
FM –6 tally of photon heating in the MOSFET junction calculated using a detailed
model of the MOSFET package and junction. The resulting tallies along the central
axis of the cube were recorded. These results are shown below in Figure 12-11. The
data is shown normalised to unity at the maximum point in each curve, which occurs
at a depth of 1cm for all of the curves.
The MCNP statistical uncertainties are approximately 2% or less for the
majority of the data points displayed. Clearly using all three different response curves
yields the same result.
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Figure 12-11. MOSFET relative neutron response along the central axis of the perspex cube
phantom exposed in the HB11 epithermal neutron beam. The responses calculated using
electron flux, photon kerma and photon heating in the silicon oxide layer are all shown. The
curves derived by the three different methods are normalised to unity at a depth of 1 cm.

The induced gamma tissue dose was tallied in the same central axis cells of
the phantom. This component of the dose will only include the gamma dose that is
generated due to neutron interactions within the cube phantom itself. The other main
component of the gamma dose would be those originating from the epithermal beam
filters and collimators as well as whatever fraction of reactor core gammas reach the
treatment point. These will be considered in more detail below. The induced gamma
dose is shown in Figure 12-12.
A maximum induced gamma dose of approximately 170 cGy.hr-1 is reached
at depths between 2.5 and 3.5 cm in the phantom.
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Figure 12-12. MCNP calculation of neutron induced gamma radiation dose along the
central axis of the perspex cube phantom exposed in the HB11 epithermal neutron beam.

MOSFET measurements were performed at 2, 5 and 8 cm depths within the
perspex phantom. One measurement was performed at each depth using the same
MOSFET. A second measurement was performed at the 8 cm depth using a second
MOSFET.
The measured threshold voltage changes for each of these MOSFETs were
corrected for the neutron contribution to the MOSFET measurement. The MOSFET
neutron response curves calibrated in the bare HB11 beam were used for this
correction along with the MOSFET gamma sensitivity calibrations performed using
the Petten standard Co-60 calibration facility.
The MOSFET measurements of the total gamma dose at the three
measurement points in the phantom is shown in Figure 12-13.
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Figure 12-13. Gamma dose measured using MOSFET dosimeters at three points along the
central axis of the perspex cube phantom exposed in the HB11 epithermal neutron beam.
The MOSFT data have been corrected for the neutron contribution to the measurement using
MCNP derived neutron response functions. The MCNP calculated induced gamma dose is
also shown as are measurements using a Mg/Ar ionisation chamber (with lithiated end cap).

It can be seen from Figure 12-13 that there is a fraction of the total gamma
dose as measured using the MOSFETs that is not accounted for by gamma dose
induced by neutrons in the phantom alone. The difference is probably due to gamma
rays originating in the filter components and other sources external to the phantom.
On the basis of the data above this would be approximately 60 cGy.hr-1 at each of the
measurement points.
It can also be assumed that the presence of the MOSFET shields leads to a
neutron and gamma flux suppression similar to that demonstrated in the cylinder
phantom. If this is taken into account the upper estimate of the total gamma dose
(assuming no beam gamma contribution to the MOSFET measurements) would be
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approximately 20-30% greater than measured in the presence of the lithiated
MOSFET shields.
SKULL

The lithium covered MOSFET measurement results along the three axes of
the skull phantom are shown below. Poorer agreement was obtained in the skull
phantom than in the PMMA cube phantom. However a general pattern similar to the
tissue equivalent cylinder phantom results is present. The MOSFET measurement at
approximately 2.5 cm depth along the beam axis gives a gamma dose rate
comparable to the MCNP calculated induced gamma dose rate.
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Figure 12-14. MOSFET measured gamma dose in skull phantom along beam axis.
MOSFET measurements corrected for neutron contribution. Also shown is the MCNP
calculated induced gamma dose.
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Figure 12-15. MOSFET measured and MCNP calculated gamma dose along vertical axis of
skull phantom.

However the MOSFET measurement of gamma dose at greater depths
exceeds the MCNP calculated induced gamma dose rate by approximately 40 –50
cGy.hr-1. This depression at shallow depths was also observed in the cylinder
phantom but not in the PMMA phantom.
MOSFET measurements corrected for linearity and temperature effects as
well as neutron response for the vertical axis of the skull phantom are shown in
Figure 12-15 and for the anterior-posterior axis in Figure 12-16. Both of these sets of
data correspond to measurement points at depth in the phantom. The MOSFET
measurements follow the general shape of the calculated induced gamma dose rate
but exceed the value of the MNCP induced gamma dose rate by approximately 50 –
70 cGy.hr-1. This difference is of a similar magnitude to the expected dose rate in the
HB11 beam.
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Figure 12-16. Horizontal axis. MOSFET measured gamma dose and MCNP induced gamma
dose in skull phantom.

During the calibration measurements for the MOSFETs a dose rate of 61
cGy.hr-1 was measured in the bare beam. However a gamma flux originating from the
beam port would be expected to be forward directed and therefore should contribute
more to measurement points closer to the surface of the phantom on which the beam
is incident. In contrast to this the difference between the MCNP calculated induced
gamma dose and the measured gamma dose does not reduce with increased depth in
the phantom. Therefore if a gamma flux originating external to the phantoms is the
hypothesised explanation for the difference between the measured gamma dose and
the calculated induced gamma dose then the external gamma field must be quite
isotropic.
For the cube phantom at 2 cm depth the magnitude of the correction to
account for the neutron contribution is equivalent to approximately 20% of the total
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threshold voltage change. At a depth of 5 cm this has reduced to 8% and at a depth of
8 cm the neutron contribution is about 3%. The corrections for the other two
phantoms were a similar proportion of the total threshold voltage change at
comparable depths.

CONCLUSIONS

MOSFETs were applied as gamma dosimeters in phantoms exposed to an
epithermal neutron beam. The MOSFET neutron sensitivity was determined by
irradiating the lithiated polymer covered MOSFETs in the bare HB11 beam. In this
way the energy dependant MOSFET neutron response functions were calibrated.
In a simple well defined PMMA cube phantom it was possible to produce
gamma dose measurements that agreed with Mg/Ar ionisation chamber
measurements. MCNP calculated induced gamma doses in this phantom were
approximately 60 cGy.hr-1 less than the measured total gamma dose rates in the
phantom. (Note that the ionisation chamber measurements were performed with a
lithiated end cover in place as per the procedure used by Raaijmakers at that
time43,200.)
When more complex phantoms are considered the comparison between the
measured total gamma dose using MOSFETs is less consistent. For both the tissue
equivalent gel filled cylinder phantom and the skull phantom the MOSFET
measurements at 2 – 2.5 cm yielded dose rates consistent with the calculated induced
gamma dose rate alone. At greater depths the MOSFET measurements exceed the
calculated induced gamma dose rate by approximately 60 cGy.hr-1.
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The presence of the lithiated covers on the MOSFETs will perturb the neutron
flux in the locality of the MOSFET. This leads to an underestimate of the true
gamma dose rate at the measurement point. The upper limit of this underestimate was
calculated to be 30% of the induced gamma dose rate at a depth of 2cm in the
cylinder phantom and dropped off with increasing depth. The total measured gamma
dose consists of induced and beam gamma components and the lithiated shield only
perturbs the induced component. Therefore the actual correction to the measured
gamma dose rate at any point will always be less than 30%. The required corrections
would probably be similar for the skull phantom. This effect should be similar in all
phantoms and was not observed to cause any discrepancy between the MOSFET and
ion chamber measurements where these were possible in the PMMA cube phantom.
However the ionisation chamber measurements are expected to display a similar
underestimate also due to the lithiated cap used on the Mg/Ar chamber.
It has been demonstrated here that MOSFETs can probably be applied to
gamma dosimetry in mixed epithermal neutron and gamma fields. However further
work is required in order to make MOSFETs useful dosimeters for this application.
Reducing the neutron response by modifying the encapsulation of the MOSFETs
should lead to more accurate results especially near the regions of peak thermal flux.
For the current encapsulation and lithiated shields the correction neutron contribution
is approximately 20% of the total MOSFET response. Removing the kovar
encapsulation and replacing it with a material of minimal neutron interaction cross
sections would reduce the magnitude of the neutron correction that needs to be
applied. This would be preferable to increasing the amount of lithiated shielding
around the MOSFETS which may reduce the neutron response but will perturb the
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system being measured too much.
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CHAPTER 13 MOSFET AND PIN DIODE MEASUREMENTS IN
THE BMRR EPITHERMAL NEUTRON BEAM
INTRODUCTION
Measurements using the MOSFET and PIN diode dosimeters were performed
in the epithermal neutron beam at the Brookhaven Medical Research Reactor
(BMRR). These measurements were performed using the same type of MOSFET and
PIN diode detectors as were used for the other experiments described in this thesis.
For the measurements on the BMRR epithermal beam the MOSFETs were
encapsulated in a thicker 6LiF shield than was the case for the measurements on the
Petten HB11 epithermal neutron beam. The MOSFET measurements were performed
with a bias applied to the gate electrode to increase sensitivity. The phantom used
here was a 15 cm cube phantom consisting of polymethyl methacrylate (PMMA).
This avoided the problems experienced with dehydration of the tissue equivalent gel
in the Petten series of measurements.

MATERIALS AND METHODS

BMRR EPITHERMAL NEUTRON BEAM

The Brookhaven Medical Research Reactor (BMRR) commenced operation
in 1959 and at that time was used to provide a thermal neutron beam for the initial
trials of BNCT201. The epithermal beam has more recently been used in clinical trials
of BNCT for glioblastoma until it the reactor was shut down for political reasons in
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2000.
The reactor17, 201 has a maximum operating power of 3 MW and is moderated
and cooled with light water. The core is surrounded by a graphite reflector. The
reactor has a number of irradiation facilities including the epithermal neutron
irradiation facility (ENIF). The ENIF opens into an epithermal neutron irradiation
room. The exit port of the beam in the irradiation room is approximately 177 cm
from the centre of the reactor core.
The epithermal neutron spectrum at the beam exit port17, 201 is produced by a
series of filters which neutrons from the core must pass through. The core itself is
surrounded with graphite reflector. The next layer along the beam line consists of 19
cm of Bi which acts as a gamma ray attenuator. The Bi is followed by a 12 cm thick
void. A combination of Al and AlO3 occupies the next position in the filter
arrangement (A and B in Figure 13-1 below) and serves as the principle moderator of
the fission neutrons from the core. This is followed by a thin layer of Cd and a further
thin layer of Bi to reduce the thermal neutron and gamma components respectively.
The wall of the irradiation room surrounding the beam exit port is lined with lead and
lithiated polyethylene. The beam is collimated with lithiated polyethylene
collimators. These consists of polyethylene containing Li2CO3 (93% enriched 6Li)
with an overall 6Li content of 7% by weight and 7.9% hydrogen by weight. The
original 7.6 cm thick collimator with an exit aperture of 8 cm may be exchanged with
a 15.2 cm thick collimator to obtain a larger beam diameter of 12 cm. The 12 cm
beam diameter was used for all of the experimental measurements described in this
chapter.
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Figure 13-2. One slab of the PMMA phantom showing MOSFET probe inserted into
dosimeter access hole.

Additional PMMA slabs were fabricated with holes penetrating from the edge
of the slab to the centre allowing insertion of dosimeters into the midline of the
phantom (Figure 13-2). In combination with the other 2.5cm thick PMMA slabs this
meant that dosimeters could be located at depths of 1.25 cm, 3.75cm, 6.25 cm,
8.25cm, 11.25 cm, etc (i.e. increments of 2.5 cm starting at a depth of 1.25 cm). The
dosimeters were inserted into these holes on lengths of solid PMMA rod to eliminate
any voids in the phantom. In the case of the MOSFETs this rod was 16mm in
diameter and had a 5 mm hole along its axis in order to allow cables to be connected
to the MOSFET.
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MCNP MODEL
An MCNP model of the collimators and the phantom used in the
measurements was performed. This was based upon geometry and spectral
information supplied by B Liua. The model consisted of a 15 cm PMMA cube of
density 1.17 g.cm-2 divided into transaxial slices of 0.5cm thickness. Tallies of
silicon damage kerma, induced photon dose and three different estimates of
MOSFET neutron response were calculated (Chapter 5) in each of these slices within
a cylinder of 1.0 cm diameter along the beam axis. The parallel neutron source was
defined as a plane at the exit hole of the collimator. A 7.6cm thick Li-polyethylene
collimator material with a conical beam port was used. This did not actually
collimate the beam in the model but was present for any small scattering contribution
it may make.

PIN
A set of PIN diode calibration measurements were performed in the BNL
epithermal beam in air with no phantom present. In phantom measurements were
performed on the central axis of the phantom at depths of 1.25 cm, 6.25 cm and 8.75
cm.

PIN READOUT CIRCUIT
The PIN diode readout system used was an improved version of the one used

a

B Liu, private communication to BJ Allen, May 1996.
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in previous measurements. The main difference being that in the final readout stage a
sample and hold circuit was used rather than a peak detector circuit. It was designed
by A Rosenfeld and produced by P Ihnat of the University of Wollongong,
Department of Engineering Physics. The main parameter of importance, the current
through the PIN junction was 1 mA as previously used. A similar duty cycle was
used (i.e. ~ 1 mS duration pulses at intervals of ~10 mS).

DESCRIPTION OF PIN MEASUREMENTS

The phantom was located at the beam exit hole in the collimator. The centre
of the beam was aligned with the central (measurement) axis of the PMMA phantom.
The forward bias voltage of the PIN diodes was measured immediately before each
irradiation (i.e. 1- 2 minutes prior to opening the beam shutter). The beam shutter
takes approximately 10 seconds to open and shut. No correction was made for this
since the shortest exposure was 5 minutes. Therefore the opening time of the shutter
would be approximately 3% of the total exposure time in this case. After each
irradiation the PIN diodes were readout within 2-3 minutes of shutter closure.
The diodes were readout in the irradiation room and the periods of each
irradiation ranged from 5 minutes to 15 minutes. Therefore it was assumed that no
temperature changes occurred over this time and so it was not necessary to apply any
temperature corrections to the forward bias voltage changes before and after the
irradiations. This assumption was supported by observations of the temperature in the
irradiation room. This was observed to be constant at 75°F.
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MOSFET

Both lithium shielded and bare MOSFETS were used to perform
measurements at various depths in the PMMA phantom and in air on the axis of the
beam at the exit of the collimator.

READOUT

The readout system used for the MOSFET measurements was also an updated
version of the readout system used elsewhere in this thesis. It was integrated with the
PIN diode readout system described above. The current used to define the threshold
condition was 42 µA which corresponds to the approximate thermostable point of the
MOSFETs when new.
DESCRIPTION OF MOSFET MEASUREMENTS

Gamma dose measurements were performed using MOSFETS encapsulated
in lithiated shields. These shields were thicker than the shields used for
measurements on the HB11 beam at Petten. Therefore the neutron contribution to the
response of the detector was expected to be less. The MOSFETS were assembled
with cables attached and housed in lithiated polymethylmethacrylate shields. These
can be seen in Figure 13-3.
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~ 1 cm

Figure 13-3. MOSFET dosimeters in lithiated shields with PMMA rods and cables
permanently attached.

Greater accuracy was also achieved by using the MOSFETS in active mode.
A bias of 5 volts was applied to the gate electrode during the irradiations to increase
their sensitivity. This meant that larger threshold voltage shifts were observed and
therefore the relative error in determining the threshold voltage change was reduced.
The phantom was assembled and located at the face of the beam port. The
central axis of the phantom was aligned with the central axis of the beam. Prior to
each measurement the MOSFET dosimeters were inserted vertically into the recessed
PMMA slab which was located at the depth in the phantom where a measurement
was required. Immediately prior to the irradiation (i.e. within approx 1 minute of
vacating the room and opening the beam shutter) the MOSFET threshold voltage was
measured. The accuracy of these measurements was to better than 1 mV. After the
threshold voltage was measured a 5.0 volt bias was applied to the gate electrode and
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the shutter was opened. The irradiations were performed for durations of between 5
minutes and 15 minutes at a reactor power of 3 MW. As for the PIN diode
measurements the beam shutter opening and closing time was approximately 10
seconds and no correction was made for this.
Following the closure of the shutter the bias voltage was disconnected and the
final threshold voltage was measured. This measurement was generally performed
within 2-3 minutes of the beam being shut off.
Due to the limited number of measurements being performed and the use of
the MOSFETS in active mode (biased during measurements) no linearity corrections
were applied for this series of measurements. Temperature corrections were also not
performed for the measurements described here because the MOSFETs were not
removed from the irradiation room for readout and the irradiation room had a
constant temperature to within less than 1°C.
One measurement was performed without the phantom in the beam. For this
measurement the MOSFET probes were located so that the actual MOSFET
(encapsulated in LiF PMMA shielding) was located on the central axis of the
epithermal neutron beam. The threshold voltage shift from this measurement was
attributable to the MOSFET neutron response as well as the gamma dose component
that originates in the core of the reactor and the beam filters. The gamma dose rate
during this measurement was assumed to be known based on previous beam
characterisation measurements by others at BNL202. The MOSFET gamma dose
sensitivity is also known based on calibration of the MOSFETs in a 6 MV linac
photon beam at the Illawarra Cancer Care Centre.
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RESULTS

PIN DIODE MEASUREMENTS

The PIN diode forward bias voltage changes in volts per hour at a reactor
power of 3 MW are shown in Table 13-1. The values shown are the average of pairs
of measurements at each depth with a relative mean error of ~ 10% for each data
point.
This data is shown plotted with MCNP calculated silicon damage kerma for
the same experimental arrangement. Since we did not perform any foil activation
measurements during this series of experiments it is not possible to determine an
independent factor to normalize between measurements and the number of source
neutrons per hour in the MCNP model.

Table 13-1. PIN diode forward bias voltage shifts for PIN diodes exposed in BMRR beam
along central axis of PMMA phantom.

Depth (cm)

Forward bias voltage change.
mV.hr-1

In air

228

1.25

210

6.25

52

8.75

40
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Figure 13-4. Comparison of MCNP and measured silicon damage kerma in 15 x 15 cm
PMMA cube phantom exposed in BMRR epithermal neutron beam.

Therefore to compare between the calculated PIN diode dose in the phantom
and the measured PIN diode voltages in the phantom the normalization of the MCNP
model was based on the calculated and measured response for a PIN diode exposed
in the bare beam.

MOSFET MEASUREMENTS

The results of the measurements in air and at various depths in the phantom in
the BMRR epithermal neutron beam are shown in Table 13-2. The threshold voltage
changes in the MOSFET photon sensitivity calibration measurements at the Illawarra
Cancer Care Centre are shown in Table 13-3.
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Table 13-2. Threshold voltage changes observed for Lithium shielded MOSFETs exposed
in the BMRR epithermal neutron beam.

MOSFET

Depth

Threshold voltage

Time

Threshold voltage

(cm)

change (mV)

(minutes)

change per hour (mV)

Li 1

0 (in air)

75

6

750

Li 1

1.25

417

15

1668

Li 1

3.75

137

5

1644

Li 1

6.25

107

5

1284

Li 1

8.75

72

5

864

Table 13-3. Calibration of MOSFET in Li shielding in 6MV linac beam at Illawarra Cancer
Care Centre.

MOSFET

Depth

X-ray Dose

Threshold voltage

MOSFET gamma

(cm)

(cGy)

change (mV)

sensitivity
(mV.cGy-1)

Li 1

1.5

40

247

6.175

Li 2

1.5

40

257

6.425

These threshold voltage changes are plotted in Figure 13-5 with no
corrections. Also shown on the same graph is the calculated gamma depth dose
profilea in a PMMA phantom exposed in the BMRR beam.
The gamma depth dose profile is normalised to unity at its maximum. The
threshold voltage changes were normalised so that the measurement at 1.25 cm depth
corresponded to 93% of the maximum dose for the calculated gamma dose profile
(i.e. to match the calculated % gamma dose at a depth of 1.25cm).

a

B Liu private communication, May 1996.
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Figure 13-5. BMRR epithermal neutron beam. Calculated gamma dose profile in 15 cm
cubic PMMA phantoma. The measured data points are the normalised lithium shielded
MOSFET threshold voltage changes. No other corrections have been applied.

To take into account the neutron contribution to the MOSFET response the
MCNP derived MOSFET neutron response functions were used as neutron tally
multipliers in a MCNP4a simulation of the cube phantom exposed in the BMRR
beam. All three MOSFET neutron response functions were used to see if there were
any differences. For the purpose of comparison the neutron responses calculated
using the three different tallies were normalised to unity at 0.25 cm depth on the
central axis of the cube phantom.
These three curves are shown in Figure 13-6. There is negligible difference
between them for the first 10 cm of depth. Beyond 10 cm a non significant variation
of < 0.1% of the response at 0.25 cm depth is observed.
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MOSFET neutron response
(unity at 0.25 cm)
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Figure 13-6. Comparison of calculated MOSFET neutron responses in 15 cm cube PMMA
phantom.

By combining the MCNP calculated MOSFET neutron response in air in the
BMRR beam with the measured threshold voltage shift and the known gamma dose
rate in air in the beam the neutron response curves can be calibrated to give absolute
values.
To determine the absolute values of the neutron contributions to the
MOSFET threshold voltage change the following process was followed.
The gamma dose rate in air at the midline of the beam202 at the face of the Lipoly collimator was assumed to be approximately 84 cGy.hr-1. The observed
threshold voltage change of the Li shielded MOSFET at this point was 750 mV.hr-1
(see Table 13-2 above). From Table 13-3 the sensitivity of the MOSFET to gamma
rays is 6.175 mV.cGy-1.
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Therefore the expected change in threshold voltage per hour at this point due
to the gamma dose rate is 518.7 mV.hr-1 (that is: 84cGy.hr-1 × 6.175 mV.cGy-1). The
observed threshold voltage change per hour was 750 mV.hr-1. Therefore the threshold
voltage change per hour due to the neutron response of the MOSFET at this point in
the bare beam is 231.3 mV.hr-1 (that is: 750 mV.hr-1 – 518.7 mV.hr-1).
This value is then used to determine the absolute value of the MCNP
calculated MOSFET neutron response in air in terms of mV.hr-1 per tallied neutron
response. When this calibration factor is applied to the calculated neutron responses
along the central axis of the phantom the appropriate correction for a MOSFET at
any point along the axis can be seen. This is shown in Figure 13-7. Under the current
assumptions this correction amounts to a 9.7% correction at a depth of 1.25 cm a
1.3% correction at a depth of 3.75 cm. For depths greater than this the magnitude of
the correction is too small to take into account compared to other uncertainties in the
measurements.
When these corrections are applied to the total threshold voltage shifts
measured by the Li shielded MOSFET along the central axis of the phantom the
results shown in Figure 13-8 are obtained. These are plotted with the calculated
gamma depth dose profile which was provided by HB Liu but has been renormalised
for comparison.
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Figure 13-7. The measured total threshold voltage change along the axis of the phantom
exposed in the BMRR beam. The threshold voltage change due to neutrons as calculated
using MCNP and normalised using an in air measurement is shown in terms of mV.hr-1.
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Figure 13-8. MOSFET measured gamma dose in PMMA phantom exposed in BMRR beam.
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DISCUSSION

It can be seen from Figure 13-5 that apparently good agreement is observed
between MOSFET threshold voltage measurements and the expected gamma depth
dose profile relative to the gamma Dmax in the BMRR beam. This apparent agreement
is in part fortuitous since Figure 13-7 shows that there is a significant neutron
contribution to the MOSFET response at the shallower depths in the phantom. Once
this is taken into account an absolute gamma dose profile can be obtained as shown
Figure 13-8.
However to obtain such a concordance between the measurements and a
calculated gamma depth dose profile provided by B Liua it was necessary to
renormalize the gamma dose rate provided by B Liu by multiplying by a factor of
0.68. That is the MOSFET measurements give results approximately 30% lower than
the anticipated gamma dose rate. It is highly probably that this discrepancy is due to
the presence of the relatively large lithiated covers on the MOSFETs. As well as
attenuating the neutron contribution to the MOSFET threshold voltage change these
shields suppress the local neutron field and thereby also perturb (reduce) the gamma
dose in the phantom close to the measurement point. Note that the induced gamma
dose suppression due to the presence of lithiated shields in the cylinder phantom
exposed in the Petten HB11 beam was approximately 30%. This is likely in this set
of measurements due to the use of larger shields than were used for the previous
measurements in the Petten beam.
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CHAPTER 14 CONCLUSIONS

Despite increasing sophistication of conventional radiotherapy (e.g.
stereotactic radiotherapy and intensity modulated radiotherapy) and chemotherapeutic
techniques the prognosis for patients with glioblastomas and malignant melanomas
remains poor. The current round of BNCT clinical trials (and most of the previous
clinical trials) have been directed at these two tumor types. The increased number of
epithermal beam facilities where trials are taking place and the improved
understanding of the pharmacokinetics and microdosimetric aspects of the two most
established boron pharmaceuticals (BPA, BSH) means that the data necessary to
assess the efficacy of BNCT for these tumors is accumulating at an increasing rate.
Advances in accelerator technology and the trend towards near threshold minimal
moderation accelerator sources mean that if the efficacy of BNCT is demonstrated
the possibility of BNCT treatment facilities in medical centres without the need for a
reactor neutron source is becoming more plausible. Similarly the BNCT treatment
planning tools necessary for efficient and accurate calculation of patient doses are
becoming more streamlined and have a form that would be quite familiar to
radiotherapists and dosimetrists used to performing conventional radiotherapy
treatment planning.
It is in this context that the current thesis investigates the use of two
semiconductor radiation detectors for measuring dose distributions in epithermal
neutron beams. Changes in PIN diode forward bias voltage due to silicon
displacement damage have been used previously for fast neutron dosimetry (MeV
energies). This work is the first (to the best knowledge of the author) dedicated
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specifically to determining the utility of forward bias voltage changes in PIN silicon
detectors for neutron dosimetry in BNCT epithermal neutron beams. It is also the
first to characterise the neutron response of a particular MOSFET device and then
attempt to use MOSFETS purely as gamma detectors in BNCT epithermal beams
correcting for the neutron response. (Complementary work by G Kaplan136 has
shown that MOSFETS with boron or 235U radiators can be used for mapping thermal
neutron distributions in epithermal beams).

MOSFET NEUTRON RESPONSE

The response of MOSFET changes in threshold voltage is principally
determined by the entrapment of holes in the silicon oxide insulating layer under the
gate electrode when the device is irradiated with photons or electrons. The intrinsic
response of the silicon oxide to neutron irradiation is minimal. However when the
MOSFET junction is encapsulated in standard electronic device packaging such as a
kovar TO-18 can then significant neutron sensitivity is observed. This is due to the
dose deposited in the silicon oxide layer by secondary electrons and photons
generated as a result of neutron reactions in the device packaging. To determine the
energy dependency of this neutron response for the MOSFETs used in this thesis the
MCNP Monte Carlo code was used. A detailed model of the MOSFET and its
package was constructed and the photon and electron dose deposited in the silicon
oxide layer was calculated for a range of incident neutron energies from thermal to
fast neutrons. A similar calculation was performed with a lithiated Perspex shield (~
1.8mm thick) incorporated into the model. This reduced the MOSFET neutron
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response by several orders of magnitude at thermal and low energies. A thicker
lithiated shield (~5mm thick) was also modelled and further reduced the low energy
neutron response. The absolute values of these calculated relative neutron energy
response functions were later normalised by exposing the MOSFET in a neutron
beam with known gamma dose and neutron spectrum. These absolute neutron
response functions could then be used to make corrections to MOSFET
measurements in phantoms. Future applications of MOSFETs to gamma dosimetry in
mixed radiation fields would benefit from using MOSFETs with minimal
encapsulation. This would minimise the amount of neutron shielding (lithium)
required and minimise any perturbation on the neutron field near the point of
measurement. Potentially a graphite encapsulation would lead to less neutron
response.

IDEAL BEAM STUDY OF PIN DIODE TISSUE EQUIVALENT DOSE
MEASUREMENTS

The neutron energy response function of PIN diodes (as measured by forward
bias voltage change following irradiation) follows the silicon displacement damage
KERMA function. Silicon displacement damage KERMA is not directly proportional
to tissue KERMA at all energies of interest for epithermal neutron beams used in
BNCT. Therefore measurements with PIN diodes (eg depth dose profiles) do not
necessarily represent tissue dose distributions. For fast neutron fields (MeV energy
range) approximate equivalence can be achieved where the fast neutron contribution
dominates both the silicon and tissue dose.
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By using a series of Monte Carlo ideal beams incident on a cylindrical tissue
equivalent phantom it is possible to calculate the silicon dose, tissue dose and
expected foil activations at points within the phantom. It is possible to use these
arrays of doses and activations to generate (by regression) a set of coefficients that
allow the tissue dose to be expressed as a linear combination of silicon displacement
damage and foil activation. For some energy ranges it possible to determine a set of
coefficients that are the same for each ideal beam within the energy range of interest.
It was shown that it is possible to express tissue dose as a function of silicon damage
dose and foil activations with reasonable accuracy for the energy range from thermal
to 100 keV. The accuracy of the obtainable relationship between silicon dose foil
activation and tissue dose increases when the maximum energy is reduced. Up to
incident energies of 50 keV the tissue dose can be parameterised as a combination of
silicon dose and foil activation with an accuracy of better than 10% for depths along
the central axis. Most of the depth dose profile shows a better agreement than this.
Up to 100 keV the maximum discrepancy increases to 20% but again this is restricted
to the superficial depths.
In practice this means that in some epithermal neutron beams (eg accelerator
beams with maximum neutron energies of approximately 100 keV or thereabout)
tissue dose could be measured by means of a PIN diode measurement and a bare foil
activation (Au, Cu or Mn) measurement. This may provide a simple and quick
method for mapping tissue dose in these environments. For beams with higher
maximum neutron energies (most reactor epithermal neutron beams) the technique as
developed here is not applicable.
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The PIN diodes used in this thesis were exposed to approximately
monoenergetic neutrons in the energy range 90 - 890 keV using a Van de Graaff
proton accelerator and lithium target. These measurements demonstrated that the
forward bias voltage change of the PIN diodes matched the expected silicon
displacement damage KERMA function over this energy range. On this basis the
ASTM displacement damage KERMA function for silicon125 was used in
calculations of PIN diode (forward bias voltage) response in this thesis. This result
was anticipated but was verified for completeness and confidence that the silicon
displacement KERMA could be used to calculate PIN diode response for the other
experiments in this thesis. An approximate sensitivity of 130±44 mV.cGy-1 (silicon
dose) was also determined for the PIN diodes based on these measurements.

MOSFET CHARACTERISATION USING MEDICAL LINAC

For similar reasons the MOSFETs used in this thesis were investigated in
well characterised medical linac (Varian 2100C) x-ray beams. Measurements of the
MOSFET sensitivity for gate potentials between 0 and 15 volts were performed. A
second order polynomial was found to fit the sensitivity versus gate bias voltage and
this allows the MOSFET sensitivity to be determined for any potential applied to the
MOSFET gate during irradiation. Dose depth profiles measured using the MOSFET
from Dmax to 10 cm depth in RMI solid water material were found to be in agreement
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with dose depth data measured using a Farmer ionisation chamber. Similar
measurements with the MOSFET kovar cap removed also showed good agreement.
More detailed measurements were performed in the buildup region using MOSFETs
with and without the kovar encapsulation present. It was found that when the kovar
was removed good agreement with both Monte Carlo (MCNP) calculations and
ionisation chamber measurements of dose in the buildup region. When a kovar cap
was present the surface dose was over estimated by the MOSFET in the first several
millimetres of depth.
Measurements were also performed with the MOSFET at the surface of the
phantom using different incident beam angles. An angular dependence (reflecting the
dose buildup distributions for beams incident on a slab phantom at different angles
was observed. Anisotropy of the angular response of the MOSFET in isolation or in
equilibrium situations is negligible for high energy gamma rays.
X-ray dose enhancement effects were studied for low energy x-rays obtained
from a Pantak Therapax superficial x-ray unit. When MOSFET responses were
normalised to the 6MV sensitivity observed using a linac beam the low energy x-ray
measurements showed an over response of approximately six times at an average xray energy of 30 keV for a MOSFET without a kovar cap. For a MOSFET with a
kovar cap the over response was approximately 8-9 times at an average x-ray energy
of 50 keV. These results also suggest the advantage of using a low Z, low neutron
cross section encapsulation for MOSFETs used in BNCT beams.
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MOSFET AND PIN DIODE MEASUREMENTS IN A THERMAL NEUTRON
BEAM

By exposing PIN diodes in the TC-10 thermal column of the Ansto Moata
reactor with and without cadmium or lithium shielding it was possible to determine
the thermal neutron contribution to the PIN diode response per unit thermal flux (as
measured using gold foils). This allowed a sensitivity factor of approximately 121
mV.cGy-1 to be derived for the PIN diodes. However the uncertainty in this value is
probably quite large.
MOSFET measurements in the TC-10 beam with various thicknesses of
lithiated shields allowed the neutron contribution to the MOSFET response to be
determined. The thermal neutron sensitivity for MOSFETs in passive mode was
determined to be approximately 1.01×10-10 mV/n.cm-2 using this approach.
Further measurements in the thermal column using the MOSFET in active
mode and calibrated against a theratron Co-60 source yielded a gamma dose rate in
the TC-10 column of 4.7±0.1 Gy.hr-1 which is in good agreement with the previously
measured gamma dose rate of 4.8 Gy.hr-1. For a MOSFET with a 5 volt bias during
irradiation a thermal neutron sensitivity of 3.84×10-10 mV/n.cm-2 was measured. For
a MOSFET with a 10 volt gate bias the thermal neutron sensitivity was 5.04×10-10
mV/n.cm-2. The corresponding

60

Co gamma sensitivities were 6.59 and 8.97

mV.cGy-1 respectively. A direct linear relationship is therefore observed between
gamma and neutron sensitivities for applied gate potentials between 0 and 10 volts.
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PIN DIODE MEASUREMENTS IN PETTEN HB11 EPITHERMAL NEUTRON
BEAM

Silicon damage dose using PIN diodes was measured in a several phantoms
exposed in the Petten HB11 BNCT beam. A human head phantom and cylindrical
tissue equivalent phantom were constructed by S Wallace. The original MCNP
simulations of these phantoms in the Petten HB11 beam were also performed by S
Wallace. A 15 cm cube perspex phantom was also used. This thesis concerns the
measurements performed in these phantoms and the associated MCNP calculations
based on modified versions of the original models.
Very good agreement was obtained between the measured and calculated
absolute silicon damage doses in the Perspex cube phantom. Good agreement was
also achieved (discrepancies of < 10%) in the tissue equivalent cylinder phantom
once allowance was made form some dehydration of the gel used in phantom
construction. For the more complex and detailed head phantom discrepancies
between measured and calculated absolute silicon doses of 25-300% were observed
at depth in the phantom. However it should be noted that these disagreements only
amount to 2-3% errors as a proportion of the maximum silicon damage dose.
These results support the application of small easy to use PIN diodes as
dosimeters for BNCT. While they do not directly yield tissue equivalent dose they
would allow validation of calculated dose distributions indirectly. They will be most
sensitive to the faster components of the neutron spectrum but also have a useful
response to thermal and epithermal components.

301

MOSFET

GAMMA

DOSE

MEASUREMENTS

IN

PETTEN

HB11

EPITHERMAL NEUTRON BEAM

MOSFETs were used to measure gamma doses in the same three phantoms as
were used for the PIN diode measurements. For the Perspex cube phantom good
agreement was observed between lithium shielded MOSFETs and ionisation chamber
measurements. The MCNP calculated induced gamma dose was approximately
60cGy.hr-1 less than the total measured dose.
The measured results in the cylinder and head phantoms were not able to be
compared with ionisation chamber results but were compared to calculated MCNP
induced gamma dose distributions. There were some inconsistencies in these two sets
of data with the measured gamma dose at a depth of 2 cm appearing to be too low.
This discrepancy was resolved by a more detailed MCNP model of the cylinder
phantom which included the lithiated shield around the MOSFET. It is clear that
within the first few cm of the surface the presence of a lithiated shield suppresses the
thermal flux to such an extent that the measured gamma dose is incorrect. Although
explicitly modelling the lithiated shield in the phantom leads to consistent results this
defeats the purpose of using the shielded MOSFET for experimental determination of
gamma dose. It is therefore concluded that to be useful for gamma measurements the
MOSFET encapsulation must be modified so that lithiated shielding is not necessary.
A MOSFET with graphite encapsulation may eliminate the need for shielding and
would also have the advantage of decreasing the magnitude of the neutron sensitivity
correction required.
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It should be noted that at depths way from the thermal neutron maximum the
presence of the lithiated shielding around the MOSFET does not seem to make a
large impact on the measured gamma dose. This is born out by MCNP simulations.

PIN DIODE AND MOSFET MEASUREMENTS USING THE BMRR
EPITHERMAL BEAM

Measurements using PIN diodes and MOSFETs were performed in the
BMRR epithermal neutron beam in a Perspex cube phantom. Reasonable agreement
was observed between calculations and measurements for the PIN diodes.
In the case of the MOSFETs the lithiated shield used in this case were
approximately 5 mm thick and therefore probably lead to a significant thermal flux
depression around the measurement point. For this reason although good agreement
was observed for the relative gamma depth dose curve the absolute measured results
were approximately 30 % lower than expected. This is probably due to the effect of
neutron and consequent gamma flux depression.

SUMMARY

The response of PIN diodes was measured in quasi-monoenergetic neutron
beams and found to be proportional to silicon damage KERMA. The response of the
same silicon PIN diodes was measured in a reactor thermal neutron field and found to
be consistent with the accelerator measurements. Ideal beam Monte Carlo modelling
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was used to show that PIN diode measurements when combined with bare foil
activation could be used to experimentally measure tissue dose in neutron spectra
with maximum energies up to approx 100 keV.
PIN diode measurements were then performed in phantoms in two epithermal
neutron beams. Where the beam parameters and the phantom composition and
geometry was well defined good agreement was obtained. Small size and ease of
readout (including possible realtime dose readout) make PIN diodes useful for
epithermal neutron dose mapping and verification of dose calculations.
MOSFET responses were measured in well characterised medical x-ray
beams. The MOSFET x-ray sensitivity was determined for various gate potentials
and for different x-ray energies. The neutron energy response as a function of neutron
energy was determined using MCNP calculations. The thermal neutron response of
MOSFETs was measured in a reactor thermal neutron column.
Measurements of gamma doses in phantoms exposed in two epithermal
neutron beams were then attempted. It was possible to obtain dose profiles using
MOSFETs however the use of lithiated shielding perturbed the neutron field at the
measurement point leading to a lower than expected measured gamma dose near the
thermal flux maxima.
In order to use MOSFETs for gamma dosimetry in mixed epithermal neutron
/ gamma fields it will be necessary to optimise the the encapsulation to minimse
neutron response and obviate the need for extra neutron shielding which has the
effect of perturbing the field being measured.
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APPENDIX A

MCNP4A MODEL OF MOSFET

MCNP4A model of mosfet including smaller lithiated shielding cap (as used
in Petten HB11 experiments) for purposes of determining mosfet neutron energy
response.

c
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16

1
1
4
4
5
4
4
4
2
3
0
0
0
0
0
0

tops
18 0
19 0
20 0
21 0
22 6
23 6
24 6
25 6
c
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15

cells to define mosfet - modified to include 6LiF cap
-8.4 7 -8 -10
$ mos top plate
-8.4 1 -7 -10 11
$ mos can/tube
-8.4 2 -3 -11 13 14 15
$ inner can top plate
-8.4 1 -2 -11 12
$ inner can tube
-2.23 1 -2 -12 13 14 15
$ glass plug at base of mos
-8.4 -6 9 -13
$ lead 1
-8.4 -6 9 -14
$ lead 2
-8.4 -6 9 -15
$ lead 3
-2.4 3 -4 -16 17 -18 19
$ silicon chip
-2.4 4 -5 -16 17 -18 19
$ sio2 layer
-7 6 -11
$ empty space in can
-22 -20
$ empty space beneath
-1 9 13 14 15 -24
$ ditto
-21 22 23 -20
$ empty space around can
21 -20
$ empty space above lif cap
20
$ rest of universe
17 0 -6 5 -11 13 14 15
$ space above chip below lead
-5 3 -11 13 16
-5 3 -11 14 -17
-5 3 -11 15 18 -16 17
-5 3 -11 -19 -16 17
-1.69 8 -21 -23
-1.69 -8 -23 10 1
-1.69 -1 -23 24 9
-1.69 -9 -23 22

planes to define
pz 0
pz 0.230
pz 0.250
pz 0.280
pz 0.295
pz 0.300
pz 0.480
pz 0.500
pz -0.556
cz 0.232
cz 0.212
cz 0.192
c/z 0.15 0 0.02
c/z -0.15 0 0.02
c/z 0 0.15 0.02
16 px 0.1
sio2chip
17 px -0.1
18 py 0.1
19 py -0.1
20 so 2

$
$
$
$
$
$
$
$

"round chip bel. surf
"round chip bel. surf
"round chip bel. surf
"round chip bel. surf
lif top of cap
lif around can
lif around lead volume
lif base i.e. bottom disc of cap

the mosfet
$ base of mos
$ underside of ni/au substrate
$ upper side if Ni/Au substrate
$ upper side of si chip
$ upper side of sio2/Al
$ plane for top of leads
$ underside of Ni lid
$ upperside of Ni lid
$ plane for bottom end of leads
$ cyl for outer of ni can
$ cyl for inner of ni can
$ cyl for inner of inside half can ni/au
$ lead number 1
$ lead number 2
$ lead number 3
$ planes to define the sides of si &
$
$
$
$

ditto
ditto
ditto
sphere about origin
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21
22
23

pz 0.84
pz -1.156
cz 0.475
24 cz 0.296
dia part)

$ plane for top of Lif cap
$ plane for base of lif cap
$ cylinder for outer of lif
$ cylinder for inner of lif (larger

c
define materials
mode n p e
imp:n 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1
imp:p 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 0 2 2 2 2 2 2 2 2 2
imp:e 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 0 2 2 2 2 2 2 2 2 2
m1
26000.55c -0.54 28000.50c -0.29 27059.50c -0.17 estep=100
$kovar
m2
14000.50c 1 estep=100
$ silicon
m3
14000.50c 10 8016.50c 20 13027.35c 0.1 estep=100
$ sio2/al
m4
26000.55c -0.54 28000.50c -0.29 27059.50c -0.17
79197.35c -0.034 estep=100 $ Kovar/Au for leads and inner can
m5
5010.50c -0.0074 5011.56c -0.0296 13027.50c -0.01
11023.50c -0.041 8016.50c -0.535 14000.50c -0.377 estep=20
$glass
m6
3006.50c -0.133 9019.50c -0.423 6012.50c -0.268
1001.50c -0.036 8016.50c -0.143 $lif resin mix
c
data card to describe source tally etc
sdef sur=20 nrm=-1 dir=d1 erg=d2 par=1
sb1
-21 2
si2
h 0.001e-6 0.01e-6
sp2
d 0 1
c
tallies
*f8:p 10
fc8 sio2 pulse height tally
f4:p (9 10)
fc4 photon tally in mosfet
e4 0.001 0.003 0.005 0.007 0.01 0.03 0.05 0.07 0.1 0.3
0.5 0.7 1.0 3.0 5.0 7.0 10.0 15.0
f14:p (9 10)
fc14 photon heating using -6 multiplier
fm14
1 3 -6
f24:p (9 10)
f24c photon tally in mosfet times silicon gamma kerma (plotxs)
de24
.015
.025
.0375
.0525
.0649999
.125
.175
.25
.35
.425
.511
.556
.65
.75
.9
1.415
1.58
1.83
2.25
2.75
3.75
4.25
4.75
5.25
5.75
6.75
7.25
7.75
9
11
17
df24 2.284222E-11 8.190444E-12 3.495018E-12
1.782612E-12 1.211255E-12 7.141306E-13
8.353256E-13 1.163867E-12 1.662457E-12
2.048793E-12 2.466298E-12 2.665177E-12
3.094492E-12 3.518312E-12 4.126257E-12
5.918366E-12 6.46583E-12 7.166327E-12
8.336321E-12 9.68157E-12 1.226261E-11
1.359546E-11 1.493106E-11 1.629781E-11
1.76978E-11
2.046066E-11 2.190036E-11
2.330236E-11 2.704061E-11 3.290582E-11
5.116297E-11
f34:e (9 10)
fc34 electron tally in mosfet
e34 0.001 0.004 0.007 0.01 0.03
0.05 0.1 0.2 0.5 0.7 1.0 2.0 5.0 10.0
f44:n (9 10)
fc44 silicon oxide average neutron dose
fm44 1 3 -4
prdmp -120 -120
ctme 120
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MCNP4A model of mosfet including thicker lithiated shielding cap (as used in
BMRR, BNL experiments) for purposes of determining mosfet neutron energy
response.

c
c
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
c
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25

1
1
4
4
5
4
4
4
2
3
0
0
0
0
0
0
0
0
0
0
0
6
6
6
6
7

cells to define mosfet - modified to include 6LiF cap
modified for large LiF shield as used for BNL experiments
-8.4 7 -8 -10
$ mos top plate
-8.4 1 -7 -10 11
$ mos can/tube
-8.4 2 -3 -11 13 14 15
$ inner can top plate
-8.4 1 -2 -11 12
$ inner can tube
-2.23 1 -2 -12 13 14 15
$ glass plug at base of mos
-8.4 -6 9 -13
$ lead 1
-8.4 -6 9 -14
$ lead 2
-8.4 -6 9 -15
$ lead 3
-2.4 3 -4 -16 17 -18 19
$ silicon chip
-2.4 4 -5 -16 17 -18 19
$ sio2 layer
-7 6 -11
$ empty space in can
-22 -20
$ empty space beneath
-1 9 13 14 15 -24
$ ditto
-21 22 23 -20
$ empty space around can
21 -20
$ empty space above lif cap
20
$ rest of universe
-6 5 -11 13 14 15
$ space above chip below lead tops
-5 3 -11 13 16
$ "round chip bel. surf
-5 3 -11 14 -17
$ "round chip bel. surf
-5 3 -11 15 18 -16 17
$ "round chip bel. surf
-5 3 -11 -19 -16 17
$ "round chip bel. surf
-1.69 8 -21 -23
$ lif top of cap
-1.69 -8 -23 10 1
$ lif around can
-1.69 -1 -23 24 9
$ lif around lead volume
-1.69 -9 -23 22 25
$ lif base ie bottom disc of cap
-8.96 -9 22 -25
$ copper cabble thru base

planes to define
pz 0
pz 0.230
pz 0.250
pz 0.280
pz 0.295
pz 0.300
pz 0.480
pz 0.500
pz -0.5
cz 0.232
cz 0.212
cz 0.192
c/z 0.15 0 0.02
c/z -0.15 0 0.02
c/z 0 0.15 0.02
px 0.1
px -0.1
py 0.1
py -0.1
so 2
pz 1.3
$
pz -1.1
$
cz 0.8
$
cz 0.3
$
cz 0.075
$

the mosfet
$ base of mos
$ underside of ni/au substrate
$ upper side if Ni/Au substrate
$ upper side of si chip
$ upper side of sio2/Al
$ plane for top of leads
$ underside of Ni lid
$ upperside of Ni lid
$ plane for bottom end of leads
$ cyl for outer of ni can
$ cyl for inner of ni can
$ cyl for inner of inside half can ni/au
$ lead number 1
$ lead number 2
$ lead number 3
$ planes to define the sides of si & sio2chip
$
ditto
$
ditto
$
ditto
$ sphere about origin
plane for top of Lif cap
plane for base of lif cap
cylinder for outer of lif
cylinder for inner of lif (larger dia part)
cylinder for cable tru base of shield

c
define materials
mode n p e
imp:n 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1
imp:p 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 0 2 2 2 2 2 2 2 2 2 2
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imp:e 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 0 2 2 2 2 2 2 2 2 2 2
m1
26000.55c -0.54 28000.50c -0.29 27059.50c -0.17 estep=100 $kovar
m2
14000.50c 1 estep=100
$ silicon
m3
14000.50c 10 8016.50c 20 13027.50c 0.1 estep=100
$ sio2/al
m4
26000.55c -0.54 28000.50c -0.29 27059.50c -0.17
79197.35c -0.034 estep=100 $ Kovar/Au for leads and inner can
m5
5010.50c -0.0074 5011.56c -0.0296 13027.50c -0.01
11023.50c -0.041 8016.50c -0.535 14000.50c -0.377 estep=20
$ glass
m6
3006.50c -0.1366 9019.50c -0.433 6012.50c -0.258
1001.50c -0.0347 8016.50c -0.1377 $lif resin mix, 43%PMMA, 57%LiF
m7
29000.50c 1
c
data card to describe source tally etc
sdef sur=20 nrm=-1 dir=d1 erg=d2 par=1
sb1
-21 2
si2
h 0.001e-6 0.01e-6
sp2
d 0 1
c
tallies
*f8:p 10
fc8 sio2 pulse height tally
f4:p (9 10)
fc4 photon tally in mosfet
e4 0.001 0.003 0.005 0.007 0.01 0.03 0.05 0.07 0.1 0.3
0.5 0.7 1.0 3.0 5.0 7.0 10.0 15.0
f14:p (9 10)
fc14 photon heating using -6 multiplier
fm14
1 3 -6
f24:p (9 10)
f24c photon tally in mosfet times silicon gamma kerma (plotxs)
de24
.015
.025
.0375
.0525
.0649999
.125
.175
.25
.35
.425
.511
.556
.65
.75
.9
1.415
1.58
1.83
2.25
2.75
3.75
4.25
4.75
5.25
5.75
6.75
7.25
7.75
9
11
17
df24 2.284222E-11 8.190444E-12 3.495018E-12
1.782612E-12 1.211255E-12 7.141306E-13
8.353256E-13 1.163867E-12 1.662457E-12
2.048793E-12 2.466298E-12 2.665177E-12
3.094492E-12 3.518312E-12 4.126257E-12
5.918366E-12 6.46583E-12 7.166327E-12
8.336321E-12 9.68157E-12 1.226261E-11
1.359546E-11 1.493106E-11 1.629781E-11
1.76978E-11
2.046066E-11 2.190036E-11
2.330236E-11 2.704061E-11 3.290582E-11
5.116297E-11
f34:e (9 10)
fc34 electron tally in mosfet
e34 0.001 0.004 0.007 0.01 0.03
0.05 0.1 0.2 0.5 0.7 1.0 2.0 5.0 10.0
f44:n (9 10)
fc44 silicon oxide average neutron dose
fm44 1 3 -4
prdmp -120 -120 1
ctme 120
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APPENDIX B

MCNP4A MODEL OF SOLID WATER PHANTOM
IN LINAC BEAM

c model of block of solid water in 10x10cm 6mv linac beam
1
1 -1.04 -1 2 -3 4 -5 6 #(47 -48 49 -50 -1 2) $cube excl tally core
2
0 -2 $ volume below cube
imp=0
3
0 3 2 $ volume to right of cube
"
4
0 -4 2 $ volume to left of cube
"
5
0 5 2 $ volume to front of cube
"
6
0 -6 2 $ volume behind cube
"
7
0 7 -3 4 -5 6 $ volume above source
"
8
0 1 -8 -3 4 -5 6 $ above cube below coll.
imp=1
9
0 8 -9 -10 11 -12 13 $ apperture in coll.
imp=1
10 0 9 -7 -3 4 -5 6 $ abov coll below source
imp=1
11 0 8 -9 4 -11 6 -5 $ coll. imp=0
12 1 -1.04 47 -48 49 -50 -1 14
13 1 -1.04 47 -48 49 -50 -14 15
14 1 -1.04 47 -48 49 -50 -15 16
15 1 -1.04 47 -48 49 -50 -16 17
16 1 -1.04 47 -48 49 -50 -17 18
17 1 -1.04 47 -48 49 -50 -18 19
18 1 -1.04 47 -48 49 -50 -19 20
19 1 -1.04 47 -48 49 -50 -20 21
20 1 -1.04 47 -48 49 -50 -21 22
21 1 -1.04 47 -48 49 -50 -22 23
22 1 -1.04 47 -48 49 -50 -23 24
23 1 -1.04 47 -48 49 -50 -24 25
24 1 -1.04 47 -48 49 -50 -25 26
25 1 -1.04 47 -48 49 -50 -26 27
26 1 -1.04 47 -48 49 -50 -27 28
27 1 -1.04 47 -48 49 -50 -28 29
28 1 -1.04 47 -48 49 -50 -29 30
29 1 -1.04 47 -48 49 -50 -30 31
30 1 -1.04 47 -48 49 -50 -31 32
31 1 -1.04 47 -48 49 -50 -32 33
32 1 -1.04 47 -48 49 -50 -33 34
33 1 -1.04 47 -48 49 -50 -34 35
34 1 -1.04 47 -48 49 -50 -35 36
35 1 -1.04 47 -48 49 -50 -36 37
36 1 -1.04 47 -48 49 -50 -37 38
37 1 -1.04 47 -48 49 -50 -38 39
38 1 -1.04 47 -48 49 -50 -39 40
39 1 -1.04 47 -48 49 -50 -40 41
40 1 -1.04 47 -48 49 -50 -41 42
41 1 -1.04 47 -48 49 -50 -42 43
42 1 -1.04 47 -48 49 -50 -43 44
43 1 -1.04 47 -48 49 -50 -44 45
44 1 -1.04 47 -48 49 -50 -45 46
45 1 -1.04 47 -48 49 -50 -46 2
46 0 8 -9 10 -3 6 -5 $ coll. imp=0
47 0 8 -9 11 -10 6 -13 $ coll. imp=0
48 0 8 -9 11 -10 12 -5 $ coll. imp=0
c planes for phantom
1 pz 0
$top of phantom
2 pz -30
$bottom of phantom
3 px 15
$side of phantom
4 px -15
$side of phantom
5 py 15
$side of phantom
6 py -15
$side of phantom
7 pz 100.1
$plane at source
8 pz 50
$collimator
9 pz 95.1
$collimator
10 px 2.5
$collimator apeture
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11 px -2.5
$collimator apeture
12 py 2.5
$collimator apeture
13 py -2.5
$collimator apeture
c planes for tallies
14 pz -0.1
15 pz -0.2
16 pz -0.3
17 pz -0.4
18 pz -0.5
19 pz -0.6
20 pz -0.7
21 pz -0.8
22 pz -0.9
23 pz -1
24 pz -1.2
25 pz -1.4
26 pz -1.6
27 pz -1.8
28 pz -2.0
29 pz -3
30 pz -4
31 pz -5
32 pz -6
33 pz -7
34 pz -8
35 pz -9
36 pz -10
37 pz -11
38 pz -12
39 pz -13
40 pz -14
41 pz -15
42 pz -16
43 pz -17
44 pz -18
45 pz -19
46 pz -20
c planes for sides of tallies
47 px -0.25
48 px 0.25
49 py -0.25
50 py 0.25
100 pz 100
mode p e
m1
1001 8.09 6012 67.22 7014 2.41 8016 19.84
20000 0.13 estep=40 $Brain ICRU 92
imp:p 1 0 0 0 0 0 0 1 1 1 0 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0
imp:e 1 0 0 0 0 0 0 1 1 1 0 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0
sdef pos 0 0 100 vec 0 0 -1 dir 1 erg=d1 rad=d2 sur=100
si1 0.45 0.55
0.65 0.75 0.9
1.125 1.375
1.750 2.250 2.750 3.5
4.250 4.75 5.5
7.0
sp1 0
0.002 0.005 0.01 0.025 0.049 0.056
0.089 0.091 0.064 0.062 0.029 0.009 0.006 0.001
si2 0.01
fq0 u e
f4:p 12 13 14 15 16 17 18 19 20 21 22
23 24 25 26 27 28 29 30 31 32 33
34 35 36 37 38 39 40 41 42 43 44
fm4 1 1 -6
fc4 photon heating tally
f14:e 12 13 14 15 16 17 18 19 20 21 22
23 24 25 26 27 28 29 30 31 32 33
34 35 36 37 38 39 40 41 42 43 44
fc14 electron tally
*f8:e 12 13 14 15 16 17 18 19 20 21 22
23 24 25 26 27 28 29 30 31 32 33
34 35 36 37 38 39 40 41 42 43 44
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fc8 electron pulse height tally
nps 100
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APPENDIX C MCNP4A MODEL OF TISSUE EQUIVALENT
CYLINDER FOR IDEAL BEAM STUDIES OF PIN
DIODE

c model of a TE cylinder phantom for the purposes comparing ideal
beams
c in tissue and Si damage kerma. E=0.25e-6
1
2 -1.04 -150 101 -102
2
2 -1.04 -150 102 -103
3
2 -1.04 -150 103 -104
4
2 -1.04 -150 104 -105
5
2 -1.04 -150 105 -106
6
2 -1.04 -150 106 -107
7
2 -1.04 -150 107 -108
8
2 -1.04 -150 108 -109
9
2 -1.04 -150 109 -110
10
2 -1.04 -150 110 -111
11
2 -1.04 -150 111 -112
12
2 -1.04 -150 112 -113
13
2 -1.04 -150 113 -114
14
2 -1.04 -150 114 -115
15
2 -1.04 -150 115 -116
16
2 -1.04 -150 116 -117
17
2 -1.04 -150 117 -118
18
2 -1.04 -150 118 -119
19
2 -1.04 -150 119 -120
20
2 -1.04 -150 120 -121
21
2 -1.04 -150 121 -122
22
2 -1.04 -150 122 -123
23
2 -1.04 -150 123 -124
24
2 -1.04 -150 124 -125
25
2 -1.04 -150 125 -126
26
2 -1.04 -150 126 -127
27
2 -1.04 -150 127 -128
28
2 -1.04 -150 128 -129
29
2 -1.04 -150 129 -130
30
2 -1.04 -150 130 -131
31
2 -1.04 -150 131 -132
101
2 -1.04 -152 151 101 -102
102
2 -1.04 -152 151 102 -103
103
2 -1.04 -152 151 103 -104
104
2 -1.04 -152 151 104 -105
105
2 -1.04 -152 151 105 -106
106
2 -1.04 -152 151 106 -107
107
2 -1.04 -152 151 107 -108
108
2 -1.04 -152 151 108 -109
109
2 -1.04 -152 151 109 -110
110
2 -1.04 -152 151 110 -111
111
2 -1.04 -152 151 111 -112
112
2 -1.04 -152 151 112 -113
113
2 -1.04 -152 151 113 -114
114
2 -1.04 -152 151 114 -115
115
2 -1.04 -152 151 115 -116
116
2 -1.04 -152 151 116 -117
117
2 -1.04 -152 151 117 -118
118
2 -1.04 -152 151 118 -119
119
2 -1.04 -152 151 119 -120
120
2 -1.04 -152 151 120 -121
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121
122
123
124
125
126
127
128
129
130
131
201
202
203
204
205
300
301
302
303
c
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
140
150
151
152
153

2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
0
0
0
0

-1.04 -152 151
-1.04 -152 151
-1.04 -152 151
-1.04 -152 151
-1.04 -152 151
-1.04 -152 151
-1.04 -152 151
-1.04 -152 151
-1.04 -152 151
-1.04 -152 151
-1.04 -152 151
-1.04 150 -151
-1.04 150 -151
-1.04 152 -153
-1.04 152 -153
-1.04 132 -140
-100
140
153 100 -140
-153 -101 100

121 -122
122 -123
123 -124
124 -125
125 -126
126 -127
127 -128
128 -129
129 -130
130 -131
131 -132
101 -103
103 -132
101 -103
103 -132
-153

Surface Cards
py -0.1
py 0.0
py 0.25
py 0.75
py 1.25
py 1.75
py 2.25
py 2.75
py 3.25
py 3.75
py 4.25
py 4.75
py 5.25
py 5.75
py 6.25
py 6.75
py 7.25
py 7.75
py 8.25
py 8.75
py 9.25
py 9.75
py 10.25
py 10.75
py 11.25
py 11.75
py 12.25
py 12.75
py 13.25
py 13.75
py 14.25
py 14.75
py 15.25
py 23.0
cy 0.25
cy 2.25
cy 2.75
cy 8.0

c
data cards
mode n
m1
1001 -5.55 6012 -75.58 8016 -18.88
$polycarbonate
m2
1001 -10.7 6012 -14.5 7014 -2.2 8016 -71.2
11023 -0.2 15031 -0.4 16032 -0.2 17000 -0.3 19000 -0.3
$Brain ICRU 92
mt2 lwtr.01t
mt1 poly.01t
m51
79197 1 $gold
m52
29000 1 $ copper
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m53
25055.50c 1 $Manganese
c
m54
49115 1 $ indium
c
no indium xsections present
imp:n 1 66r 0 0 0 1
c
c
Source definition.
c
==================
sdef sur=101 pos=0.0 0.0 0.0 dir=1 erg=0.25e-6 rad=d1
si1
5
c
c
G E N E R A L program data
c
===========================
fq0 f t $vertical listing of cell scores in each tally
c
tally cards
f4:n 1 29i 31 101 29i 131
fc4 neutron flux
e4
1e-9 3e-9 1e-8 3e-8 1e-7 3e-7 1e-6 3e-6 1e-5 3e-5 1e-4 3e-4
1e-3 3e-3 1e-2 3e-2 1e-1 3e-1 1 3 14.5
fq4
f e
f14:n 1 29i 31 101 29i 131
fc14 neutron dose
e14
0.414e-6 1e-5 1e-4 4e-4 3e-2 1e-1 1.4e-1 2e-1 4e-1 1.45e1
fq14 f e
c
f24:n 1 29i 31 101 29i 131
c
fc24 30ppm 10B dose
c
f34:p 1 29i 31 101 29i 131
c
fc34
photon dose
f44:n 1 29i 31 101 29i 131
fc44 silicon damage cGy
e44 0.414e-6 1e-5 1e-4 4e-4 3e-2 1e-1 1.4e-1 2e-1 4e-1 1.45e1
fq44 e f
c
neutron tissue dose conversion
de14 2.5e-8 2e-6 2e-5 2e-4 2e-3 2e-2 1.05e-1 1.05e+00
1.05e+1 1.55e+1 $MeV
df14 1.5e-11 1.73e-12 7.51e-13 2.29e-12 2.10e-11 1.89e-10
6.95e-10 2.56e-9 5.98e-9 7.03e-9 $Kerma cGy*cm**2
c
30ppm B10 dose conversion
c
de24 1e-8 2.5e-8 3.6e-8 2.51e-7 6.84e-7 1.86e-6 5e-6
c
1.37e-5 3.73e-5 1.01e-4 2.75e-4 7.49e-4 2.03e-3 $MeV
c
df24 4.14e-10 2.62e-10 2.19e-10 8.76e-11 5.43e-11 3.27e-11
c
1.91e-11 1.2e-11 7e-12 4.41e-12 2.7e-12 1.64e-12
c
9.8e-13 $Kerma cGy*cm**2 30ppmB10 dose only
c
photon tissue dose conversion
c
de34 1e-3 2e-3 5e-3 1e-2 2e-2 5e-2 1e-1 2e-1 5e-1 1e+0
c
2e+0 5e+0 1e+1 2e+1 $Mev
c
df34 5.99e-08 1.8e-8 3.24e-9 7.75e-10 1.75e-10 3.24e-11
c
4.04e-11 9.46e-11 2.63e-10 4.94e-10 8.29e-10
c
1.52e-9 2.48e-9 4.38e-9 $Kerma cGy*cm**2
de44 2.24068e-09 $Si damage kerma (MeV energy)
3.69425e-09 $cGy*cm**2*sec
6.09079e-09
1.0042e-08 1.31589e-08 1.45429e-08 1.60723e-08 1.77626e-08
1.96307e-08 2.16954e-08 2.39771e-08 2.64988e-08 2.92856e-08
3.23656e-08 3.57697e-08 3.95316e-08 4.36892e-08 4.82839e-08
5.33619e-08 5.89743e-08 6.51765e-08 &.20311e-08 7.96066e-08
8.79788e-08 9.72321e-08 1.07458e-07 1.18759e-07 1.31249e-07
1.45053e-07 1.60309e-07 1.77168e-07 1.95801e-07 2.16393e-07
2.39151e-07 2.64305e-07 2.92101e-07 3.22821e-07 3.56772e-07
3.94294e-07 4.35765e-07 4.81594e-07 5.32243e-07 5.88218e-07
6.5008e-07 7.18454e-07 7.94014e-07 8.7752e-07 9.69806e-07
1.0718e-06 1.18453e-06 1.30911e-06 1.44679e-06 1.59895e-06
1.76711e-06 1.95295e-06 2.15835e-06 2.38535e-06 2.63622e-06
2.91347e-06 3.49344e-06 4.48567e-06 5.75971e-06 7.39562e-06
9.49614e-06 1.21933e-05 1.56565e-05 2.01034e-05 2.58132e-05
3.31448e-05 4.25588e-05 5.46466e-05 7.01676e-05 9.00971e-05
1.15687e-04 1.48545e-04 1.90735e-04 2.44909e-04 3.14469e-04
4.03787e-04 5.18473e-04 6.65732e-04 8.54816e-04 1.09761e-03
1.31626e-03 1.49151e-03 0.0016901
1.91514e-03 2.17014e-03
2.45909e-03 2.78652e-03 3.15754e-03 3.57796e-03 4.05435e-03
4.59418e-03 5.20589e-03 5.89905e-03 0.0066845
7.57453e-03
8.58307e-03 0.0097259
0.0110209
0.0124883
0.0141511
.0160353
0.0181703
0.0205897
0.0233312
0.0264377
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.0299578
.0339467
.0384666
.0435884
.0493922
.0559687
.0634207
.0718651
.0814339
.0922766
.104563
.118486
.134262
.147242
.156739
.166847
.177608
.189063
.201256
.214236
.228053
.242761
.258418
.275085
.292826
.311712
.331816
.353216
.375996
.400246
.426059
.453538
.482789
.513926
.547071
.582355
.619913
.659894
.702454
.747758
.795984
.84732
.901968
.96014
1.02206
1.08798
1.15815
1.23285
1.31236
1.397
1.4871
1.58301
1.6851
1.79378
1.90947
2.03262
2.16371
2.30326
2.45181
2.60993
2.77826
2.95744
3.14818
3.35122
3.56735
3.79743
4.04234
4.30305
4.58057
4.876
5.19047
5.52522
5.88157
6.2609
6.66469
7.09453
7.55209
8.03915
8.55762
9.10954
9.69706 10.3224
10.9882
11.6969
12.4513
13.044
13.4581
13.8853
14.3261
14.7808
df44 1.139608e-13 $Si damage kerma (kerma)
8.872022e-14 $cGy*cm**2*sec
6.911985e-14
5.382809e-14 4.698947e-14
4.467793e-14
4.249707e-14
4.042712e-14 3.845414e-14
3.658561e-14
3.479285e-14
3.307903e-14 3.146068e-14
2.991504e-14
2.845421e-14
2.705426e-14 2.572107e-14
2.44644e-14
2.32737e-14
2.214843e-14 2.108652e-14
2.009261e-14
1.913243e-14
1.820844e-14 1.73249e-14
1.649836e-14
1.570998e-14
1.496096e-14 1.423965e-14
1.354101e-14
1.285803e-14
1.221635e-14 1.163057e-14
1.10634e-14
1.05213e-14
1.00054e-14
9.516939e-15
9.023816e-15
8.575672e-15
8.172521e-15 7.780097e-15
7.406513e-15
7.048285e-15
6.712682e-15 6.374564e-15
6.064049e-15
5.78651e-15
5.494637e-15 5.231793e-15
4.968984e-15
4.714971e-15
4.477693e-15 4.260399e-15
4.053349e-15
3.862171e-15
3.687897e-15 3.507276e-15
3.334228e-15
3.170209e-15
2.878356e-15 2.541229e-15
2.240582e-15
1.982931e-15
1.75226e-15
1.549848e-15
1.371894e-15
1.20275e-15
1.063582e-15 9.378355e-16
8.263944e-16
7.314748e-16
6.441276e-16 5.681734e-16
5.024657e-16
4.410407e-16
1.01183e-15
4.943858e-15
8.634314e-15
1.310663e-14
1.935209e-14 2.556637e-14
3.365582e-14
4.320152e-14
5.229323e-14 5.955156e-14
6.725444e-14
7.583962e-14
8.567795e-14 9.688433e-14
1.092836e-13
1.230059e-13
1.383673e-13 1.556411e-13
1.778341e-13
2.030548e-13
2.268539e-13 2.540585e-13
2.842102e-13
3.170536e-13
3.540249e-13 3.939739e-13
4.406613e-13
4.95467e-13
5.550313e-13 6.170442e-13
6.830327e-13
7.464381e-13
8.175346e-13 9.01417e-13
9.916632e-13
1.207613e-12
1.045831e-12 7.946789e-13
1.469681e-11
2.524801e-12
2.318469e-12 2.133843e-12
1.964938e-12
1.742369e-12
1.335893e-12 7.838897e-13
5.806286e-13
2.368042e-12
9.439942e-12 2.663609e-11
3.885624e-11
3.409585e-11
2.740755e-11 2.339778e-11
2.084227e-11
1.923364e-11
1.807755e-11 1.760321e-11
1.725335e-11
1.697778e-11
1.721205e-11 1.735033e-11
1.789191e-11
1.79938e-11
1.830144e-11 1.893635e-11
2.015418e-11
3.295358e-11
2.475467e-11 1.825112e-11
1.927201e-11
2.032588e-11
2.377295e-11 3.696862e-11
3.332297e-11
3.059793e-11
3.840454e-11 3.099449e-11
2.43371e-11
2.229745e-11
2.90611e-11
3.056374e-11
3.218565e-11
3.494228e-11
4.293426e-11 4.585451e-11
3.461053e-11
4.448711e-11
3.479863e-11 3.671302e-11
3.579939e-11
4.098488e-11
4.192978e-11 3.951167e-11
3.454923e-11
4.516524e-11
3.919306e-11 3.578532e-11
3.857847e-11
4.53553e-11
5.11644e-11
4.973329e-11
5.391368e-11
5.51605e-11
4.520707e-11 5.365942e-11
5.938245e-11
5.248903e-11
5.205755e-11 5.609426e-11
5.755874e-11
5.699389e-11
5.581579e-11 5.464705e-11
5.652209e-11
5.488637e-11
5.700434e-11 5.752392e-11
5.801822e-11
5.762e-11
5.699998e-11 5.770559e-11
5.832971e-11
f54:n 1 29i 31 101 29i 131
fc54 Gold Activation
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e54
0.414e-6 0.5e-6 14.5
fm54 1 51 102
fq54 f e
f64:n 1 29i 31 101 29i 131
fc64 Copper Activation
e64
0.414e-6 0.5e-6 14.5
fm64 1 52 102
fq64 f e
f74:n 1 29i 31 101 29i 131
fc74 Manganese Activation
e74
0.414e-6 0.5e-6 14.5
fm74 1 53 102
fq74 f e
c
f84:n 1 29i 31 101 29i 131
c
fc84 Indium Activation
c
e84
0.414e-6 0.5e-6 14.5
c
fm84 1 54 102
c
fq84 f e
c
no indiumxs present in tables
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APPENDIX D LONG COUNTER CALIBRATION FOR ANSTO
VAN DE GRAFF MEASUREMENTS

Before the PIN diode measurements were commenced the long counter was
calibrated using a AmBe neutron source of known activity (The 4π fluence was
known to be 6.5×105 n.cm-2.s-1). For this calibration the AmBe source was placed 2
cm from the centre of the target along the axis of the beam line. The AmBe source
was in a brass housing of dimensions 28 × 28 × 30 mm. To determine the geometric
counting dependence of the AmBe source / long counter arrangement the source
detector distance was varied from 45 cm to 207 cm. The number of counts was
recorded at each location of the long counter as shown below. The distance was
corrected to take into account the effective centre the long counter. The effective
centre of the detector is located approximately 6 cm behind the front face of the
detector for neutrons of approximately 4.2 – 4.5 MeV such as are emitted from the
AmBe source203.

Table D-1. Change in efficiency of long counter as function of source counter distance.

Distance

Effective

Counts per

Incident

Geometric Efficiency

(cm)

Distance (cm)

second

neutrons

(counts per neutron

(-background)

incident on face)

205

211

7.305

821

8.89e-3

165

171

9.405

1250

7.58e-3

125

131

9.253

2130

6.47e-3

85

91

13.78

4420

5.52e-3

45

51

24.356

14100

4.60e-3
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The sensitive area of the long counter was taken to be the entire front face of
the detector. This face has a radius of 15 cm and therefore an area of 707 cm2. From
Figure D-1 below it can be seen that the long counter efficiency tends to increase with
distance from the neutron source. This is due primarily to two effects. The first is that
the neutron source though not large relative to the source - detector distance is of
finite size and is therefore not the ideal point source assumed in the calculation of the
number of incident neutrons. That is, the 1/r2 assumption will not be completely
correct especially at shorter distances between the source and detector. The second
and more significant effect is that at greater source – detector distances a larger
proportion of the neutrons impinging on the detector are closer to normal incidence
than for lesser separations. Neutrons impinging on rim of the detector at angles of up
to 20° when the detector is 40 cm from the source have less chance of being detected
than those impinging on the rim at angles of up to 4° when the detector is 211 cm
from the source. Therefore as the source detector distance increases the fraction of
impinging neutrons which yield counts from the detector also increases.
Because the effective centre of the Long Counter detector varies with the
energy of the incident neutrons a small correction to the actual source – detector
distance was required for each of the different energies used to irradiate the PIN diode.
For all of the PIN diode irradiations the actual distance between the Li target on the
accelerator and the face of the long counter was 207 cm. These corrections to the
effective location of the detector are based on those given by Fowles

203

and are shown

in Table D-2.
Based on these corrections to the actual distance of 207 cm between the
counter and the target / source, geometric efficiencies for the long counter were
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derived. These geometric efficiencies only take into account the effect of the location
of the long counter relative to the neutron source. They do not include a factor for the

Geometric Efficiency (counts per
incident neutron)

intrinsic energy dependence of the long counter neutron detection sensitivity.
1.00E-02
0.4462

9.00E-03

y = 0.0008x
2
R = 0.9663

8.00E-03
7.00E-03
6.00E-03
5.00E-03
4.00E-03
3.00E-03
2.00E-03
1.00E-03
0.00E+00
0

50

100

150

200

250

Source - Detector Distance (cm)
Figure D-1. Geometric Efficiency of Long Counter used to monitor neutron flux for PIN
diode irradiations on the Ansto Van de Graff accelerator.

Table D-2. Variation of effective centre of long counter with neutron energy.

Nominal neutron energy (keV)

Distance of effective centre behind
front face of detector (cm)

90

1.7

141

2.0

165

2.0

196

2.1

230

2.2

350

2.75

891

3.75

4000

6.0
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The geometric efficiencies of the long counter for the experimental setup were
derived by extrapolating a curve fitted to the efficiency versus distance data shown in
Figure D-1. Use of this curve gives geometric efficiency factors for the nominal
neutron energies as shown in Table D-3. That is Table D-3 shows geometric
efficiencies corrected for the effective centre of the long counter for each of the
neutron energies used to irradiate the PIN diode.
The efficiency of the long counter is relatively energy independent for energies
above approximately 1.5 MeV. However since all of the neutrons that we are dealing
with will be below this energy it is necessary to make a further energy dependant
correction to the long counter efficiency.

Table D-3. Geometric efficiency factors for the Long Counter showing the minimal energy
dependence of the geometric efficiency factor due to the change in effective centre of the
detector at different neutron energies.

Nominal Neutron Energy (keV)

Geometric Efficiency of Long
Counter

90

0.0083

141

0.0083

165

0.0083

196

0.0083

230

0.0080

350

0.0083

891

0.0083

The approximate energy dependence of the long counter was derived from data
203

given by Fowler

. The energy dependant efficiencies are as shown in Table D-4. The
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efficiency of the long counter taking into account both the geometric and the energy
dependant factors is given in Table D-5.

Table D-4. Approximate energy dependant efficiencies for the long counter 203.

Nominal Neutron Energy keV

Relative efficiency (=1 at E >
1.5 MeV)

90

0.863

140

0.871

165

0.875

196

0.879

230

0.885

350

0.902

891

0.984

Table D-5. Overall long counter efficiency at the position and nominal neutron energies
used.

Nominal Neutron Energy keV

Relative efficiency (=1 at E >
1.5 MeV)

90

0.007158

140

0.007229

165

0.007262

196

0.007297

230

0.007348

350

0.007498

891

0.008197
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APPENDIX E

ESTIMATE

OF

MOATA

TC-10

NEUTRON

EPITHERMAL FLUX

The cadmium ratio, RCd is the ratio of activities of bare and cadmium covered
foils irradiated under the same conditions:

RCd =

Activation Bare
ActivationCd cov ered

E-1

If the spectrum is considered to consist of a Maxwellian thermal component
and a 1/E slowing down component the reaction rate R can be represented as:
R = σ oφ o + Iθ

E-2

Where σo is the thermal cross section, φo is the thermal fluence, I is the
resonance integral and θ is the flux per unit lethargy. The resonance integral I is just:
E2

I=

∫

σ ( E )dE

E1

E-3

E

Where the limit E1 is generally taken as the cadmium cutoff (about 0.55eV for
1mm thick Cd), and E2 is an upper limit of 2 MeV.
From

RCd =

Activation Bare
ActivationCd cov ered

E-1

And
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R = σ oφ o + Iθ

E-2

the cadmium ratio can be written as:

RCd =

σ oφ o + Iθ
Iθ

E-4

Therefore

θ=

σ oφ o

E-5

I ( RCd − 1)

For simple approximate calculations the resonance integral can be considered
to be made up of two components, the resonance part and the 1/v part upon which the
resonance component is superpositioned, i.e.:

I = I1 / v + I r

E-6

For Au197 the total measured resonance integral is 1558 barns. The 4.9 eV
resonance component Ir1 is 1180 barns and the 61 eV resonance component Ir2 is 36
barns. The total resonance component Ir is thus 1216 barns. Therefore the 1/v
component I1/v is 342 barns. The resonance integral must be corrected for self
shielding effects. The self shielding correction is applied to the resonance part of the
integral. For 20 µm gold foils in a 1/E spectrum the selfshielding factor for the
resonance part of the spectrum is approximately 0.4. When this is applied to Ir1 and Ir2
323

the total effective I becomes 828 barns. The thermal cross section, σo, is taken as 98
barns. When the corrected value of I and the measured RCd of 38 is substituted into
equation E-5 we get an expression for the flux per unit lethargy at ~ 5 eV (for a Au197
foil) in terms of the known thermal flux.

θ=

φo

E-7
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Therefore in first decade (1 eV – 10 eV) the epithermal flux is approximately
2.3φo/313, and from 10 eV – 100 eV approximately 0.23φo/313 and similarly for the
remainder of the epithermal spectrum. (N.B. 2.3 lethargy units per decade.) This gives
a total epithermal fluence of approximately 0.00816φo.
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APPENDIX F

FOIL ACTIVATION DATA

Table F-1. Gold foil measured activation in the cylinder phantom exposed in HB11 epithermal neutron beam.
Foil type

Foil #

AU
AU
AU
AU
AU
AU
AU
AU
AU
AU
AU
AU
AU
AU
AU
AU
AU
AU
AU
AU
AU
Continued next page …

2
13
19
51
53
50
52
47
32
48
33
22
15
28
35
45
37
44
4
5
29

Activity (Bq)

Mass (mg)

Bq/mg

Bq/atom

Exposure time
(minutes)

Sat Act (Bq)

Depth (cm)

Cover

3.29E+03
7.39E+03
4.17E+02
1.88E+03
1.12E+04
8.44E+03
4.47E+03
1.94E+03
6.63E+03
1.55E+03
4.68E+03
7.23E+02
3.43E+03
1.07E+02
1.45E+04
4.35E+03
1.29E+04
9.33E+02
1.54E+04
4.48E+03
1.61E+04

16.44
15.06
16.58
16.81
16.46
17.09
17.32
16.35
16.96
17.05
16.88
6.6
14.49
6.18
15.44
16.08
15.66
17.08
16.65
15.11
17.04

2.00E+02
4.91E+02
2.52E+01
1.12E+02
6.82E+02
4.94E+02
2.58E+02
1.19E+02
3.91E+02
9.08E+01
2.77E+02
1.09E+02
2.37E+02
1.73E+01
9.38E+02
2.71E+02
8.26E+02
5.46E+01
9.27E+02
2.96E+02
9.43E+02

6.55E-17
1.60E-16
8.23E-18
3.66E-17
2.23E-16
1.62E-16
8.45E-17
3.88E-17
1.28E-16
2.97E-17
9.06E-17
3.58E-17
7.74E-17
5.65E-18
3.07E-16
8.85E-17
2.70E-16
1.79E-17
3.03E-16
9.70E-17
3.09E-16

15
15
15
15
15
15
15
15
15
15
15
15
15
15
20.15
20.15
60.4666
60.4666
20
20
20.0666

2.44555E-14
5.99412E-14
3.07572E-15
1.36815E-14
8.33743E-14
6.03507E-14
3.15597E-14
1.4485E-14
4.77428E-14
1.1095E-14
3.3852E-14
1.33775E-14
2.8902E-14
2.11186E-15
8.53531E-14
2.46321E-14
2.5132E-14
1.66306E-15
8.50297E-14
2.71864E-14
8.61872E-14

2
4
6
8
2
4
6
8
4
8
2
4
6
8
2
2
7
7
2
2
2

cd
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cd

cd
cd
cd
cd
cd

Table F-1. Continued. (Gold foil measured activation in the cylinder phantom exposed in HB11 epithermal neutron beam.)
Foil type

Foil #

Activity (Bq)

Mass (mg)

Bq/mg

Bq/atom

Exposure time
(minutes)

Sat Act (Bq)

Depth (cm)

Cover

AU
AU
AU
AU
AU

46
18
20
93
105

4.47E+03
1.44E+04
4.37E+03
8.46E+02
7.38E+02

17
16.29
16.43
3.758
3.287

2.63E+02
8.85E+02
2.66E+02
2.25E+02
2.24E+02

8.61E-17
2.90E-16
8.69E-17
7.37E-17
7.34E-17

20.0666
20.0166
20.0166
20.0166
20.0166

2.40516E-14
8.11002E-14
2.43458E-14
2.06322E-14
2.05644E-14

2
2
2
2
2

cd

Cover

cd
Li
Li

Table F-2. Copper and Manganese foil measured activation in the cylinder phantom exposed in HB11 epithermal neutron beam.
Foil type

Foil #

Activity (Bq)

Mass (mg)

Bq/mg

Bq/atom

Exposure time
(minutes)

Sat Act (Bq)

Depth (cm)

CU
CU
CU
CU

2
10
15
11

1.53E+04
8.00E+02
1.41E+04
1.22E+02

13.287
13.347
13.449
13.407

1.15E+03
5.99E+01
1.05E+03
9.07E+00

1.22E-16
6.37E-18
1.12E-16
9.64E-19

68.58333
68.58333
180.01666
180.01666

2.04867E-15
1.06848E-16
7.49382E-16
6.46924E-18

2
2
7
7

MN
MN
MN
MN

3
6
22
17

7.10E+05
3.72E+04
5.47E+05
5.10E+03

30.64
30.91
30.7
30.21

2.32E+04
1.20E+03
1.78E+04
1.69E+02

2.11E-15
1.10E-16
1.63E-15
1.54E-17

68.58333
68.58333
180.01666
180.0167

7.99969E-15
4.15994E-16
2.93999E-15
2.78551E-17

2
2
7
7
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cd
cd

cd
cd

Table F-3. Gold foil measured activation in the NKI PMMA cube phantom exposed in HB11 epithermal neutron beam.
Foil type

Foil #

Activity (Bq)

Mass (mg)

Bq/mg

Bq/atom

Exposure time
(minutes)

Sat Act (Bq)

Depth (cm)

AU
AU
AU
AU

x
83
98
200

9.66E+03
2.13E+03
2.81E+03
4.56E+03

12.45
3.726
3.192
12.076

7.76E+02
5.72E+02
8.82E+02
3.78E+02

2.54E-16
1.87E-16
2.88E-16
1.24E-16

15.1666
30.0333
25.73333
29.51666

9.37E-14
3.5E-14
6.29E-14
2.35E-14

2
2
5
8

Cover

cd

Table F-4. Bare gold foil measured activation in the skull phantom exposed in HB11 epithermal neutron beam.
Foil type

Foil #

Activity (Bq)

Mass (mg)

Bq/mg

Bq/atom

Exposure time
(minutes)

Sat Act (Bq)

Position in
phantom

AU
AU
AU
AU
AU
AU
AU
AU
AU
AU
AU
AU
AU
AU

34b
24
49
6
31
76
21
9
7
36
27
128
30
38

1.99E+04
6.74E+03
5.20E+03
1.77E+03
6.32E+03
8.62E+03
4.08E+03
9.04E+03
7.23E+03
8.64E+03
4.11E+03
9.31E+03
8.33E+03
6.38E+03

16.970
6.450
16.300
15.315
15.902
16.168
6.430
16.642
16.592
17.078
6.570
16.455
16.967
16.748

1.18E+03
1.05E+03
3.19E+02
1.16E+02
3.97E+02
5.33E+02
6.34E+02
5.43E+02
4.36E+02
5.06E+02
6.25E+02
5.66E+02
4.91E+02
3.81E+02

3.84E-16
3.42E-16
1.04E-16
3.78E-17
1.30E-16
1.74E-16
2.07E-16
1.78E-16
1.43E-16
1.66E-16
2.05E-16
1.85E-16
1.61E-16
1.25E-16

29.9666
29.9666
29.9666
29.9666
29.9666
29.9666
29.9666
29.9666
29.9666
29.9666
29.9666
29.9666
29.9666
29.9666

7.19714E-14
6.40339E-14
1.95441E-14
7.07501E-15
2.43396E-14
3.26488E-14
3.88466E-14
3.3261E-14
2.66978E-14
3.09987E-14
3.82985E-14
3.46477E-14
3.00716E-14
2.33332E-14

a1
a2
a3
a4
h1
h2
h3
h4
h5
v1
v2
v3
v4
v5
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Table F-5. Cadmium covered gold foil measured activation in the skull phantom exposed in HB11 epithermal neutron beam.
Foil type

Foil #

Activity (Bq)

Mass (mg)

Bq/mg

Bq/atom

Exposure time
(minutes)

Sat Act (Bq)

Position in
phantom

AU
AU
AU
AU
AU
AU
AU
AU
AU
AU
AU
AU
AU

16b
11
41
14
75
87
16a
82
84
80
97
34a
101

5.71E+03
7.10E+03
1.29E+03
4.47E+02
1.19E+03
1.18E+03
9.75E+02
1.18E+03
1.57E+03
1.30E+03
1.19E+03
8.03E+02
5.74E+02

4.330
14.505
16.402
16.600
3.709
3.605
3.465
3.710
3.805
3.400
4.100
3.770
3.390

1.32E+03
4.89E+02
7.86E+01
2.70E+01
3.22E+02
3.28E+02
2.81E+02
3.17E+02
4.11E+02
3.84E+02
2.90E+02
2.13E+02
1.69E+02

4.32E-16
1.60E-16
2.57E-17
8.82E-18
1.05E-16
1.07E-16
9.21E-17
1.04E-16
1.35E-16
1.25E-16
9.47E-17
6.97E-17
5.54E-17

84.65
84.65
84.65
84.65
84.65
84.65
84.65
84.65
84.65
84.65
84.65
84.65
84.65

2.87E-14
1.07E-14
1.71E-15
5.87E-16
7.00E-15
7.14E-15
6.13E-15
6.92E-15
8.96E-15
8.35E-15
6.31E-15
4.63E-15
3.68E-15

a1
a2
a3
a4
h1
h2
h3
h4
h5
v1
v2
v3
v4

328

REFERENCES

1

Solares GR, Cano G, Palano J, Zamenhof R, “High resolution quantitative
autoradiography and its application to microdosimetry of boron neutron capture
therapy”, in “Topics in Dosimetry and treatment planning for neutron capture
therapy” edited by Zamenhof R, Solares G and Harling O, Advanced Medical
Publishing Madison, Wiosconsin 1994, pp13-27.

2

Charlton DE, Allen BJ, “Monte carlo Calculations of Ion Passages Through
Brain Endothelial nuclei During Boron Neutron Capture Therapy”, Int. J.
Radiat. Biol, 1993, 64:6, pp739-747.

3

Ziegler JF, 1992, TRIM Version ‘92 (Yorktown , IBM Research).

4

ICRU (1989) International Commission on Radiation Units and Measurements,
Tissue Substitutes in radiation Dosimetry and Measurement, ICRU Report 44
(International Commission on Radiation Units, Bethesda, Maryland).

5

Thermal Neutron Cross Sections downloaded from XS averaged from
JENDL3.2,

Courtesy

of

T.Nakagawa

at

JAERI

accessed

via

http://www.dne.bnl.gov/CoN/ on 11 Apr 2001.
6

Blue TE, Gupta N, Woollard JE, “A calculation of the energy dependence of
the RBE of neutrons”, Phys Med Biol 1993 (38):1693-1712.

7

Moss RL, “Review of Reactor Based Neutron Beam Development for BNCT
Applications” in Advances in Neutron Capture Therapy edited by Soloway AH
et al, Plenum Press, New York, 1993, pp1-7.

8

Storr GJ, “Assessment of Ideal Neutron beams for Neutron Capture Therapy”,
Rad. Res. 131, pp235-242 (1992).

9

Yanch JC, Harling OK, “A Monte Carlo Study of Ideal Beams for Epithermal
Neutron Beam Development for Boron Neutron Capture Therapy” in Progress
in Neutron Capture Therapy for Cancer edited by Allen BJ et al, Plenum Press
New York 1992, pp 133-136.
329

10

Choi JR, Clement SD, Harling OK, Zamenhof RG, “Neutron Capture Therapy
Beams at the MIT Research Reactor” in Neutron Beam Design, Development,
and Performance for Neutron Capture Therapy, edited by Harling OK et al,
Plenum Press New York 1990. pp 201 - 218.

11

Yanch JC, Zhou XL, Brownell GL, “A Monte Carlo Investigation of the
Dosimetric Properties of Monoenergetic Neutron Beams for Neutron Capture
Therapy” Rad. Res., 126:1-20, 1991.

12

Wallace SA, Allen BJ, Mathur JN, “Monte Carlo calculations of epithermal
boron neutron capture therapy with heavy water”, Phys Med Biol,

1995

Oct;40(10):1599-608
13

____________, Current status of neutron capture therapy, May 2001, IAEATECDOC-1223, IAEA Vienna 2001.

14

Greenwood RC, “The design of Filtered Epithermal Neutron Beams for
BNCT” in “Workshop on NCT”, BNL Jan 1986, pp123-142, BNL-51994.

15

Choi JR, Clement SD, Harling OK, Zamenhof RG, “Neutron Capture Therapy
Beams at the MIT Research Reactor” in “Neutron Beam Design, Development,
and Performance for Neutron Capture Therapy”, Edited by OK Harling et al
Plenum Press NY 1990, pp201-218.

16

Ross D, Constantine G, Weaver DR, Beynon TD, “Designing an epithermal
neutron beam for boron neutron capture therapy for a DIDO type reactor using
MCNP”, Nucl Instr & Meth, 1993, A334:596-606.

17

Liu HB, Brugger RM, Rorer DC, Tichler PR, Hu JP, “Design of a high flux
epithermal neutron beam using 235U fission plates at the Brookhaven Medical
Research Reactor”, Med Phys, 1994, 21(10):1627-1631.

18

Wangler TP, Stokes RH, “The radio frequency quadrapole linear accelerator”,
1981, IEEE Trans Nucl Sci NS-28(2):1494-1499.

330

19

Wu TH, Brugger RM, Kunze JF, “Low Energy Accelerator Based Neutron
Sources for Neutron Capture Therapy in Advances in Neutron Capture Therapy
edited by Soloway AH et al, Plenum Press, New York, 1993, pp 105-108.

20

Dolan TJ, Ottewitte, EH, Wills EE, Neuman WA, Woodal DM, “Non Reactor
Neutron Sources for BNCT”, EGG-BNCT-8319.

21

Brugger R, Kunze J, “Performance Report: Accelerator based epithermal
neutron source for neutron capture therapy”, (1991), DOE/ER/13035—T2, DEFG07-90ER13035.

22

Yanch JC, Shefer RE, Hughey BJ, Klinkowstein, “Accelerator Based
Epithermal Neutron Beams for Neutron Capture Therapy” in Advances in
Neutron Capture Therapy edited by Soloway AH et al, Plenum Press, New
York, 1993, pp 95 - 98.

23

Allen DA, Beynon TD, “What is the best proton energy for accelerator-based
BNCT using the 7Li(p,n)7Be reaction?”, Med Phys 2000 May;27(5):1113-8

24

Zimin S, Allen BJ. “Evaluation of useful neutron flux for accelerator boron
neutron capture therapy using the 7Li(p,n) reaction”, Australas Phys Eng Sci
Med 1998 Dec;21(4):193-9.

25

Lee CL, Zhou XL, Kudchadker RJ, Harmon F, Harker YD, “A Monte Carlo
dosimetry-based evaluation of the 7Li(p,n)7Be reaction near threshold for
accelerator boron neutron capture therapy”, Med Phys 2000 Jan;27(1):192202.

26

Tanaka K, Kobayashi T, Sakurai Y, Nakagawa Y, Ishikawa M, Hoshi M.
“Irradiation characteristics of BNCT using near-threshold 7Li(p, n)7Be direct
neutrons: application to intra-operative BNCT for malignant brain tumours”
Phys Med Biol 2002 Aug 21;47(16):3011-32

27

Gierga DP, Yanch JC, Shefer RE, “An investigation of the feasibility of
gadolinium for neutron capthure synovectomy”, 2000, Med Phys 27(7) 16851692.
331

28

Howard WB, Yanch JC, Grimes SM, Massey TN, Al-Quaraishi, Jacobs DK,
Brent CE, “Measurement of the 9Be(p,n) thick target spectrum for use in
accelerator based BNCT” , 1996, Med Phys 23 :1233-1235.

29

Wang CKC, Moore BR, “Thick Beryllium target as an epithermal neutron
source for neutron capture therapy”, Med Phys 1994, 21(10):1633-1638.

30

Randers-Pehrson G, Brenner DJ, “A practical target system for acceleratorbased BNCT which may effectively double the dose rate”,Med Phys 1998
Jun;25(6):894-6.

31

Colonna N, Beaulieu L, Phair L, Wozniak GJ, Moretto LG, Chu WT, Ludewigt
BA, “Measurements of low-energy (d,n) reactions for BNCT. Boron Neutron
Capture Therapy”, Med Phys 1999 May;26(5):793-8.

32

Burlon AA, Kreiner AJ, White SM, Blackburn BW, Gierga DP, Yanch JC, “Inphantom dosimetry for the 13C(d,n)14N reaction as a source for acceleratorbased BNCT”, Med Phys 2001 May;28(5):796-803.

33

Yanch JC, Kim JK, Wilson MJ. Design of a californium-based epithermal
neutron beam for neutron capture therapy. Phys Med Biol

1993

Aug;38(8):1145-55
34

Yanch JC, Zamenhof RG, “Dosimetry of 252Cf source for neutron
radiotherapy with and without augmentation by boron neutron capture
therapy”, Radiation Research, 1992, (131):249-256.

35

Laramore GE, Wootton P, Livesey JC et al, “Boron Neutron Capture Therapy:
A mechanism for achieving a concomitant tumour boost in fast neutron
radiotherapy”, Int J Radiation Oncology Biol Phys 28(5):1135-1142.

36

Paquis P, Pignol JP, Breteau N., “Radiotherapy of high grade glioma: use of
fast neutrons, therapy and enhancement by neutron capture”, Neurochirurgie,
2000 Feb;46(1):23-33.

332

37

Burmeister J, Kota C, Maughan RL. “Dosimetry of the boron neutron capture
reaction for BNCT and BNCEFNT”, Strahlenther Onkol 1999 Jun;175 Suppl
2:115-8

38

Burmeister J, Kota C, Maughan RL, Waker AJ, “Miniature tissue-equivalent
proportional counters for BNCT and BNCEFNT dosimetry”, Med Phys 2001
Sep;28(9):1911-25.

39

Kota C, Maughan RL, Tattam D, Beynon TD. “Use of low-pressure tissue
equivalent proportional counters for the dosimetry of neutron beams used in
BNCT and BNCEFNT”, Med Phys 2000 Mar;27(3):535-48.

40

Maughan RL, “An update on Neutron Radiotherapy” in “Teletherapy Past and
Present: Proceedings of the 1996 AAPM Summer School” edited by Mackie
TR, Palta JR, Advanced Medical Publishing, Madison Wisconson. pp723-759.

41

Nigg DW, Wemple CA, Risler R, Hartwell JK, Harker YD, Laramore GE,
“Modification of the University of Washington Neutron Radiotherapy Facility
for optimization of neutron capture enhanced fast-neutron therapy”, Med Phys
2000 Feb;27(2):359-67.

42

Rogus RD, Harling OK, Yanch JC, “Mixed field dosimetry of epithermal
neutron beams for boron neutron capture therapy at the MITR-II research
reactor”, Med Phys,1994, 21(10):1611-1625.

43

Raaijmakers CPJ, Watkins PRD, Nottelman EL, Verhagen HW, Jansen JTM,
Zoetelief J, Mijnheer BJ, “The neutron sensitivity of dosimeters applied to
boron neutron capture therapy”, Med Phys, 1996, 23(9):1581-1589.

44

Martsolf SW, Johnson JE, Vostmyer CE, Albertson BD, Binney SE. “Practical
considerations for TLD-400/700-based gamma ray dosimetry for BNCT
applications in a high thermal neutron fluence”, Health Phys

1995

Dec;69(6):966-70
45

Gambarini G, Agosteo S, Marchesi P, Nava E, Palazzi P, Pecci A, Rosi G,
Tinti R.Appl Radiat Isot, “Discrimination of various contributions to the
333

absorbed dose in BNCT: Fricke-gel imaging and intercomparison with other
experimental results”, 2000 Oct-Nov;53(4-5):765-72
46

Gambarini G, Monti D, Fumagalli ML, Birattari C, Salvadori P. “Phantom
dosimeters examined by NMR analysis: a promising technique for 3-D
determinations of absorbed dose”, Appl Radiat Isot, 1997 Oct-Dec;48(1012):1477-84

47

Farajollahi AR, Bonnett DE, Tattam D, Green S, “The potential use of polymer
gel dosimetry in boron neutron capture therapy”, Phys Med Biol, 2000, 45:N9N14.

48

Bond VP, Laster BH, Wielopolski, “The equal effectiveness ratio:a quantitative
approach to the evaluation of compounds for boron neutron capture therapy”,
Radiation Res, 1995, 141:287-293.

49

Barendsen GW, “The relationships between RBE and LET for different types
of lethal damage in mammalian cells: biophysical and molecular mechanisms”,
Radiation Res, 1994, 139:257-270.

50

Blue TE, Gupta N, Woollard JE, “A calculation of the energy dependence of
the RBE of neutrons”, Phys Med Biol, 1993, 38:1693-1712.

51

Woollard JE, Blue TE, Gupta N, Gahbauer RA. “Development and calculation
of an energy dependent normal brain tissue neutron RBE for evaluating neutron
fields for BNCT” Health Phys 2001 Jun;80(6):583-9

52

Beck-Bornholdt HP, “Quantification of relative biological effectiveness, dose
modification factor and therapeutic gain factor”, Strahlenther. Onkol., 1993,
169:42-47.

53

Allen BJ. “Dose modification factors in boron neutron capture therapy”,
Strahlenther Onkol 1993 Jan;169(1):29-33

54

Coderre JA, Morris GM, “The radiation biology of Boron Neutron Capture
Therapy”, Radiat Res, 1999, 151:1-18

334

55

Fukuda H, Hiratsuka J, Honda C et al, “Boron neutron capture therapy of
malignat melanoma using

10

B-paraboronophenylalanine with special reference

to evaluation of radiation dose and damage to the skin” Radiat Res 1994,
138:435-442.
56

Fike JR, Gobbel GT, “Central nervous system radiation injury in large animal
models” in “Radiation Injury to the Nervous System” edited by Gutin PH,
Leibel SA and Sheline GE, Raven Press Ltd New York 1991, pp 113-135.

57

Burger PC, Boyko OB, “The pathology of central nervous system radiation
injury”, in “Radiation Injury to the Nervous System” edited by Gutin PH,
Leibel SA and Sheline GE, Raven Press Ltd New York 1991, pp 191-208.

58

Morris GM, Coderre JA, Whitehouse EM, Micca P, Hopewell JW. ‘Boron
neutron capture therapy: a guide to the understanding of the pathogenesis of
late radiation damage to the rat spinal cord” Int J Radiat Oncol Biol Phys 1994
Mar 30;28(5):1107-12

59

Warren BA, “The Vascular morphology of Tumours” in Tumor Blood
Circulation: Angiogenesis, Vascular Morphology and Blood Flow of
Experimental and Human Tumors”, Edited by HI Peterson, CRC Press, Florida.
pp 1-47.

60

Stewart PA, Farrell CL, Del Maestro RF, “The effect of cellular
microenvironment on vessels in the brain. Part 1: Vessel structure in tumour,
peritumour and brain from humans with malignant glioma”, Int J Radiat Biol,
1991, 60(1/2):125-130.

61

Farrell, Cl, Farrell CR, Stewart PA, Del Maestro RF, Ellis CG, “The functional
microcirculation in a glioma model”, Int J Radiat Biol,1991, 60(1/2):131-137.

62

Morris GM, Coderre JA, Hopewell JW, et al, “Response of the central nervous
system to boron neutron capture irradiation: evaluation using rat spinal cord
model”, Radiother Oncol, 1994, 32:249-255.

335

63

Morris GM, Coderre JA, et al “Boron neutron capture irradiation of the rat
spinal cord: effects of variable doses of borocaptate sodium”, Radiother Oncol
1996, 39:253-259.

64

Barendsen GW, “Influence of fractionation on normal tissue tolerance”, in
“Radiation Injury to the Nervous System” edited by Gutin PH, Leibel SA and
Sheline GE, Raven Press Ltd New York 1991, pp 57-67.

65

Hall EJ, “A determination of oxygen enhancement ratio for 252Cf using
cultured mammalian cells”, Brit J Radiol, 1972, 45:284.

66

Jain RK, “Determinants of Tumor Blood Flow: A Review”, Cancer Research
1988, 48:2641-2658.

67

Gregoire V, Sindic C, Gahbauer RA, Wambersie A. “Alteration of the bloodbrain barrier after irradiation: implication in boron neutron capture therapy”
Strahlenther Onkol 1993 Sep;169(9):534-42

68

Morris GM, Micca PL, Rezvani M, Hopewell JW, Coderre JA. “Boron neutron
capture therapy: effects of split dose and overall treatment time” J Neurooncol
2001 Apr;52(2):101-10

69

Zaider M, Rossi HH, “The synergistic effects of different radiations”, Radiat
Res, 1980, 83:732-739.

70

Kellerer AM, Rossi HH, “A generalized formulation of dual radiation action”,
Radiation Res, 1978, 75:471-488.

71

Suzuki S, “Survival of chinese hampster V79 cells after irradiation with a
mixture of neutrons and

60

Co γ rays: experimental and theoretical analysis of

mixed irradiation”, Radiation Res, 1993, 133:327-333.
72

McNally NJ, Ronde J, Folkard M, “Interaction between x-ray and α particle
damage in V79 cells”, Int J Radiat Biol 1988, 53(6):917-920.

73

Zaider M, Wuu CS, “The biological effects of mixed radiation fields on cellular
systems of variable radiosensitivity (OER and cell cycle stage)”, in “Topics in
Dosimetry and treatment planning for neutron capture therapy” edited by
336

Zamenhof R, Solares G and Harling O, Advanced Medical Publishing
Madison, Wiosconsin 1994, pp55-66.
74

Haselsberger K, Radner H, Gossler W, Schlagenhaufen C, Pendl G.
“Subcellular boron-10 localization in glioblastoma for boron neutron capture
therapy with Na2B12H11SH” J Neurosurg 1994 Nov;81(5):741-4

75

Haritz D, Gabel D, Huiskamp R. “Clinical phase-I study of Na2B12H11SH
(BSH) in patients with malignant glioma as precondition for boron neutron
capture therapy (BNCT)” Int J Radiat Oncol Biol Phys

1994 Mar

30;28(5):1175-81
76

Mallesch JL, Moore DE, Allen BJ, et al, “The pharmacokinetics of pboronophenylalanine.fructose in human patients with glioma and metastatic
melanoma”, Int. J. Rad. Oncol. Biol. Phys. 28:5, pp1183-1188, 1994.

77

Kiger WS, Palmer MR, Riley KJ, Zamenhof RG, Busse PM. “A
Pharmacokinetic Model for the Concentration of 10B in Blood after
Boronophenylalanine-Fructose Administration in Humans” Radiat Res 2001
Apr;155(4):611-618

78

Ryynanen P, Kangasmaki A, Hiismaki P, Coderre J, Diaz AZ, Kallio M,
Laakso J, Kulvik M, Savolainen S. “Non-linear model for the kinetics of 10B
in blood after BPA-fructose complex infusion” Phys Med Biol

2002

47(5):737-45
79

Kubota R, Yamada S, Ishiwata K, Tada M, Ido T, Kubota K. “Cellular
accumulation of 18F-labelled boronophenylalanine depending on DNA
synthesis and melanin incorporation: a double-tracer microautoradiographic
study of B16 melanomas in vivo” Br J Cancer 1993 Apr;67(4):701-5

80

Ono K, Masunaga SI, Kinashi Y, Takagaki M, Akaboshi M, Kobayashi T,
Akuta

K.

“Radiobiological

evidence

suggesting

heterogeneous

microdistribution of boron compounds in tumors: its relation to quiescent cell
population and tumor cure in neutron capture therapy” Int J Radiat Oncol Biol
Phys 1996 Mar 15;34(5):1081-6
337

81

Wyzlic IM, Tjarks W, Soloway AH, Anisuzzaman AK, Rong FG, Barth RF.
“Strategies for the design and synthesis of boronated nucleic acid and protein
components as potential delivery agents for neutron capture therapy” Int J
Radiat Oncol Biol Phys 1994 Mar 30;28(5):1203-13

82

Liu L, Barth RF, Adams DM, Soloway AH, Reisfeld RA. “Critical evaluation
of bispecific antibodies as targeting agents for boron neutron capture therapy of
brain tumors” Anticancer Res 1996 Sep-Oct;16(5A):2581-7

83

Novick S, Quastel MR, Marcus S, Chipman D, Shani G, Barth RF, Soloway
AH. “Linkage of boronated polylysine to glycoside moieties of polyclonal
antibody; boronated antibodies as potential delivery agents for neutron capture
therapy”. Nucl Med Biol 2002 Feb;29(2):159-67

84

Yanagie H, Tomita T, Kobayashi H, Fujii Y, Nonaka Y, Saegusa Y, Hasumi K,
Eriguchi M, Kobayashi T, Ono K. “Inhibition of human pancreatic cancer
growth in nude mice by boron neutron capture therapy” Br J Cancer
1997;75(5):660-5

85

Barth RF, Yang W, Rotaru JH, Moeschberger ML, Boesel CP, Soloway AH,
Joel DD, Nawrocky MM, Ono K, Goodman JH. “Boron neutron capture
therapy of brain tumors: enhanced survival and cure following blood-brain
barrier disruption and intracarotid injection of sodium borocaptate and
boronophenylalanine” Int J Radiat Oncol Biol Phys 2000 Apr 1;47(1):209-18

86

Barth RF, Yang W, Bartus RT, Rotaru JH, Ferketich AK, Moeschberger ML,
Nawrocky MM, Coderre JA, Rofstad EK. “Neutron capture therapy of
intracerebral melanoma: enhanced survival and cure after blood-brain barrier
opening to improve delivery of boronophenylalanine” Int J Radiat Oncol Biol
Phys 2002 Mar 1;52(3):858-68

87

Yang W, Barth RF, Rotaru JH, Boesel CP, Wilkie DA, Bresnahan JC,
Hadjiconstantinou M, Goettl VM, Joel DD, Nawrocky MM. “Boron neutron
capture therapy of brain tumors: functional and neuropathologic effects of

338

blood-brain barrier disruption and intracarotid injection of sodium borocaptate
and boronophenylalanine” J Neurooncol 2000 Jul;48(3):179-90
88

Nichols TL, Kabalka GW, Miller LF, Khan MK, Smith GT. Improved
treatment planning for boron neutron capture therapy for glioblastoma
multiforme using fluorine-18 labeled boronophenylalanine and positron
emission tomography. Med Phys 2002 Oct;29(10):2351-8

89

J. Capala, R. Ma, A.Z. Diaz, A.D. Chanana, J.A. Coderre “Implementation of
BNCT treatment planning procedures” In IAEA-TECDOC-1223, “Current
status of neutron capture therapy.” Vienna: International Atomic Energy
Agency; 2001. p. 206-215.

90

R.G. Zamenhof, M.R. Palmer, P.M. Busse “Clinical treatment planning for
subjects undergoing boron neutron capture therapy at Harvard-MIT” In IAEATECDOC-1223, “Current status of neutron capture therapy.” Vienna:
International Atomic Energy Agency; 2001. p. 206-215.

91

Zamenhof R, Redmond E, Solares G et al “Monte Carlo based treatment
planning for boron neutron capture therapy using custom designed models
automatically generated from CT data”, Int J Radiation Oncology Biol Phys
35(2):383-397.

92

Harling OK, Rogus R, Choi JR, Moulin DJ, Zamenhof RG, Yanck JC,
“Dosimetry and dose control for clinical trials of neutron capture therapy at the
MITR_II reactor” in “Topics in dosimetry an treatment planning for neutron
capture therapy”, Zamenhof RG, Solares G, Harling O, Editors, Advanced
Medical Publishing, Madison Wisconsin 1994.

93

Wojnecki C, Green S. “A preliminary comparative study of two treatment
planning systems developed for boron neutron capture therapy: MacNCTPlan
and SERA” Med Phys 2002 Aug;29(8):1710-5

94

See

detailed

online

manual

that

http://www.cs.montana.edu/~bnct/

339

can

be

accessed

at:

95

Kotiluoto P, Hiisamaki P, Savolainen S. “Application of the new MultiTrans
SP3 radiation transport code in BNCT dose planning” Med Phys

2001

Sep;28(9):1905-10
96

Albertson BJ, Blue TE, Niemkiewicz J. “An investigation on the use of
removal-diffusion theory for BNCT treatment planning: a method for
determining proper removal-diffusion parameters” Med Phys

2001

Sep;28(9):1898-904
97

Sauerwein W, Zurlo A, "The EORTC Boron Neutron Capture Therapy (BNCT)
Group: achievements and future projects", Eur J Cancer 2002 Mar;38 Suppl
4:S31-4

98

Smilowitz HM, Micca PL, Nawrocky MM, Slatkin DN, Tu W, Coderre JA.
"The combination of boron neutron-capture therapy and immunoprophylaxis
for advanced intracerebral gliosarcomas in rats", J Neurooncol 2000;46(3):23140

99

Diaz AZ, Coderre JA, Chanana AD, Ma R, "Boron neutron capture therapy for
malignant gliomas", Ann Med 2000 Feb;32(1):81-5

100

Hideghety K, Sauerwein W, Haselsberger K, Grochulla F, Fankhauser H, Moss
R,Huiskamp R, Gabel D, de Vries M. "Postoperative treatment of glioblastoma
with BNCT at the Petten irradiation facility (EORTC protocol 11,961)"
Strahlenther Onkol 1999 Jun;175 Suppl 2:111-4

101

Barth RF, Yang W, Bartus RT, Rotaru JH, Ferketich AK, Moeschberger ML,
Nawrocky MM, Coderre JA, Rofstad EK., "Neutron capture therapy of
intracerebral melanoma: enhanced survival and cure after blood-brain barrier
opening to improve delivery of boronophenylalanine", Int J Radiat Oncol Biol
Phys 2002 Mar 1;52(3):858-68

102

Fukuda H, Honda C, Wadabayashi N, Kobayashi T, Yoshino K, Hiratsuka J,
Takahashi J, Akaizawa T, Abe Y, Ichihashi M, Mishima Y. "Pharmacokinetics
of 10B-p-boronophenylalanine in tumours, skin and blood of melanoma

340

patients: a study of boron neutron capture therapy for malignant melanoma"
Melanoma Res 1999 Feb;9(1):75-83
103

Dagrosa MA, Viaggi M, Kreimann E, Farias S, Garavaglia R, Agote M,
Cabrini RL,Dadino JL, Juvenal GJ, Pisarev MA. "Selective uptake of pborophenylalanine by undifferentiated thyroid carcinoma for boron neutron
capture therapy", Thyroid 2002 Jan;12(1):7-12

104

Miura M, Morris GM, Micca PL, Lombardo DT, Youngs KM, Kalef-Ezra JA,
Hoch DA,Slatkin DN, Ma R, Coderre JA., "Boron Neutron Capture Therapy of
a

Murine

Mammary

Carcinoma

using

a

Lipophilic

Carboranyltetraphenylporphyrin", Radiat Res 2001 Apr;155(4):603-610
105

Allen BJ, Wallace SA, Carolan MG, “Can epithermal BNCT treat primary and
metastatic liver cancer?” in Advances in NCT, vol 1, B Larsson, J Crawford, R
Weinreich, Elsevier Science 1997 pp.118-121.

106

Yanagie H, Tomita T, Kobayashi H, Fujii Y, Nonaka Y, Saegusa Y, Hasumi
K,Eriguchi M, Kobayashi T, Ono K. "Inhibition of human pancreatic cancer
growth in nude mice by boron neutron capture therapy", Br J Cancer
1997;75(5):660-5

107

De Vita, Hall, Cancer: Principles and Practice of Oncology, 6th Edition,
Lippincott Williams & Wilkins

108

Nelson JS, Tsukada Y, Shoenfeld D et al, "Necrosis as a prognostic criterion in
malignant supratentorial astrocytic gliomas", Cancer 52(3): 550-554, 1983.

109

Barth RF, Soloway AH, Fairchild RG, “Boron Neutron Capture Therapy for
Cancer”, Scientific American, October 1990, pp100-107.

110

Sweet WH., “Early history of development of boron neutron capture therapy of
tumors” J Neurooncol 1997 May;33(1-2):19-26

111

Fairchild RG, Benary V, Kalef-Ezra J, et al “An Optimised Epithermal Neutron
Beam for Neutron Capture Therapy (NCT) at the Brookhaven Medical
Research Reactor (BMRR)” in Progress in Neutron Capture Therapy for
Cancer edited by Allen BJ, et al, Plenum Press New York 1992, pp1-6.
341

112

Barth RF, Soloway AH, Fairchild RG, Brugger RM, “Boron Neutron Capture
Therapy for Cancer”, Cancer 1995 70:12, pp2995-3007.

113

Hatanaka H, Sano K, Yasukochi H, “Clinical results of Boron Neutron Capture
Therapy” in Progress in Neutron Capture Therapy for Cancer edited by Allen
BJ, et al, Plenum Press New York 1992, pp 561-568.

114

Hideghety K, Sauerwein W, Haselsberger K, Grochulla F, Fankhauser H, Moss
R, Huiskamp R, Gabel D, de Vries M. “Postoperative treatment of
glioblastoma with BNCT at the petten irradiation facility (EORTC protocol
11,961)” Strahlenther Onkol 1999 Jun;175 Suppl 2:111-4

115

Sauerwein W, Zurlo A; EORTC Boron Neutron Capture Therapy Group. “The
EORTC Boron Neutron Capture Therapy (BNCT) Group: achievements and
future projects” Eur J Cancer 2002 Mar;38 Suppl 4:S31-4

116

J.Burian, M.Marek, J.Rataj, et al “Report on the First Patient Group of the
Phase I BNCT Trial at the LVR-15 Reactor” accessed on 28 April 2003 at
http://www.csvts.cz/cns/news/030311r.pdf

117

Beth Israel Deaconess Medical Centre / MIT BNCT web site.

118

Chadha M, Capala J, Coderre JA, Elowitz EH, Iwai J, Joel DD, Liu HB,
Wielopolski L, Chanana AD. “Boron neutron-capture therapy (BNCT) for
glioblastoma multiforme (GBM) using the epithermal neutron beam at the
Brookhaven National Laboratory” Int J Radiat Oncol Biol Phys 1998 Mar
1;40(4):829-34

119

A.Z. Diaz “The Phase I/II BNCT Trials at the Brookhaven medical nresearch
reactor: Critical considerations”, In IAEA-TECDOC-1223, “Current status of
neutron capture therapy.” Vienna: International Atomic Energy Agency; 2001.
p. 257–267.

120

Sauerwein W, Hideghety K, Rassow J, et al. First clinical results from the
EORTC phase I trial “Postoperative treatment of glioblastoma with BNCT at
the Petten irradiation facility.” In IAEA-TECDOC-1223, “Current status of
342

neutron capture therapy.” Vienna: International Atomic Energy Agency; 2001.
p. 250–256.
121

Verbakel WF, Sauerwein W, Hideghety K, Stecher-Rasmussen F. “Boron
concentrations in brain during boron neutron capture therapy: in vivo
measurements from the phase I trial EORTC 11961 using a gamma-ray
telescope” Int J Radiat Oncol Biol Phys 2003 Mar 1;55(3):743-56

122

Messenger GC, Ash MS, “The effects of radiation on electronic systems” Van
Nostrand Reinhold NewYork 1992, p198.

123

Rogers VC, HarrisL, Steinman DK, Bryan DE, "Silicon Ionisation and
Displacement KERMA d\for Neutrons from Thermal to 20 MeV", IEEE Trans
Nucl Sci, 1975, NS-22(6): 2326-2329.

124

Ougouag, AM, Williams JG, Danjaji MB, Yang JL, Meason JL, "Differential
displacement KERMA cross sections for neutron interactions in Si and GaAs",
IEEE Trans Nucl Sci, 1990, NS-37(6 part II):1937-1944.

125

ASTM Committee E-10, "Standard Practice for Characterising Neutron Energy
Fluence Spectra in Terms of an Equivalent Monoenergetic Neutron Fluence for
Radiation Hardness Testing of Electronics", 1993, ASTM E 722-93, American
Society for Testing and Materials.

126

Swartz JM, Thurston MO, Analysis of the Effect of Fast Neutron
Bombardment on the Current-Voltage Characteristic of a Conductivity
Modulated p-i-n Diode, Journal of Applied Physics 1966, 37(2):745-755.

127

Van Antwerp WR, Youngblood JE, Calculated and Measured Displacement
Damage in Silicon for Monoenergetc Neutrons, IEEE Trans Nucl Sci, 1977,
NS-24 (6): 2521-2526.

128

Aschalom M, Florian RJ, Tatcher M, "Neutron Dosimetry: an PIN diode
reader", November 1985, Fermi National Accelerator Laboratory, FN-426.

343

129

Nagarkar V, Entine G, Stoppel L, CirignanoL, Swinehart P, "Solid State
Neutron Dosimeter for Space Applications", IEEE Trans Nucl Sci 1992, 39(4);
966-970.

130

Speers RR, "Neutron Energy Dependence of Excess Charge Carrier Lifetime
degradation in Silicon", IEEE Trans Nucl Sci. 1968 NS-15(5): 9-17.

131

Various reader circuits were constructed throughout the course of this work.
This one which was used for the measurements at Petten was initially
prototyped on a breadboard and then constructed on a printed circuit board by
H Meriaty at ANSTO.

132

All work in this thesis was performed with PIN diodes fabricated from low
resistivity silicon. It was later demonstrated by Anatoly Rosenfeld (Centre for
Medical Radiation Physics, University of Wollongong) that a PIN diode with a
base of high purity, high resistivity silicon can achieve greater linear range and
greater sensitivity when used as a dosimeter.

133

Zhou X, Lim KY, Lim D, "A simple and Unambiguous definition of threshold
voltage and its implications in Deep-Submicron MOS device modelling", IEEE
Trans Electron Dev. 1999, 46(4):807-809.

134

Rosenfeld AB, Lerch ML, Kron T, Brauer-Krisch E, Bravin A, Holmes-Siedle
A, Allen BJ, "Feasibility study of online high-spatial-resolution MOSFET
dosimetry in static and pulsed x-ray radiation fields", IEEE Trans Nucl Sci,
2001, 48(6):2061-2068.

135

Buehler MG, Blaes BR, Soli GA, Tardio GR, "On-chip, pMOSFET dosimetry",
IEEE Trans Nucl Sci 1993, 40:1442-1449.

136

Kaplan G, "Integral and pulse mode silicon dosimetry for dose verification on
radiation oncology modalities", PhD Thesis, Department of Engineering
Physics, University of Wollongong, 2001.

137

Freeman R, Holmes-Siedle "A simple model for predicting radiation effects in
MOS devices", IEEE Trans Nucl Sci, 1978, NS-25 (6):1216-1225.

344

138

McGarrity JM, "Considerations for hardening MOS devices and circuits for
low radiation doses", IEEE Trans Nucl Sci 1980, NS-27 (6): 1739-1744.

139

Fleetwood DM, Winokur PS, Riewe LC, Flament O, Paillet P, Leray JL, "The
role of electron transport and trapping in MOS Total Dose modeling", 1999,
IEEE Trans. Nucl. Sci. NS-46 (6): 1519 - 1525.

140

Hughes RC, "Charge carrier transport phenomenon in amorphous SiO2: Direct
Measurement of the drift mobility and lifetime" Phys Rev Lett 30, 1333 (1973).

141

Brown DB, Dozier CM, "Electron Hole recombination in irradiated SiO2 from
a microdosimetry viewpoint", IEEE Trans Nucl Sci., 1981, NS-28(6):41424144.

142

Dozier CM, Brown DB, "Effect of photon energy on the response of MOS
devices", IEEE Trans Nucl Sci 1981, NS-28(6): 4137-4141.

143

Boesch HE, McGarrity JM, IEEE Trans Nucl Sci., 1976, NS-23 (6): 1520

144

Sour JR, Chiu KY, IEEE Trans Nucl Sci, 1977, NS-24(6): 2040

145

Curtis OL, Srour JR, Chiu KY, J Appl Phys, 1974, 45, 4506.

146

Messenger GC, Ash MS, “The effects of radiation on electronic systems”Van
Nostrand Reinhold NewYork 1992, p 298.

147

Long DM, Millward DG, Wallace J, "Dose enhancement effects in
semiconductor devices", IEEE Trans Nucl Sci, 1982, NS-29(6): 1980-1984.

148

Fleetwood DM, Winokur PS, Lorence LJ, Beezhold W, Dressendorfer PV,
Schwank JR, "The response of MOS devices to dose-enhanced low energy
radiation", IEEE Trans Nucl Sci, 1986 NS-33 (6): 1245-1251.

149

Hamm RN, "Dose calculations for Si-SiO2Si layered structures irradiated by xrays and 60Co gamma rays", IEEE Trans Nucl Sci NS-33(6): 1236-1239.

150

Soubra M, Cygler J, Mackay G, Thompson I, Ribes A, "Evaluation of dual
bias, dual metal oxide silicon semiconductor field effect transistor detector as
radiation dosimeters", Med Phys, 1994, 21:567-572.
345

151

Temperature stabilisation using the pn junction in the MOSFETs has been
developed and refined by A Rosenfeld at the University of Wollongong.

152

Kronenberg S, Bruker GJ, "The use of hydrogenous material for sensitizing
pMOS dosimeters to neutrons", IEEE Trans Nucl Sci, 42(1): 20-26.

153

Blamires NG, Totterdel DHJ, Holmes-Siedle A, Adams L, "PMOS Dosimeters:
Long term annealing and neutron response", IEEE Trans Nucl Sci, 1986,
33(6):1310-1314.

154

J.L. Titus and C.F. Wheatley, “Experimental Studies of Single Event Gate
Rupture and Burnout in Vertical Power MOSFETs”, IEEE Trans. Nuc. Sci.,
NS-43, 533, April 1996

155

A.B. Rosenfeld, M.G. Carolan, G.I. Kaplan, E.J.Allen, V.I. Khivrich,
"MOSFET

Dosimeters:

The

Role

of

Encapsulation

on

Dosimetric

Characteristics in Mixed Gamrna-Neutron and Megavoltage X-ray Fields", in
IEEE Trans. Nuc. Sci. 1995, NS42, N6 Dec 1995 pp1870-1877.
156

Soubra M, Cygler J, Mackay G, Evaluation of a dual bias dual metal oxidesilicon semiconductor field effect transistor detector as radiation dosimeter,
Med Phys 1994 Apr;21(4):567-72.

157

Gladstone DJ, Chin LM, Automated data collection and analysis system for
MOSFET radiation detectors, Med Phys 1991 May-Jun;18(3):542-8

158

Dong SL, Chu TC, Lan GY, Wu TH, Lin YC, Lee JS. Characterization of highsensitivity metal oxide semiconductor field effect transistor dosimeters system
and LiF:Mg,Cu,P thermoluminescence dosimeters for use in diagnostic
radiology, Appl Radiat Isot 2002 Dec;57(6):883-91.

159

Dong SL, Chu TC, Lee JS, Lan GY, Wu TH, Yeh YH, Hwang JJ. Estimation
of mean-glandular dose from monitoring breast entrance skin air kerma using a
high sensitivity metal oxide semiconductor field effect transistor (MOSFET)
dosimeter system in mammography, Appl Radiat Isot 2002 Dec;57(6):791-9

346

160

Hintenlang KM, Williams JL, Hintenlang DE. A survey of radiation dose
associated with pediatric plain-film chest X-ray examinations, Pediatr Radiol
2002 Nov;32(11):771-7

161

Sessions JB, Roshau JN, Tressler MA, Hintenlang DE, Arreola MM, Williams
JL, Bouchet LG, Bolch WE, Comparisons of point and average organ dose
within an anthropomorphic physical phantom and a computational model of the
newborn patient, Med Phys 2002 Jun;29(6):1080-9

162

Pomije BD, Huh CH, Tressler MA, Hintenlang DE, Bolch WE, Comparison of
angular free-in-air and tissue-equivalent phantom response measurements in pMOSFET dosimeters, Health Phys 2001 May;80(5):497-505.

163

Peet DJ, Pryor MD, Evaluation of a MOSFET radiation sensor for the
measurement of entrance surface dose in diagnostic radiology, Br J Radiol
1999 Jun;72(858):562-8

164

Bower MW, Hintenlang DE, The characterization of a commercial MOSFET
dosimeter system for use in diagnostic x ray, Health Phys 1998 Aug;75(2):197204

165

Butson MJ, Rozenfeld A, Mathur JN, Carolan M, Wong TP, Metcalfe PE A
new radiotherapy surface dose detector :the MOSFET. Med Phys 1996
May;23(5):655-8

166

Kron T, Rosenfeld A, Lerch M, Bazley S, Measurements in radiotherapy beams
using on-line MOSFET detectors, Radiat Prot Dosimetry 2002;101(1-4):445-8.

167

Rosenfeld AB, MOSFET dosimetry on modern radiation oncology modalities,
Radiat Prot Dosimetry 2002;101(1-4):393-8.

168

Quach KY, Morales J, Butson MJ, Rosenfeld AB, Metcalfe PE., Measurement
of radiotherapy x-ray skin dose on a chest wall phantom. Med Phys 2000
Jul;27(7):1676-80

169

Scalchi P, Francescon P, Calibration of a mosfet detection system for 6-MV in
vivo dosimetry, Int J Radiat Oncol Biol Phys 1998 Mar 1;40(4):987-93.
347

170

Ramani R, Russell S, O'Brien P, Clinical dosimetry using MOSFETs, Int J
Radiat Oncol Biol Phys 1997 Mar 1;37(4):959-64

171

Chuang CF, Verhey LJ, Xia P, Investigation of the use of MOSFET for clinical
IMRT dosimetric verification, Med Phys 2002 Jun;29(6):1109-15

172

Orion I, Rosenfeld AB, Dilmanian FA, Telang F, Ren B, Namito Y, Monte
Carlo simulation of dose distributions from a synchrotron-produced
microplanar beam array using the EGS4 code system, Phys Med Biol 2000
Sep;45(9):2497-508.

173

Kaplan GI, Rosenfeld AB, Allen BJ, Booth JT, Carolan MG, Holmes-Siedle A,
Improved spatial resolution by MOSFET dosimetry of an x-ray microbeam,
Med Phys 2000 Jan;27(1):239-44

174

Howell RW, Goddu SM, Rao DV, Design and performance characteristics of
an experimental cesium-137 irradiator to simulate internal radionuclide dose
rate patterns, J Nucl Med 1997 May;38(5):727-31.

175

Gladstone DJ, Chin LM, Real-time, in vivo measurement of radiation dose
during radioimmunotherapy in mice using a miniature MOSFET dosimeter
probe, Radiat Res 1995 Mar;141(3):330-5.

176

Gladstone DJ, Lu XQ, Humm JL, Bowman HF, Chin LM, A miniature
MOSFET radiation dosimeter probe, Med Phys 1994 Nov;21(11):1721-8

177

Edwards CR, Green S, Palethorpe JE, Mountford PJ, The response of a
MOSFET, p-type semiconductor and LiF TLD to quasi-monoenergetic x-rays.
Phys Med Biol 1997 Dec;42(12):2383-91

178

Kron T, Duggan L, Smith T, Rosenfeld A, Butson M, Kaplan G, Howlett S,
Hyodo K, Dose response of various radiation detectors to synchrotron
radiation, Phys Med Biol 1998 Nov;43(11):3235-59

179

Kelleher A, Lane W, Adams L, "A design solution to increasing the sensitivity
of pMOS dosimeters: the stacked RADFET approach", IEEE Trans Nucl Sci
1995, 42(1):48-51.
348

180

Conneely C, O'Connel BO, Hurley P, Lane W, Adams I, "Strategies for
millirad sensitivity in PMOS dosimeters", IEEE Trans Nucl Sci, 1998,
45:1475-1480.

181

Rosenfeld AB, Kaplan GI, Kron T, Allen BJ, Dilmanian A, Orion I, Ren B,
Lerch MLF, Holmes-Seidle A, "MOSFET dosimetry of an X-ray microbeam",
IEEE Trans Nucl Sci, 1999, 46(6):1774-1780.

182

MCNP – A general Monte Carlo N-Particle transport Code Version 4A, La12625-M, Nov 1993.

183

Van de Graff irradiation facility, Australian Nuclear Science and Technology
Organisation, Lucas Heights NSW Australia.

184

Kron T, Duggan L, Smith T, Rosenfeld A, Butson M, Kaplan G, Howlett S,
Hyodo K. Dose response of various radiation detectors to synchrotron
radiation. Phys Med Biol. 1998 Nov;43(11):3235-59.

185

GAMMEX RMI, P.O. Box 620327 Middleton, WI 53562-0327 USA.

186

Mohan R, Chui C, Lidofsky L. Energy and angular distributions of photons
from medical linear accelerators, Med Phys 1985 Sep-Oct;12(5):592-7

187

Butson MJ, Yu P, Kan M, Carolan M, Young E, Mathur JN, Metcalfe PE. Skin
dose reduction by a clinically viable magnetic deflector. Australas Phys Eng
Sci Med. 1997 Jun;20(2):107-11.

188

Briesmeister JF, MCNP – A General Monte Carlo N-Particle Transport Code,
LA-12625M, 1993, p 2-59.

189

Allen BJ, Corderoy-Buck S, Mallesch JL, Crotty K, Moore DE, “Local control
of subcutaneous murine melanoma xenografts in nude mice by neutron capture
therapy, 1992, Melanoma Research 2:253-262.

190

Allen BJ, Neutron capture therapy research in Australia. Pigment Cell Res.
1989 Jul-Aug;2(4):235-9.

349

191

Allen, BJ, Corderoy-Buck, S, Moore DE, Mishima Y, Ichihashi M, "Local
Control of Murine Melanoma Xenografts in Nude Mice by Neutron Capture
Therapy" in Progress in Neutron Capture Therapy for Cancer (1992) , Allen BJ,
Moore DE, Harrington BV Editors, Plenum Press NY pp 425-428.

192

XCOM1 (Version 1.3) M J Berger 17 June 1991, on KAERI web site.

193

Raaimakers CPJ, Konijnenberg MW, Mijnheer BJ Clinical Dosimetry of an
epithermal neutron beam for boron neutron capture therapy; dose distributions
under reference conditions. Int J Radiat. Oncol. Biol Phys 37: 941-951, 1997.

194

Wallace S, PhD Thesis, University of Wollongong 1996.

195

Gabel D, Goals of the European Collaboration on Boron Neutron Capture
Therapy, in Progress in Neutron Capture Therapy for Cancer, Allen BJ, Moore
DE, Harrington BV Eds, Plenum Press New York 1992. P32.

196

Watkins P, Constantine G, Stecher Rasmussen F, Freundenreich W, Moss RL,
Ricchena "MCNP Calculations for the design and characterisation of the Petten
BNCT Epithermal neutron Beam in Progress in Neutron Capture Therapy for
Cancer, Allen BJ, Moore DE, Harrington BV Eds, Plenum Press New York
1992. P 71.

197

Moss Rl, Stecher-Rasmussen F, Ravensberg K, Constantine G, Watkins P,
"Design, Construction and Installation of and Epithermal Neutron Beam for
BNCT at the High Flux Reactor Petten" in Progress in Neutron Capture
Therapy for Cancer, Allen BJ, Moore DE, Harrington BV Eds, Plenum Press
New York 1992. p 63.

198

Goodman LJ, Health Physics 24:71, 1973.

199

ICRU, Photon, electron, proton and neutron interaction data for body tissues,
ICRU Report 46, 1992

200

Raaijmakers

CPJ,

“Determination of

Konijnenberg

MW,

Herhagen

HW,

Mijnheer BJ,

Dose Components in phantoms irradiated with an

350

epithermal neutron beam for boron neutron capture therapy”, Med Phys 1995,
22(3):321-329.
201

Liu HB, Greenberg DD, Capala J, Wheeler F, "An improved neutron collimator
for brain tumour irradiations in clinical boron neutron capture therapy", Med
Phys 23(12):2051-2060, Dec 1996

202

HB Liu, RM Brugger, DD Greenberg, DC Rorer, JP Hu, HM Hauptman,
“Enhancement of the Epithermal Neutron Beam used for Boron Neutron
Capture Therapy” Int J Radiation Oncology Biol Phys. Vol 28, No. 5, pp 11491156, 1994.

203

WD Allen, “Flat Response Counters” in “Fast Neutron Physics: Part 1”, JB
Marion and JL Fowler Editors, Interscience Publishers NY 1960, p366.

351

